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TH00 i  
A NOVEL ROLE OF EXODUS BEYOND CHEMOTAXlS: 
INDUCTION OF CARTILAGE DEGRADATION IN 
OSTEOARTHRITIS 
N. Alaaeddine, S. Hashimoto, T. Olee, A. Shikhman, M. Lotz 
The Scripps Research/nstitute, La Jo//a, CA, USA 
Chemokines are primarily known as chemotactic factors for 
specific leukocyte subsets. They play a role in a wide variety of 
diseases that are associated with inflammatory tissue destruction, 
such as rheumatoid arthritis. 
In this study, we investigated the production and function of the 
chemokine Exodus in articular chondrocytes. 
Exodus mRNA was not detected in unstimulated monolayer 
cultures of normal human articular chondrocytes, but was induced 
by IL-1B, TNF-cz, IL-17 and IL-18. Analysis of cartilage by im- 
munohistochemistry demonstrated the presence of Exodus in the 
superficial and mid layers of CA cartilage but not in normal 
cartilage. Exodus mRNA was also detected in CA but not in normal 
human cartilage. 
Addition of Exodus to normal chondrocytes resulted in mRNA 
expression of iNOS, IL-y, and COX-II. IL-6 gene expression was 
associated with the production of IL-6 protein. Increases in NO 
release were not observed. Treatment of CA human articular 
cartilage with Exodus increased the release of glycosamino- 
glycans and MMP-I. 
Taken together, these results identify Exodus as a new member in 
the family of cytokines contributing to the degradation of cartilage 
in osteoarthritis. 
TH002 
FUNCTIONAL GENOMIC ANALYSIS IN 
ARTHRITIS-AFFECTED CARTILAGE: YIN-YANG 
REGULATION OF INFLAMMATORY MEDIATORS BY ~5pl 
AND uvp3 
M. G. Attur*, M. N. Dave*, R. M. Clancy', I. R. Patel', 
S. B. Abramson*t, A. R. Amin*t:l:§ 
*Department of Rheumatology, Hospital for Joint Diseases, New 
York, NY 10003. t Medicine & Kaplan Cancer Center, Departments 
of :~Pathology and §Medicine, New York University Medical Center, 
New York, NY 10016 
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Abstract: Osteoarthritis-affected cartilage exhibits enhanced 
expression of fibronectin (FN) and osteopontin (OPN) mRNA in 
differential display and bioinformatics creen. Functional genomic 
analysis shows that the engagement of the integrin receptors o~5~1 
and ctv133 of FN and OPN, respectively, have profound effects on 
chondrocyte functions. Ligation of o~5~1 using activating mono- 
clonal antibody JBS5 (which acts as agonist similar to FN-N- 
terminal fragment) upregulates the inflammatory mediators such 
as nitric oxide (NO) and prostaglandin E2 (PGE2) as well as the 
cytokines, IL-6 and IL-8. Furthermore, upregulation of these 
proinflammatory mediators by ~5[51 integrin ligation is mediated 
via induction and autocrine production of IL-1 ~ since type II soluble 
IL-1 decoy receptor inhibits their production. In contrast, rJ.vl]3 
complex-specific function-blocking monoclonal antibody (LM609), 
which acts as an agonist similar to OPN, attenuates the production 
of IL-I~, NO and PGE 2 (triggered by cJ.5131, IL-I~, IL-18, or IL-I~ + 
TNF~ + LPS) in a dominant negative fashion by CA-affected 
cartilage and activated bovine chondrocytes. These data demon- 
strate a cross-talk in signaling mechanisms among integrins and 
shows that integrin mediated 'outside in' and 'inside out' signalling 
very likely influences cartilage homeostasis and its deregulation 
may play a role in the pathogenesis of osteoarthritis. 
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TETRACYCLINE UPREGULATES COX-2 EXPRESSION AND 
PGE 2 PRODUCTION INDEPENDENT OF ITS EFFECT ON 
NITRIC OXIDE 
M. G. Attur*l-, R. N. Patel*l-, P. D. Patel*, S. B. Abramson*:l:, 
A. R. Amin*t:l: 
*Department of Rheumatology, Hospital for Joint Diseases, New 
York, NY 10003. tDepartments of Pathology and :~Medicine, 
New York University Medical Center, New York, NY 10016 
Key Words: Cycloxygenase-2, Nitric oxide, PGE 2, Tetracyclines 
Abstract: Tetracyclines (doxycycline and minocycline) aug- 
mented (1-2-fold) the PGE 2 production in human CA-affected 
cartilage (in the presence or absence of cytokines and endotoxin) 
in ex vivo conditions. Similarly, bovine chondrocytes stimulated 
with LPS showed (1-5 fold) increase in PGE 2 accumulation in the 
presence of doxycycline. This effect was observed at drug concen- 
trations which did not affect nitric oxide production. In murine 
macrophages (RAW264.7) stimulated with LPS, tetracyclines 
inhibited NO release and increased PGE 2 production. Tetracy- 
cline(s) and L-NMMA (NOS inhibitor) showed an additive effect on 
inihibition of NO and PGE 2 production. The enhancement of PGE 2 
production in RAW 264.7 cells by tetracyclines was accompanied 
by the accumulation of both COX-2 mRNA and cytosolic COX-2 
protein. 
In contrast to tetracyclines, L-NMMA at low concentrations 
(_<1001JM) inhibited the spontaneous release of nitric oxide in 
CA-affected explants and LPS stimulated macrophages, but had 
no significant effect on the PGE 2 production. At higher concen- 
trations L-NMMA (500 IJM) inhibited NO release but augmented 
PGE 2 production. This study indicates a novel mechanism of 
action of tetracyclines to augment the expression of COX-2 and 
PGE 2 production, an effect which is independent of endogenous 




GENE DISCOVERY AND FUNCTIONAL GENOMICS IN 
HUMAN OSTEOARTHRITIS: UPREGULATION OF 
OSTEOPONTIN IN HUMAN-OSTEOARTHRITIS AFFECTED 
CARTILAGE AND REGULATION OF NITRIC OXIDE AND 
PROSTAGLANDIN E 2 
M G. Attur, M. N. Dave, S. Stuchin, A. S. Kowalski, C. A. Lopez, 
J. Zhang, S. B. Abramson, A. R- Amin 
Departments of Rheumatology and Orthopaedic Surgery, Hospital 
for Joint Diseases, New York, New York. Nelson B~ological Labo- 
ratories, Rutgers University, Piscataway, New Jersey. Departments 
of Pathology and Medicine, Kaplan Cancer Center New York 
University Medical Center, New York, New York 
Abstract: Differential display and RT-PCR analysis (using Gene 
Hunter Kits and subtraction cDNA libraries) of mRNA from human 
CA-affected cartilage and normal cartilage showed overexpression 
of fibronectin (FN) and osteopontin (OPN) mRNA in OA-FN was 
confirmed by RT-PCR analysis of RNA obtained from 10 
CA-affected and 5 normal cartilage samples. Analysis of the role of 
excessive OPN in CA-affected cartilage showed that (a) Addition of 
20 nM of exogenous recombinant OPN to human CA-affected 
cartilage in ex vivo conditions, inhibited spontaneous (and IL-I~- 
induced) nitric oxide (NO) and prostaglandin E2 (PGE2) production; 
(b) whereas anti-OPN anti-serum (which neutralized the effects of 
endogenous OPN) augmented the NO production in human 
CA-affected cartilage. The present study suggests that OPN (that 
is overexpressed in CA-affected cartilage) may act as an endo- 
genous inhibitor of NO and PGE 2 in human CA-affected cartilage 
and influence cartilage homeostasis. 
TH005 
REGULATION OF IL-113 GENE TRANSCRIPTION IN HUMAN 
CHONDROCYTES AND MACROPHAGES: PREFERENTIAL 
SUSCEPTIBILITY OF CHONDROCYTES TO IL-1 AND 
DIVERSE SIGNALING PATHWAYS 
G. Thakker, I. Patel, M. Attur*, J. Gray§, M. Goldring¶, 
S. Abramson*t, A. Amin*t:l: 
*Department of Rheumatology, Hospital for Joint Diseases, New 
York, NY 1003. Departments of ~rMedicine and ~.Pathology, 
New York University Medical Center, New York, NY 10016. §Glaxo 
Wellcome, Inc., Five Moore Drive, Research Triangle Park, NC 
27709. ¶Harvard Medical School, Massachusetts General 
Hospital, 149 13th Street, The Navy Yard, Charlestown, MA 02129 
Abstract: A human chondrosarcoma (ATCC:HTB-94) was 
examined for IL-113 gene expression. This cell line, like the well 
characterized T/C 28a4 human chondrocyte cells and human 
osteoarthritis-affected chondrocytes, showed constitute expres- 
sion of mRNA for 1L-1~, aggregan, collagen-type I, -type II and 
actin, mRNA for MMP-3 and -13 could be induced in T/C 28a4 and 
HTB-94 cells in the presence of exogenous IL-113. HTB-94 (unlike 
microphage cell line: U937 or THP-1) showed upregulation of IL-1 [3 
transcription by IL-113, whereas LPS + PMA + cAMP induced 
transcription in HTB-94, U937 and THP-1 cells. Furthermore, the 
IL-1 ~ transcription in HTB-94 induced by various inducers such as 
LPS, PMA, cAMP and TNFcc in combination or individually was 
quantitatively and qualitatively distinct from that observed in U937 
cells. Transfection of the full length, and various deletion mutants 
of the IL-113 promoter in HTB-94 cells+lL-l[3 showed that the 
(-3134 to -2729) enhancer is required for upregulation of IL-I~ 
transcription by IL-l~ in HTB-94. Furthermore, point mutations in 
the CREB/ATF and NF-IL-6 sites within the full length IL-113 pro- 
moter showed that each of these motifs were independently 
required for IL-113 transcription by IL-113 in HTB-94. These exper- 
iments show that the regulation of IL-113 transcription by IL-l~ is 
distinct in human chondrosarcomas and other macrophages tumor 
cells lines such as THP-1 and U937 cells. This super sensitivity of 
chondrocytes to IL-1 [3 by various stimuli to induce IL-113 transcrip- 
tion may account for the pathophysiology and imbalance in 
cartilage homeostasis in osteoarthritis. 
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A NOVEL MECHANISM OF ACTION OF CHEMICALLY 
MODIFIED TETRACYCLINES (CMTS): INHIBITION OF COX-2 
MEDIATED PGE 2 PRODUCTION 
R N. Patel*t, M, G. Attur*l-, M. N. Dave*, I. R. Patel*, 
S. A. Stuchint, S. B. Abramson*§, A. R. Amin*:l:§ 
*Department of Rheumatology, "~Department of Orthopedic 
Surgery, Hospital for Joint Diseases, New York, NY 10003. Depart- 
ments of :~Pathology, §Medicine & Kaplan Cancer Center, New 
York University Medical Center, New York, NY 10016 
Key Words: Tetracyclines, Macrophages, Cyclooxygenases, 
PGE 2 
Abstract: Tetracyclines (doxycycline and minocycline) inhibit 
iNOS expression, augment COX-2 expression and PGE 2 produc- 
tion. In contrast, chemically modified tetracyclines (CMTs) such as 
CMT-3 and -8 (but not CMT-1, -2 and -5) that lack anti-microbial 
activity, inhibit both NO and PGE 2 production in LPS stimulated 
murine macrophages, bovine chondrocytes and human 
CA-affected cartilage which spontaneously produces NO and 
PGE 2 in ex vivo conditions, Furthermore, CMT-3 augments COX-2 
protein expression but inhibits net PGE 2 accumulation. This 
coincides with the ability of CMT-3 and -8 to inhibit COX-2 enzyme 
activity in vitro. The action of CMTs is distinct from those observed 
with tetracyclines because (a) CMT-3 mediated inhibition of PGE 2 
production coincides with modification on COX-2 protein, which is 
distinct from the non-glycosylated COX-2 protein generated in the 
presence of tunicanycin as observed by Western blot analysis and 
(b) CMT-3 and -8 have no significant effect on COX-2 mRNA 
accumulation. In contrast, CMT-3 and -8 does not inhbit COX-1 
expression in A549 human epithelial cells at the level of protein 
and mRNA accumulation or modification of COX-1 protein. CMT-3 
and -8 inhibits the specific activity of COX-2 (but not COX-l) in 
cell-free extracts. These results demonstrate differential action of 
CMT-3 (Metastat) on COX-1 and -2 expression, which is distinct 
from other tetracyclines. 
TH007 
REVERSAL OF AUTOCRINE AND PARACRINE EFFECTS OF 
IL-1 IN HUMAN ARTHRITIS BY TYPE II IL-1 RECEPTOR: 
POTENTIAL FOR PHARMACOLOGICAL INTERVENTION 
M. G. Attur*, M. Dave*, C. Cipolletta :I:, P. Kang*, M. B. Goldring¶, 
I. R. Patel*, S. B. Abramson*l-, A. R. Amin*l-§ 
*Department of Rheumatology, Hospital for Joint Diseases, New 
York, NY 10003. tDepartments of Pathology and Medicine, New 
York University Medical Center, New York, NY 10016. ~.UMR- 
CRNS 7561 Laboratoir de Pharmacologie, Vandoeuvre-les-Nancy, 
France. §Department of Medicine, Kaplan Cancer Center, New 
York, NY. ¶Harvard Medical School, Massachusetts General 
Hospital, 149 13th Street, The Navy Yard, Charlestown, MA 02129 
Key Words: Chondrocytes, Cartilage, Synovial cells, IL-1, IL-1 
receptors, Nitric oxide, PGE 2 
Abstract: Interleukin 1 (IL-1), which acts in an autocrine fashion 
in arthritis-affected joints, may play a pivotal role in the patho- 
physiology of the disease in the absence of endogenous IL-1 
antagonizing mediators such as IL-lra and IL-1RII. Gene array 
analysis of human (normal and CA-affected) cartilage showed 
mRNA expression of IL-1RAcp > IL-1RI but not detectable mRNAs 
encoding IL-1 antagonizing mediators such as IL-lra and IL1RII. 
Similarly, human synovial and epithelial cells show lack of IL-1RII 
expression. In view of these observations, we examined the role of 
IL-1RII in chondrocyte and synovial cell function. 
IL-113 induced NO and/or PGE 2 production in bovine or human 
chondrocytes, human or rabbit synovial cells and human epithelial 
cells could be inhibited significantly by slL-1RII at concentrations 
ranging from 100 to 500 pg/ml. Similarly, IL-1 induced (or spon- 
taneously produced) NO and/or PGE 2 by human CA-affected 
cartilage could be inhibited by >50% with 125 pg/ml of IL-1RII (and 
-1 mg/ml by IL-1RII in ex vivo conditions. IL-1RII ÷ transfected 
human chondrocytes showed decreased sensitivity to IL-1 with 
respect to induction of NO and PGE 2 production, endogenous 
IL-113 mRNA accumulation, and proteoglycan synthesis as com- 
pared to nontransfected cells. In conclusion, IL-1RII (soluble or 
membrane form) attenuation of the autocrine and paracrine effects 
of IL-1 by IL-1RII may have important herapeutic onsequences in 
joint tissues that lack IL-1RII. 
TH008 
MODELLING OF OSTEOARTHRITIS IN RATS 
V. Astrauskas, L. Leonav!~iene, E. Bernotiene, R. Bradenait¢, 
D. Vaitkiene 
Institute of Experimental and Clinical Medicine, Vilnius, Lithuania 
Introduction: Experimental osteoarthritis (CA) is reproduced by 
a number of local experimental manipulations on the joints of 
animals as the incision and partial removal of meniscus, the 
rupture of the intraarticular ligament or by intraarticular introduction 
of chemical substances. 
Objectives: To propose a simple model of CA in rats by using 
a surgical rupture of intraarticular ligaments and intraarticular 
injection of small doses of inflammatory agent. 
Methods: Three experiments were carried out on 40 Wistar rats. 
In the first experiment (14 rats) the rupture of intraarticular liga o 
merits were made in the left hind-paw knee joint in comparison with 
the performation into the bone marrow cavity carried out in the right 
hind-paw. In the second experiment (14 rats) the same surgery 
with intraarticular injections of 2% carrageenan or dextran sulfate 
were performed. Intraarticular administration of inflammatory 
agents at a dosage of 0.02 ml prepared in distilled water was 
undertaken on the same day before of surgery. In the third 
experiment (12 rats), the intraarticular administration of 0.02 ml 
dextran sulfate solution was undertaken the day before rupture of 
intraarticular ligaments. The operations were performed under 
sterile conditions. Animals were anaesthetized with 1% propofol i.v. 
The animals were euthanised 1,3 or 4 weeks after the surgery. The 
joints were taken for histological analysis. 
Results: In the first experiment, a month after operation, 
observed were a weaker y-metachromasia, more expressed 
erosions and thinning of the cartilage in joints with ruptured 
intraarticular ligaments as compared with perforation into the bone 
marrow cavity. However, fibrotic processes and inflammatory 
infiltration in synovium were more marked in joints with perforation 
into the bone marrow cavity. In the second experiment, the greater 
changes in animals with ruptured ligaments on the bone of dextran 
sulfate injection were found. Weaker t-metachromasia, fissures 
and thinning of cartilage have appeared in 3 weeks after operation. 
The more expressed changes in the cartilage (weakening of 
y-metachromasia, erosions) were revealed on the fourth week in 
animals after the same intervention. In rats of the third group 
received dextran sulfate on day before operation (rupture of 
ligaments), the intensification in thinning of cartilage (by 2 fold), 
erosions (by 40%) and weakening of ),-metachromasia (by 45%) 
and synovium inflammatory infiltration (by 3 fold) were observed in 
comparison with changes revealed in a week after operation. 
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Conclusion: The modelling of CA in rats by injection of dextran 
sulfate the day before the rupture of intraarticular ligaments 
appeared to be more similar to the human CA and successfully 
may be applied for investigating of antiarthritic ompounds. 
THO09 
THE COLLAGEN NETWORK IN OSTEOARTHRITIS: 
INSTANTANEOUS DEFORMATION AND SWELLING OF 
CARTILAGE IS CORRELATED WITH INCREASED LEVELS 
OF DEGRADED COLLAGEN MOLECULES 
R. A. Bank*, A. Maroudasl', J. M. TeKoppele ° 
*TNO Prevention and Health, P.O. Box2215, 2301 CE Leiden, The 
Netherlands (RA.Bank@pg.tno.nl). tDepartment of Biomedical 
Engineering, Technion (Israel Institute of Technology), Haifa 
32000, Israel 
Aim of the study: The increase in swelling and instantaneous 
deformation (ID; a parameter representing the tensile and shear 
properties of the collegen network) of osteoarthritic (CA) cartilage 
compared to normal cartilage has long been attributed to a 
damaged collagen network, although this relationship has never 
been previously biochemically demonstrated. The present study 
was designed to provide for the first time biochemical evidence 
and biomechanical evidence that the loss of tensile stiffness in CA 
cartilage is indeed correlated with increased levels of damaged 
collagen molecules. To achieve this, we measured in the same 
sample (a) swelling properties, (b) ID, (c) fixed charge density 
(FCD) as a measure of the amount of proteoglycans, (d) amount of 
degraded collagen molecules and (e) amount of the cross-link 
hydroxylysylpyridinoline (HP). This correlative approach makes it 
possible to determine the relationship between the level of damage 
to the collagen network and the impaired functional properties of 
CA cartilage (as measured by swelling and ID). 
Methods: Full depth CA cartilage cylinders (e=6 mm) were 
excised from a 75-year old subject that had undergone a total hip 
replacement. The samples were immediately weighed after 
excision from the joint; after soaking (overnight, 4°C) in isotonic 
(0.15 M) and hypotonic (0.015 M) NaCI the weight was measured 
again (isotonic and hypotonic swelling, respectively). The FCD was 
determined using a radioactive tracer method. The samples were 
subsequently pricked with a pin-point, marked with Indian ink (to 
reveal the prick-line pattern), and subjected to unconfined 
compressive step-loading to determine its ID. Finally, the amount 
of damaged collagen (residues/triple helix) were determined 
with reversed-phase high performance liquid chromatography 
techniques. 
Results: Biomechanical tests have shown that cartilage is more 
strain-limiting in tension along the split-line direction. The ID is in 
line with this: it is least along (parallel to) the split-line direction and 
greatest perpendicular to it. A good-relationship was found 
between the ID parallel and the ID perpendicular to the prick-line 
(r=0.91). As expected, swelling in isotonic solution was highly 
correlated to swelling in hypotonic saline (r=0.94). A close relation- 
ship between the ID in both directions of the prick line and swelling 
in hypotonic saline (r=0.95) as well as with isotonic swelling 
(r=0.92) was also demonstrated. Significantly, both isotonic and 
hypotonic swelling and the ID parallel and perpendicular to the 
prick-line were highly correlated to the amount of damaged colla- 
gen molecules (r=0.8). The CA specimens had on a dry weight 
basis either a completely normal FCD, or showed only a slight 
(<15%) decrease as compared with normal tissue. Thus, the 
decrease in tensile stiffness of the cartilage specimens tested 
cannot be due to a loss of proteoglycans. In addition, the cross-link 
level (hydroxylysylpyridinoline) of collagen was Comparable with 
that of normal cartilage and, like the FCD, no correlations were 
found between cross-link levels and swelling or ID (data not 
shown). As a consequence, the decrease in tensile stiffness in CA 
cartilage is not due to altered (lower) cross-link levels. 
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Conclusion: Our results clearly show that swelling and ID are 
highly correlated to one another, and that both are correlated to the 
amount of degraded collagen molecules incorporated into the 
collagen network. Thus, both swelling and ID sensitively detect 
changes in the amount of intrafibrillar degraded collagen 
molecules. The degraded collagen molecules in the network are 
still cross-linked, hence they remain incorporated in the fibrils. 
However, because of the cleaved collagen molecules the cross- 
links are not functional any more (cross-links between both ends of 
the molecule have lost their contact). As a consequence, the 
depolymerized collagen molecules will slide alon£ each other 
during tensile loading, explaining why the fibrils swell more easily 
at a given osmotic pressure or stretch more easily under a given 
load. 
This study was supported by the "Dutch League against 
Rheumatism". 
TH010 
MESENCHYMAL STEM CELLS FROM PATIENTS WITH 
ADVANCED OSTEOARTHRITIS 
J. M. Murphy*, K. Dixon*, S. C. Beck*, D. E Fabian1, A. Feldmanl, 
E P. Barry* 
*Osiris Therapeutics Inc., Baltimore, USA. tUniversity Place 
Orthopedics, New York, USA 
Mesenchymal stem cells (MSCs) are a population of bone marrow 
cells with the capacity to differentiate to mesenchymal tissues, 
including bone and cartilage. In a cell therapy applications these 
cells may retard the onset and progression of osteoarthritis (OA). 
To determine whether functionally normal MSC populations could 
be isolated from patients with advanced OA, we compared cells 
from OA patients undergoing joint replacement to normal, 
age-matched donors. 
MSCs were isolated and expanded in culture from bone marrow 
aspirates obtained from the lilac crest (IC) of normal healthy 
donors. In the case of OA patients marrow aspirates were taken 
from the lilac crest and also the proximal end of the femur in the 
case of a hip replacement or the tibial plateau in the case of a knee 
replacement (T/F). Culture-expanded cells were placed in chon- 
drogenic, osteogenic and adipogenic cultures. Chondrogenic pel- 
lets were harvested for glycosaminoglycan (GAG) quantitation and 
histological evaluation. Formalin-fixed, paraffin-embedded sec- 
tions were stained with Toluidine blue, Safranin-O and collagen 
type II. Osteogenesis was assessed by alkaline phospatase 
activity and calcium deposition, and by histological staining. Adi- 
pogenic differentiation was evaluated by the accumulation of oil 
red O-positive lipid vacuoles and a ratio of nile red fluorescence: 
DAPI (diamidino-2-phenylindole, nuclear stain). 
OA MSCs formed colonies in primary culture and cells were 
characteristically spindle-shaped with normal MSC morphology. 
Cell yield was low but fell within the range found for MSC cultures 
from normal donors in 37 of 39 cultures. MSCs from OA patients 
retain multipotentiality: in a sample of 12 cultures that had sufficient 
cells to perform all three assays, seven were positive for all three 
lineages, all were positive for osteogenesis, 10 were positive for 
adipogenesis and nine were positive for chondrogenesis. The 
potential to undergo adipogenic differentiation was significantly 
lower than for normal donors (p=0.0002) and chondrogenic differ- 
entiation was also significantly reduced in MSCs from OA partients 
when compared to normal donors, Despite high intra-donor varia- 
bility. GAG deposition per DNA was significantly lower in OA 
donors after 21 days in pellet culture (p=0.03 for T/F MSCs and 
p=0.046 for IC MSCs). 
These results demonstrate that multipotent MSCs can be isolated 
from bone marrow of OA patients and may be used in autologous 
cell therapy. 
TH011 
ADHESION OF MESENCHYMAL STEM CELLS TO 
FIBRILLATED OSTEOARTHRITIC CARTILAGE 
K. Kavalkovich, J. M Murphy, F. P. Barry 
Osiiris Therapeutics Inc., Baltimore, USA 
The delivery of mesenchymal stem sells (MSCs) to osteoarthritic 
joints provides a therapeutic opportunity to modify disease 
progression by stimulating the regeneration of eroded cartilage. 
MSCs derived from bone marrow and multipotent cells with a 
capacity to undergo chondrogenic differentiation when exposed to 
appropriate conditions. However, the therapeutic effect may 
depend on adhesion between the delivered cells and the fibrillated 
surface of articular cartilage. In this study the ability of fluorescent- 
labeled or Green Fluorescent Protein (GFP)-transduced syngeneic 
goat MSCs to adhere to normal and fibrillated cartilage in explant 
cultures was evaluated. 
Goat MSCs were fluorescently labeled with CMTMR (Molecular 
Probes) or transduced with a GFP-expressing retroviral vector, 
pOT24. Tissue explants were taken from the unprotected medial 
tibial plateau of goats where there is frequent evidence of spon- 
taneous fibrillation or chondromalacia, Cartilage slices (0.5-1 mm 
thick and 4 mm diameter) from this site as well as macroscopically 
normal slices from the lateral tibial plateau of the same animals 
were placed in culture in complete chondrogenic media containing 
TGF-~3. Labeled MSCs (2 x 106) were added for 2 hr at 37°C and 
then washed stringently to remove unattached cells. One set of 
normal and fibrillated explant cultures was processed immediately 
and additional cultures were maintained for 5-14 days. Cartilage 
disks incubated without cells were used as controls. Formalin- 
fixed, paraffin-embedded sections were stained with Toluidine 
blue, Safranin-O and by immunohistochemistry for type II collagen. 
Adjacent sections were de-paraffinized and mounted with an 
aqueous solution to allow a visualization of fluorescently labeled 
cells. 
Under all conditions tested (with the exception of chondrogenic 
media without TGF-,B3) explants survived and maintained an intact 
matrix over a 14 day period. Conditions required for chondrogenic 
activation of the MSCs and the maintenance of the cartilage 
phenotype in the explants were found to be fully compatible. 
Adherence of CMTR-labeled and GFP-transduced MSCs to 
eroded cartilage was detected both immediately following treat- 
ment and after culture for two weeks. This indicated that binding of 
MSCs to these sites was both rapid and persistent. In some cases 
labeled MSCs were seen in clusters within deep clefts or crevices 
on the surface of the tissue. There was less binding of MSCs to 
normal cartilage. Adhesion of MSCs to the eroded surface of 
articular cartilage provided an opportunity for elaboration of matrix 
at this site. Collagen II immunostaining of the discs after 14 days in 
chondrogenic culture showed that the MSCs did in fact deposit a 
cartilaginous matrix leading to a decline in the degree of fibrillation 
compared to controls. 
The loss of the proteoglycan-rich network in osteoarthritic artilage 
may expose cell-binding components within the matrix that pro- 
mote MSC adhesion. The indications from this study are that 
MSCs, delivered by direct injection to the osteoarthritic joint, may 
bind to the surface of fibrillated host tissue and potentially alter the 
progression of the disease. 
TH012 
EXPRESSION OF SOLUBLE TUMOR NECROSIS FACTOR 
RECEPTOR II BY TRANSDUCED HUMAN MESENCHYMAL 
STEM CELLS PREVENTS ARTHRITIS IN A BALBC/SCID 
MOUSE MODEL 
L. N. Liu, G. Wang, K. Lee, K. Hendricks, D. Buyaner, R. Deans, 
J. D. Mosca 
Osiris Therapeutics, Inc., Baltimore, MD, USA 
Rheumatoid arthritis (RA) is a systemic autoimmune disease 
affecting 1% of the world population with significant morbidity and 
mortality. Though the etiology and pathogenesis of RA is poorly 
understood, tumor necrosis factor-alpha (TNFo 0 has been shown 
to have a critical role in the disease, causing inflammation and 
degeneration of effected joints. Soluble TNF receptor II (Enbrel) is 
used to treat severe RA patients based on the rationale that 
sTNFRII binds TNFcq thereby blocking inflammation and possible 
joint destruction. Here we report functional in vitro and in vivo 
sTNFRII protein delivery from genetically engineered human 
mesenchymal stem cells (hMSCs). A retroviral vector containing 
the extracellular portion of the TNFRII gene fused to the Fc portion 
of human IgG1, with the green fluorescent protein (GFP) translated 
from an internal ribosmal entry site, was used to transduce 
hMSCs. Transduction efficiency measured by flow cytometry of 
GFP expression was > 90% after two successive exposures of 
hMSCs to ProPak-A based retroviral vector supematants. 
sTNFRII-transduced hMSCs secreted 800 ng/106 cells/24 hr and 
expression was demonstrated for greater than 5 months in culture. 
Blocking TNFct-dependent ICAM-1 surface expression on trans- 
duced hMSCs and nitric oxide production from TNF~-treated 
bovine chondrocytes demonstrated functionality of the transgene 
in vitro. In vivo implantation studies in NOD/SCID mice resulted in 
plasma sTNFR concentration of 800 pg/ml. In vivo functionality of 
sTNFR-transduced hMSCs was demonstrated by decreased 
circulation of mouse TNFct. plasma level after lipopolysaccharide 
(LPS) challenge (20 mg/kg, IP). Furthermore, we established an 
arthritic model in BalbC/SCID mouse to test efficacy of sTNFRII- 
transduced hMSCs. Intravenous injection of a collagen type II 
monoclonal antibody cocktail, followed by LPS challenge, resulted 
in paw swelling, chondrocyte destruction, and inflammatory cell 
infiltration in BalbC/SCID animals. Intramuscular injection of 
sTNFRII-transduced hMSCs inhibited paw swelling and blocked 
chondrocyte destruction. The data illustrate the utility of hMSCs as 
a therapeutic gene delivery vehicle and the potential use in 
alleviating inflammation due to cytokines within inflammatory 
arthritic joints. 
TH013 
REGENERATION OF MENISCAL TISSUE AND PROTECTION 
OF ARTICULAR CARTILAGE IN OSTEOARTHRITIS BY 
INJECTION OF MESENCHYMAL STEM CELLS 
J. M. M.urphy, K. W. Kavalkovich, D. Fink, F. P. Barry 
Osiris Therapeutics Inc., Baltimore, USA 
Mesenchymal stem cells (MSCs) demonstrate a capacity to differ- 
entiate along a chondrogenic pathway and as such represent a 
potentially useful therapeutic approach in the treatment of joint 
damage due to osteoarthritis (OA), Injected cells are retained 
within the joint, colonize soft tissue surfaces and can be recovered 
in a viable form and thus may impact the progression of osteo- 
arthritis. The therapy investigated in this study involved the delivery 
of MSCs as a suspension to the intact osteoarthritic joint. 
MSCs were prepared from bone marrow samples taken from 
9 goats. All goats were subject to both anterior cruciate ligament 
(ACL) resection and medial meniscectomy in one knee. This 
procedure, in combination with mild exercise, had been previously 
shown to result in the development of severe experimental 
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osteoarthritis by 12 weeks. The goats were randomized into 
2 groups, vehicle alone (5 ml hyaluronan at 4 mg/ml) (n=3) and 
vehicle + MSCs (n=6). MSCs from the test goats were transduced 
with Green Fluorescent Protein (GFP)-expressing retroviral vector, 
pOT24. Six weeks post-surgery vehicle was injected into the 
operated knee of control goats and GFP-transduced MSCs (10 x 
108) + vehicle into the operated knee of test goats. All goats were 
sacrificed at 12 weeks post-surgery and the knee joints were 
macroscopically assessed for joint effusion, osteophyte production 
and cartilage degradation. Synovial fluid, before and after lavage, 
was collected as were samples of capsule, fat pad, tendon, 
ligament and meniscus, and macroscopically normal and fibrillated 
cartilage. All tissue was fixed in formalin. Soft tissue was em- 
bedded in paraffin, and the distal head of the femur and tibial 
plateau were processed in methylmethacrylate for histological 
assessment. 
Autologous MSCs, infused directly into arthritic stifles of goats 6 
weeks after medial meniscectomy and ACL resection, stimulated 
the generation of meniscal-like tissue in the posterior compartment 
of the knee of all 6 goats. In 4/6 goats this tissue was organized. 
No similar tissue was observed in the joints of 3 control goats 
infused with the vehicle alone. In those joints where organized 
meniscal-like tissue was observed the progressive destruction of 
cartilage on the articular surfaces was slowed, based on gross 
scoring of the joint surfaces. This effect was not observed in the 
vehicle-only, control joints. Other changes such as joint effusion, 
osteophyte formation on the femoral condyle and joint broadening 
were also reduced in these same 4 goats, consistent with the 
protective effect of the MSC treatment. Immunohistochemical 
staining of the posterior meniscal-like tissue indicated a dense, 
cellular, type I collagen-positive, fibrous network with small areas 
of more rounded cells that were type II collagen-positive. These 
areas were found in the center of the tissue as has been described 
previously for developing rabbit meniscus at 3 weeks to 8 months 
postnatal. These observations suggest that MSCs injected into 
arthritic joints in the goat have a therapeutic effect by regenerating 
neomeniscal tissue that stabilizes the joint and protects the 
articular surfaces against progressive degeneration. 
TH014 
DIFFERENTIATION REGULATES IL-I-INDUCED 
CYCLOOXYGENASE-2 IN tsT/AC62 HUMAN ARTICULAR 
CHONDROCYTES: ROLE OF p38 MAP KINASE 
B.Th0.mas*, L. Humbert*, J. Authier'.l:, S. Thiron °, M. B. Goldringt, 
F. Berenbaum* 
*UPRES-A CNRS 7079, Pierre & Marie Curie University Paris VI, 
France. tRheumatology Division, Beth Israel Deaconness Medical 
Center, Harvard Institutes of Medicine, Boston, MA, USA. 
$GERMEN Paris, XII University, Creteil, France 
Background: OA is 'characterized by a limited capacity of 
chondrocytes to repair major cartilage lesions, and this has 
been related to loss of differentiated phenotype. It has been 
demonstrated in vitro that IL-113 induces the dedifferentiation of 
choncrocytes. On the other hand, prostaglandin E2, an inflam- 
matory mediator, can promote chondrocyte differentiation. In 
articular chondrocytes, we and others have shown that IL-113 
induces expression of the prostaglandin-forming enzyme COX-2, 
whereas COX-1 is unchanged. We previously demonstrated that 
the capacities of cultured articular chondrocytes to express COX-2 
and synthesize IL-l~-induced PGE2markedly decreased co- 
incident with their loss of phenotype in vitro. The purpose of this 
study was to determine the signaling pathway involved in this 
modulation. 
Methods: The tsT/AC62 adult human articular chondrocyte cell 
line was developed as a reproducible culture model for studying 
the regulation of chondrocyte functions [Robbins et al. Arthritis & 
Rheum, in press]. The tsT/AC 62 cells in alginate culture deposited 
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abundant alcian blue-stainable matrix. Type II collagen and 
aggrecan mRNAs were expressed in both monolayer and alginate 
cultures but were observed to increase after alginate culture. 
COX-2 expression was assessed by Northern and Western 
blotting. Type I IL-l-receptor (IL-1RI) expression was measured 
by Western blotting and immunohistochemistry. The IL-1RI- 
associated proteins TRAF-6, IL-1-Rac and IRAK were analysed on 
Western blots, p38 MAP kinase activity was assayed after 
immunoprecipitation with phospho p38 MAPK monoclonal 
antibody using the ATF-2 fusion protein as substrate. 
Results: The differences in the patterns of COXZ2 expression 
suggested an increased sensitivity to IL-I~ in differentiated 
chondrocytes in alginate culture compared to cells cultured in 
monolayer. Immunostaining experiments along with Western blot 
analysis did not detect any difference in IL-1RI expression in 
alginate and monolayer cultures. Further analysis of TRAF-6, 
IL-1-Rac and IRAK showed the presence of all three proteins in 
tsT/AC62 chondrocytes, but no modulation in the levels of these 
proteins was observed in alginate compared with monolayer 
cultures. The p38 MAPK inhibitor SB203580, but not the p44/42 
inhibitor PD98059, inhibited the level of IL-lJ}-induced COX- 
2 mRNA, thus suggesting a positive role for the p38 MAP kinase 
pathway in IL-l~-induced COX-2 expression in tsT/AC62 
chondroctyes. Interestingly, p38 MAP kinase activity was 
modulated by the differentiation stage of the cells, since it was 
increased in differentiated alginate compared to monolayer 
cultures. 
Conclusions: Our study provides the first evidence that human 
articular chondrocytes have the necessary components to 
transduce IL-1p-induced signals via both the NF-~B and stress- 
activated kinase pathways. These findings also suggest that 
culturing tsT/AC62 human articular chondrocytes in alginate to 
promote their differentiation results in upregulation of COX-2 gene 
expression by a mechanism involving p38 MAP kinase pathway 
thereby leading to increased synthesis of PGE2. 
Supported by a grant from the French Society of Rheumatology 
TH015 
ISOLATION OF MECHANICALLY REGULATED GENES FROM 
ARTICULAR CARTILAGE THAT AFFECTS MATRIX 
TURNOVER 
E. J. Blain, D. J. Mason, V. C. Duance 
Connective Tissue Biology Laboratories, Cardiff University, Cardiff, 
Wales, U.K. 
Hypothesis: Mechanical stimuli regulate specific genes in 
chondrocytes that ultimately alter matrix composition and 
predispose cartilage to degradative changes in vitro. 
Experimental Approach: The initial objective was to define a 
minimal loading regime that causes significant up-regulation of 
MMP levels. Articular cartilage to an approximate depth of 1 cm 
including underlying subchondral bone was dissected out from 
7-day-old bovine carpal metacarpal joints. Explants were cyclically 
loaded at a peak stress of -0.5 Mpa (1 Hz) for a period of 
1-16 hours using a pneumatic compression system; unloaded 
joints served as controls. Plugs of articular cartilage (5 mm 
diameter trephines) were removed and the subchondral bone and 
cartilage separated for analysis. Levels of MMP 2 and 9 
expression and activation were assessed using: gelatin substrate 
zymography and MMP Activity Assay System kits (Amersham 
Pharmacia Biotech). Samples were analysed for TIMP expression 
levels using gelatin reverse zymography. Loading in the presence 
of 10 .3 M cycloheximide, a general protein synthesis inhibitor was 
used to confirm new synthesis as a consequence of load. MMP 
message levels were determined using real-time quantitative PCR 
(Gene-Amp@5700 sequence detection system, Perkin Elmer) to 
verify up-regulation of MMPs at the gene level in response to 
mechanical stimuli. Preliminary differential displays (DD) (Clontech 
Delta TM Differential Display kit) are in progress to isolate putative 
mechanically regulated genes. 
Results: Analysis of culture supernatants and tissue extracts 
after tissue loading at a peak stress of ~0.5 Mpa (1 Hz, 3 hrs) by 
zymography and activity assays has shown that levels of pro-MMP 
2 and 9 activation were significantly increased in response to load. 
Inhibition of translation using cycloheximide indicated that de novo 
synthesis was affected with MMP production being abolished. 
Levels of MMP mRNA were also shown to be up-regulated in the 
loaded articular cartilage demonstrating that loading increases 
both synthesis and activation of these proteinases. DD will identify 
genes involved in the control of these processes. 
Conclusion: We have demonstrated for the first time that 
mechanical loads increase MMP synthesis and activation. Mech- 
anical stimuli therefore have the potential to induce matrix catab- 
olism and hence initiate matrix degradation, the hallmark of 
diseases such as osteoarthritis. 
BBSRC CASE Studentship: sponsored by Amersham Pharmacia 
Biotech, Cardiff, U.K. 
TH016 
BIOLOGICAL ACTION OF HYALURONIC ACID ON HUMAN 
OSTEOARTHRITIC CHONDROCYTES 
F. J. Blanco*, E. Maneirol, J. L. Fern,~ndez-Sueiro', F. J. de Toro*, 
E Galdo" 
*Rheumatology Division, Investigation Laboratory, Hospital Juan 
Canalejo. tFundacidn Juan Canalejo, A Coru4a, Spain 
Introduction: Hyaluronic acid (HA) is a component of the 
articular cartilage and synovial fluid. HA can be synthesized by 
chondrocytes and synoviocytes. HA is being used as a treatement 
for osteoarthritis with the aim of providing long-term relief of pain. 
Objective: To study the biological action of HA on human 
osteoarthritic articular chondrocytes. 
Materials and methods: Chondrocytes were isolated from 
cartilage obtained from joint replacement in osteoarthritic patients. 
The HA used was Hyalgan® (molecular weight 500.000- 
730.000 Da., Bioiberica Laboratorios) with the following concen- 
trations: 0.5 mg/ml, 1 mg/ml, 2 mg/ml, 5 mg/ml and 10 mg/ml. 
Chondrocytes (50.000 cells/well) were cultured for 24 hours, 
afterwards they were stimulated with cytokines IL-1 5 ng/ml and 
with HA. The supernatant was collected 24 hours later and the 
production of NO and PGE2 was determined. The effect of HA on 
apoptosis induced by a NO donor (SNP 0.5 mM) was quantified by 
cytometry. 
Results: HA at this molecular weight does not induce synthesis 
of NO nor PGE2. HA can inhibit 70% of NO production and 45% of 
PGE2 synthesis induced by IL-I. HA reduced 40% of the apoptosis 
induced by NO in chondrocytes. 
Conclusion: HA at this molecular weight induces a positive 
biological response in human articular chondrocytes. 




EFFECT OF NSAIDs ON SYNTHESIS OF IL-1 RECEPTOR 
ANTAGONIST (IL-1 Ra) BY HUMAN ARTICULAR 
CHONDROCYTES 
F. J.Blanco', E. Maneirot, F. J. de Toro*, J. L. Fernandez-Sueirol*, 
M. Freire', J. Grafial', A. Atanes*, F. Galdo* 
*Laboratory of Investigation, Rheumatology Division, Hospital 
Juan Canalejo. t Fundaci6n Juan Canalejo, A Corufla, Spain 
Introduction: IL-1 receptor antagonist (IL-1 Ra), a protein syn- 
thesized by synoviocytes and chondrocytes plays an important 
role in cartilage degradation by inhibiting IL-1 activity and therefore 
blocking IL-1 stimulation of PGE2 synthesis. 
Aim: The objective of this study was to determine the possible 
effects of three NSAIDs (aceclofenac, piroxicam and aspirin) on 
IL-1 Ra production in human articular chondrocytes. 
Material and methods: Normal and OA samples were obtained 
from autopsy and joint prosthetic-joint surgery respectively. 
Chondrocytes were isolated and cultured until used. Cells were 
planted into the well (200,000 cells in 24 well plate) with 0.5 ml of 
medium and incubated for 144 hours with four different stimuli: IL-1 
(0.1 ng/ml, 1 and 5 ng/ml), TNF-cc (0.1 ng/ml, 1 ng/ml and 5 ng/ml), 
LPS (1 mg/ml, 10 mg/ml and 100 mg/ml) and IGF (1 ng/ml 10 ng/ 
ml and 100 ng/ml). The three NSAIDs (aceclofenac, aspirin and 
piroxicam) were added simultaneously to each different concen- 
tration of stimulus. IL-1 Ra was measured in supernatant by ELISA 
(R&D). 
Results: OA samples produced spontaneously higher level of 
IL-1 Ra than normal samples• IL-1, TNF-e. and LPS effected 
dose-dependent increases in the synthesis of IL-1 Ra. IL-1 Ra was 
detected in supernatant at 48 hours, but the highest level was 
measured at 144 hours. The most potent stimuli was IL-1 followed 
of TNF-(z. The growth factors IGF and FBS did not modify the basal 
levels of IL-1 Ra. In contrast to piroxicam and aspirin, aceclofenac 
increased the synthesis of IL-1 Ra in presence of the pro- 
inflammatory stimuli and its effect was stronger in OA than normal 
samples. 
Conclusion: Pro-inflammatory stimuli induce IL-1 Ra synthesis 
in human articular chondrocytes. Aceclofenac may modulate the 
IL-1 effect by increasing the IL-1 Ra production. 
Supported by grants FIS 98/1138 and AlmirallProdesfarma. 
TH018 
CHONDROITIN SULFATE: HOW DOES IT WORK? 
F. J. Blanco*, E. Maneirot, J. L. Fernandez-Sueiro', F. J. de Toro*, 
F. Galdo* 
*Rheumatology Division, Investigation Laboratory, Hospital Juan 
Canalejo. "r Fundaci6n Juan Canalejo, A Corufla, Spain 
Chondroitin sulfate (CS) belongs to the group of SYSADOAs 
(symptomatic slow acting drug for osteoarthritis). These com- 
pounds, despite having a slow onset of action, gradually increase 
its clinical effect reaching a global efficacy similar to that of 
NSAIDs. 
For years, the mechanisms of action of this drug have been 
studied and nowadays we can assert that most of them have 
already been identified. The therapeutic activity of CS in OA 
patients is due at least to four mechanisms of action: (1) Anti- 
inflammatory activity, (2) Modulation on the synthesis of proteo- 
glycans and hyaluronic acid, (3) Reduction of metallo- 
proteases activity on chondrocytes, (4) Protective effect of cellular 
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It is believed nitric oxide (NO) exerts a damaging effect on the 
articular cartilage and it may induce apoptosis in chondrocytes. On 
the other hand it has recently been evidenced that NO inhibition by 
joint tissues slows down cartilage degeneration. We have studied 
the role of CS in the inhibition of NO and according to the results in 
our laboratories, CS is able to reduce NO synthesis induced by 
IL-1, TNF or LPS by 21%, 32% and 31% respectively. Therefore, 
it seems appropriate to assert that CS can retard cartilage 
deterioration. 
This new mechanism of action, together with the other mecha- 
nisms of action known for CS, could explain the therapeutic activity 
of CS shown in OA patients. 
University of A Coru4a. FIS 98/1138 and Bioiberica Laboratorios. 
TH019 
EFFECT OF IL-lJ~, INDUCED PROTEOGLYCAN DEPLETION 
ON THE MACROSCOPIC ORDER OF THE EXTRA-CELLULAR 
MATRIX OF ARTICULAR CARTILAGE 
A. Borthakur', E. M. Shapirot, J. Beers*, S. Kudchodkar*, 
J. B. Kneeland*, R. Reddy* 
Departments of *Radiology and tChemistry, University of 
Pennsylvania, Philadelphia, PA 
Objective: The purpose of this work was to quantify the effect of 
interleukin-1 (IL-113) induced proteoglycan (PG) depletion on the 
macroscopic order of the extra-cellular matrix in cartilage using 
sodium multiple quantum filtered (MQF) NMR spectroscopy. 
Background: The early stage of osteoarthritis is associated with 
the preferential loss of PG from the extra-cellular matrix (ECM). PG 
maintains a fixed negative charge in the ECM and attracts sodium 
ions and water molecules. PG loss is associated with a loss of 
sodium in cartilage. Recently it has been shown that sodium NMR 
can be used to measure the PG content of cartilage. Cartilage, like 
most biological tissues, is heterogeneous-in ature. However, at 
the local level, there exist some order. This ordering is primarily 
due to the anisotropic arrangement of collagen filbril bundles, PG 
and other prteins in the ECM. The ordering in the ECM in cartilage 
produces a non-zero electric field gradient (efg). The interaction of 
this efg with quadrupolar nuclei, like 23Na, results in a residual 
quadrupolar interaction. The quadrupolar interaction is dependent 
on the orientation of the efg with respect to external static magnetic 
field, Bo. Recently, the presence of residual quadrupolar interaction 
in cartilage has been demonstrated by sodium MQF NMR spec- 
troscopy. The degree of order can be attributed to the magnitude of 
quadrupolar interation frequency (coo). Hence by measuring this 
parameter, it is possible to obtain information about the structural 
integrity of cartilage non-invasively. 
Methods: Fifteen 8 mm-diameter cartilage plug specimens were 
cored from the articular surface of fresh bovine patellae. All 
specimens were kept in culture media and nine of the specimens 
were subjected to IL-113 induced degeneration of cartilage for 4, 6 
and 7 days. Sodium NMR spectra were obtained from each 
$28 
sample with a 1 cm-diameter solenoid coil in a 2T whole-body 
magnet interfaced to a custom built spectrometer. We employed a 
previously described theoretical model to analyze sodium MQF 
NMR spectra obtained from normal cartilage and cartilage treated 
with IL-I~. The model assumes a static Gaussian distribution of 
(eo, in the sample. MQF spectra from each sample were fitted with 
the appropriate signal expressions to determine (o o, as well as the 
transverse relaxation times T2f and T 2 s. An inversion-recovery 
sequence was used to determine the longitudinal relation time, T~, 
of each specimen. Spectrophotometric assay was used to deter- 
mine the amount of PG. Histology was performed t6 visualize the 
PG loss in cartilage specimens. We defined an 'order' parameter, 
as the product of co o and T2~, whch provides a measure of changes 
in macroscopic order in the tissue. 
Results: The theoretical model provided excellent fits for the 
experimental data. We were able to determine the relaxation times 
as well as the e)Q from thse fits. m2f ranged between 2.26-3.50 ms, 
decreasing with increased PG loss. Over the range of PG 
depletion investigated, T2s increased from 12.3 to 14.9 ms and T 1 
increased from 16 ms to 21 ms, while (,~o decreased from 180 Hz 
to 120 Hz. The order parameter of the cartilage tissue decreased 
substantially with PG loss. Histology sections clearly showed the 
PG loss in cartilage following treatment with IL-11~. 
Conclusions: We demonstrated that IL-I~ induced PG 
depletion in cartilage not only changes the relaxation characteris- 
tics of sodium but also changes the residual quadrupolar inter- 
action frequency of sodium in the tissue. Using MQF sodium 
spectroscopy we quantified these changes in c~ o and showed that 
PG loss reduces the order parameter of the tissue. 
Results: The sections contained a wide range of lesions of OA, 
from very minimal changes to severe and extensive bone and 
cartilage lesions. Overall, the bony changes were the most striking 
and included numerous bone cysts, osteophytes, and large areas 
of woven bone. The articular cartilage lesions appeared to be most 
severe in the medial tibial plateau, followed by the medial femoral 
condyle. These ranged from slight superficial fibrillation to nearly 
complete loss of articular cartilage involving more than half of the 
tibial plateau. The principal components analysis generated six 
factors that explained approximately 70% of the variation in the 
data, three of which each explained _>10% of the variation in the 
data. Factor 1 was weighted by medial morphological scores, 
Factor 2 was weighted by medial cartilage measurements, and 
Factor 3 was weighted by lateral morphology scores and measure- 
ments. In the tibia, Factors 1 and 2 were highly dependent on age 
(p<0.01 by ANOVA for both) and increased between 4 and 
9 months. In the medial tibial plateau, the articular cartilage struc- 
ture score, toluidine blue staining score, and cartilage thickness 
were highly dependent on age (p<0.005 by ANOVA for all three). 
Cartilage structure and staining shores showed a marked increase 
between 4 and 9 months, Together these data indicate that there is 
an age-related variation in medial cartilage thickness and area in 
both the tibia and femur, but that only the tibia shows age-related 
changes in cartilage morphology. None of the variables showed a 
signficant relationship with age in the lateral tibia or lateral femur. 
Conclusions: We conclude that future evaluations of OA in 
guinea pigs should focus in the tibia, particularly the medial tibial 
plateau, and that animals <9 months of age are the most suitable 
for evaluation of therapies. 
TH020 
PROGRESSION OF KNEE JOINT OSTEOARTHRITIS WITH 
AGE IN GUINEA PIGS 
C. S. Carlson', C.P. Jerome1-, R. A. Dodds:l:, S. Blake:J:, 
A. M. Badger-J:, B. Swift:l:, M. W. Lark:l: 
*University of Minnesota, St. Paul, MN, USA. tSkeleTech, Inc., 
Bothell, WA, USA. :~SmithKline Beecham Pharmaceuticals, King of 
Prussia, PA, USA 
Aim: Naturally occurring osteoarthritis (OA) is highly prevalent in 
Hartley albino guinea pigs and these animals commonly are used 
as models for OA in humans. The aim of this study was to develop 
a quantitative grading scheme to assess the severity of OA in 
aging guinea pigs. 
Methods: The right knee joint was collected from 3 Hartley 
albino guinea pigs of each of the following ages: 4, 9, 14, and 
21 months. Each proximal tibia and femur was bisected and the 
anterior and posterior halves were decalcified, embedded in par- 
affin, section and stained with toluidine blue and safranin O 
(96 sections total). All sections were randomized and evaluated 
without knowledge of age or site. Each medial and lateral tibial 
plateau and femoral condyle was graded using a semiquantitative 
grading scheme that included evaluation of articular cartilage 
structure (fibrillation, clefts, loss), toluidine blue and safranin O 
staining, chondrocyte clones, tidemark qualities (clefts, tidemark 
lines, and vessels crossing), bone cysts, and osteophytes. In 
addition, articular cartilage, calcified cartilage, and subchondral 
bone areas were measured in each plateau and condyle the using 
the OsteoMeasure bone morphometry system and average thick- 
nesses were calculated. The data were summarized using 
principal components analysis (SAS Proc Factor), in which cor- 
related variables are grouped into factors that summarize the data. 
One-way analysis of variance (ANOVA) was done on individual 
variables and on factor scores. Guidelines of the institutional 
animal care and use committee were followed. 
TH021 
NEOCHONDROGENESlS IN REPAIR OF FULL-THICKNESS 
ARTICULAR CARTILAGE DEFECTS USING FREE 
AUTOGENOUS PERIOSTEAL GRAFTS IN THE RABBIT. 
A FOLLOW-UP IN SIX MONTHS 
L. Garcia-Paino M.D., A Carranza-Bencano M.D., J. R. 
Armas-Padron M.D. 
University Hospital 'Virgen del Rocio', Seville 
Aim of the study: To analyse the repair of lesions of articular 
cartilage with periosteum-free implants and follow-up at 6 months. 
Methods: 36 New Zealand rabbits, 4-6 weeks old were used for 
creation of full-thickness articular cartilage defects in the medial 
femoral condyle. Spontaneous evolution occurred in 18 animals. 
Treatment with a free autogenous periosteal tibial implant fixed 
with "lqssucol ® was provided in the other 18 animals. Animals were 
sacrificed in groups of 6 at 8, 12 and 24 weeks. Macroscopic, 
histologic and histochemical results were evaluated. Statistical 
analysis was done using the Mann-Whitney 'U' Test. 
Results: The spontaneous evolution of the lesion did not lead to 
complete repair in any case. The periosteum-free implant provided 
complete repair of the lesion and statistically significant restoration 
of the articular surface. 
Conclusions: This study confirms, in the rabbit, the scarce 
spontaneous repair of articular cartilage and the chondro- 
genic potential of tibial periosteum-free implants, with long term 
maintenance of the macroscopic, histologic and histochemical 
characteristics of neo-cartilage. 
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ENDOGENOUS OSTEOGENIC PROTEIN-1 IS A CARTILAGE 
REPAIR FACTOR 
S. Chubinskava', D. C. Rueger:l:, K. E. Kuettner*t 
Departments of *Biochemistry and tOrthopedic Surgery, Rush 
Medical College at Rush Presbyterian St. Luke's Medical Center, 
Chicago USA. :~.Stryker Biotech, Hopkinton, USA 
The mechanisms responsible for cartilage destruction in osteo- 
arthritis (OA) are not well understood, however increasing 
evidence suggests that anabolic processes take place simul- 
taneously whereby bone morphogenetic proteins (BMPs) may play 
a critical role as inducers of attempted repair. The objective of our 
continuing study focuses on osteogenic protein-1 (OP-1) or 
BMP-7. Previously we showed that endogenous OP-1 can induce 
a strong anabolic response in adult human articular cartilage and 
importantly that it is endogenously expressed by human articular 
chondrocytes in two forms (pro- and mature). The goal of the 
current project was to investigate the response of endogenous 
cartilage OP-1 to the catabolic mediator IL-1 and to establish a 
quantitative method to monitor changes in OP-1. Using two mono- 
clonal antibodies against the mature OP-1 domain we were able to 
develop a new sandwich ELISA method indicating that the esti- 
mated concentration of OP-1 in human articular cartilage is 
between 5 to 500 pg per mg of total extracted protein. Further- 
more, normal adult articular cartilage from femoral condyles was 
cultured for 2 and 4 days in the presence of 0.1 and 1.0 ng/ml of 
IL-I. Tissue extracts and culture media were analyzed by western 
blotting with antibodies both against pro- and against mature OP-1 ; 
densities of immunoreactive bands were quantified by Fluor S 
Image Analyzer. By day 2, both doses of IL-1 caused a two-fold 
increase, while by day 4, the content of total pro-OP-1 decreased 
reaching control levels. Interestingly this down-regulation of 
pro-OP-1 by day 4 was stronger at the lower concentrations 
(0.1 ng/mi) of IL-I. Even though several immunoreactive bands 
could be detected, the IL-1 induced differences were detectable 
primarily between hemidimer and mature forms of OP-1 thus 
reflecting possible processing/activation of OP-I. At day 2, neither 
dose of IL-1 led to any substantial changes in total mature OP-1, 
however by day 4 the content of detectable mature OP-1 was 
elevated. This increase was more pronounced under the influence 
of the higher dose (1 ng/ml of IL-1). Analyses of the culture media 
showed that IL-1 did not induce a release of OP-1 from the 
cartilage. Our results indicate (1) a balance exists between inactive 
(pro-) and processed (mature forms) of OP-1 in normal adult 
human cartilage; (2) adult chondrocytes react to a catabolic event 
with an initial anabolic response; and (3) low doses of IL-1 may be 
involved in the processing/activation of endogenous OP-1. The 
response of endogenous OP-1 to the induced or naturally occurred 
degenerative processes indicates its important role as a regulator 
or inducer of repair in cartilage biology. 
Acknowledgements: This work is supported in part by NIH grant 
2P50-AR-39239-11 and Stryker Research Grant KK-O01. 
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CYCLIC MECHANICAL LOADING AND TYPE II COLLAGEN 
DENATURATION: EVIDENCE OF A DOSE RESPONSE 
K. M. Clements*, A. P. Hollander:l:, M. Sharift, M. A. Adams* 
Departments of *Anatomy & t Rheumatology, University of Bristol, 
UK. ~.Human Metabolism & Clinical Biochemist~ University of 
Sheffield, UK 
Introduction: Epidemiological studies suggest that high levels of 
mechanical oading are associated with the initiation and progres- 
sion of OA. Denaturation of type II collagen is also postulated to be 
involved in the early OA disease process. 
Hypothesis: Cyclic mechanical load alone can denature type II 
collagen in a dose-related manner. 
Methods: 20mmx20mm specimens of bovine cartilage-on- 
bone, taken from the patella grooves of 2 year old animals, were 
pre-incubated for 2 hours in a cocktail of protease inhibitors 
(Boehringer Mannheim) in order to minimise the influence of cells 
and matrix enzymes on the results obtained. Specimens were 
loaded on a computer-controlled hydraulic materials testing 
machine (Dartec, UK) using a 9 mm diameter flat, impermeable, 
metal indentor with a bevelled edge. Loading was for 3,600 linear 
ramp cycles at 1 Hz. The maximum loads applied were equal to 
10% (n=13), 20% (n=24) and 40% (n=18) of the estimated 
cartilage compressive strength (peak forces were 168, 336 and 
672 N respectively). The highest load (40%) probably represents 
the high end of the physiological range of joint loading. Immedi- 
ately after testing, full depth cartilage sections were removed from 
the underlying subchondral bone, snap frozen and then assayed 
for type II collagen denaturation. We assayed cartilage from the 
loaded area (directly under the indentor), the surrounding 
unloaded area and also control tissue from completely unloaded 
patella grooves (n= 13). The assay was an inhibition ELISA assay 
using the Col 2-3/4 m antibody as described previously, r
Results: Cyclic mechanical loading increased type II collagen 
denaturation in a dose related manner with a significant increase in 
type II denaturation being observed in samples loaded at 20% 
(p<0.003) and 40% (p<0.006) loads when compared to unloaded 
controls. 
No significant difference was noted when comparing the type II 
denaturation in surrounding unloaded tissue with control samples. 
At the 40% load level a significat difference was seen in the level 
of type II denaturation between loaded and surrounding unloaded 
tissue (p<0.05.) 
Conclusions: Loading does appear to have an effect on type II 
collagen denaturation. This could possibly be due to physical 
disruption of the collagen triple helix caused by the rapid expulsion 
of water from the loaded area. It is also possible, however, that 
loading may activate residual enzymes. We are currently testing to 
see if this is the case. If it proved that loading alone causes 
denaturation, it provides an alternative mechanism for collagen 
degradation in articular cartilage, bypassing the need for 
collagenases. 
References: 1. Hollander A. P., Heathfield T. F., Webber C., 
Iwata Y., Bourne R., Rorabeck C., Poole A. R. Increased damage 
to type II collagen in osteoarthritic articular cartilage detected by a 
new immunoassay. J. Clin. Invest. 1994; 93: 1722-23. 
TH024 
MONO-IODOACETATE INDUCED UNILATERAL 
OSTEOARTHRITIS. A STUDY OF HYPERALGESIC 
SYNDROME AND GLYCOSAMINOGLYCAN METABOLISM ON 
YOUNG MALE AND ELDERLY FEMALE RATS 
S. Colombo, M. Tamburini, S. Mazzari 
Rotta Research Laboratorium spa, Monza (Milan), Italy 
Introduction: Osteoarthritis (OA) is prevalent on elderly people. 
Experimental studies utilising animals of comparable age should 
better predict anti-OA effects of new agents. To this aim we studied 
the hyperalgesic syndrome (HS) and the glycosaminoglycam 
(GAG) metabolism on animals of different age/sex after unilateral 
intraarticular (ia) injection of mono-iodoacetate (MIA). 
Methods: Wistar rats were used (n=6), either young male 
(2 months old) or retired female breeder (1 year old). HS was 
evaluated both as reduction of mechanical withdrawal threshold 
(MWT) on hind paw and as difference on hind paw weight bearing 
(incapacitance, INC). GAG metabolism was studied by sulfate 
incorporation (SI) and by GAG content in patellar cartilage. 
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Resu l ts :  (i) MIA ia injection on young male (1 mg) and old female 
(0.03-1 mg) rats produced a long lasting reduction of MWT on the 
injected side (no contralateral changes) and increase of INC. The 
HS peak on elderly rats was delayed (fig A-D). (ii) On young rats, 
MIA ia injection reduced patellar GAG content only ipsilaterally 
( -  35% at 14 days) while on older rats this effect (close-dependent) 
was bilateral ( -  35% with 1 mg at 14 days). (rio Patellar SI on 
young rats was already reduced 2 clays after MIA only on the 
central area with a partial recovery at later time points. In contrast, 
SI on the peripheral patella was increased (fig E-F). No modifica- 
tions of SI were observed contralaterally on both/young and old 
animals. 
Incapacitance (g) 
60 I i ,~_ A 
50 I I  
2O . /  
Io 
-2 0 2 4 6 ~ lO 12 14 
Mechanical  withdrawal threshold (g) 




l 8 o ', 
160 








T C ~,o 
• i i  ~ 190 
, ,0  
130 
D 
'~ . ×" 
i/'- 
-2 0 2 4 6 g 10 12 14 "2 0 2 4 6 S l0  I I  14 
Time (days)  Time (days)  
[ ]  vehic le ~1' MIA 0 .03  =~ MIA l mg 
35SO 4 incorporated ( pm) Oh1 rem.le 
Iooo0 Young mi le  1800 F 
800 periphcr=t 
6000 300 
g/  a-  ,oo 
u Joo ,1 o ~  9 
~ _ _  x ,  , - - - J L_  zoo / 
0 2 4 6 g I0 12 14 too i 
o / 
0 2 4 6 g I0 12 1,4 
D - -  ~n: . , *~. l  - - I - -S l l~ l~,h~, ,  Time (days} 
--O~-~ PB5 $ MIA0<0$ =l  
- - i t - -  Ml^0 .i =, - - I - -  i, l l^ t ~,l 
Conc lus ions :  (i) MIA ia injection on young male and old female 
rats produced similar long lasting HS and changes of patellar GAG 
anabolism. (ii) SI was widely reduced on patellar cartilage of old 
rats compared to younger ones, suggesting an anabolic deficit 
impairing recovery after insult. This OA-model allows functional 
and metabolic assessments of potential anti-OA agents. 
TH025 
EXPRESSION LEVELS OF SMALL  PROTEOGLYCANS ARE 
PREDICTIVE OF CARTILAGE DEGENERATION LEADING TO 
OSTEOARTHRITIS 
G. Cs-Szabo, D. Ragasa-San JIJan, K. E. Kuettner 
Rush Medical College, Chicago, IL, USA 
We have demonstrated earlier that the levels of small proteo- 
glycans (PGs) are elevated in OA cartilage samples as compared 
to normal controls2 The goal of the present study was to identify 
changes affecting a group of small PGs (biglycan and decorin) at 
different stages of cartilage degeneration that may serve as a 
predictor of the OA processes. 
Cartilage was harvested from the load-bearing areas of the femo- 
ral condyles and tibial plateaus of donors with no known joint 
disease (age-matched with the OA patient group used in our 
prevous studies1). Cartilage samples were graded for tissue dam- 
age according to a modified Collins scale: 2 grade 0 cartilage is 
non-damaged and grades 1-4 indicate increasing severity in tissue 
damage ranging from surface fibrillation (grade 1) to the loss of 
more than 30% of the cartilage from the subchondral bone (grade 
4). Tissues were processed for RNA isolation and protein extrac- 
tion. Semi-quantitative reverse transcriptiompolymerase chain 
reactions (RT/PCR) were used to determine the amounts of 
biglycan and decorin mRNAs compared to GAPDH. Protein levels 
of biglycan and decorin were determined by semFquantitative 
Western blotting using affinity-purified antibodies. A newly devel- 
oped ELISA assay was used to quantify biglycan and decorin in 
cartilage extracts and in synovial fluid samples from the same 
donors 
Decorin mRNA declines in heavily degenerated samples after a 
3-fold increase in grade 1. However, it stays in a higher level than 
in grade 0 samples. Grade 0 and grade 1 samples have similar 
decorin core protein contents (about 6 mg/g cartilage wet weight). 
However, that increases gradually in samples that show more 
damage (grades 2-4). The level at grade 4 (21 mg/g) is close to 
the level that is measured in OA samples (29 rag/g). Biglycan 
message increases in parallel with the severity of cartilage de- 
generation. Biglycan core protein undergoes degradation and 
fragments (processed mainly from the N-terminal) are generated. 
The intact core protein level decreases in grade 1, increases in 
grades 2 and 3 and declines to the grade 0 level in grade 4. The 
fragment content, however, rises progressively as the tissue 
undergoes further degeneration. As a result, the combined (intact 
and fragmented) core protein level of biglycan is slightly decreased 
~n grade 1 and steadily increases in more severely degenerated 
cartilage. Synovial fluid samples were negative (or below the 
detection level) for decorin; however, immunoreactive biglycan 
was released from damaged cartilage. 
In summary the changes observed at the protein and mRNA levels 
indicate that decorin accumulates in cartilage with damage, most 
likely reflecting the collagen content of the tissue. Biglycan syn- 
thesis is elevated in damaged tissue, however, in seriously 
damaged cartilage proteolytic attack occurs shortly after the 
molecule is synthesized. Some of these fragments are detectable 
in the synovial fluid. Thus, small PGs are sensitive markers of 
cartilage degeneration. Damage-related changes of small PGs 
(especially of biglycan) may be a tool to follow or predict tissue 
degeneration. These data are consistent with our previous findings 
that late-stage QA cartilage contains more of these small PGs, and 
suggest that tissue damage may potentially progress to OA. 
References :  
1. Cs-Szabo: Arthritis Rheum 40, 1037, 1997. 
2. Meuhleman: Osteoarthritis Cartilage 5, 23, 1997. 
"-I'his work was supported by the. NIH (AG 16024 and 2P50 AR 
39239) and through a research collaboration agreement with the 
GlaxoWellcome Pharmaceuticals. 
TH026 
N-ACETYL GLUCOSAMINE INHIBITS DEVELOPMENT OF 
POST-TRAUMATIC ARTHRITIS 
D. D. D'Lima, A. Shikhman, S. Hashimoto, M. Lotz 
The Scripps Research/nstitute, La Jo//a, CA, USA 
Introduction: Glucosamine represents a new class of drugs 
aimed at chondroprotection through the prevention of cartilage 
degeneration. N-acetyl glucosamine is several times more potent 
and has been shown to enhance matrix production and reduce 
enzymatic matrix degradation in vitro. This study investigates the 
effect of N-acetyl glucosamine on the development of post- 
traumatic osteoarthritis in an animal model. 
Methods: 20 New Zealand White rabbits were divided into 
Control and NAGL groups. Both groups underwent bilateral 
anterior cruciate ligament transection. The NaGL group was 
injected with N-acetyl glucosamine 500 mg/Kg subcutaneously, 
three times a week for six weeks while the control group received 
saline injections. Rabbits were euthanized at six weeks and 
femoral and tibial articular cartilage evaluated semiquantitatively 
by India ink preparation and histologic Mankin grading using 
Safranin-o stain. Synovial lining was also examined histologically. 
Results: Clinically, the NAGL knees demonstrated less swelling 
than the Control knees with smaller effusions consisting of clear 
viscous synovial fluid. On macroscopic examination using India 
ink, both groups demonstrated grades ranging from II to IV. Three 
knees in the Control group demonstrated Grade IV lesions com- 
pared to only one knee in the NAGL group. The mean Mankin 
score for the Control group was 6.8 while that for the NAGL group 
was 4.9, with more Control knees demonstrating rades of 5 or 
higher. Histologically, the NAGL knees developed synovium that 
was more hyperplastic with increased angiogenesis and evidence 
of invasion with inflammatory cells when compared to the Control 
knees. 
Conclusions: N-acetyl glucosamine appears to a chondro- 
protective agent that reduces the grade of arthritis following 
anterior cruciate ligament ransection in a rabbit model. 
TH027 
CARTILAGE INJURY, CHONDROCYTE APOPTOSIS AND 
DEVELOPMENT OF ARTHRITIS 
D. D. D'Lima, J. Hermida, S. Hashimoto, M. Lotz 
The Scripps Research Institute, La Jolla, CA, USA 
Introduction: Cartilage injury has been shown to result in 
chondrocyte death. This study investigates the nature of cell death 
and whether reducing cell death affects development of post- 
traumatic osteoarthritis in an animal model. 
Methods: Full-thickness disk shaped (5 mm diameter) human 
patellar cartilage explants were cultured and divided into Control, 
Loaded and Loaded+CI groups. Loaded and Loaded+CI groups 
were subjected to mechanical stress (30% strain applied for 
500 msec). Loaded+CI groups were cultured in media containing 
100 mM z-VAD.fmk (a broad spectrum caspase inhibitor). Control 
explants were not loaded. 96 hours after injury explants were 
examined histologically using TUNEL method and the percentage 
of cells demonstrating apoptosis counted. Eight New Zealand 
White rabbits were divided into ACLT and ACLT+CI groups. Both 
groups underwent bilateral anterior cruciate ligament ransection. 
The ACLT+CI group was treated with intra-articular injections of 
25 pg of z-VAD.fmk three times a week for six weeks while the 
control group received saline injections. Rabbits were euthanized 
at six weeks and femoral and tibial articular cartilage evaluated by 
India ink staining and histologic Mankin grading after Safranin-O 
stain. 
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Results: Chondrocytes in Control explants demonstrated mean 
8.7 (+6.3)% apoptosis while Loaded explants, mean 23.6 
(+17.4)%. This was reduced to 12.5 (+4.8)% in Loaded+Cl 
explants. Under India ink examination, all the ACLT rabbits dem- 
onstrated cartilage lesions on both femoral condyles, lateral tibial 
condyles and posteromedial tibial condyles, ranging from grade II 
(overt fibrillation) to grade IVa (erosions<5 mm). The ACLT+CI 
rabbits demonstrated lesions that were smaller in area. The grade 
ranged from II (minimum fibrillation) to III, with only one rabbit 
having a Grade IVa lesion. Histologically, more knees from the 
ACLT group had higher Mankin grades. Seven out of 8 ACLT 
knees had grades 5 or higher, while 4 of the 8 ACLT+CI knees 
demonstrated grades 5 or higher. 
Conclusions: This study demonstrates that cartilage injury is 
associated with chondrocyte apoptosis. This apoptosis can be 
inhibited by caspase inhibitors. Administration of Z-VAD.fmk 
appeared to reduce the arthritic grades on both gross and 
histologic examination. This suggests a novel approach at 
chondroprotection targeting primarily the cells rather than the 
matrix. 
TH028 
SECRETION OF CYCLOPHILIN B BY GUINEA PIG 
ARTICULAR CHONDROCYTES IN CULTURE 
F. De Ceunn!ck, J. Bonnet 
Division of Rheumatology, Institut de Recherches Servier, 92150 
Suresnes, France 
Aim: Cyclophilin B (CyPB), a cyclosporin-binding protein present 
in the endoplasmic reticulum and partially released in biological 
fluids, exhibits peptidylprolyl cis-trans isomerase activity in vitro, 
but its biological function remains unclear. This study reports on 
the purification and regulation of CyPB secreted by guinea pig 
articular chondrocytes in culture. 
Methods: Articular cartilage was obtained from tibial plateaus 
and femoral condyles of three week-old Hartley guinea pigs. 
Isolated chondrocytes were cultured in Ham's F12 medium con- 
taining 10% fetal calf serum. At confluency, the medium was 
replaced by a serum-free medium. After 72 h, the medium was 
harvested, diafiltered and fractionated sequentially by anion 
exchange, heparin, and reversed phase (rp)HPLC. N-terminal 
sequence was studied by Edman degradation. Secretion of CyPB 
by chondrocytes was studied by SDS-PAGE and Western blot 
using a rabbit antiserum against human CyPB. 
Results: Among the proteins unretained on the anion exchange 
column at pH 7.4, one was strongly retained on heparin, with 
elution at 0.7 M NaCI and an apparent molecular weight of 24 kDa 
as revealed by SDS-PAGE. After rpHPLC, N-terminal sequencing 
identified the purified, protein as the (luinea pig homologue of 
human CyPB, with more than 91% homology over the 24 first 
residues. Cyclosporin had a dose-dependent stimulatory effect on 
the release of CyPB by chondrocytes. Under unstimulated condi- 
tions, CyPB reached a steady-state after 2 days of culture in 
serum-free medium and remained constant for at least 8 days. 
When a secretion medium of 3 days was replaced in cell-free 
conditions, no alteration of the CyPB signal was observed up to 7 
days of incubation at 37°C. Spontaneous CyPB release signal was 
observed up to 7 days of incubation at 37°C. Spontaneous CyPB 
release was unchanged in first and second passage culture. 
Neither TGF-~ nor IGF-I or -II, known to enhance protein synthesis 
by chondrocytes, affected the secretion of CyPB. 
Conclusions: This study demonstrates the secretion of CyPB by 
chondrocytes. The increase of CyPB by cyclosporin suggests that 
this drug may interfere with the association of CyPB with endo- 
genous proteins produced by chondrocytes, as prevously 
observed in HeLa and BHK cell lines. In addition, the secretion 
pattern of CyPB by cultured chondrocytes - steady-state reached 
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after 48 h; no susceptibility to degradation in cell-free medium; no 
effect of anabolic growth factors; unaltered secretion after 2 
passages - suggests that CyPB may act as a chaperone rather 
than have a regulatory role in the extracellular matrix of cartilage. 
Acknowledgements: We thank Dr D. Herbage (IBCP, CNRS, Lyon) 
for N-terminal sequence analysis and Pr G. Spik (USTL, Villeneuve 
d'Ascq) for providing antibodies against CyPB. 
TH029 
AGE-RELATED DECREASE OF ARTICULAR CARTILAGE 
SUSCEPTIBILITY TO PROTEOLYTIC DEGRADATION DUE TO 
NONENZYMATIC GLYCATION 
J. DeGroot'l-, N. Verzijl*l-, R. A. Bank*, M. J. G. Wenting-Van 
Wijkl, J. W. J. Bijlsmal", F. P. J. G. Lafeberl-, J. M. TeKoppele °
"TNO Prevention and Health. Leiden, The Netherlands (J. 
DeGroot@pg.tno.nl). tRheumatology & Clinical Immunology, 
University Medical Center, Utrecht, The Netherlands 
Aim of the study: Proteolytic degradation of extracellular matrix 
proteins by proteinases from the synovial fluid (SF) is considered 
to be a major contributor in cartilage degradations in OA and RA. In 
general, proteolytic degradation is dependent on the structure of 
the extracellular matrix. Nonenzymatic glycation is the spon- 
taneous reaction of reducing sugars with proteins resulting in the 
formation of advanced glycation endproducts (AGEs). In tissues 
with slow turnover, these AGEs accumulate during life and change 
the physical, chemical and mechanical properties of the matrix. In 
articular cartilage a 50-fold increase in the AGE product pento- 
sidine was observed between age 20 and 80 years. The present 
study was designed to examine the effect of AGE levels of articular 
cartilage on the proteolytic degradation by RA SF proteinases. 
Methods: To assess its susceptibility to enzymatic degradation 
human articular cartilage was incubated with aminophenyl mercu- 
ric acetate-activated RA SE The effect of cartilage AGE levels on 
RA SF-induced proteoloysis was studied in cartilage from donors 
of different ages (humeral head, n=18, 33-83 yr.) and in cartilage 
with enhanced AGE levels by in vitro incubation with ribose 
(femural condyles, n=7, 50-76 yr.) Matrix glycation was assessed 
by measurement of pentosidine; colorimetric assessment of 
glycosaminoglycan release was used as measure of cartilage 
proteolysis. 
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Fig. 1. Correlation between cartilage glycation (pentosidine level) 
and degradation (glycosamino glycan release) in an age range (A) 
and in in vitro glycated cartilage (B). 
Results: In cartilage from donors aged 33 to 83 years an 
age-related increase in cartilage pentosidine levels was observed 
(r=0.93, p<0.0001). Concomitantly, cartilage from these donors 
showed a strong age-related decrease in GAG release upon 
incubation with 20% RA SF (r= -0.70, p<0.002). In these cartilage 
samples, the decrease in GAG release was related to the increase 
in pentosidine levels (r=-0.74, p<0.0005; Figure 1A). Multiple 
regression analysis howed that the pentosidine levels was the 
strongest predictor for the decrease in GAG release; the age of the 
cartilage donor did not contribute (p<0.0005 and p > 0.8) 
In addition, independent of age, in vitro enhancement of AGE 
levels resulted in reduced proteolysis (r=-0.27, p<0.001; Fig. 1B). 
Conclusion: The present data show that an increase in cartilage 
AGE levels results in a decreased susceptibility to proteolytic 
degradation by proteinases as present in synovial fluid of RA and 
OA patients. 
This study was supported by the 'Dutch League against 
Rheumatism' and the Dutch organisation for Scientific Research. 
TH031 
LONGITUDINAL MEASUREMENT OF KNEE CARTILAGE 
VOLUMES IN OSTEOARTHRITIS USING MRI 
S. J. Gandy' l ,  A. D. Brett:l:, P. A. Dieppe°l , M. C. Keen'1 -, 
R. A Maciewicz§, C. J. Taylor$, J. C. Waterton§, I. Watt" 
*United Bristol Healthcare NHS Trust, Bristol, UK. tUniversity of 
Bristol Bristol, UK. SUniversity of Manchester, Manchester, UK. 
§AstraZeneca, Macclesfield, UK 
Aims Modern MRI and advanced image processing techniques 
are able to provide accurate characterisation f soft tissues associ- 
ated with osteoarthritis. The aim of this study was to use MRI to 
monitor compartmental knee cartilage volume changes in a group 
of patient volunteers with osteoarthritis over a period of one year. 
Methods: Patients with clinical osteoarthritis of the knee were 
selected for imaging, and given a full clinical examination of their 
condition. The patient group comprised 10 males (age range 
52-75 years, mean 63 years) and 6 females (age range 54-70 
years, mean 64 years). 
Imaging was performed on a 1.0T Siemens Impact clinical 
scanner using a fat-suppressed 3D gradient echo sequence. 
Imaging parameters were TR/-I-E=50/11 ms (40 ° flip angle), 
generating 64 sagittal image slices each 1.56 mm thick. Patients 
were imaged at 0, n and 12 months (n=2, 4 or 6). 
Femoral, tibial and patellar cartilage volumes were measured 
quantitavely using commercial image segmentation software 
(TOSCA, IBM, Winchester, UK), and 3D segmentation maps were 
created from the volume data to allow qualitative analysis ('Data 
Explorer', IBM, Winchester, UK). 
Fig. 1. Reconstructed 3D MRI segmentations howing lesions in 
the femoral cartilage of a 65 year old female at 0, 6 and 12 months. 
Results: All patients had lesions that were detectable by MRI. 
The most commonly affected areas displaying lesions were the 
anterior aspect of the medial condyle, the inter-condylar notch, and 
the middle aspect of the lateral condyle. 
Table 1 shows the rate of change of cartilage volume in pl per year 
for each cartilage compartment. There was little change in 
cartilage volume over the course of the study, the greatest 
changes were found when the data were split between BMI > 30 
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over one year 
Conclusions: In this cohort of OA patients there was no signifi- 
cant cartilage volume loss over the course of the study as 
measured by MRI, even at a rate as small as 1 percent per annum. 
However, those patients with high BMI showed a greater rate of 
cartilage volume loss than those with low BMI, indicating that more 
selective patient recruitment may allow clearer visualisation of 
disease progression. 
TH034 
APOPTOSlS OF OSTEOARTHRITIS CHONDROCYTES 
INDUCED BY ANTI-FAS IS REDUCED BY HYALURONAN 
G~Lisigno!i*, F. Grassi*, N. Zinil-, A. Piacentini*, L. Scorzoni*, 
S. Toneguzzi*, A. Puggioli*, L. Cattini*, C. Bevilacqua:l:, 
D. Guidolin:l:, A. Facchini*§ 
*Laboratorio di Immunologia e Genetica, Istituti Ortopedici Rizzoli, 
Bologna, Italy. t lstituto di Citomorfologia Normale e Patologica 
CNR, c/o IOR Bologna, Italy. $.Fidia SpA, Abano Terme, Padova, 
Italy. §Dipartimento di Medicina Intema e Gastroenterologia, 
Universita degfi Studi di Bologna, Italy 
Osteoarthritis (OA) is a degenerative joint disease characterised 
by cartilage degradation, reduction in tissue cellularity and abnor- 
mal matrix calcification. Cartilage matrix degradation, and particu- 
larly loss of collagen type II, is a primary event that favours OA 
progression. It is also associated with chondrocyte apoptosis. 
Induction of apoptosis would lead to a reduction in cartilage 
cellularity and to the accumulation of apoptotic bodies. Hyaluronan 
(HA) is a chondroprotective drug that slows down the progression 
of cartilage lesions by promoting repair at extracellular matrix 
levels. We evaluated in vitro whether HA reduces anti-fas-induced 
apoptosis of OA chondrocytes. Isolated chondrocytes from OA 
patients were grown to confluence. They were then either treated 
or untreated with HA (500 and 1000 U/ml). Apoptosis was induced 
by monoclonal anti-fas (0.75 IJg/ml) for 14 h. Apoptosis was esti- 
mated at different levels, evaluating: (1) DNA strand-breaks by 
TUNNEL; (2) DNA fragmentation both in the cells and in the 
supernatants by the JAM test; (3) cell morphology by electron 
microscopy. The TUNNEL and JAM tests demonstrated that HA 
reduced apoptosis both in basal conditions and after anti-fas 
induction: 30-40% less apoptosis were consistently recorded in 
HA-treated anti-fas-induced chondrocytes with respect to 
untreated ones. Electron microscopy confirmed this reduction. 
Interestingly, HA-treated chondrocytes displayed a different 
morphotype from typical apoptotic cells. 
These preliminary data suggest that as well as slowing down 




STUDY OF CHONDROCYTE APOPTOSlS IN 
OSTEOARTHRITIS USING ELECTRON MICROSCOPE 
J. Monfort, M. Nacher, J. Lloreta, P. Benito 
Institut Municipal d'lnvestigaci6, Medica-Hospital del Mar, 
Universitat Autonoma de Barcelona, Barcelona, Spain 
Introduction: The arthrosic cartilage shows a marked hypocel- 
lularity. Among the mechanisms responsible for this phenomenon 
are the processes of cell death. There exists studies which show 
predominance of apoptotic chondrocytes in the arthrosic cartilage 
with respect to normal cartilage. There exists, however, no works 
which relate the different loading areas of the arthrosic cartilage 
with the apoptosis process. The aim of our work was to study at 
tissue level the degree of apoptosis in the chondrocytes from more 
or less loading areas of arthrosic individuals. 
Methods: Femoral hip cartilage was obtained from osteoarthritic 
patients who were submitted for femoral hip arthroplasty (n=7). 
From each hip cartilage, samples from loading and non-loading 
areas were obtained. Each of these samples was fixed in 2.5% 
glutaraldehyde in cacodilate buffer for 24 hours and washed in 
0.2M cacodilate buffer twice for 10 minutes. Then, samples were 
post-fixed in 0.2M osmium tetroxide pH 7.4 for 1 hour followed by 
two washes in cacodilate buffer for 10 minutes. Subsequently, 
cartilage samples were dehydrated in 96% ethanol, absolute 
ethanol and embedded in epoxy resin. Thin sections were stained 
with uranyl acetate and lead citrate and examined using a Philips 
CM100 electron microscope. To study the apoptosis, pictures of 
the different samples of tissue were shot on which a semi- 
quantitative assessment method was applied. The apoptotic 
structural changes were expressed as percentage of apparition in 
each group of samples. Non parametric tests were used for the 
statistical study of the results. 
Results: In cartilage samples of loading and non-loading areas, 
3.1 + 1.2% chondrocytes and 5.3±3.0% respectively of a total of 60 
chondrocytes analyzed in each sample presented apoptotic 
changes. Nuclear changes were considered consistent with apo- 
ptosis when there was chromatin clumping towards the periphery 
of the nuclear membrane and the heterochromatin patterns were 
lost. No cells with complete nuclear fragmentation were identified. 
Only occasional cytoplasmic degenerative changes, including 
mitochondrial swelling and disruption, were observed in isolated 
cells. No statistically significant differences were obtained between 
the averages of the two populations. 
Conclusions: We could not see a relationship between the 
loads sustained by the chondrocyte and the degree of apoptosis. 
Possibly other mechanisms could play a more important role in the 
effect of load on chondrocyte in osteoarthritic artilage. Larger 
studies, however, ought to be carried out in order to confirm this 
hypothesis. 
TH036 
IDENTIFICATION OF CHANGES IN CHONDROCYTE GENE 
EXPRESSION IN AN IN VlVO ANIMAL MODEL OF 
OSTEOARTHRITIS 
S. J.__Gi!be_~, V. C. Duance, D. J. Mason 
Connective Tissue Biology Laboratories, School of Biosciences, 
Cardiff University, Cardiff, CF1 3 US, UK. 
Changes in chondrocyte gene expression initiate the cascade of 
degradative events in the cartilaginous matrix, which is the 
hallmark of osteoarthritis (OA). 
Aim: To verify a technique for investigating ene expression in 
an in vivo model of OA which will provide early markers of OA prior 
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to cartilage degradation, aid our understanding of the disease 
mechanisms involved and identify potential novel targets for 
treatment. 
Method: We have used the RNA fingerprinting technique of 
differential display to identify genes involved in degradative 
changes in guinea pigs that spontaneously develop OA in the 
medial compartment of the knee. RNA extracted from cartilage 
from individual medial (OA) and lateral (control) tibial plateaus of 4 
and 8 week old animals was reverse transcribed, amplified by 
PCR, (Delta Differential Display kit, Clontech) and/separated on 
5% non-denaturing polyacrylamide gels. After autoradiography, 
DNA was extracted from bands representing putatively regulated 
genes and reamplified prior to cloning and DNA sequencing. 
Genbank databases were used to search for sequence homology. 
Results: cDNA was generated from individual cartilage samples 
which allowed us to compare differential gene expression in the 
medial and lateral tibial plateaus from the same knee of individual 
guinea pigs. Using one primer pair, nineteen putatively regulated 
genes have been isolated, successfully reamplified and cloned. 
Differential Southern blotting is being performed to confirm pre- 
symptomatic regulation of these genes in OA prior to further 
studies to assess their potential role in the disease mechanism. 
Conclusion: Our data show for the first time that it is possible to 
detect gene expression, which may be associated with the onset of 
human OA, in an in vivo model of osteoarthritis. 
TH037 
EXTRACELLULAR ATP AND CARTILAGE MATRIX 
NOMEOSTAIS IN RESTING AND DYNAMICALLY LOADED 
CHONDRON PELLET CULTURES 
R. D. Graft, A. J. Banes, G. M. Lee 
Department of Orthopaedics, University ofNorth Carolina, Chapel 
Hill, NC 
Chondrocytes in three dimensional matrices alter matrix synthesis 
and deposition in response to mechanical stimulation. Autocrine 
and paracrine stimulation due to local release of soluble signaling 
molecules such as prostaglandin E2 (PGE2) and nitric oxide (NO) 
may mediate these biosynthetic changes. We have recently dem- 
onstrated the release from viable chondrocytes of an additional 
signaling molecule, ATP, which activates the P2Y2 purinoceptor on 
the chondrocyte plasma membrane. Chondrocytes release endog- 
enous ATP continuously at rest and the rate of ATP release is 
increased in response to mechanical load. In these experiments 
we begin to examine the role of endogenous extracellular ATP in 
the biosynthesis of cartilage extracellular matrix at rest and during 
cyclic compressive loading. Chondrons were isolated from porcine 
articular cartilage by enzymatic digestion and maintained in pellet 
culture following centrifugation in 0.75 ml disposable polypropyl- 
ene tubes (Matrix Technologies Corp). Pellets were maintained in 
serum-supplemented media for one week and serum-free media 
thereafter. Dynamic compression of 3-4 week old pellets was 
performed using a Compression Plus TM device (Flexercell Intl. 
Corp). Cyclic compression was applied at 3.75-15 kPa, 0.5 Hz for 
8 hours, followed by 16 hours of rest for 3 days. In some samples, 
the ecto-ATPase apyrase was added (3 U/ml) to degrade extracel- 
lular ATP. 20 IJI aliquots of culture media were sampled 2, 5, 15 and 
30 min. after the start of each loading period, for ATP determination 
using a firefly luciferase assay. Media were collected each day for 
analysis of glycosaminoglycans (DMMB assay), NO (Greiss reac- 
tion), PGE2 (immunoassay kit, R&D), and LDH (Cytotoxicity assay 
kit, Oxford). Pellets were extracted with 4M guanidine hydro- 
chloride for glycosaminoglycan analysis. GAG synthesis was sig- 
nificantly increased by compressive loading and by enzymatic 
degradation of extracellular AT though the effects were not addi- 
tive. GAG release to culture media was also significantly increased 
by apyrase in resting pellets. The increase in GAG release in 
resting and loaded cultures, without a corresponding increase in 
GAGs in pellets, suggests that an ATP-dependent signaling 
mechanism may contribute to the retention of newly synthesized 
matrix. PGE2 release was dramatically elevated in response to 
compressive loading. NO was also increased. Apyrase did not 
significantly alter load-induced changes in either PGE2 or NO, 
though a small increase in PGE2, and in one experiment NO, was 
observed in resting pellets. Some load-induced LDH release was 
detected at the highest (15 kPA) compression, but apyrase had no 
apparent effect on cell viability. These data indicate that extra- 
cellular ATP released endogenously by chondrocytes may play an 
important role in the homeostasis of cartilage extracellular matrix 
and in the response to mechanical stimulation. 
Total  GAGs In loaded (7.5 kPa) porcine chondron 
pellets +1 o apyrase (3U/ml) for 3 days 
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TH038 
CHONDROPROTECTIVE AND GENE EXPRESSION EFFECTS 
OF NUTRITIONAL SUPPLEMENTS ON ARTICULAR 
CARTILAGE 
D. Grande, C. O'Grady, E. Garone, L. Lippiello, S. Marwin 
Dept. of Orthopaedic Surgery, North Shore~Long Island Jewish 
Health System, Manhasset, NY 
Introduction: Osteoarthritis is a crippling disease characterized 
by degradation of articular cartilage. Recent reports claim positive 
benefits by use of nutritional supplements which promote 'cartilage 
health'. These agents commonly include glucosamine, a metabolic 
precursor of aggrecan metabolism, and chondroitin sulfate, a GAG 
component of the aggrecan molecule. Our study examined 
whether an altered gene expression by chondrocytes may be a 
mechanism whereby these agents 'protect' cartilage. 
Methods: Preparation of Supplemental Solutions: low, medium, 
and high concentrations of glucosamine*, chondroitin sulfate* and 
manganese/ascorbate and combinations of all three were 
prepared in DMEM media based on recommended osages being 
distributed in the average fluid volume of a 70 Kg individual. 
Culture Conditions: Bovine articular cartilage explants were pre- 
pared by coring full thickness 4 mm dia. plugs from the ankle joint. 
IL-1 Induced Model of Aggrecan Depletion: Explants were incu- 
bated for 72 hrs in supplemented media or media alone (control). 
Cartilage explants were labeled with 35S sulfate to label aggrecan, 
followed by incubation with IL-1 (10 ng/ml) for 24 and 48 hrs. 
Media was collected, extracted with 4M GuCL, column purified and 
scintillation counted. RT-PCR Analysis: In a second experiment 
RNA was harvested from explants at 48 and 96 hrs following 
incubation with supplements. Following reverse transcription, PCR 
was performed using primers for collagen type I, II, and aggrecan 
core protein. 
Results: All experimenally supplemented explants demon- 
strated signficant chondroprotective effects by reducing IL-1 
induced aggrecan depletion compared to untreated controls. The 
combination of glucosamine and chondroitin sulfate exhibited the 
highest degree of protection. The effect of chondroitin sulfate was 
inversely proportionate to conc. showing the highest protective 
effect at low levels. In the second experiment RT-PCR analysis 
revealed that by 96 hrs, the combination of glucosamine and 
chondroitin sulfate which had the strongest effect, had upregulated 
aggrecan and collagen type II synthesis in a dose dependent 
manner. Type I collagen was not affected. 
*Glucosamine (FCHG49) and chondroitin sulfate (TRH122) are 
exclusive components of Cosamin DS patented by Nutramax 
Laboratories ®, Edgewood, MD. 
TH039 
THE ROLE OF CC CHEMOKINES AND THEIR RECEPTORS 
CCR2 AND CCR5 IN OSTEOARTHRITIS 
Yuan Guohua, K. Masuko-Hongo, M Sakata, J. Tsuruha, 
H. Ohnuma, H. Nakamura, T. Kato, K. Nishioka 
Rheumatology, Immunology and Genetics Program, Institute of 
Medical Science, St. Marianna University School of Medicine, 
Kawasaki, Japan 
Objective: To evaluate the role of CC chemokines in cartilage 
degradation of osteoarthritis (OA). 
Methods: Production and expression of four CC chemokines, 
MCP-1, MIP-la, MIP-lb and RANTES, and their receptors CCR2 
and CCR5, in chondrocytes derived from 11 OA patients and 5 
normal controls were assessed using reverse transcription poly- 
merase chain reaction (RT-PCR), an enzyme-linked immunosorb- 
ent assay (ELISA), immunochemistry and flow cytometric analysis, 
in basal condition or after stimulation with IL-lb and/or TNF-a. 
Expression and production of matrix metalioproteinases (MMP) 
and tissue inhibitor of metalloproteinase (TIMP) were assayed by 
RT-PCR and ELISA before and after treatment with chemokines. 
Results: Unstimulated chondrocytes produced detectable 
amount of MCP-1, with higher level in OA chondrocytes than in 
normal chondrocytes, mRNA expression of MIP-la, MIP-lb and 
RANTES was also detected in both OA and normal chondrocytes. 
However, MIP-lb was more frequently expressed in normal 
chondrocytes than in OA. Although the protein level of MIP-la, 
MIP-lb and RANTES in unstimulated chondrocytes were either 
undetectable or in very low, the addition of IL-lb and/or TNF-a 
increased production of all the chemokines. The receptors for 
these chemokines, CCR2 and CCR5, were also found to be 
expressed on a surface of a minor subset of OA and also of normal 
chondrocytes. However, intracellular staining revealed that rela- 
tively large number of chondrocytes tored CCR2 and CCR5 in 
cytoplasm, with no difference between OA patients and normal 
controls. When the chondrocytes were stimulated with chemo- 
kines, MCP-1 and RANTES were found to enhance the expression 
of MMP-3 mRNA and proMMP-3 production, whereas MMP-9, 
MMP-13 and TIMP-1 production was not affected by chemokine 
stimulation. 
Conclusion: Production and expression of CC chemokines and 
their receptors by chondrocytes indicates that chemokines may 
exert direct effects on chondrocytes. Chemokines may play a role 
in the pathogenesis of OA though increasing MMP-3 production 
and consequently causing cartilage degradation. 
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TH040 
THE EXPRESSION AND FUNCTION OF VASCULAR 
ENDOTHELIAL GROWTH FACTOR IN ARTICULAR 
CHONDROCYTES 
S. Hashimot 0, K. K0hn, L. Creighton, N. Alaaeddine, A. Shikhman, 
D. C. Brinson, M. Lotz 
Division of Arthritis Research, The Scripps Research Institute, 
La Jolla, CA, USA 
Vascular endothelial growth factor (VEGF) is a mitogen for vascu- 
lar endothelial cells and promotes angiogenesis in vivo. This 
growth factor is also produced by synovial fibroblasts and thought 
to contribute to synovial hyperplasia in arthritis. During endo- 
chondral bone formation VEGF was recently shown to couple 
hypertrophic cartilage remodeling, ossification and vascular 
invasion of growth plate cartilage. 
In this study, we examined the expression of VEGF and its 
receptors fit-1 and flk-1 in normal and osteoarthritic human articu- 
lar chondrocytes and analyzed the modulation of this growth factor 
and its receptor by IL-1 and TGF~. We also determined the 
relationship between VEGF expression and the extent of cartilage 
degradation and chondrocyte apoptosis. 
Protein expression of VEGF and its receptors was seen in the 
superficial and upper middle zone in normal cartilage and it was 
increased to include the deeper zone in OA cartilage. VEGF 
expression was correlated with OA grade. In vitro treatment of 
normal chondrocytes with IL-1 and TGFI~ increased VEGF and 
receptor expression. VEGF stimulated nitric oxide production from 
articular cartilage. 
The secretion of chondroitin sulfate into the media was significantly 
increased in cartilage culture by VEGF. The new synthesis of 
proteoglycans was elevated in VEGF treated cartilage by the same 
magnitude as IGF, known as a potent inducer of proteoglycan 
synthesis. Furthermore, we demonstrated that VEGF inhibited 
anti-Fas induced apoptosis in chondrocyte monolayer culture. 
These results suggest that VEGF modulates extracellular matrix 
degradation and cell survival in arthritic artilage. 
TH041 
ANALYSIS OF T CELLS ISOLATED FROM SYNOVIAL FLUID 
AND TISSUE OF OSTEOARTHRITIS PATIENTS 
M.K. Hayn_es, E. L. Hume, J. B. Smith 
Jefferson Medical College, Thomas Jefferson University, 
Philadelphia, PA 
Osteoarthritis (OA) can be associated-with synovitis but it is 
unclear what role these immune cells may play in the disease 
process. Previously, we evaluated syovial specimens by immuno- 
histochemistry (IHC) using a panel of monoclonal antibodies that 
recognize phenotypic markers of myeloid and lymphoid-derived 
cells as well as activation-associated antigens such as class II 
MHC and CD69. Angio-centric accumulations of immune cells 
detected in OA tissue by these techniques demonstrated high 
expression of LFA-1 and its ligand partner ICAM-1. CD4 and CD8 
T cells were also identified. CD4+ cells markedly outnumbered 
CD8+ cells. Molecular expression of CD28, CD40, and CTLA-4 as 
well as class II MHC were also of interest since these molecules 
are involved in T cell activation events. In contrast o RA synovium, 
neither CD28 nor CD40 ligand were detected in OA synovial 
tissue, We have extended this work by using dual-staining tech- 
niques to confirm this interesting lack of expression of 
co-stimulator molecules by cells in OA synovium. Our new data 
confirms our earlier findings indicating that CD3+T cells in OA 
synovium lack co-stimulator molecules CD28, CTLA-4 and CD40 
ligand. We also observed a maintenance of this phenotype after 
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T cells were grown with IL-2 condition media. In these experiments 
T cell populations, collected after minced synovial tissue or 
synovial fluid was placed in short-term culture with IL-2, were dual 
stained and analyzed by FACS. Cells from outgrowth cultures 
appear activated since the cells co-express IL-2 receptor (CD25), 
MHC class II, and CD69 whereas they lack the CD45 isotype 
associated with naive lymphocytes. More importantly, these cells 
also lack co-stimulator molecules suggesting that these cells no 
longer need co-stimulation to proliferate. This is being investigated 
using antibody-coated microtiter plates to stimulate ~ynovial fluid- 
derived lymphocytes. Cultures have been set-up in wells contain- 
ing anti-CD3 monoclonal antibody with and without concomitant 
anti-CD28. CD2 associated reactions are also being studied. Such 
mechanistic analysis of the requirements for proliferation in vitro 
will further our understanding of the role these cells pay in 
perpetuating the disease process. 
Additionally, T cells from all cultures started from both synovial fluid 
and synovial tissue are being analyzed for T cell receptor expres- 
sion by RT-PCR based spectral typing. These data are being 
compared to similarly analyzed RNA freshly isolated from cells 
before culture to control" for possible 'skewing' of results. 
This work was supported, in part, by the John Sharpe Foundation. 
TH042 
THE ANTIOXlDANT PROPERTIES OF NON STEROIDAL 
ANTI-INFLAMMATORY DRUGS 
Y. Henrotin, A Mouithys-Mickalad, M. Mathy-Hartert, S. X. Zheng, 
G. Deby, J. Y. Reginster 
Bone and Cartilage Metabolism Research Unit, University of Liege, 
Liege, Belgium 
Reactive Oxygen Species (ROS) are now recognised to play an 
important role in the pathogenesis of rheumatic diseases and 
constitute an interesting target for drugs. This in vitro study was 
designed to evaluated the antioxidant activities of some 
non steroidal anti-inflammatory drugs (NSAIDs) and their main 
metabolites. 
The antioxidant properties of nimesulide (NIM), 4-hydroxy- 
nimesulide (4-HONIM), aceclofenac (ACE), 4-hydroxyaceclofenac 
(4-HOACE), diclofenac (DICLO) and indomethacin (INDO) were 
tested on six different reactive oxygen species generating 
systems: (I) phorbol-myristate acetate (PMA)-activated neu- 
trophils, (ll) xanthine/xanthine oxidase system, (111) the Fenton 
reaction, (IV) Fe2+/ascorbate-induced lipid peroxidation, (V) 
HOCL-induced light emission, (VI) the kinetics of ONOO- decom- 
position followed by spectrophotometry. ROS production was 
monitored by luminol-enhanced CL or by electron spin resonance 
(ESR) using 5,5-dimethylpyrroline-N-oxide (DMPO) and o~-(4- 
pyridyI-N-oxide)-tert-butylnitrone (4-POBN) as spin trappers. 
Moreover, the effect of NIM and 4-HONIM on ROS production by 
human articular chondrocytes was recorded by horse radish 
peroxidase (HRP) and luminol enhanced chemiluminescence. The 
drug concentrations used were 10, 50 and 100 IJM. 
At 10 IJM, ACE, NIM, 4-HONIM, 4-HOACE and DICLO decreased 
luminol enhanced CL generated by PMA-activated neutrophils. 
Inversely, INDO slightly increased the luminol enhanced CL. Inter- 
estingly, hydroxylated metabolites were more powerful antioxidant 
than the parent drugs. NIM and 4-HONIM were potent scavengers 
of °OH whereas only 4-HONIM was capable of scavenging O2-. All 
drugs tested, except ACE, reduced lipid peroxidation induced by 
Fe2+/ascorbate system. ACE and DICLO, even at the highest 
concentration tested, did not significantly reduce the HOCL 
induced CL whereas the other drugs were potent scavengers. 
Finally, all the NSAIDs accelerated the decomposition of 
ONOO-, suggesting a potential capacity of the molecules to 
scavenge peroxinitrite. Furthermore, when chondrocytes were 
pre-incubated for 48 to 96 hours with NIM or 4-HONIM, the luminol 
and HRP-dependent CL produced by the cells was significantly 
inhibited in a dose dependent manner. 
The NSAIDs possess variable degress of antioxidant activities 
linked to their ability to react with HOCL, lipid peroxides or ONOO-. 
These antioxidant activities could offer interesting targeted side- 
effects in the treatment of joint inflammation diseases. Further- 
more, these findings suggest that some NSAIDs could protect 
cartilage against oxidative stress, by scavenging ROS but also by 
inhibiting their production by chondrocytes. 
TH043 
INCREASED RISK OF OSTEOPOROSlS IN CARRIERS OF 
ALLELE C OF 9G/C POLYMORPHISM IN 
OSTEOPROTEGERIN (OPG) GENE 
W. Horst-Sikorska', R. Kalakt:l:, J. Kwiatkowskat, D. 
Baszko-Blaszyk', K. Ziemnicka', R. Slomskit:l: 
"Department of Endocrinology, University School of Medical 
Sciences, Poznarf, Poland. tlnstitute of Human Genetics, Polish 
Academy of Sciences, Poznarf, Poland. :~Department of Bio- 
chemistry and Biotechnology, Agricultural University, Poznar~, 
Poland 
Osteoporosis is a common human disease and is under genetic 
control, with several genes most likely contributing to the develop- 
ment of the disorder. One of many gene candidates that could 
potentially regulate bone remodeling is osteoprotegerin gene 
(OPG). Scanning of the 5 exons of OPG gene was performed for 
85 patients with osteoporosis or osteopenia. PCR-HD and PCR- 
SSCP analyses showed evidence of 7 different variants in exons 
1-4. Sequence analysis of genomic DNA revealed 6 polymor- 
phisms localized in the intronic region and one polymorphism 
detected in exon 1 in analyzed groups. Five of these different 
polymorphic variants were detected in exon 1 in analyzed groups. 
Five of these different polymorphic variants were substitutions. 
IVS1+15C>T, IVS2+4C>T, IVS3-5C>T, IVS4-24C>A, IVS4+ 
8A>C and one was a two base pairs deletion: IVS3+46delTC. One 
polymorphism, 9G>C, detected in exon 1 resulted in a change in 
the encoded amino acid from positively charged lysine to neutral 
asparagine and was previously observed in cDNA clones. Because 
this polymorphism affects conserved region of the osteoprotegerin 
signal peptide and could influence of secreted protein, we studied 
the polymorphic allele frequencies in the patient and control 
population and looked for evidence of association between the 
polymorphism and osteoporosis. The change 9G>C does not 
create a new restriction site, and therefore PCR-SSCP analysis 
was used to determine allele status, by comparison with 
sequenced control samples. First, we observed that genotype 
distribution was in Hardy-Weinberg equilibrium for control popula- 
tion (CC=23/97, GC=45/97, GG=29/97, ;(2=0.458, df=2, p=0.79) 
we then determined OPG genotype distribution for patients with 
severe osteoporosis: CC= 13/56, GC=36/56, GG =7/56. The geno- 
type and allele frequencies in a combined group of 85 patients with 
osteoporosis or osteopenia revealed CC=25/85, GC=47/85 and 
GG=13/85. There were no significant differences in lumbar spine 
BMD for groups of osteoporotic women and men with different 
genotypes but genotypes with allele C were over-represented in 
patients with severe osteoporosis as compared with population 
group (;(2=5.69. df=l,  p<0.02). This is equivalent o odds ratio for 
osteoporosis of 2.99 for individuals who carry allele C (95% 
confidence interval 1.20-7.42). Signficant differences in combined 
group of patients with severe osteoporosis or osteopenia, as 
compared with population group (;(2=5.31, df=l,  p<0.025), 




HETEROZYGOUS INACTIVATION OF MURINE Col2al GENE 
MAKES ARTICULAR CARTILAGE SOFTER, CHANGES 
COLLAGEN FIBRIL NETWORK AND SUBCHONDRAL BONE 
VOLUME 
Mika M. Hyttinen °, Juha T6yr&sl-, Tuomo Lapvetal~.inen*, 
Juha Lindblom °, Darwin Prockop:l:, Shi-Wu Lit, Machiko Arita:l:, 
Jukka Juvelinl, Heikki J. Helminen* 
*Dept. of Anatomy, University of Kuopia; tDept of Clinical 
Physiology and Nuclear Medicine, Kuopio University Central Hos- 
pital Kuopio, Finland. ~.School of Medicine, MCP Hahnemann 
University of Health Sciences, Philadelphia, U.S.A. 
Aim: To study in mice the effect of heterozygous inactivation of 
one allele of type II procollagen gene (Col2al) on the biomech- 
anical behaviour, articular cartilage properties and subchondral 
bone structure, and osteoarthritis (OA) development. 
Methods: Specimens from heterozygous C57B1 Col2al knock- 
out male mice (n = 15) and their wild-type littermates (n= 19) were 
taken for investigation at the age of 15 months. Indentation stiff- 
ness of the proximal humerus articular cartilage was determined. 
The proximal heads of humerus were embedded in paraffin and 
prepared for quantitative polarized light microscopy (PLM) of 
fibrillar collagen, volume fraction and microstructure analysis of 
subchondral bone (SB), OA-scoring and digital densitometry (DD) 
of proteoglycans (PGs). 
Results: Indentation stiffness decreased by 53% (p<0.002) due 
to the heterozygous inactivation of one allele of Col2a1. Similarly, 
collagen birefringence decreased in the intermediate (22% reduc- 
tion, p<0.05) and deep zones (20% reduction, p<0.01) of articular 
cartilage determined by PLM. The SB volume fraction decreased 
from 43 to 31% (p<0.02). Also SB birefringence decreased slightly 
but significantly (p<0.007). Qualitatively, no clear histological dif- 
ferences could be seen in the articular cartilage of the knockouts 
as compared to controls. In the knockout group, OA prevalence 
was 73% while in the controls it was 22% (p=0.002). In both 
groups the OA lesions were superficial. Interestingly, DD did not 
reveal any significant differences in the absolute content or zonal 
distribution pattern of PGs with depth to the articular cartilage. 
Conclusions: Elimination of one Col2al gene allele makes 
murine bone ends softer. Softening is associated with the 
simultaneous change in the fibrillar collagen network of articular 
cartilage and alterations in subchondral bone volume and micro- 
structure. By modulating these parameters which are crucial for 
joint loading, heterozygous inactivation of Col2al can increase the 
risk for OA. However, heterozygous expression of Col2al gene is 
sufficient for the formation of normal-looking, yet functionally softer 
than normal articular cartilage with no changes in PG content. 
TH045 
IMMUNOLOCALIZATION OF VASCULAR ENDOTHELIAL 
GROWTH FACTOR (VEGF) IN HUMAN NORMAL AND 
OSTEOARTHRITIC ARTICULAR CARTILAGE 
D. Koertje, D. Fffander, G. Weseloh, B. Swoboda 
Division of Orthopedic Rheumatology, Department of Orthopedic 
Surgery, University of Erlangen-Nuernberg, Erlangen, Germany 
Objective: Vascular endothelial growth factor (VEGF) is 
expressed by hypertrophic hondrocytes during enchondral bone 
formation. VEGF was proposed to be involved in vessel formation, 
as well as in the induction of apoptosis of hypertrophic hondro- 
cytes by unknown mechanisms. The objective of this study was to 
analyze VEGF protein expression in healthy and degraded human 
cartilage. 
Methods: Human knee cartilage was obtained during total knee 
replacements or amputations. The samples were decalcified and 
routinely paraffin embedded. The severity of articular degradation 
was scored according to Mankin. The samples were divided into 
healthy (n=5), mild (n=5), moderate (n=9), and severe (n=9) 
osteoarthritic artilage. From immunolocalization of VEGF the 
samples were sectioned and immunostained with two different 
antibodies. To test whether articular chondrocytes express VEGF- 
mRNA, polymerase chain reaction was performed. 
Results: VEGF immunostaining was found to be present in 
healthy and osteoarthritic cartilage. Also VEGF-mRNA was 
detected by PCR. The number of VEGF-positive chondrocytes 
increased with severity of osteoarthritic hanges. The ratio of 
positive versus negative chondrocytes was highest in severe OA 
cartilage. While most of the cell clusters showed strong immuno- 
staining for VEGF, some clusters, however, showed no staining. 
Healthy and mild osteoarthritic cartilage showed a small number of 
chondrocytes with weak staining in all cartilage layers. 
Conclusions: VEGF is expressed in healthy and osteoarthritic 
knee cartilage. Its protein expression significantly increases in 
severe forms, where articular chondrocytes were proposed to 
differentiate in a hypertrophic phenotype. Further, it can be 
speculated that VEGF may be involved in apoptotic changes of 
osteoarthritic chondrocytes and vessel invasion from the 
subchondral bone in late stage disease, 
TH046 
THE RANK/RANKL/OPG SYSTEM IN CARTILAGE 
H. Komuro, T. Olee, J. Quach, A. Shikhman, D. C. Brinson, 
S. Hashimoto, L. Creighton, K. KL~hn, M. Lotz 
Division of Arthritis Research, The Scripps Research Institute, 
La Jolla, California, U.S.A. 
The receptor for activation of NF-~B(RNAK) is a new member of 
the TNF receptor family. It is activated by the secreted or cell- 
surface bound RANK ligand (RANKL). Osteoprotegerin (OPG) is a 
soluble non-signaling receptor for RANKL and interferes with 
RANK activation. This receptor-ligand system has been shown to 
be important in the differentiation of osteoclasts and dendritic ells. 
The present study examined human articular cartilage for the 
expression of these molecules and the role of RANKL in the 
regulation of chondrocyte function. 
The results demonstrate that OPG and RANKL mRNA are 
expressed in normal cartilage. OPG mRNA and immunoreactivity 
are increased in OA cartilage. Treatment of normal chondrocytes 
with soluble RANKL caused a dose dependent increase in nitric 
oxide (NO) release. OPG did not induce NO release but neutral- 
ized the effects of RANKL. Stimulation of cllondrocyte cultures with 
RANKL induced the expression of genes involved with joint inflam- 
mation and cartilage degradation, including iNOS, RANTES, IL-6, 
and in some donors COX-2. In cartilage explant cultures RANKL 
caused the release of increased levels of glycosaminoglycans. 
In summary, these results demonstrate xpression of OPG and 
RANKL in cartilage and identify this ligand receptor system as a 




EXPERIMENTAL STUDY TO DETERMINE THE APPROPRIATE 
,COMBINATION OF MONOLAYER AND 3-DIMENSIONAL 
CULTURE METHODS TO PREPARE OPTIMUM 
AUTOLOGOUS- CHONDROOYTE-GRAFTS 
M, Kuriwaka, M. Ochi, Y. Ochio, N. Adachi, K. Kawasaki, R. Mori 
Department of Orthopaedics, Shimane Medical Universi~ Japan 
Introduction: Cartilage defect is still a troublesome problem for 
orthopaedic surgeons. For treatment of osteochondra] defects we 
developed a cultured auto!ogous chondrocyte transplantation 
using Atelocollagen gel Short4erm follow-up study showed good 
results~ In this method, however, the number of available Chondro- 
cytes from the non-weight-bearing area of the knee is limited and 
it has not been Clarified yet that cultivation for 3 weeks in 
3-dimensional culture is the best method. 
Purpose: To prepare a high quality cultured graft for autologous 
chondr0cytes transplantation, we attempted to investigate the 
optimum combination of monolayer culture (M) and 3-dimensional 
culture (3-D), 
Materials and methods: Articular chondrocytes of Japanese 
White rabbits were cultured in a total of 3 weeks, and divided into 
4 Groups (A: M of 3 weeks, B: M of 2 weeks and 3-D of 1 week, C: 
M of 1 week and 3-D of 2 weeks, D: 3-D of 3 weeks). Each culture 
group was evaluated histologically and biochemically after the 3 
weeks of culture. 
Results: The number of chondrocytes was multiplied by 96, 10, 
5 and 4 times in Groups A, B, C and D respectively at 3 weeks. 
Histological examinations indicated that the cells were 
chondrocyte-shaped in Groups B, C and D; whereas, those were 
f-ibroblastic-shaped inGroup A. Immunohistochemical examination 
showed that expression of type II collagen was detected around 
chondrocytes in Group B, C, and D. However, there was no 
expression in Group A. Chondroitin sulfate (C6S and C4S) was 
expressed most abundantly in Group B, followed by Groups C and 
D but was scarce in Group A. Using by RT-PCR method, the 
expression of mRNA of type II collagen and aggrecan were 
observed in all Groups. 
Discussion: Group B provided the most abundant quantity of 
matrix and the number of chondrocytes was higher than that of 
3-dimensional culture for 3 weeks. Therefore Group B was consid- 
ered to be the best cell culture combination in our Study. 
Conclusion: A combination of 1 week 3-D culture after 2 weeks 
monolayer culture is suggested to have the potential to provide the 
optimum autologous: graft preparation. 
development of osteoarthritis. This hypothesis was tested by 
evaluation of the progression of QA in the canine ACLT modet. 
Methods: Five dogs received intra,articular injections of ribose 
to increase cartilage NEG levels (350 riM; twice weekly for 7 
weeks). Five other dogs were'injected with PBS. In these two 
groups, joint instability was induced, two weeks after the last 
injection, by anterior cruciate ligament transection (ACLT). The 
contralateral knee joint served as untreated control. Osteoarthritic 
features were evaluated 7 weeks post surgery. In addition 5 control 
dogs received ribose injections only, without ACLT. 
Results: NEG levels were -5 fold higher in ribose-injected joints 
compared to PBS iniected joints (p<0.05). ACLT surgery resulted 
in osteoarthritic features such as an increased proteoglycan 
synthesis, a diminished retention of these newly formed proteo- 
glycans, an increased proteoglycan release (see figure) and as a 
consequence a decreased proteoglycan content. In PBS injected 
dogs, none of these changes reached statistical significance, due 
to the short period of joint instability (7 weeks). In the dogs injected 
with ribose these changes were all statistically significant (p<&05 
for all parameters). Comparison of PBS and ribose injected ACLT 
joints showed statistical!y significantly more pronounced charac- 
teristics of CA in the ribose injected joints (e.g. compare grey bars 
in figure). No statistically significant effects were observed 
between control and ribose injected knees of dogs with intaCt 

















Conclusion: Elevated levels of NEG products in cartilage accel- 
erate the process of CA induced by joint instability. This suggests 
that non-enzymatic glycation of cartilage is a predisposing factor 
for the development Of CA. 
This study was supported by the 'Dutch League against Rheuma- 
tism' and the Dutch Organization for Scientific Research 
TH048 
NONENZYMATIC GLYCATION INCREASES THE SEVERITY 
OF OSTEOARTHRITIS IN THE ACLT MODEL: A 
BIOCHEMICAL BASIS FOR AGE AS A RISK FACTOR OF CA 
J. De Groot*t, N. Verzijl*l-, J. W. J. Bijlsmal-, J, U. TeKoppele* and 
R R J. G. Lafebed" 
*TNO Prevention and Health, Leiden, and tRheumatology & Clin, 
ImmunoL, University Medical Center Utrecht, The Netherlands 
(ELafeber@DIGD.AZU.NL) 
Aim of the study: The incidence of CA increases with age. Qne 
of the major age-related Changes in articular cartilage is the 
accumulation of nonenzymatic glycation (NEG) products, resulting 
from the spontaneous reaction of reducing sugars with proteins. 
NEG products affect the properties of articular cartilage: they 
increase the stiffness of the cellagen network and adversely affect 
the matrix turnover. We hypothesise that the accumulation of 
NEG products in articular cartilage with age predisposes for the 
TH049 
THE CANINE GROOVE MODEL FOR OSTEOARTHRITIS 
(WITHOUT PERMANENT JOINT INSTABILITY) SNOWS 
CHARACTERISTICS IDENTICAL TO THE ACLT MODEL 
A. C. A. Marijnissen, J. M. TeKeppele, J. Bijlsma and 
F. P. J. G. Lafeber 
Rheumatology & Clin. Immunol., University Medical Center 
Utrecht, Utrecht, The Netherlands (ELafeber@DIGD.AZU.NL) 
Aim of the study: Anterior cruciate ligament ransection (ACLT) 
in the dog results in joint instability with as a result osteoarthritic 
features mimicking human early osteoarthdtfs (CA), as such pro- 
viding a proper in vivo model for CA. Unfortunately, although from 
a clinical point of view relevant, the permanent joint instability 
persists as a trigger for OAand may counteract possible beneficial 
effects of therapy, especially in long-term follow-up after treatment 
has stopped. Therefore a new canine model, without permanent 
joint instability was developed. 
Methods: Surgery was carried out on 23 Beagle dogs. In 13 
animals the condylar cartilage was damaged without affecting the 
subchondral bone, followed by a 10 weeks intensified loading of 
the affected joint by fixing the contralateral control limb to the trunk 
(4 hours/day, 3 days/week). In 10 dogs the severity of the OA was 
evaluated 10 weeks after surgery; 3 dogs were evaluated 40 
weeks after surgery. As a control, ACLT was carried out in 10 dogs 
and joints were evaluated 15 weeks after surgery. 
Results: In the groove model, collagen damage, proteoglycan- 
synthesis, -retention, -release and -content were changed, char- 
acteristically to the process of OA. All changes were statistically 
significant, were quantitatively similar for all animals, were also 
found in tibial cartilage (though this cartilage was not surgically 
affected), were found for up to 40 weeks after surgery and were 
identical to those found for the ACLT model. Histologically deter- 
mined cartilage damage in the groove model was slightly more 
severe at 40 weeks than at 10 weeks and statistically more severe 
than in the ACLT model. Synovial inflammation determined histo- 
logically and by synovial fluid MMP-1, -3 and -13 activity was 
slightly but statistically more advanced in the ACLT model than in 
the groove model. Values for contra-lateral control knees did not 
differ between both models and between 10 and 40 weeks of 
follow-up. 
Conclusion: The canine groove model for OA shows character- 
istics similar to the ACLT model but has the advantage that these 
characteristics become evident without permanent joint instability. 
This makes the groove model more sensitive to treatment and 
allows prolonged follow-up after treatment has stopped. 
This study was supported by the 'Dutch League against 
Rheumatism '.
TH050 
COLLAGENASE-INDUCED CHANGES IN THE ARTICULAR 
CARTILAGE COLLAGEN NETWORK ARE READILY 
REVEALED BY ELECTRON MICROSCOPIC STEREOLOGY 
T. K. L&ngsj6", A. Pelttaril-, H. J. Helminen* 
*Department of Anatomy, tLaboratory of Electron Microscopy, 
University of Kuopio, Kuopio, Finland 
In order to evaluate the effects of collagenase digestion on articular 
cartilage collagen network at the ultrastructural level and to test the 
ability of electron microscopic (EM) stereology to detect these 
effects, collagenase (30 U/ml) was allowed to digest bovine 
patellar articular cartilage tissue plugs for 24 h or 48 h. 
Culturing of plugs (diameter 18mm) was done in Minimum 
Essential Medium with Eade's salts, ascorbic acid, and antibiotics, 
and control samples were obtained at 0 h, 24 h, and 48 h. Number 
of animals was ten in each group and two samples (diameter 
3 ram) per animal for electron microscopy were processed rou- 
tinely from the central area of the tissue plug. Zonal IUR sampling 
of the specimens was done using an isector for either a 50-pm- 
thick cartilage surface slice or a 100-pm-thick deep zone slice that 
was taken at the depth of 750 IJm from the surface. U~trathin 
sections with silver-gray interference colour were sectioned and 
minimally biased indirect estimates of interterritorial collagen vol- 
ume (Vv) and surface (Sv) densities were calculated from electron 
micrographs using average collagen fibril diameters (d), length 
densities (Iv), and formulae 
Vv= ~/4*E(d2)*L,, and (1) 
S~=~'E(d)*Lv (2) 
In the superficial zone, average diameter of the collagen fibrils 
decreased from 37 to 14 (p<0.001) or 8 nm (p<0.001) after 24 or 
48 h digestions, respectively. Lv of the collagen fibrils remained 
unchanged and was 0.000205 nm/nm 3 in the control and digested 
groups. V~ of the collagen fibrils decreased from 25 to 3 (p<0.001) 
S39 
or 1% (p<0.001) after 24 or 48 h digestions, respectively. Sv of the 
collagen fibrils decreased from 0.024 to 0.009 (p<0.001) or 
0.005 nm2/nm 3 (p<0.001) after 24 or 48 h digestions. In the deep 
zone, average diameter of the collagen fibrils decreased from 48 to 
31 nm (p<0.001) after 48 h digestion. ~ of the collagen fibrils 
increased from 0.00014 to 0.00035 nm/nm 3 (p<0.001) after 48 h 
digestion. In the deep zone, V v of the collagen fibrils remained 
unchanged and average V v was 30% in the control and digested 
groups. S v of the collagen fibrils increased from 0.021 to 
0.034nm2/nm 3 (p<0.01) after 48h digestion. Stereological 
parameters remained unchanged in the deep zone after 24h 
collagenase digestion. 
In the superficial zone, collagenase caused a clear decrease in 
average collagen fibril diameter while I_,, remained unchanged. As 
V v of the collagen fibrils is in direct proportion to the second power 
of average fibril diameter (1), V,, is a sensitive parameter in 
detecting changes in the superficial collagen network. In the deep 
zone, collagenase digestion decreased average collagen fibril 
diameter but also appeared to bring fibrils closer to each other and 
so increased Iv. This increase in L~ caused V v to remain 
unchanged (1). In this case average fibril diameter together with 
collagen fibril L v are the most informative stereological parameters 
in revealing changes of the collagen network. 
TH051 
ASSESSMENT OF SPECIFIC mRNA LEVELS IN CARTILAGE 
SURFACES IN A LAPINE MODEL OF OSTEOARTHRITIS 
M. P. Hellio Le Graverand, E. Vignon*, L. Barclay and D. A. Hart 
McCaig Center for Joint Injury and Arthritis Research, Calgary, 
Canada and *Claude Bernard University, Lyon, France 
Aim of the study: Patients with meniscal and ligament injuries of 
the knee are at high risk to develop osteoarthdtis. Therefore, the 
purpose of this study was to evaluate molecular and structural 
changes occurring in four articular cartilage surfaces from the 
knees of anterior cruciate ligament-transected rabbits at 3 and 8 
weeks post-surgery. 
Methods: Rabbit articular cartilage tissues from the lateral and 
medial femoral condyles (LFC and MFC) and the lateral and 
medial tibial plateaus (LTP and MTP) were processed for histology 
and for semFquantitative Reverse Transcriptase-Polymerase 
Chain Reaction (RT-PCR) analysis for a subset of relevant 
molecules. 
Results: While the most severe histological changes were 
observed in the MTP starting as early as 3 weeks post-ACL 
transection based on Mankin scores, histological examination also 
demonstrated the progression of osteoarthritic hanges in the MFC 
from 3 to 8 weeks post-surgery. In contrast, very few structural 
changes were observed within both the LFC and LTP, and these 
changes did not worsen with increasing time after surgery. The 
water content increased significantly in the MFC at 3 weeks 
post-ACL transection and at both 3 and 8 weeks post-ACL tran- 
section in the MTP. Significant decreases in DNA content were 
observed for the MFC, LTP and MTP at 8 weeks post-ACL 
transection. Total RNA yields from the MFC and MTP were 
significantly elevated at 8 weeks post-ACL transection. Total RNA 
yields from the MFC and MTP were significantly elevated at 8 
weeks post-ACL transection, while in the lateral compartment otal 
RNA was unchanged following ACL transection. Analysis of mRNA 
levels for a subset of relevant molecules by RT-PCR demonstrated 
complex changes in the four articular cartilage surfaces following 
ACL transection: (i) at both 3 and 8 weeks post-ACL transection: 
Type II collagen mRNA levels were significantly higher within the 
tibial plateaus compared to mRNA values in the femoral condyles. 
MRNA levels for decorin were significantly lower within the MFC 
compared to values in the other cartilage surfaces. MRNA levels 
for COX-2 were significantly higher within the NFC compared to 
S40 
values in the LTP. Transcript levels for IGF-2 were significantly 
higher within the LFC compared to values in the LTP. (ii) at 3 weeks 
post-ACL transection: MMP-1 mRNA levels were significantly 
higher in the LFC compared to values in the MFC. iNOS mRNA 
levels were significantly higher in the LFC compared to values in 
the MFC and LTP. (iii) In contrast, no statistical significant differ- 
ences in mRNA levels were detected between cartilage surfaces 
for aggrecan, biglycan, fibromodulin, MMP-13, MMp-3, TNF-c~ and 
TGF-I~. 
Conclusions: These results show that following ACL tran- 
section, complex molecular and structural changes occur early in 
cartilage and that the observed changes are both surface specific 
and time-dependent. 
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TH052 
ANTIOXlDANT MODEILATION OF IL-I-INDUCED EFFECTS 
ON NO, MMP-13, PGE2 AND PROTEOGLYCANS 
G. M Lee, M. "Reran, M. Jansen, S. S. Kelley and P. Lin 
University of North Carolina, Chapel Hill and GlaxoWellcome, 
Research Triangle Park, NC 
Reactive oxygen species are involved in cytokine activation of 
NF~:B and JNK. Three antioxidants were tested for their ability to 
counteract IL-1 's effects on chondrocyte metabolism. 
N-acetylcysteine (NAC) protects against fibronectin fragment- 
induced matrix catabolism. However, 10 nM NAC, a concentration 
frequently used, acidifies culture m dia. Ascorbate-2-PO4 (A2P), a 
potent antioxidant is used in vitro as a stable analog of ascorbic 
acid to promote matrix synthesis. N-propyl gallate (nPG), a com- 
mon food preservative and protectant against photo-bleaching, 
protects proteoglycans from oxidant damage. Normal and OA 
human chondron pellet cultures were treated in triplicate with 
1 ng/ml IL-1I~ in the presence and absence of the above antioxi- 
dants for 2 wk. The media were changed every 2-3 days adding 
fresh IL-1 and antioxidant. Because of instability, additional NAC 
was added daily. Aliquots of conditioned media collected on days 
3, 5, 7, 9 and 14 were analyzed for NO (Griess reaction), MMP-13 
(ELISA), PGE2 (ELISA) and glycosaminoglycans (DMMB colori- 
metric). Glycosaminoglycans were also measured in the pellets. 
The antioxidants had no effect on IL-11~-induced NO on day 3 when 
it was highest. One and 10 mM NAC and 66 and 133 pM (25 
and 50 pg/ml) A2P slowed the decline to the same low levels on 
day 14. 
NPG had no effect on IL-1 induced NO. By day 14, NAC and nPG 
had reduced both II-l~-induced MMP-13 and PGE2 in a dose 
response manner and with roughly equal effects on MMP-13 and 
PGE2. A2P reduced PGE2 much more than MMP°13 (37 vs 22%), 
and on day 14 there was no dose response. Except for 66 pM A2P, 
the antioxidants did not attentuate IL-l's effects on proteoglycan 
synthesis and degradation. 5 to 30 nM NAC in the presence and 
absence of IL-1 reduced proteoglycan synthesis by 8 to 65%. nPG 
had a lesser effect but also reduced proteoglycan synthesis by 8 to 
28%..Only 66 pM A2P consistently reduced the inhibition of 
proteoglycan synthesis by IL-1 (2 to 31%). However, in the 
absence of I1-1, A2P had a widely variable effect on proteoglycan 
synthesis (-33 to +33%) depending on the specimen. In conclu- 
sion, the antioxidants significantly reduced IL-1 ~-induced MMP-13 
and PGE2 synthesis but had little effect on NO and, except for A2P, 
may exacerbate the ffect on proteoglycan synthesis. The lack of 
an effect on NO while reducing PGE2 and MMP-13synthesis 
indicates the involvement of different signaling pathways. The 
antioxidants' differential effects on chondrocyte metabolism 
indicate that antioxidant activity is not their only activity. 
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TH053 
COS-2JCOX-1 SELECTIVITY OF ACECLOFENAC IN 
COMPARISON WITH CELECOXlB AND ROFECOXlB IN THE 
HUMAN WHOLE BLOOD ASSAY 
P. Lidbury, I. Vojnovic and T. Warner 
The William Harvey Research Institute, London, United K ngdom 
Inhibition of cyclo-oxygenases (COX), and therefore prostaglandin 
production, is the common basis for the therapeutic benefits of 
NSAIDs. Cyclo-oxygenase exists in multiple isoforms. Cyclo- 
oxygenase-1 (COX-l) is present constitutively in the endothelium, 
stomach and kidney, whereas cyclo-oxygenase-2 (COX-2) is 
induced by pro-inflammatory c tokines and endotoxin in cells in 
vitro and at inflammatory sites in vivo. To evaluate the inhibitory 
effects of aceclofenac in comparison with celecoxib and rofecoxib 
on COX-1 and COX-2, we studied them in the human Whole Blood 
Assay (WBA), the more standardized in vitro assay to assess 
selectivity between COX. 
Method: Blood was collected from volunteers by venupuncture 
into hepain (19 U/ml). For COX-1 assays, blood was treated with 
test agents (10 -~° to 10 .3 M) or vehicle (0.1% v/v dimethyl 
sulfoxide) followed 60 min later by calcium ionophore, A23187, 
(50 pM). After 30 min the blood was centrifuged (1500 g, 4°C, 
5 min) and the plasma removed and immediately frozen. For 
COX-2 assays, blood was treated with aspirin (12 pg/ml) to inac- 
tivate COX-l, and 6 h later with LPS (10 pg/ml) plus test agents 
(as above) or vehicle. Incubation was continued for a further 18 h, 
after which time the blood was centrifuged and the plasma 
removed and frozen. Concentrations of thromboxane (Tx) B2 (as a 
measure of TxA 2 formation and so COX activity) in samples from 
both protocols were then determined by radioimmunoassay. 
Results: In this human WBA, aceclofenac, celecoxib or 
rofecoxib produced inhibition of both COX-1 and COX-2 with 
varying selectivities ( ee Table). 
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IC5o (pM) IC8o (pM} Rallos (Cox-2/1) 
COX-1 COX-2 COX-1 COX-2 1(}50 IC_,ao 
Aceclofenac 16 4 1 170 49 0.218 0.29 
Celecoxib 2 1 4 25 30 0.70 1.20 
Rotecoxib 56 0.69 652 t2 O.12 - 0,018 
From the results of this in vitro assay, aceclofenac showed an 
apparent selectivity towards the inhibition of COX-2slightly 
superior to that of celecoxib both on the IC5o and IC8o ratios, which 
places it between celecoxib and rofecoxib. 
This study was supported, and all NSAIDS supplied, by Admirall- 
Prodesfarma S.A. 
TH054 
MOLECULAR BASIS FOR THE ANTI-CYTOKINE EFFECT OF 
DIACERHEIN IN HUMAN ARTICULAR CHONDROCYTES 
M. Malpeli *, B. Dozin', R. Cancedda* and A. Pietrangelot 
*Centro Biotecnologie Avanzate/Istituto Nazionale per la Ricerca 
sul Cancro, Genova, Italy, and tDipartimento Medicina Intema, 
Universita' di Modena e Reggio Emilia, Modena, Italy 
Aim of the study: To investigate the molecular effects of 
diacerhein (DAR), a novel slow acting drug in osteoarthritis, on 
human articular chondrocytes treated with interleukin 1 cz and 
tumor necrosis factor rJ.. 
Methods: Adult articular chondrocytes, kept in primary culture, 
were stimulated with cytokines in the absence or presence of 
different concentrations of diacerhein (10(-6), 5x10(-5), 10 
(-4)M). By using metabolic labeling of secreted proteins, 
zymographic, western blot analysis of metalloproteinases, and 
protein micro-sequencing, we determined the effects of DAR on 
chondrocyte metabolism. 
Results: Cytokine treatment induced a specific pattern of protein 
secretion and metalloproteinase activity. This pattern of chondro- 
cyte gene expression and activity was also found, at least in part, 
in chondrocytes from aged and from osteoarthritic patients. Thera- 
peutic concentration of diacerhein (5x10 (-5) M) was able to 
reduce the expression of interleukin 6, fib-type collagenase and 
stromelysin-1 induced by cytokine stimulation. Also the activity of 
MMPs (stromelysin-1 and fib-type collagenase) was decreased by 
the drug. We then tested the role of nitric oxide (NO), a mediator of 
cytokine and inflammation signaling. The NO production induced 
by IL1/TNF~ was inhibited by DAR. Surprisingly, using NO inhibitor 
(NMMA) or donor (SNAP), we found that NO was not involved in 
the specific pattern of chondrocyte gene response elicited by 
cytokines and blocked by DAR under our experiment conditions. 
Conclusion: We have found that several metabolic modifica- 
tions occur in human articular chondrocytes upon induction with 
ILl and TNFo~ and that such modifications partially resemble those 
present in cartilage from aged subjects or osteoarthritic patients. 
The efficacy of diacerhein in reverting these processes appears to 
be due to its ability to interrupt the pathways activated by 
cytokines. The latter, however, does not seem to involve NO. This 
suggests that other signaling molecules (free oxygen radicals?) 
induced by cytokines are intercepted and blocked by DAR in 
human chondrocytes. Work is now in progress to verify this 
hypothesis and to identify these molecular mediators. 
TH058 
MODULATION OF COLLAGENASE-3 IN HUMAN 
OSTEOARTHRITIC CARTILAGE BY ACTIVATION OF 
EXTRACELLULAR TGF-I]: ROLE OF FURIN CONVERTASE 
F. Moldovan, J.-P. Pelletier, F. Mineau, M. Dupuis, J.-M. CIoutier, 
and J. MarteI-Pelletier 
Osteoarthritis Research Unit, Centre Hospitafier de I'Universite de 
Montreal, H6pital Notre-Dame, Montreal, Quebec, Canada 
We previously reported that TGF-13 treatment of normal cartilage 
can increase the synthesis of collagenase-3 by chondrocytes and 
mimic the in situ distribution of this enzyme in osteoarthritic (OA) 
cartilage, which occurs predominantly in the deep zone. In this 
study we examined which elements of the TGF-# system are 
potentially relevant to this effect. 
TGF-[~I and TGF-132 levels in cultured cartilage explants were 
determined by ELISA. OA cartilage explants were treated with 
small latent TGF-[31 complex in the presence of inhibitors of serine 
proteases, plasmin, cathepsin and furin, and a neutralizing anti- 
body against the mannose-6 phosphate/IGF-II receptor (M6P/IGF- 
IIR) and collagenase-3 levels were determined by ELISA. The 
small latent TGF-!31, TGF-~ receptors (TGF-I 3 R), M6P/IGF-IIR and 
furin were immunolocalized in cartilage. 
Our data showed that latent TGF-[31 is the major isoform synthe- 
sized. Levels of 17.2 ± 1.7 and 1.1 ± 0.3 pg/mg tissues wet weight 
were found for total TGF-~I and TGF-~2, respectively. A general 
serine protease inhibitor abrogated both endogenous and exo- 
genous small latent TGF-131 activation. Plasmin and furin inhibi- 
tors, and anti-M6P/IGF-IIR reduced exogenous small latent 
TGF-~I complex-induced collagenase-3 by 33%, 95%, and 76% 
respectively, but the cathepsin inhibitor had no effect. Immuno- 
localization of small latent TGF-I~I complex as well as TGF-[3 RI 
and RII revealed a statistically significant increase of the chondro- 
cyte score only in the deep zone of OA cartilage. M6P/IGF41R level 
was significantly higher in OA in both superficial and deep zones. 
Furin was found in normal cartilage exclusively in the superficial 
zone. In OA cartilage, a level similar to normal was found in the 
superficial zone, but a significantly higher cell score (23.6 ± 4.7%) 
registered in the deep zone. 
This study, showing the enhancement of small latent TGF-I3, 
TGF-13R, M6P/IGF-IIR and furin production exclusively in the deep 
zone of OA cartilage, is consistent with an upregulation of TGF-~ 
activity/activation and corresponds to the preferential site of 
collagenase-3 production. Our data suggests that, in the deep 
zone of OA cartilage, extracellular small latent TGF-131 might be 
endocytosed via M6P/IGF-IIR, which could then be activated 
extracellularly by furin, making it possible for active TGF-~ to be 
released extracellularly. This hypothesis does not exclude some 
participation of the plasmin system. 
TH059 
A ROLE OF IMMUNE RESPONSE TO A 
CHONDROCYTE-DERIVED PROTEIN, YKL-39, IN ARTHRITIC 
DISEASES 
K. Masuko-Ho_ngo*, M. Sakata*'j-, J. Tsuruha*l, T. Sekine*, 
H. Nakamura °, T. Kato °, K. Nishioka* 
"Rheumatology, Immunology and Genetics Program, Institute of 
Medical Science, St Marianna University, Kawasaki, Japan. 
"~ Torii Pharmaceutical Co. Ltd., Tokyo, Japan 
YKL-39 is a recently cloned, chondrocyte-derived protein which 
belongs to chitinase family and is homologous to HC gp-39. Since 
patients with arthropathy are reported to exert immune response to 
an array of chondrocyte- or cartilage-derived proteins, including 
HC gp-39, we explored whether YKL-39 was recognized as an 
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autoantigen in patients with rheumatoid arthritis (RA) and osteo- 
arthritis (OA). Recombinant fusion protein of YKL-39 was 
expressed by E. cofiand purified. Antibody production to YKL-39 in 
sera from patients with OA or RA, and healthy controls was 
analyzed using the recombinant protein by ELISA and western 
blotting. T cell response to the recombinant YKL-39 was investi- 
gated by 3H-thymidine incorporation. As a result, anti-YKL-39 
antibody was detected in approximately 10% of the tested patients 
with OA as well as the patients with RA. Interestingly, T cell 
response to YKL-39 was more frequent in the antibbdy-positive OA 
patients than in the RA patients. In addition, YKL-39-immunized 
mice exerted inflammatory arthritis with surface irregularity of 
cartilage. Our results indicate that proteins which are produced 
from chondrocytes can be a target of autoimmune response in 
patients with arthropathy such as OA and RA, and also that such 
an immune reaction may play a role in the deteriorating cascade of 
cartilage degradation of the joint diseases. 
TH060 
APOPTOSlS VIA CD95/TNF SIGNALING IN 
OSTEOARTHRITIS 
H. Mau, J. Fellenberg, Th. Veiel, H. G. Simank, V. Ewerbeck 
Orthopaedic Department, University of Heidelberg, Germany 
Apoptosis is one of the features in osteoarthrosis. However it is not 
clear which pathways are involved in triggering the apoptotic 
response. Here we provide further evidence that the CD95/TNF 
signaling is involved in chondrocyte apoptosis. 
Methods: Medial tibial plateaus obtained during knee 
arthroplasty were processed for immunostaining and primary 
chondrocyte cultures. All patients had idiopathic varusgon- 
arthrosis. Pathology specimens with no history of osteoarthritis 
served as controls. Specimens were fixed in buffered formalde- 
hyde, EDTA decalcified and paraffin embedded. Deparaffinized 
4 pm serial sections were stained for CD95 and TNFp55. In situ 
detection of apoptotic chondrocytes was done by Tunel- and 
anti-Parp(poly-ADP-ribose-polymerase)-p85 staining. Cartilage 
degradation was determined by safranin-O-staining. 
Primary chondrocyte cultures were obtained by enzymatic diges- 
tion. Apoptosis was induced after 72 h by incubation of agonistic 
anti-CD95 IGg3 antibody and rh-TNF~. Apoptosis was measured 
by annexin V-Fitc staining and Facs analysis. 
Results: Chondrocytes positive for CD95 and TNFp55 were 
almost exclusively localized in the area of cartilage damage as 
indicated by the safranin-O-staining. The same staining pattern 
was found for Tunel- and anti-Parp-p85 staining. The control 
specimens showed rarely positive stained chondrocytes for CD95, 
TNFp55, Tunel and anti-Parp-p85. 
Apoptosis was induced in more than 50% of the chondrocytes after 
24 h incubation with agonistic anti-CD95 IGg3 and in 30% after 
72 h incubation with rh-TNFo~. 
Conclusion: One of the main features in arthrotic cartilage are 
apoptotic chondrocytes as these are found almost exclusively in 
the areas of cartilage degradation. The chondrocytes die by 
activation of caspases as the anti-Parp-p85 staining shows. This 
antibody recognize the cleavage product of Parp after caspase3/7 
activation. The local distribution of CD95/TNFp55 positive 
chondrocytes to the area of cartilage degradation together with the 
in vitro induction of apoptosis in primary chondrocytes makes the 
involvement of the CD95/-INF signaling pathway in arthrosis most 
likely. 
TH061 
SUSCEPTIBILITY OF HUMAN OSTEOARTHRITIC 
CHONDROCYTES, ISOLATED FROM ARTICULAR 
CARTILAGE WITH NORMAL OR FIBRILLATED SURFACES 
AND FROM MARGINAL OSTEOPHYTES, TO IGF-1 AND 
TGF-p 
A. Panasyuk'l, G. Colantuoni*:l:, M. Quintero*l:, and 
D. R. Mitrovic" 
"U-349 of INSERM, Lariboisiere Hospital, Paris, France; 
~ lnstitut for Rheumatology, AMS, Moscow, Russia; and 
:~Department of Rheumatology, University Hospital, Los Andes, 
Merida, Venezuela 
Aim of the study: To compare the in vitro responses of osteo- 
arthritic chondrocytes isolated from the normal-like cartilage, 
cartilage with fibrillated surface of weight-bearing area, and from 
fibro-cartilage of peripheral osteophytes to IGF-1 and TGF-I~ with 
respect to their capacity to proliferate and synthesize matrix 
macromolecules. 
Methods: Cells were isolated in a routine way from tissue 
fragments taken from a single joint of a female patient, 76 years 
old, undergoing surgery for knee OA. Serum-starved passage-2 or 
primary cell monolayers were incubated 24 h in DMEM containing 
2.5% FCS without and with the IGF-1 (25 ng/ml and 100 ng/ml), 
and TGF-~ (0.1 and 1 ng/ml) given separately or combined and 
then cell responses were studied. 3H-thymidine incorporation was 
used to evaluate a mitotic effect of growth factors in passage- 
2 subconfluent monolayers. 3sSO4 and 3H-glycine incorporations 
into cell-associated and secreted proteoglycans and proteins were 
used to evaluate their respective synthesis. Proteoglycans were 
precipitated from the culture media at -20°C with 2 volumes of 
ethanol in the presence of 5% Na acetate, and proteins at 4°C with 
a mixture of 5% TCA and 5% wolframophosphoric acid. The 
incorporated radioactivities of cell monolayers and respective 
culture media were determined and combined. The differences 
were evaluated statistically. 
Results: In the preliminary experiments both factors elicited the 
best responses in the presence of 2.5% FCS, This concentration 
was then used in all subsequent experiments. Cell proliferation: 
IGF-1 induced greater stimulation (35%-38%) than TGF-~ (17%- 
32%) in all three cell lines. TGF-13 elicited greater stimulation in 
osteophytic cells (32%) than in cell lines derived from normal-like 
cartilage (22%) and fibrillated cartilage (17%). When cells were 
exposed to both factors TGF-~, down regulated IGF-l-induced 
stimulation in cell lines derived from normal-like and fibrillated 
cartilages but slightly increased the effect in osteophytic cell line. 
Proteoglycan synthesis: IGF-1 and TGF-I3 had no effect on cell 
lines from normal-like and fibrillated cartilages but stimulated 
osteophytic cell line (IGF-1, 46%; TGF-~, 26%). Given in 
combination, TGF-~ down regulated IGF-1 induced effect in a 
concentration dependent manner. Protein synthesis: IGF-1 
induced stimulation in cell lines derived from fibrillated and osteo- 
phytic cartilages (21% and 33%, respectively for soluble proteins; 
and 36% and 52% for cell associated proteins) but had no effect on 
cell line from normal-like tissue. TGF-J~ had no effect on either cell 
line alone or in combination. 
In conclusion: These results show that IGF-1 is a principal 
mitogenic and metabolic regulatory factor for human articular 
chondrocytes acting more strongly on younger, osteophytic cells. 
TGF-~, appears to be mainly mitogenic factor. Its metabolic effect is 
inconsistent and directed to younger less differentiated osteophytic 
chondrocytes. 
TH062 
REGULATION OF NITRIC OXIDE SYNTHESIS IN HUMAN 
OSTEOARTHRITIC ARTICULAR CARTILAGE 
T. Moilanen, K. Vuolteenaho, E. Moilanen 
The Immunopharmacological Research Group, Medical School, 
University of Tampere; Departments of Surgery and Clinical 
Chemistry, Tampere University Hospital, Tampere, Finland 
Nitric oxide (NO) produced by cartilage and synovial membrane 
has a role in the pathogenesis of osteoarthritis (OA) and 
rheumatoid arthritis (RA). In the present study cartilage specimen 
collected from OA and RA patients undergoing knee replacement 
surgery were studied for iNOS expression and NO production in 
organ culture to allow intact chondrocyte-matrix interactions. 
Inflammatory cytokines IL-I~ and TNFc( as well as bacterial 
lipopolysaccharide (LPS) caused a dose- and time-dependent 
stimulatory effect on NO synthesis and inducible NO synthase 
(iNOS) expression in OA and RA cartilage. OA cartilage responded 
to IL-115 stimulation with higher NO production than RA cartilage. 
Various NOS inhibitors suppressed NO production in OA cartilage 
in the following order of potency: 1400W (selective iNOS inhibitor) 
> L-NIO (non-selective NOS-inhibitor) > L-NMMA (non-selective 
NOS-inhibitor) while L-NAME (a rather selective inhibitor of 
neuronal type of NOS) was quite ineffective. Also cycloheximide 
(an inhibitor of protein synthesis), pyrrolidonedithiocarbamate 
(PDTC; NF-KB inhibitor) and genistein (an inhibitor of tyrosine 
protein kinase) inhibited cytokine-induced NO production, while 
dexamethasone (10 #M), diaminohydroxypyrimidine (DAHP; an 
inhibitor of tetrahydrobiopterin synthesis, 1 mM) and PD 98059 
(MAP-kinase inhibitor, 10 pM) had no effect. 
In comparative studies, inducible NO synthesis in OA cartilage was 
very similarly regulated as NO synthesis by iNOS pathway in 
J774 macrophages in terms of sensitivity to NOS inhibitors and 
basic signalling mechanisms involved in iNOS transcription. 
TH063 
CHARACTERIZATION OF T CELLS INFILTRATING INTO THE 
SYNOVlUM OF OSTEOARTHRITIS: ANALYSIS OF T CELL 
RECEPTOR VI~ GENES 
H. Nakamura*, K. Masuko*, T. Kato*, M. Sakatal-, J. Tsuruhal, 
K. Nishioka" 
"St Marianna University School of Medicine, Kawasaki 
t Torii Pharmaceutical Co. Ltd., Tokyo, Japan. 
Objective: Inflammation is implicated in the progression of 
osteoarthritis (OA). Proinflammatory cytokines such as IL-1 dev- 
astate articular cartilage and are detected not only in the joint of 
rheumatoid arthritis (RA) but also in OA. In OA, these cytokines are 
originated from the synovium and infiltration of inflammatory cells 
is observed. The aim of this study is to identify the dominant 
T cell clones in the synovium of OA and characterize their T cell 
receptors (TCRs). 
Materials and methods: Synovial tissues from 11 knees of 9 
patients with primary OA were obtained during the knee opera- 
tions. To distinguish each T cells in respect to the TCR, synovial 
tissues were analyzed by single-strand conformation poly- 
morphism (SSCP) method. Total RNA was prepared from the 
synovial tissues and genes encoding CDR3 regions of TCR 
chain were amplified by RT-PCR using V~1-V~320 specific primers 
for SSCP. To characterize TCRs further, PCR products were 
cloned and sequenced. HLA-DRB1 genotypes were also deter- 
mined. 
Results: SSCP analysis showed mono or multiple bands in 
restricted V~ families. Three sets of amino acid motifs (LEFGV, 
VPTGVG, LRGS) in CDR3 region were common in different 
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samples with the identical HLA haplotypes. Seven AA motifs 
(CASSLRG, CASSLSG, YGSHFSG, LAGG, GSGY, SGYN, 
GLAG) were also commonly found in the V-D-J junction region. 
Conclusions: T cells with common amino acid motifs in CDR3 
regions of the TCR were found in the synovium of OA. The results 
suggest that the antigen-driven immune reaction against some 
antigenic candidate is present in the proinflammatory process 
of OA. 
TH064 
EFFECTS OF LOW-ENERGY PULSED ULTRASOUND ON 
PROLIFERATION AND MATRIX SYNTHESIS OF CULTURED 
CHONDROCYTES EMBEDDED IN ATELOCOLLAGEN® GEL 
T. Nishikori, Y. Uchio, S. Maniwa, H. Kataoka, K. Kawasaki, 
K. Katsube, M. Kuriwaka and M. Ochi 
Department of Orthopaedics, Shimane Medical University, 
Shimane, Japan 
Purpose: We had developed the transplantation of autogenic 
cultured chondrocytes embedded in Atelocollagen® gel to repair 
osteochondral defects and have started clinical application since 
1996. The present study investigated the effects of low-energy 
pulsed ultrasound (US) on proliferation and matrix synthesis of 
chondrocytes cultured in Atelocollagen® gel in order to promote 
the high quality chondrocytes-Atelocollagen® implants. 
Materials and methods: Articular cartilage was derived from the 
humerus, femur and tibia of 10-week-old Japanese white rabbits. 
Chondrocytes were isolated by collagenase digestion and embed- 
ded in Atelocollagen® gel at 2x106 cells/ml. Aliquots of 125 pl 
were cultured in Dulbecco modified Eagle's medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS) and antibiotics. 
US treatment was administered for 20 minutes per day, and the 
medium was replaced twice per week [US signal: 1.5 MHz, 200 #s 
repeating pulsation at 1.0 KHz, delivered at intensities of 30 mW/ 
cm 2 (US group) and 0 (control)]. At post-culture 3 weeks, the 
effects of US on chondrocyte metabolism were determined by cell 
numbers, histological examination, stiffness of gel, and amounts of 
chondroitin 6-sulfate (,~ di-6S) and chondroitin 4-sulfate (/', di-4S) 
produced by the chondrocytes, and measured by high perform- 
ance liquid chromatography (HPLC) combined with fluorometer. 
Results: (1) The cell cumbers increased 1.1- and 1.2-fold in the 
control and US groups from the starting numbers, respectively. 
However, there was no significant difference between both groups. 
(2) Histological examination showed that the cells in the US group 
had more metachromatic matrix stained with toluidine blue than 
the control, although the cells in both groups maintained the 
rounded shape. (3) In the mechanical testing, the stiffness of gel 
between both groups indicated no significant difference. (4) The 
HPLC analysis showed that the production of total chondroitin 
sulfate in the US group increased more significantly compared with 
the control. (5) Moreover, the ,3 di-6S/,3 di-4S ratio in the US group 
increased more significantly than the control. 
Conclusion: It was suggested that the administration of 
the low-energy pulsed ultrasound enhanced the synthesis of 
chondroitin sulfates of the cultured chondrocytes embedded in 
Atelocollagen® gel, although it did not stimulate the proliferation of 
the chondrocytes. US might be beneficial to obtain the high quality 




PREFERENTIAL UPTAKE AND INCORPORATION OF 
GLUCOSAMINE INTO PROTEOGLYCAN IN ARTICULAR 
CARTILAGE EXPLANTS 
E. A. Noyszewski, K. Wroblewski, G. Dodge, J. Beers, 
S. Kudchodkar, A. V. S. Sarma, R. Reddy 
University of Pennsylvania, Philadelphia, PA, USA, and DuPont 
Hospital for Children, Wilmington, DE, USA 
Aim: The purpose of this study was to determine the metabolic 
fate of glucosamine in cultural articular cartilage explants using 
carbon-13 (~3C) magnetic resonance spectroscopy (MRS). ~3C is a 
stable isotope of carbon that can be used to trace metabolic 
pathways because the resonance positions of these atoms are 
highly sensitive to their molecular environments. 
Methods: We examined cartilage explants from veal patellae 
maintained in a high glucose (4.5 mg/ml) Dulbecco's modified 
Eagle's medium supplemented with one of three components: (1) 
0.4 mg/ml glucose labeled with ~3C at the first carbon position, i.e., 
the anomeric carbon, (2) 0.4 mg/ml glucose labeled with ~3C at the 
anomeric carbon, and (3) control (no labeling). Three samples from 
each group were removed every three to four days and frozen in 
liquid nitrogen to stop all biochemical processes. Broadband, 
proton-decoupled ~3C MRS were obtained at 125.8 MHz on the 
intact tissue. After MRS data acquisition, the cartilage samples 
were digested in papain and analyzed for proteoglycan, glucose, 
and lactate. 
Results: The anomeric carbons for all of the components of 
chondroitin-6-sulfate and chondroitin-4-sulfate could be uniquely 
identified with 13C MRS. Samples grown with either labeled 
carbohydrate showed an increase in signal intensity in the ano- 
meric region of the spectrum relative to the control, unlabeled 
specimens. Labeled glucosamine was preferentially incorporated 
into the hexosamine moieties (N-acetylgalactosamine) of both 
types of chondroitin sulfate at levels 300% higher than an equiva- 
lent amount of labeled glucose. In contrast, glucosamine was 
incorporated into the glucuronic acid moieties at levels 40-60% 
lower than glucose. Proteoglycan content was similar for the three 
sample groups, but proteoglycan release into the medium occurred 
at a slightly decreased rate (25% less) when glucosamine was 
added to the culture medium. The three sample groups did not 
differ in other metabolic characteristics (glucose utilization or 
lactate production). 
Conclusions: These results indicate that chondrocytes prefer- 
entially metabolize glucosamine over glucose for production of the 
hexosamine components of proteoglycan. The results suggest 
that glucosamine promotes proteoglycan synthesis in articular 
cartilage. 
TH066 
REPAIR OF ARTICULAR CARTILAGE DEFECTS WITH 
CULTURED CHONDROCYTES IN ATELOCOLLAGEN GEL: 
COMPARISON WITH CULTURED CHONDROCYTES IN 
SUSPENSION 
M. Ochi, K. Katsube, Y. Uchio, S. Maniwa, M. Matsusaki, M. Tobita, 
J. Iwasa, K. Kawasaki 
Shimane Medica/ University, /zumo, Japan 
Purpose: We attempted to repair full-thickness articular cartilage 
defects in rabbit knee joints with allogeneic cultured chondrocytes 
embedded in Atelocollagen gel. 
Materials and methods: An articular cartilage defect was 
created on the patellar groove of the femur. The defect was filled 
with chondrocytes cultured in the collagen gel and covered with 
periosteal flap (G group). In three other experimental groups, the 
same defects were transplanted with cultured chondrocytes in 
suspension with periosteal flap (M group), periosteal graft only (P 
group), or left empty (E group). At 3, 12, and 24 weeks after 
operation, the reparative tissue was analyzed macroscopically and 
histologically. 
Results: At 4 weeks after operation, the surfaces of the repara- 
tive tissue were smooth, and the defects were filled with reparative 
tissues that resembled hyaline cartilage in all four groups. How- 
ever, the reparative tissues degenerated gradually with time in the 
M, P, and E groups. In contrast, in the G group, the reparative 
tissue retained its thickness, and there was a steady integration of 
the grafted tissue into the adjacent normal cartilage even at 24 
weeks after operation. 
Conclusion: The results suggest that transplantation of 
allogeneic chondrocytes cultured in Atelocollagen gel is effective in 
repairing an articular cartilage defect. 
TH067 
SEQUENTIAL CHANGES OF TGF-JH CONCENTRATION IN 
SYNOVIAL FLUID AND mRNA EXPRESSION OF TGF-~I 
RECEPTORS IN CHONDROCYTES AFTER IMMOBILIZATION 
OF RABBIT KNEES 
R. Okazaki, A. Sakai*, Y. Uezonol-, A. Ootsuyama, N. Kunugita:l:, 
T. Nakamura*, T. Norimura 
Department of Radiation Biology and Health, *Department of 
Orthopaedic Surgery, Sch. of Med., SDepartment of Health 
Information Science, Sch. of Health Sciences, TDepartment of 
Pharmacology, Sch. of Med., Miyazaki Medical College, Miyazaki, 
Japan 
Objectives We previously reported that a combination of trans- 
forming growth factor (TGF)-~I and basic fibroblast growth factor 
(bFGF) synergistically increased the chondrocyte proliferation 
obtained from knee joint immobilized for 7 to 14 days in rabbits. In 
the present study, we used chondrocytes and synovial fluid 
obtained from rabbit knees immobilized for 0 to 42 days, to clarify 
sequential changes of TGF-~I and bFGF concentrations in syno- 
vial fluid and mRNA expressions of TGF-J~I receptor type I (RI) and 
II (RII) in chondrocytes. 
Methods: The right knees of male Japanese white rabits were 
immobilized in full extension using fiberglass casts for 0 to 42 days. 
Primary cultured chondrocytes were obtained from cartilages of 
the femoro-tibial joints. Cell proliferation was evaluated by 
3H-thymidine incorporation and cell numbers. The concentrations 
of TGF-~I and bFGF in synovial fluid samples from immobilized 
knee joints were measured by using ELISA, Expressions of RI and 
RII mRNA were determined with reverse transcription polymerase 
chain reaction assay. 
Results: A combination of TGF-~I and bFGF had synergistic 
effect on the proliferation of chondrocytes obtained from knee 
joints immobilized for 7 to 14 days. The concentration of TGF-~I in 
synovial fluid at 7 to 28 days after immobilization was significantly 
higher (up to 3.6-fold) compared to that at 2 days. The concen- 
tration of bFGF in synovial fluid did not significantly change at 2 to 
7 days and decreased at 14 to 28 days after immobilization. 
Expressions of mRNA of RI were maintained at 0 to 14 days and 
significantly decreased at 21 to 42 days, while that of RII was 
significantly increased at 14 days after immobilization. The con- 
"centration of bFGF was kept at the same level at 2 to 7 days after 
immobilization, and gradually decreased thereafter. 
Conclusion: These data suggest that high concentrations of 
TGF-I~I and bFGF in the synovial fluid and the increase of mRNA 
expression of RII could contribute to the chondrocyte proliferation 
in the early stage of degenerated cartilage after immobilization. 
TH068 
IL-1I~ INDUCED EXPRESSION OF ANAPHYLATOXIN 
RECEPTOR C5aR (CD88) ON HUMAN ARTICULAR 
CHONDROCYTES IN VITRO 
Hiroyuiki Onuma°t, Kayo Masuko-Hongo °, Guohua Yuan °, 
Masahiro Sakata", Hiroshi Nakamura', Tomohiro Kato °, 
Haruhito Aokil, Kusuki Nishioka* 
*Rheumatology, Immunology, and Genetics Program, Institute of 
Medical Science, and tDepartment of Orthop. Surg., St Marianna 
University School of Medicine, KawasakL Kanagawa, Japan 
Objective: To investigate whether human articular chondrocytes 
could express anaphylatoxin receptor C5aR (CD88), especially 
upon stimulation by inflammatory cytokines. 
Materials and methods: Specimens of human articular cartilage 
were obtained from patients with osteoarthritis (OA), rheumatoid 
arthritis (RA) or with traumatic injury in occasions of surgical 
operation with their informed consent. Cartilage tissue was 
minced, dispersed by enzymatic digestion for overnight 
using collagenase and then cultured in vitro. A part of cells was 
stimulated either with IL-11~ or with TNF o.. 
Expression of mRNA of C5aR (CD88) in chondrocytes was 
analyzed by RT-PCR using a C5aR-specific primer pair. Surface 
expression of C5aR was analyzed using flow cytometric analysis. 
Results: In basal condition without stimulation, mRNA of C5aR 
was detected by RT-PCR in 30% of the chondrocyte samples. As 
for the cell surface expression, C5aR was negligible in the non- 
stimulated chondrocytes. However, stimulation by IL-11~, but not by 
TNFo., was found to increase the expression of C5aR up to 40% of 
the cultured chondrocytes. 
Conclusion: Our results indicate that IL-l~ could induce the 
expression of anaphylatoxin receptor C5aR on human articular 
chondrocyte. The C5a-C5aR system, which would be induced 
by inflammatory response, may have a role in chondrocyte 
metabolism or cartilage pathology. 
TH069 
DIFFERENTIAL GENE EXPRESSION BETWEEN NORMAL 
AND OSTEOARTHRITIC ARTICULAR CARTILAGE 
G. L. Pahel, E. E Dixon, A. Cole, G. Cs-Szabo 
Department of Molecular Sciences, Giaxo Weflcome Research, 
RTP, NC: Department of Biochemistry, Rush Medical College, 
Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL 
Our goal is to gain a greater understanding of the etiology of 
osteoarthritis via both large scale analysis of gene expression 
patterns and detailed analysis of the expression of particular 
genes. 
For large scale patterns RNA from normal and OA articular 
cartilage was used to analyze gene expression in several closed 
microarray systems. Slides or membranes containing more than 
2,000 human genes were hybridized with labelled cDNA prepared 
from RNA pooled from either normal or OA cartilage. We have 
demonstrated the presence as well as the up- or down-regulation 
of a large number of genes previously reported to be in cartilage as 
well as others whose expression by chondrocytes has not been 
reported. This list includes, but is not limited to, prolyl hydroxylase, 
BMP7, Erkl/2, fibronectin receptor alpha subunit (3-fold up in OA) 
sox9 (6-fold up OA), type 1 collagen (-10-fold up for alpha1 and 
alpha2), type Vl collagen (3-5-fold up for alpha 1, 2 and 3), 55kd 
TNF receptor (6-fold up), and others. Analysis of the data reveals 
numerous additional changes both expected and surprising. 
We have also investigated gene expression profiles of catabolic 
and anabolic factors involved in osteoarthritis utilizing normal 
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human articular cartilage obtained from the Regional Organ Bank 
of Illinois and 'normal looking' cartilage from OA patients who 
underwent otal knee arthroplasty. A modified protocol for extrac- 
tion of the total RNA was used to isolate high quantity and quality 
RNA from articular cartilage. Expression of the metalloproteinases 
ADAMTS4, ADAMTS5, and ADAM 10 were investigated by reverse 
transcription and polymerase chain reaction. Aggrecanase (TS4 
and TS5) gene expression was demonstrated in both normal and 
diseased cartilage tissue. We have also confirmed detectable 
levels of expression of ADAM10 message in normal and OA 
articular cartilage. Sequence analysis revealed the presence in 
R NA of an alternately spliced variant of ADAM 10 that lacked part of 
the catalytic domain. This raises the possibility that the variant may 
regulate ADAM10 metalloproteinase activity in articular cartilage. 
Particularly exciting about these data is the identification of genes 
not previously known to be expressed by chondrocytes. These 
data, although somewhat unexpected, should provide significant 
insight into the metabolic processes of the chondrocytes in normal 
adult articular cartilage relative to the changes that occur during 
the degenerative processes of OA. 
TH070 
THE EFFECT OF PENTOXlFYLLINE ON THE SYNTHESIS OF 
TNF-ALPHA AND IL-1 AND THEIR SOLUBLE RECEPTORS IN 
OSTEOARTHRITIC SYNOVIAL FLUID 
P. T. Paradowski*, L. Pokocat, K. Zotyr~ski* 
"Department of Trauma Surgery and Orthopaedics, t Department 
of Pathophysiology and Clinical Immunology, Mifitary University 
Medical School, L6dz., Poland 
Rationale: Methylxanthine derivative, pentoxifylline (PTX) has 
been extensively studied with regard to TNF-suppressing activity. 
We have previously shown that the drug produces complex effects 
on the cell activity and cytokine network within the osteoarthritic 
joint. 
Objective: The aim of this study was to characterize the effect of 
PTX on the proinflammatory c tokine expression in joint synovial 
fluid. 
Materials and methods: We investigated the effect of PTX on 
the production of cytokines (TNF-r.~ and IL-11~), IL-1 receptor 
antagonist (IL-1Ra) and soluble receptors (p55 TNF-R, p75 
TNF-R, IL-1 sRII) by unstimulated and LPS-treated peripheral 
blood mononuclear cells (PBMC). The cells were isolated from 
healthy volunteers and cultured in vitro with synovial fluid from 
patients with OA of knee joints. The concentration of cytokines and 
receptors were measured by ELISA. 
Results: As expected, PTX strongly inhibited TNF-[z, and, to a 
lesser extent, IL-11~ production. Similarly, the drug significantly 
inhibited the expression of IL-1 sRII. We observed dose- 
dependent stimulation of IL-1Ra. In contrast, the concentration of 
p55 (TNF-R and p75 TNF-R in joint fluid treated with PTX was 
significantly higher (up to 2 fold) after PTX treatment han that 
without stimulation. This also occurred in a dose-dependent 
fashion. 
Conclusion: These findings suggest that PTX is able to regulate 
the cytokine and receptor balance in the joint. Since over- 
production of cytokines may be involved in the pathological 
processes, the drug could lessen the joint cartilage degradation. 
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TH071 
THE EFFECTS OF OVARIECTOMY AND ESTROGEN 
TREATMENT ON CARTILAGE INTEGRITY IN AN OVINE 
MODEL OF OSTEOARTHRITIS 
D. Pa~'ker, S. M. Smith, S.-Y. Hwa, M. M. Smith and P. Ghosh 
Institute of Bone & Joint Research, University of Sydney at The 
Royal North Shore Hospital, Sydney, Australia 
Objectives: In the post-menopausal female, the risk and severity 
of osteoarthritis (CA) is greater than males of similar age, suggest- 
ing that estrogen plays an important role in the pathogenesis of this 
disease. To date, however, studies on the effects of this hormone 
on CA progression have generated conflicting results. The aim of 
the present study was to establish the effects of estrogen depletion 
produced by ovariectomy (Ovx), in conjunction with or without 
estrogen replacement therapy (ERT) on articular cartilage integrity 
in a sheep model of CA induced by meniscectomy (Mx), 
Methods: Thirty 8-year-old Merino ewes were used for the study. 
18 were ovariectomi'zed, of which 12 plus 6 non-Ovx sheep 
underwent bilateral lateral Mx to induce CA. Six Ovx+Mx sheep 
received ERT via Femtran-50 (3M) patches (50 pg/day) applied to 
the skin of the inner thigh. The remaining 6 non-Ovx and non-Mx 
ewes were used as non-operated controls (NOC). All sheep were 
killed 3 months post surgery. Histological sections were preapred 
from the articulating surface of the lateral femoral condyle (LFC), 
stained with Toluidine blue (TB) and histomorphormetrically scored 
both manually using a modified Mankin scale of the lesion site (2 
independent assessors) and by computerized image analysis 
(CIA) (ImagePro Plus v3.0.1), measuring AC cross-sectional area 
and mean greyscale density of TB staining (an index of proteo- 
glycan (PG) content) separately for the outer, middle and inner 
zones of the condylar articulating cartilage surfaces. 
Results: Ovx (p<0.05) and Mx (p>0.005) significantly increased 
cartilage Mankin scores compared to the NOC group, the extent of 
damage associated with the two procedures being additive. ERT 
did not significantly lower Mankin scores but the AC cross- 
sectional area was significantly elevated in the outer zone of the 
LFC in both the Ovx+Mx and the Ovx+Mx+estrogen groups 
(p<0.05). PG density in the middle (p<0.0005) and inner (p<0,05) 
zones of the LFC was severely reduced by Mx but not by Ovx. In 
the inner zone, ERT of Ovx+Mx sheep signficantly increased the 
PG staining density to levels which were not significantly different 
from that found in NOC sheep. There was a significant correlation 
(r2=0.85) between Mankin scores of the lesion site and PG 
staining density of the middle zone (generally containing the lesion 
site) but not with the outer or inner zones. 
Conclusions: Although Ovx was detrimental to articular carti- 
lage as assessed by the Mankin scoring method, no significant 
effect was found on PG content as determined by CIA. In contrast 
Mx caused significant changes in all measured parameters. ERT 
was found to be only effective in the inner zone of femoral cartilage 
which is normally under high mechanical stress and it appeared to 
reverse the deleterious effects produced by Ovx. Hormone 
replacement therapy may thus be helpful in reducing the 
progression of CA in post menopausal women. 
TH072 
BIOCHEMICAL CHANGES OF THE CARTILAGE MATRIX IN 
DIFFERENT COMPARTMENTS OF THE TIBIOFEMORAL 
ARTICULATION IN MENISCECTOMIZED GUINEA PIGS 
P. Pastoureau, N. Picaud, S. Gaufillier, A. Chomel and J. Bonnet 
Rheumatology Division, Institut de Recherches Servier, Suresnes, 
France 
Previous studies on spontaneous osteoarthritis (CA) in Hartley 
guinea pigs have indicated that, concomitantly to morphologic 
changes, the articular cartilage responds to increased mechanical 
demands by changing the composition of its organic matrix. In this 
study, cartilage matrix biochemical composition was analyzed in 3 
compartments of the osteoarthritic knee of meniscectomized 
(MNX) Hartley guinea pig. 
MNX and sham-operated (SH) guinea pigs were studied 1 and 
3 months after partial meniscectomy at the medial side of the left 
knee. After dissection, patella, proximal tibia and distal femur of 
each knee were separately fixed in 96% alcohol and decalcified 
overnight in 20% formic acid. The cartilage layer was stripped from 
the underlying bone; for the tibial plateaus and the femoral 
condyles the cartilage from the medial part was separated from its 
lateral part. The dry weight (DW) was measured and the cartilage 
subsequently digested in papain to estimate the glycosamino- 
glycan (GAG) content. Hydroxyproline (OHpro) was measured 
after hydrolysis of the giested samples. GAG and OHpro concen- 
tration (conc) were calculated. The results (expressed as % of 
MNX vs SH) are presented for the entire patella (P), the medial 
tibial plateau (MTP) and femoral condyle (MFC) in the left operated 
knee, 1 and 3 months after surgery: 
1 month 
DW GAG OHpro  
cone conc 
P +48°= . . .  ÷11oo -4°°  
MTP -15% " +11% -13% 
MFC +32% ""  +11Go " -13% "'" 
n=12 Io 15 group: 'p<0.5;  ""p<O.O01. 
3 months  
DW GAG OHpro 
conc conc 
+60°o "'" +2°°  -4% 
0% -6% -9°0  " ' "  
+58% "'"  +8% -17% ""  
In the affected knee of MNX animals, cartilage reacted differentially 
in the 3 compartments of the joint: increase in quantity of matrix in 
P and MFC at 1 and 3 months and loss of matrix in the MTP at 
1 month. No significant variations were observed for GAG conc 
(except for MFC at 1 month) but there were significant decreases 
of OHpro conc in MFC and MTP. We conclude that in this animal 
model, CA is characterized by a compensating response as 
observed on the DW at the P and FC levels which results in a 
degeneration of collagen in the new accumulated matrix of FC. In 
MTP, the early loss of matrix mainly due to collagen breakdown is 
in accordance with the well characterized morphologic feature of 
fibrillation observed as early as 1 month post-surgery. Absence 
of variation in the DW after 3 months is due to accumulation of 
cartilage matrix related to osteophyte formation in the periphery 
of the MTP. 
TH073 
QUANTITATIVE ASSESSMENT OF ARTICULAR CARTILAGE 
HISTOMORPHOMETRY. APPLICATION IN THE 
MENISCECTOMY-INDUCED OSTEOARTHRITIS IN GUINEA 
PIGS 
P. Pastoureau, S. Leduc, A. Chomel, N. Picaud, and J. Bonnet 
Rheumatology Division, Institut de Recherches Servier, Suresnes, 
Fance 
Microscopic morphometry remains the only recognized method for 
a complete assessment of articular degeneration and cartilage 
repair. The usefulness of scoring systems is limited by their 
descriptive and subjective nature. Computerized image analysis 
.reduces this subjectivity. In the present study, a new image 
analysis system was employed to quantify the main histological 
parameters reflecting osteoarthritic (CA) features induced by 
meniscectomy in the guinea pig. 
Meniscectomized (MNX) and sham-operated (SH) guinea pigs 
were studied 1 and 3 months after partial meniscectomy at the 
medial side of the left knee. After dissection, right and left proximal 
tibias were included in methylmethacrylate without prior decalcifi- 
cation. Sections of the tibial plateau were cut in the coronal plane 
of the attachment site of the menisco-femoral ligament and stained 
with safranin O. Parameters were quantified at various magnifica- 
tions using for each one special programs of a Biocom image 
analyser. The following parameters of the cartilage were evalu- 
ated: thickness (Th, mm); ratio of safranin O staining intensities: 
superficial/deep zone (Is/d); fibrillation index (Fi, %) and cellular 
density (Cd, cell/mm2). The degree of user interaction varied 
from manually tracing objects (Cd) to almost complete computer 
automation (Th, Fi). 
Reproducibility was established for 6 sections obtained from differ- 
ent specimens of normal and OA cartilage: the coefficient of 
variation was found to be less than 10% for each parameter. The 
results (mean + sem) are presented for the medial tibial plateau 
of the operated knee in SH and MNX after 1 and 3 months 
post-surgery: 
1 month 
(n=) SH MNX MHX vs 
(12) (10) SH 
TH 0,26±001 0.26=0.01 0% 
IsJd 0,67=0.04 0.47=0.07 -17% 
FI 6.9±0.7 42.6=8.6 +520% "" 
Cd 1086--.35 956±101 -12% 
"p<0.01;  *"p-=0.001 
3 months 
SH MNX MNX vs 
(12) (11) SH 
0,26=0.01 0,24±001 -8% 
0.51=0,02 0.32=002 -37% "'" 
16.5=4.0 43.1=6.2 +160%' -  
1100=46 751 ~28 -32% "'" 
Contrary to scoring evaluation (previous results), this system 
allows us to show the time-dependent impact of the pathology, with 
an early fibillation of the medial tibial cartilage appearing as soon 
as 1 month post-surgery. Furthermore these results suggest that, 
in this model, collagen breakdown (Fi) precedes proteoglycan 
degeneration (Is/d) which appears here after 3 months when 
chondrocyte density is also significantly decreased in OA cartilage. 
TH074 
MESENCHYMAL STEM CELLS LABELED WITH A 
FLUORESCENT DYE CAN BE DETECTED FOLLOWING 
IMPLANTATION INTO ARTICULAR CARTILAGE DEFECTS 
T. C. Pellas, J. Yin, E. Boehnlein, E. O'Byrne, G. Pastor, 
H, N. Singh, V. Vlancuzzi, S. UzieI-Fusi, and J. Quintavalla 
Novartis Institute for Biomedical Research, Summit, N J, USA 
Mesenchymal stem cells (MSCs) isolated from bone marrow are 
multipotent, possessing the capacity to differentiate into cartilage, 
bone, tendon, muscle, adipose and other connective tissues. 
Several studies have reported enhanced repair of damaged carti- 
lage following implantation of MSCs into full-thickness cartilage 
defects suggesting that the cells in the repair tissue were derived 
from the implant. However, it is not known if repopulation of the 
repair tissue was from the implanted MSCs or from host cells 
recruited into the defect from surrounding tissues. This report 
demonstrates a method of labeling MSCs to allow tracking in vitro 
and in vivo without interfering with their multipotential function. 
Goat MSCs labeled with a fluorescent vital dye, CMTMR, 
(5(and6)-(((4-chloromethyl)-benzoyl)amino)tetramethylrhodamine; 
CellTracker TM Orange, Molecular Probes, Eugene, OR) retained 
viability, expandability, and multipotential function in vitro. In 
monolayer cultures the dye was retained in MSCs and was 
detectable by FACScan analysis over a four-week period. The 
fluorescent probe did not affect MSC viability or their ability to 
undergo osteogenic and chondrogenic differentiation in vitro. For 
in vitro and in vivo studies, labeled autologous goat MSCs were 
seeded into absorbable gelatin sponges (Gelfoam®, Pharmacia 
and Upjohn, Kalamazoo, MI) and implanted into full-thickness 
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osteochondral defects in the trochlear groove and femoral condyle 
of the knee. Histological analysis of defects showed MSCs 
maintained fluorescence for up to two weeks after implantation 
in vivo. Labeled cells remained attached to the gelatin scaffold 
while smaller infiltrating cells were observed throughout the 
gelatin/MSC implants. At later intervals (1 and 2 wks post- 
implantation), fragments of gelatin sponge containing labeled 
MSCs were noted in deep marrow spaces well away from the 
original defects--up to 6 mm from base of defect--indicating 
fragmentation, dislodgment and passive migration. These results 
indicated that the gelatin sponge biomaterial in its current formu- 
lation was not suitable for therapeutic approaches delivering MSCs 
to osteochondral defects. Studies to detect labeled MSCs at longer 
intervals following implantation are ongoing. Based on our in vitro 
data, it appears possible to detect the implanted cells for at least 
four weeks. 
Enhanced cartilage repair emanating from implanted MSCs can 
only be assessed after newly formed tissue has filled the defect, 
usually a minimum of four to six weeks. At that time point, the fate 
of the implanted cells cannot be determined and the repair is 
based on the presumption that MSCs are incorporated into repair 
tissues. By assessing implanted cell retention and viability at early 
time points modifications can be incorporated into carrier matrices 
that better retain cells and enhance chondrogenesis, We suggest 
that this novel methodology can significantly reduce the cost, 
investment of time and complexity of efficacy studies designed 
to optimize cell-based therapies for the treatment of cartilage 
damage. 
TH076 
NIMESULIDE REDUCES INTERLEUKIN-113-1NDUCED 
CYCLOOXYGENASE-2 GENE EXPRESSION IN HUMAN 
SYNOVIAL FIBROBLASTS. ROLE OF CELLULAR CALCIUM 
J.-P. Pelletier, N. Fahmi, Y. He, M. Zhang, J. MarteI-Pelletier, and 
J. A. Di Battista 
Osteoarthritis Research Unit, Centre Hospitalier de I'Universit# de 
Montreal, H6pital Notre-Dame, Montreal, Quebec, Canada 
The aim of this study is to characterize the effects of nimesulide on 
basal and induced cyclooxygenase-2 (COX-2) gene expression in 
human synovial fibroblasts and to define the intracelleular 
mechanisms that mediate the changes in COX-2 expression and 
synthesis in response to the drug. 
Human synovial fibroblasts were incubated with sub- and thera- 
peutic concentrations of nimesulide and NS-398 (0, 0.03, 0.3, 
3 pg/mL) in the absence or presence of the COX-2 inducers 
interleukin-ll3 (IL-113) or endotoxin (LPS). Treated cells were 
analyzed for COX-2 mRNA and proteinby Northern and Western 
blotting analysis, respectively. Putative transcriptional, post- 
transcriptional, and signaling effects of nimesulide on basal and 
induced-COX-2 expression were investigated by human COX-2 
promoter studies, calcium flux and reactive oxygen species (ROS) 
evaluations, electrophoretic mobility shift analysis (EMSA), and 
half-life studies of COX-2 mRNA. 
Nimesulide inhibited IL-1!5-induced COX-2 expression and protein 
at sub- and therapeutic concentrations (0.03-0.3 pg/mL) and 
antagonized the increase in COX-2 synthesis induced by eleva- 
tions in intracellular calcium levels. Our data clearly demonstrate 
that the suppression of IL-113 induced-COX-2 expression by sub 
and therapeutic concentrations of nimesulide is not due to 
inhibitory effects on NF-KB or c/EBP associated signaling cas- 
cades. Furthermore, the scavenging mechanism of nimesulide on 
chemical species of oxygen could be ruled out as an explanation of 
the inhibitory effect on COX-2, Finally, nimesulide blocked 
ionomycin + thapsigargin-induced COX-2 synthesis, arguing that 
a role for nimesulide in calcium metabolism may be of some 
consequence in this regard. 
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Nimesulide inhibits cytokine-induced COX-2 expression and 
synthesis at sub- and therapeutic concentrations. The inhibitory 
effect may be due to the influence of nimesulide on cellular calcium 
metabolism altered by IL-lJ~ cellular activation. 
TH077 
DIFFERENT REGULATION OF MMP-9 AND TIMP-1 
SYNTHESIS BY ANTI-INFLAMMATORY CYTOKINES AND 
PGE 2 IN IL-17-STIMULATED HUMAN 
MONOCYTES/MACROPHAGES 
D. V. Jovanovic, J. A. Di Battista, J. MarteI-Pelletier, P. Reboul, 
M. Bendedour, Y. He, E C. Jolicoeur, J.-P. Pelletier 
Osteoarthritis Research Unit, Centre Hospitafier de I'Universite de 
Montreal, H&pital Notre-Dame, Montreal Quebec, Canada 
In chronic rheumatoid diseases such as rheumatoid arthritis (RA), 
an excess metalloproteinase (MMP) activity over tissue inhibitors 
of metalloproteinase (TIMP) is observed. We examined the 
mechanisms regulating the synthesis of 92-kd gelatinase (MMP-9) 
and TIMP-1 by IL-17-stimulated human monocytes/macrophages 
in primary cultures. 
IL-17 stimulated human monocytes, isolated from the peripheral 
blood of healthy donors, were cultured in the presence of PGE 2, 
cAMP-mimetics (IBMX, forskolin, cholera toxin), cAMP, or anti- 
inflammatory cytokines (IL-4, IL-10, IL-13), or with protein kinase 
inhibitors of diverse specificity. MMP-9 and TIMP-1 measurements 
were performed using specific enzyme-linked immunosorbent 
assays, while the expression of specific messenger RNA was 
determined by Northern blotting. 
There was a spontaneous release of proMMP-9 and TIMP-1 by 
unstimulated cells which increased over time. IL-17 stimulated an 
increased level (3-fold) of proMMP-9 production relative to TIMP-1 
production (1.4-fold) in a dose- and time-dependent manner. This 
stimulation was accompanied by the up-regulation of specific 
mRNA expression. Exogenous PGE2, cAMP or cAMP-mimetics 
completely inhibited proMMP-9 protein synthesis and stimulated 
TIMP-1 secretion. Spontaneous TIMP-1 production was not 
changed. IL-4 and IL-13 also reversed both IL-17-induced and 
basal MMP-9 production, whereas IL-10 decreased only the 
former. All three anti-inflammatory cytokines, inhibited only the 
IL-17 induced TIMP-1 secretion and had no effect on the basal 
TIMP-1 production. Inhibition of mitogen-activated protein kinases 
(MAPK), MEK-1/MEK-2 and p38, and the transcription factor 
NF-~:B, abrogated both basal and IL-17-induced MMP-9 and 
TIMP-1 synthesis. 
We demonstrated that in human monocytes/macrophages, TIMP-1 
was stimulated by IL-17 only modestly compared to the 
up-regulation of MMP-9. Our results suggest that in chronic 
rheumatoid diseases the excess MMP activity over TIMP activity 
occurs as the result of the increased MMP production and modified 
mechanisms of MMP inhibition. 
TH078 
TSP-1 IS DECREASED IN LATE STAGE OSTEOARTHRITIS: A 
POTENTIAL CAUSE OF VESSEL INVASION FROM THE 
SUBCHONDRAL BONE 
D. Pfander', D. Deuerling', D. K6rtje', T. Cramerl, G. Weseloh °, 
B. Swoboda* 
"Division of Orthopedic Rheumatology, Department of Orthopedic 
Surge~ University of Erlangen-Nuernberg, Erlangen; 
tDepartment of Hepatology and Gastroenterology, University 
Clinic Charite, Campus Virchow, Humboldt-University, Berlin. 
Germany 
Objective: Thrombospondin-1, a potent angioinhibitor, is known 
to be present in human normal and osteoarthrific cartilage. The 
aim of this study was to determine the expression pattern of TSP-1 
in correlation to OA progression. 
Methods: Seven healthy and 23 osteoarthritic human knee 
cartilage samples were paraffin-embedded, cut in 6 #m slides and 
routinely stained with safranin-o. The samples were scored 
according to Mankin. We carried out radioactive in situ hybridiz- 
ation and immunohistochemistry to investigate the expression 
pattern of TSP-1. 
Results: In normal cartilage TSP-1 staining was found mainly in 
the middle and upper deep zone. Predominately mid zone 
chondrocytes grained for TSP-1 (in situ hybridization). In mild and 
moderate OA cartilage the number of TSP-1 RNA positive 
chondrocytes was increased whereas interterritorial TSP-1 protein 
staining was decreased. In severe OA cartilage a strong reduction 
of TSP-1 protein was combined with a moderate decrease in 
TSP-1 RNA levels. In fibrous cartilage of osteophytes localized 
areas showed strong TSP-1 synthesis, with a patchy 
TSP-1 staining. 
Conclusion: The source of TSP-1 in cartilage are mainly mid 
zone chondrocytes. In mild and moderate OA cartilage a hypo- 
thetical interterritorial TSP-1 digestion seems to be combined with 
increased transcript levels. In severe OA cartilage, a strong 
decrease of TSP-1 protein was found, which may be explained by 
a loss of mid zone chondrocytes on the one hand and an increased 
TSP-1 degradation on the other hand. The decrease of the 
angioinhibitor TSP-1 in late stage disease leads to speculations 
about its role in cartilage, and whether its loss may be responsible 
for the invasion of mesenchymal cells and vessels from the 
subchondral bone. 
TH079 
EXPRESSION OF OSTEOPONTIN IN OSTEOARTHRITIS 
PROTEIN AND mRNA ANALYSIS IN NORMAL AND 
OSTEOARTHRITIC HUMAN CARTILAGE 
O. Pullig, G. Weseloh, and B. Swoboda 
Division of Orthopaedic Rheumatology, Department of Orthopae- 
dics, University of Erlangen-Nuremberg, Erlangen, Germany 
Osteopontin, a sulfated phosphoprotein with cell binding and 
matrix binding properties, is expressed in a variety of tissues. In 
the embryonic growth plate, osteopontin expression was found in 
bone forming cells and in hypertrophic chondrocytes. In osteo- 
arthritis, chondrocyte metabolism is characterized by an increased 
synthesis of extracellular matrix molecules and an altered gene 
expression. The aim of the study was to analyze the expression of 
osteopontin in normal and osteoarthritic human knee cartilage and 
to compare its expression with type X collagen, a marker of 
chondrocyte hypertrophy. 
Six cartilage/bone samples of normal human knee joints and thirty 
samples of osteoarthritic knee joints were analyzed immuno- 
histochemically using monoclonal antibodies against Osteopontin 
and type X collagen. Osteopontin protein was further determined 
on partially purified cartilage extracts. Osteopontin mRNA 
expression was analyzed by in situ hybridization using digoxigenin- 
labelled anti-sense probes. 
Immunohistochemistry, using a monoclonal anti-osteopontin anti- 
body, was negative on normal cartilage sections. These results 
could be confirmed in Western Blot experiments using partially 
purified extracts of normal knee artilage. On mRNA level, no 
osteopontin gene expression was observed in the articular 
chondrocytes from normal cartilage. In cartilage specimen from 
patients with osteoarthritis, osteopontin expression could be 
detected by immunohistochemistry. Western blot analysis, and in 
situ hybridization. Osteopontin protein deposition and mRNA 
expression increased with the severity of the osteoarthritic lesions. 
The localization of osteopontin expression was limited to chondro- 
cytes of the upper deep zone, showing cellular and territorial 
deposition. Expression of type X collagen was found in normal 
cartilage with zonal distribution in the deep cartilage layer and the 
calcified cartilage. In severe osteoarthritic samples, a prominent 
increase in staining intensity could be found for type X collagen. As 
for osteopontin, strongest staining for type X collagen was found 
in deep zone chondrocytes and in clusters of proliferating 
chondrocytes from severe osteoarthritic stages. 
These data show expression of osteopontin in adult human 
osteoarthritic hondrocytes suggesting that the phenotype of 
hypertrophic chondrocytes in osteoarthritis resembles that of 
epiphyseal growth plate chondrocytes. The recognition of 
mediators and pathways, preventing chondrocytes hypertrophy 
could be the basis for new therapeutic strategies in osteoarthritis. 
TH082 
IDENTIFICATION OF A NEW CHONDROCYTE-SPECIFIC 
MARKER GENE IN CULTURED CELLS 
Eric Steck, Helga Lorenz, Thomas Gress*, Markus Loew and 
Wiltrud Richter 
Department of Orthopaedic Surgery, University of Heidelberg, 
Germany; *Department of Internal Medicine, University of UIm, 
Germany 
Introduction: Cell based therapies using ex vivo cultured 
autologous chondrocytes are of potential use to augment the 
limited healing capacity of cartilage defects and prevent osteo- 
arthritis. Mesenchymal stem cells are a superior source for 
autologous cells with chondrogenic potential cells since no new 
cartilage defects have to be generated to obtain them. To identify 
chondrocyte-like cells induced in tissue culture and distinguish 
them from osteoblast-like cells we here searched for chondrocyte- 
specific marker genes constitutively expressed in cultured 
monolayers from articular cartilage which are not expressed by 
mesenchymal stem cells or osteoblast-like cells obtained from 
bone. 
Methods: Primary cell cultures of human cartilage and bone 
were obtained from the humeral head after accidental fracture and 
grown in DMEM medium with 10% FCS. Stem cells were isolated 
from bone marrow by density gradient centrifugation and grown in 
DMEM, 10% FCS. CDNA was obtained from chondrocyte mono- 
layers at passage 2 (6 weeks) and cultured osteoblasts (passage 
1, 8 weeks in monolayer). Subtractive gene expression was 
performed by representational difference analysis (RDA). Tester to 
driver ratios were 1:100 to generate the first differential product 
(DP1) and 1:800 and 1:400,000 for the two additional subtraction 
rounds (DP2 and DP3). Finally DP3 PCR-bands were isolated and 
subcloned into plasmid vector for sequencing. Differentially 
expressed genes were reanalyzed by semiquantitative RT-PCR 
with gene specific primers using GAPDH as a reference house 
keeping gene. 
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Results: Eight chondrocyte specific gene fragments were 
identified in DP3. Six sequences belonged to cartilage glycoprotein 
39 (GP-39, YKL-40) and one to human YKL-39 precursor usually 
copurified with GP-39. According to database search, one 
fragment (EScG1) was highly homologous to the middle region of 
a human sequence with unknown function and to a much shorter 
rat sequence that harbours an EGF-like, calcium binding domain. 
By semiquantitative RT-PCR experiments we confirmed the 
observed expression pattern of these 3 genes gene in two 
additional primary cell lines of chondrocytes and osteoblasts, in 
mesenchymal stem-cells and in primary cartilage tissue using 
collagen type II (Col2) as a control. 
Table 1: Expression pattern of chondrocytes pecific genes 
cultured mesenchymal cultured 
osteoblasts slem cells chondrocyles 
(+) ++ 














Using CDNA-RDA we confirmed GP-39 and 
YKL-39 as dominant chondrocyte specific genes preferentially 
expressed in cultured chondrocytes or cartilage but not in osteo- 
blasts and stem cells. We identified one new marker gene (EScG1) 
harbouring an EGF-like, Ca-binding domain, which previously was 
unknown to be expressed in this cell type. Beside the EGF domain 
with 6 conserved cystein residues, the deduced amino acid 
sequence of this gene shows no significant sequence homology to 
any other known extracellular matrix or growth inducing protein. 
Since this gene is not expressed in mesenchymal stem cells and 
cultured osteoblasts, but in cultured chondrocytes as well as in 
cartilage tissue it can serve as an additional marker gene for stem 
cell based chondrogenic tissue engineering. 
TH083 
FUNCTIONAL SIGNIFICANCE OF THE SUPERFICIAL ZONE 
OF THE ARTICULAR CARTILAGE 
J. Rieppo*, J. T6yr~st, M. T. Nieminen't, M. Hyttinen', 
J. S. Jumelint and J. J. Helminen" 
*Department of Anatomy, University of Kuopio, Kuopio; 
t Department of Clinical Physiology and Nuclear Medicine, Kuopio 
University Hospital, Kuopio, Finland 
Functional significance of the superficial zone of articular cartilage 
was evaluated with quantitative microscopy, biomechanical 
testing, and enzymatic manipulations. 
Sterile cartilage-bone plugs (dia. 13 mm, n=50) were prepared for 
mechanical and microscopic analyses from the patellae of healthy 
young bulls. Control (0 h controls, n=20; 44 h controls, n=10) were 
processed for analyses. Enzymatically treated and 44 h control 
samples were incubated for 44 h at 37°C. After treatments, a 
cartilage-bone disk (dia.=6 mm) was removed for examination 
from the center of the original plug with a steel punch. The 
biomechanical indentation testing was carried out immediately 
after digestion using a stepwise stress-relaxation technique. For 
characterization ofthe mechanical properties of the tissue, Young's 
modulus (E) and peak-to-equilibrium load ratio were determined 
for each sample. The mean stress-relaxation .curves for each 
group were also obtained. The degree of organization of fibrillar 
collagen from unstained tissue sections was estimated by 
determination of the area-integrated retardation (AIR) using the 
polarized light microscopy. Spatial proteoglycan (PG) concen- 
tration distribution was measured as optical density (OD) using 
digital densitometry (DD) of safranin-O stained sections. 
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Young's moduli of collagenase and chondroitinase ABC-treated 
samples were significantly lower than of samples from control 
groups (p<0.01, Mann-Whitney U-test). Chondroitinase 
ABC-treated samples revealed a different time-dependent load 
relaxation behavior with a higher peak-to-equilibrium load ratio 
compared to the control or the collagenase-treated samples 
(p<0.01). 
For further analyses of microscopical parameters, AIR and OD 
values of superficial zone were taken. CoUa~]enase-treated 
samples showed significantly lower superficial zone birefringence 
than the control samples (p<0.01) and the alterations were 
confined to the superficial zone. Chondroitinase ABC-treatment did 
not alter the collagen organization but DD revealed significant PG 
depletion. PG changes related to the collagenase-treatment were 
insignificant. 
A moderately positive linear correlation was established between 
microscopic parameters and the Young's modulus. AIR or OD 
alone weakly predicted the mechanical properties of cartilage 
within control samples'(AIR vs. Young's modulus R=0.563 and OD 
vs. Young's modulus R=0.462). Instead, by multiplying AIR and 
OD the correlation with the Young's modulus improved (R=0.669). 
In pooled data (n=50), the correlation of AIR*OD with the Young's 
modulus was the highest (R=0.795). 
Our results confirm the importance of the superficial zone for the 
biomechanical competence of articular cartilage. It is known that 
early osteoarthritic changes in the superficial zone lead to a 
dramatic softening of the cartilage. The results suggest that both 
collagen and PG content of the articular cartilage affect 
simultaneously the indentation behavior of articular cartilage. 
Quantitative microscopy techniques provide a powerful and 
sensitive tool to spatially estimate structural constituents of 
articular cartilage. 
TH084 
INVOLVEMENT OF MMPs IN ARTICULAR CARTILAGE 
DEGRADATION DURING MURINE TYPE II 
COLLAGEN-INDUCED ARTHRITIS 
G~ Rolland, A. Fradin, I. Richard, S. Gaufillier and J. Bonnet 
Rheumatology Division, Institut de Recherches Servier, Suresnes, 
France 
Aim of the study: The degradation of the extracellular matrix 
(ECM) of cartilage, and in particular the breakdown of type II 
collagen network, is a common feature of osteoarthritis and 
rheumatoid arthritis. A prominent role has been attributed to 
a particular class of proteolytic enzymes, namely the matrix 
metalloproteinases (MMPs). 
Methods: mRNA expression of the collagenase MMP-1, the 
stromelysin MMP-3 and 2 gelatinases (MMP-2 and MMP-9) was 
investigated by RT-PCR in cartilage of tibial plateaus during type II 
collagen-induced arthritis (CIA) development in DBA1 mice, from 
day (d) 24 to d36 after the first immunization. The pathology was 
assessed by measure of patellar contents in proteoglycans and 
collagen, as assayed by glycosaminoglycan (GAG) and 
hydroxyproline (OH-Pro) levels, respectively. 
Results: In both arthritic and non-arthritic animals, the 4 MMPs 
were expressed at each studied day: MMP-1 and MMP-2 were 
highly expressed, whereas MMP-3 and MMP-9 were expressed at 
a lesser extent. The expression of the 4 MMPs was not different 
from day to day. Only the expression of MMP-3 was stimulated by 
the pathology at each studied day. 
In control animals, GAG and OH-pro levels were non significantly 
different from d24 to d36. in CIA groups, GAG levels decreased 
with the time course of the pathology: -26% (ns), -49% 
(p<0.001), -60% (p<0.001) and -72% (p<0,001), compared to 
control groups on d24, d29, d31 and d36 respectively. This could 
be related to the pathology-induced increase in MMP-3 mRNA 
levels. OH-pro levels were increased by the pathology on d31 
(+31%, p<0.001) and decreased on d36 (-30%, p<0.01). This 
early upregulation of collagen content could represent a hyper- 
metabolism of chondrocytes as an attempt o prevent he collagen 
network to be degraded, since this pathology involves the 
induction of antibody directed against type II collagen. 
Conclusions: Stimulation of MMP-3 mRNA suggests a direct 
role for this MMP in proteoglycan and collagen breakdown 
occurring in CIA model. In addition, MMP-3 may be involved in this 
process through the activation of other MMPs, since MMP-1, 
MMP-2 and MMP-9 are expressed in CIA as well as in control 
cartilage. 
TH085 
ORAL ADMINISTRATION OF DEER-ANTLER CARTILAGE 
REDUCES DISEASE PROGRESSION IN A RAT MODEL OF 
ARTHRITIS AND CONTAINS NOVEL GENE PRODUCTS 
WHICH HAVE CHONDROGENIC POTENTIAL 
R. Roubin, M M. Smith and P. Ghosh 
Institute of Bone and Joint Research, Department of Surgery, 
University of Sydney, Sydney, Australia 
Aim of the study: Although deer-antler cartilage (DAC) has 
been used in Asia for many centuries as a treatment for arthritis 
and related disorders, there is limited experimental data to support 
such applications. The objective of the present study was to 
determine if DAC was active in an animal model of arthritis and 
attempts were also made to identify components in DAC which 
could be responsible for such activities or have potential to 
promote chondrogenesis. 
Methods: DAC (Cervusen®) was administered orally at daily 
doses of 0, 0.05, 0.2, 1.0 or 5.0 mg/kg to groups of rats (n=10/ 
dose) 7 days prior to and up to 17 days after inducing inflammation 
in a combined adjuvant arthritis model/air-pouch model. Animal 
weight (g), tail and paw thickness (ram) were measured daily and 
pouch fluid volume, cell type and numbers, PGE-2, nitrite, 
hyaluronan content and joint cartilage histology determined at 
sacrifice on day 24. The mRNA was extracted from fresh DAC or 
DAC cells electrophoresed on agarose gels and message for 
matrix collagens and proteoglycans identified using human 
riboprobes. A DAC cDNA library was also established and novel 
gene detected with the human type II collagen riboprobe was 
sequenced using standard techniques. 
Results: Anti-arthritic activity of DAC was demonstrated in the 
rat with doses of 1.0 and 5.0 mg/kg (p<0.04) while maintaining 
body weight. These effects were accompanied at the higher dose 
by a reduction in pouch fluid volume (p<0.04), PGE-2 (p<0.001), 
hyaluronan (p<0.05) and nitrite (p<0.04) (the metabolic of nitric- 
oxide free radicals) levels relative to non-DAC-treated controls. 
Aggrecan, decorin, type IX, and type X collagen were identified 
when messenger RNA was extracted from DAC cells and 
examined using Northern blot analysis. However, with the type II 
collagen riboprobe, two bands corresponding to 5.2 and 7.0kB 
were observed, rather than a single 5.2kB as expected, cDNA 
clones were screened from the DAC cDNA library and five clones 
had high homology to human o~1 pro-collagen type II but several 
others contained transcription sequences which had not been 
previously described. 
Conclusions: Since pouch fluid white cell numbers remained 
unchanged by DAC treatment it was hypothesised that the anti- 
arthritic activity could be mediated via an antigen-driven tolerance 
to the presence of type II collagen and proteoglycan epitopes in the 
DAC preparations. As the 5.2 and 7.0kB bands were subsequently 
observed in Northern blots of mRNA from human foetal cartilage 
cells at the early stages of chondrogenesis, we proposed that the 
transcribed 7.0kB gene product may be implicated in the chondro- 
genic process of matrix production in both species. Furthermore, 
as adult articular cartilage is incapable of repairing itself when 
damaged and with time, and such injuries can lead to joint failure, 
we proposed that transfecting human chondrocytes with the novel 
DAC gene then transplanting them back into cartilage defects may 
promote enhanced matrix regeneration and repair. 
TH086 
ROLE OF NO IN IL-I-INDUCED CARTILAGE LOSS: IN VITRO 
AND IN VlVO INVESTIGATIONS 
M. Sabatini, P. Pastoureau, C. Tordjman, C. Lesur, N. Picaud, 
N. Andre, A. Cordi*, and J. Bonnet 
Rheumatology Division and *Medicinal Chemistry Division, Institut 
de Recherches Servier, Suresnes, France 
Aim of the study: The mediatory role of NO on the effects of 
inflammatory cytokines on cartilage and bone is still debated. In 
the present study we examined the effects of L-NIL, a NO synthase 
inhibitor, on (a) IL-l-induced inhibition of proteoglycan (PG) 
synthesis and stimulation of cartilage degradation in vitro, (b) 
adjuvant arthritis (AI) in rats, a cytokine-dependent model of 
inflammation and joint degradation. 
Methods: Confluent primary cultures of rabbit articular chondro- 
cytes were used to study L-NIL effects on NO production and PG 
synthesis. Explants of rabbit articular cartilage were used to 
examine PG and collagen degradation. AA was induced by 
injection of complete Freund adjuvant into the right hind paw of 
female Wistar rats. Pathology was assessed by visual score and 
paw edema volume. Also measured were serum NO, bone mineral 
content of the proximal femur as well as GAG and OH-Pro content 
of patellar cartilage. 
Results: Two-day culture with IL-1 strongly increased NO 
production (x42, p<0.001) while inhibiting 35SO4 incorporation 
(47%, p<0.001) and aggrecan release (66%, p<0.001 ). Addition of 
L-NIL (10 .4 M) totally blocked NO production without significant 
recovery of PG synthesis. Similarly, L-NIL had no effect on 
IL-l-induced degradation of PG and collagen. 
In AA, preventive oral treatment with L-NIL (10 mg/kg/d) during 21 
days, inhibited both the increase of circulating NO (100%, 
p<0.001) and edema measured at the non-injected pay at day 14 
(80%, p<0.001) and day 21 (90%, p<0.001). The general 
inflammatory score was also totally reversed (97%, p<0.001). 
Nevertheless, L-NIL did not significantly inhibit glycosaminoglycan 
and hydroxyproline loss in the left patellar cartilage, nor bone 
mineral content decrease in the proximal part of the left femur. 
Conclusions: These in vitro and in vivo data do not support a 
mediatory role of NO in IL-1 effects of matrix synthesis and 
degradation, since L-NIL, which blocked NO production, did not 
affect the cytokine effects on tissue turn-over. Nevertheless, NO 
seems to play an important role in the inflammatory process, which 
was effectively inhibited by L-NIL. These results may help to clarify 




CARTILAGE INTERMEDIATE LAYER PROTEIN AS A NEW 
CANDIDATE AUTOANTIGEN IN OSTEOARTHRITIC AND 
RHEUMATOID ARTHRITIS 
M. Sa_kata*l, K. Majuko-Hongo °, H. Nakamura*, J. Tsuruha*'l-, 
T. Kato*, K. Hishioka* 
*Rheumatology, Immunology, and Genetics Program, Institute of 
Medical Science, St Marianna University School of Medicine, 
Kawasaki, Kanagawa, Japan; t Torii Pharmaceutical Co. Ltd., 
Tokyo, Japan 
Objective: To investigate the presence of an autoantibody 
against cartilage intermediate layer protein (CILP), a protein 
recently cloned from human articular cartilage, in patients with 
osteoarthritis (OA) and rheumatoid arthritis (RA), and whether the 
immune response against CILP is involved in the pathogenesis of 
arthropathy. 
Materials and methods: Recombinant fusion proteins, which 
contained the first half (C1), the second half (C2), or three 
fragments within the C2 region (designated as C2F1, C2F2 and 
C2F3) of the non-NTPPHase-homologous region of CILP, were 
prepared using E. coll. Autoantibodies against these proteins in 
serum samples from patients with OA or RA, and from age- 
matched healthy individuals were detected by enzyme-linked 
immunosorbent assay (ELISA) and western blotting. In addition, 
10-week-old DBA, C57B/6, BALB/c, and Icr mice were immunized 
with C1 and C2 proteins mixed with Freund's incomplete adjuvant 
to assess arthrogenicity of CILP. 
Results: Antibody production against the C2 region was 
detected in 10% (11/105) of OA patients and in 13% (12/94) of RA 
patients, although antibodies to the C1 region were rarely detected 
in both patient groups. Within the C2 region, all fragments (C2F1, 
C2F2 and C2F3) were found to carry autoepitopes. Autoantibody 
against the C2F2 was detected most frequently in the OA patients, 
whereas autoantibody against the C2F3 was dominantly detected 
in the RA patients. All four strains of mice immunized with the CILP 
proteins developed chronic arthritis, in particular, the ICR mice 
developed polyarthritis. Histological analysis showed infiltration of 
mononuclear cells in the synovium and exfoliation of the surface of 
cartilage. 
Conclusion: Our results indicate that an immune response to 
CILP play a role in the joint destruction in chronic arthropathy such 
as OA and RA. Suppression of the immune responses to various 
cartilage-derived components, including CILP, may have a 
therapeutic benefit in these arthropathies. 
TH088 
A NOVEL INVOLVEMENT OF RACK1 WITH PKCa IN HUMAN 
ARTICULAR CHONDROCY'FE MECHANOTRANSDUCTION 
H.-S. Lee, S. J. Millward-Sadler, M. O. Wright, G. Nuki, D. M. Salter 
Edinburgh University Medical School, Edinburgh, UK. 
Aim: To identify roles for Rack1 (receptor for activated C kinases 
1) and PKC isozymes in the intracellular signalling pathways 
activated in normal and OA human articular chondrocytes in 
response to mechanical stimulation. 
Methods: Expression of PKC isozymes and RACK1 in short 
term primary cultures of normal and OA chondrocytes and the 
immortalized human chondrocyte cell line C20A4 was assessed by 
confocal microscopy, immunoprecipitation and immunoblotting. 
Associations between PKC isozymes, RACK1 and 131 integrin 
were established by immunoprecipitation and immunoblotting 
following 0.33 Hz mechanical stimulation of monolayer cultures. 
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Results: Primary cultures of both normal and OA human articular 
chondrocytes express PKC isozymes oc, ),, ,5, t and X, while o~, y, L 
and s isozymes but not 5 or "1' are present in the immortalized cell 
line C20A4. Confocal microscopy shows that RACK1 colocalizes 
with PKCec and [Jl integrin in normal human articular chondro- 
cytes. RACK1 binds and coimmunoprecipitates with PKCct in 
normal and OA chondrocytes and the cell line. Mechanical 
stimulation resulted in increased binding of RACK1 with PKCo. and 
[31 integrin in the cell line and normal chondrocytes which was 
prevented by incubation with the PKC inhibitor cherlerythrine 
chloride. In contrast there was no increase in RACK1 association 
with ~1 integrin or PKC isozymes following mechanical stimulation 
of OA chondrocytes. 
Conclusions: Activation induced binding of PKCoc to RACK1 is 
an early event in the cellular response of normal but not OA human 
articular chondrocytes to mechanical stimulation. Differences in 
specific PKC activation and function, related to altered RACK1 
interactions, may be important in the regulation of anabolic and 
catabolic responses of chondrocytes to mechanical and other 
stimuli in normal and diseased cartilage. 
TH089 
MINERALIZATION OF THE DEEP ZONE OF ARTICULAR 
CARTILAGE IN OSTEOARTHRITIC JOINTS. ANALYSIS BY 
FOURIER TRANSFORM INFRARED SPECTROSCOPY 
M. Sato, N. Miyoshi, M. Wada, H. Tatsuo, T. Ogawa, T. Yamada, 
M. Fukuda, and H. Baba 
Fukui Medical University, Fukui, Japan 
Aim of the study: The deep layer of the articular cartilage is 
separated histologically from the calcified layer by a basophilic line 
referred to as the tidemark, which represents the mineralizing 
front. This line is not seen in the developing skeleton but is clearly 
visible in the adult and replicated in osteoarthritic joints. The aim of 
this study was to investigate the distribution and characteristics of 
the mineral phase in the deep zone of articular cartilage of 
osteoarthritic joints using Fourier transform infrared (FT-IR) 
spectroscopy. 
Methods: Female Hartley guinea pigs were sacrificed at 
12 months of age by intraperitoneal injection of sodium pento- 
barbital (150 mg/kg). The proximal epiphyses of the tibias were 
collected and anterior portions were embedded in paraffin. Serial 
frontal sections (7 IJm thick) were prepared and stained with 
hematoxylin-eosin and safranin-O fast green. The posterior 
portions were embedded in a compound and cryo-cut into 10 pm 
thick sections. Sections were placed on BaF2 FT-IR plates and 
spectra were recorded with an IRT-30 (FT-IR) microscope 
equipped with a motorized X-Y stage and coupled to a 410M 
spectrometer (both from JASCO Co., Tokyo), at a resolution of 
8 cm -1, 5 scans, in the transmission mode. A screen image- 
recording camera attached to the microcope allowed the 
acquisition of photomicrographs of the examined area. The area of 
each spectroscopically analyzed field was 80x80 pm 2. Sequential 
spectra were collected in 80 #m steps around the tidemark. 
Results: Histologically, the articular cartilage of guinea pigs 
showed severe degenerative changes. Replications of the tide- 
mark were seen in the deep layer. Comparison of the spectra of 
non-calcified cartilage with those of calcified cartilage indicated 
marked changes in the latter in the vl and v3 vibration regions of 
the phosphate (900-1200 cm~). The raw spectra in these regions 
were analyzed by the second-derivative and the curve fitting 
approach. The peaks of calcified cartilage were observed at 962, 
997, 1030, 1052, and 1092 cm 1, whereas the peaks of non- 
calcified cartilage were seen at 1037 and 1076cm -1. In the 
calcified cartilage (deeper zone), the mature and stoichiometric 
hydroxyapatite was deposited while the non-stoichiometric and 
labile apatite such as octacalcium phosphate was deposited in the 
non-calcified cartilage (upper zone). 
Conclusion: Using FT-IT spectroscopy, we were able to detect 
the mineral phase of the calcified tissue in the hyaline articular 
cartilage in situ. The mineral phase varied according to its location, 
i.e., upper or lower portion of the tidemark. 
TH091 
AGE RELATED EFFECTS OF INTERLEUKIN-1 AND 
TRANSFORMING GROWTH FACTOR-I] ON NITRIC OXIDE- 
AND PROTEOGLYCAN SYNTHESIS 
A. Scharstul, E. Vitters, H. van Beuningen, P. van der Kraan and 
W. vam den Berg 
Department of Rheumatology, University Medical Centre 
Nijmegen, Nijmegen, The Netherlands 
The incidence of osteoarthritis (OA) is highly correlated with age. A 
factor suggested to be involved in the pathogenesis of OA is 
interleukin-1 (11-1). In contrast, Transforming Growth Factor-~ 
(TGF-~) plays an important role in the counteraction of I1-1 effects. 
A disregulation in the interplay of growth factors and cytokines 
during ageing might contribute to the development of OA. To 
examine age-related effects in cytokine and growth factor 
responses, the effects of I1-1, TGF-~ and the combination of 
II-1/TGF-[~ on nitric oxide (NO)- and PG synthesis were studied in 
young and old C57BI/6 mice. 
Mice were sacrificed at the age of 3-5 months or 12-21 months. 
Patellae were dissected and placed in RPMI medium, i1-1 (10 ng), 
TGF-~ (10 ng) or the combination of the two, were added to the 
medium which was changed daily. NO was measured on day 1 and 
2 by means of the Griess reagent and PG synthesis was measured 
via 35S incorporation in patella cartilage. Results were analyzed via 
the Student's t-test or the Mann-Whitney Rank sum test. 
Patellae of young and old mice produced NO spontaneously in 
similar amounts (7pM on day 1 and 15pM on day 2). 
I1-1 stimulated NO synthesis in young mice on both day 1 and day 
2, whereas for old mice only a significant stimulation on day 2 was 
found. Moreover, young animals synthesized significantly more NO 
than old animals on day 2. TGF-[~ treatment alone resulted in a 
reduction of NO production in old animals, but not in young 
animals. However, TGH-I~ did not have significant effects on I1-1 
induced NO synthesis in both young and old mice. Although PG 
synthesis was significantly inhibited by I1-1 in both young and old 
mice, the I1-1 effect was significantly stronger in young mice. 
TGF-~ showed no effects on PG synthesis in both age groups. 
Remarkably, TGF-J5 counteracted the effects of I1-1 on PG 
synthesis in young animals but not in old. 
The potency of I1-1 and TGF-~ to either stimulate or inhibit NO 
synthesis appeared to be age dependent. Young rhice show more 
NO synthesis after I1-1 treatment han old mice. On the other hand, 
old mice show a larger reduction in NO synthesis after TGF-13 
treatment, showing that old animals are still sensitive to TGF-~. 
Furthermore, TGF- l} was in old animals unable to counteract the 
effects of I1-1 on PG synthesis. This indicates that loss of TGF-I}- 
mediated counteraction of I1-1 effects on matrix synthesis in old 




CHONDROCYTE DEATH INDUCED BY CYCLIC 
COMPRESSIVE LOADING OF ARTICULAR CARTILAGE: 
EVIDENCE FOR THE INVOLVEMENT OF APOPTOSlS 
Z. Bee, G. V. Crossingham, K. M. Clements, M. A. Adams, 
M. Sharif* 
Department of Anatomy and "Rheumatology Unit, University of 
Bristol UK 
Aims: The aims of this study were to characterize the effect of 
moderate-to-severe levels of cyclic compressive loading on 
chondrocyte viability, and to investigate the mechanisms of 
load-induced cell death. 
Methods: Cartilage-on-bone specimens, approximately 20 mm 
square, were cut from fresh, mature bovine patella grooves. 
Specimens were mounted on a computer-controlled hydraulic 
materials testing machine and subjected to 3,600 linear-ramp 
loading cycles, at a frequency of 1 Hz, by means of a 7 mm 
diameter flat metal indentor. Maximum applied stress was in the 
range 17-1176N (0.5-20 MPa). Full-depth cartilage sections were 
stained with fluorescein diacetate and propidium iodide fluorescent 
dyes and analyzed by fluorescent light microscopy for chondrocyte 
viability. The mechanisms of cell death in loaded cartilage were 
analyzed using transmission electron microscopy to detect 
morphological changes associated with apoptosis. 
Results: For loads above 250 N (approximately 6.5 MPa), 
chondrocyte death in the cartilage located under the indentor 
increased linearly with increasing load (R=0.65, P<0.001; see 
Figure). The highest level of cell death occurred in the surface 
zone. Chondrocyte death in cartilage adjacent o the loaded region 
also increased with loads above 6.5 MPa. However, below 6.5 
MPa the percentage of dead cells in loaded and adjacent cartilage 
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Cartilage loaded at 346N (9.5 MPa) had approximately equal 
numbers of live and dead cells. Transmission electron microscopy 
of specimens loaded at 9.5 MPa revealed many morphological 
features associated with apoptosis such as cells with irregular 
membranes and multiple blebs, dilated organelles, cell fragments, 
nuclear condensation and apoptotic bodies. 
Discussion A critical load threshold for chondrocyte viability in 
bovine cartilage exists at around 6.5 MPa; this is approximately 
15% of the stress required to cause gross damage to the extra- 
cellular matrix. The increased cell death above the load threshold 
may have occurred by apoptosis since some chondrocytes 
showed many of the morphological features commonly associated 
with cell death by apoptosis. Load-induced chondrocyte death may 
represent a possible link between severe joint loading and the 
onset of the degenerative disease osteoarthritis. 
TH094 
WHAT HOLDS ARTICULAR CARTILAGE TOGETHER? 
I. K. T. Cunningham, M. Sharif*, M. A. Adams 
Department of Anatomy, and *Rheumatology Unit, University of 
Bristol. UK 
Aim: To test the hypothesis that the tensile mechanical proper- 
ties of articular cartilage depend on proteoglycans as well as 
collagen. 
Methods: Patellar-grooves were obtained from skeletally-mature 
cows and stored at -20 ° until required for testing. Full-thickness 
samples of cartilage were removed from bone, and cut into a 
'dumbbell' shape for tensile testing, with a test region 5 mm long by 
2 mm wide. Tensile strength and stiffness were measured at 
constant strain rates using a Minimal computer-controlled materi- 
als testing machine. The total proteoglycan (GAG) concentration of 
each tested specimen (and adjacent control cartilage) was 
measured using the DMB dye-binding method. The GAG content 
of 16 specimens was reduced prior to testing by incubation in 
varying concentrations of bovine testicular hyaluronidase (1 mg/ 
ml-4 mg/ml) for 18 hours at 37°C. Four specimens were similarly 
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Results: The thickness of cartilage specimens influenced their 
tensile stiffness (r2=0.37, p=0.001) and strength (r2=0.77, 
p<0.001) so these properties were normalized to unit thickness 
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before comparison with GAG content. Hyaluronidase treatment 
reduced GAG content by 9-81%, depending on enzyme concen- 
tration and original GAG content. A similar relationship between 
tensile properties and GAG concentration was observed in 
enzyme-treated and control specimens, so results were pooled 
(Fig. 1). Tensile stiffness (at 20% strain) decreased with reducing 
GAG content (r2=0.38, p>0.001). When enzyme-treated speci- 
mens were compared to their adjacent controls, it was found that 
ultimate tensile strength (UTS) was markedly reduced whenever 
the GAG concentration in the treated specimen was reduced 
below 3% wet weight (Fig. 2). Collagenase treatment reduced 
tensile strengh by 57% on average. 
Discussion Results suggest that proteoglycans help cartilage to 
resist tension as well as compression. Low GAG concentrations 
make the cartilage more extensible, and reducing GAG concen- 
tration below 3% wet weight leads to severe reductions in tensile 
strength. These results are consistent with cartilage behaving as a 
'chopped fibre-composite' material, in which tissue integrity is due 
to interactions betwee~ reinforcing fibres (collagen) and their 
surrounding matrix (proteoglycans) rather than to a coherent fibre 
'meshwork'. Cartilage destruction during osteoarthritis may 
possibly be accelerated when GAG concentration falls below 3%. 
TH095 
EFFECT OF N-ACETYLGLUCOSAMINE ON HYALURONIC 
ACID PRODUCTION IN HUMAN ARTICULAR 
CHONDROCYTES AND SYNOVIAL FIBROBLASTS 
A. Shikhman*,l, H. Chantaphakul*,l, D. C. Brinson*, M Lotz* 
*Division of Arthritis Research, The Scripps Research Institute, 
La Jolla, CA, USA; tDivision of Rheumatology, Scripps Clinic, 
La Jolla, CA, USA 
Glucosamine and its derivatives, including N-acetylglucosamine, 
represent one of the most commonly used over-the-counter drugs 
to treat osteoarthritis. Nevertheless, the mechanisms of its anti- 
arthritic and chondroprotective activities are stilt poorly understood. 
Previously, it was demonstrated that glucosamine can accelerate 
the production and accumulation of sulfated glycosaminoglycans 
in chondrocytes and cartilage tissue isolated from various 
mammalian species, including humans. However, the effect of 
glucosamine and N-acetylglucosamine on hyaluronic acid prod- 
uction and accumulation has never before been studied. In the 
present communication, we analyzed the effect of glucosamine on 
hyaluronic acid production in cultured human articular chondro- 
cytes and synovial cells. The concentration of hyaluronic acid was 
measured in a competitive ELISA with hyaluronan binding protein 
(Seikagaku America, MA). Chondrocytes and synovial fibroblasts 
were isolated from the knees of patients with grade II, III and IV 
osteoarthritis. Results of the experiments demonstrated that 
N-acetylglucosamine accelerated the production and accumulation 
of hyaluronic acid in human articular chondrocytes and synovial 
fibroblasts in a dose and time dependent fashion. Surplus 
accumulation of hyaluronic acid in N-acetylglucosamine treated 
cells was statistically significant on the 3rd day of incubation as 
compared with untreated cells, and continued to rise up to the 21st 
day of culture. N-acetylglucosamine concentration below 1 mM 
was inefficient to upregulate the production of hyaluronic acid. 
Accumulation of the hyaluronic acid was noticeable in both cell- 
associated and the supernatant fractions of the culture. 
N-acetylglucosamine was more efficient than glucose, 
glucosamine sulfate and N-acetylgalactosamine, and equal to 
N-acetylmannosamine in the upregulation of hyaluronic acid 
production. Incubation of synovial fibroblasts with N-acetyl- 
glucosamine resulted in a higher level of hyaluronic acid 
production in comparison to the articular chondrocytes. Possible 
mechanisms of N-acetylglucosamine mediated upregulation of 
hyaluronic acid production are discussed in detail. These include 
the stimulatory effect of the sugar on TGF~ and HAS-2 expression. 
TH096 
HEXOSAMINIDASE INHIBITION ACCELERATES 
ACCUMULATION OF GLYCOSAMINOGLYCANS IN HUMAN 
ARTICULAR CHONDROCYTES AND CHONDROSARCOMA 
CELLS 
A. Khikhrnan*:l:, D. C. Brinson*, C.-H. Wong-I, M. Lotz* 
"Division of Arthritis Research and tDepartment of Chemist~ The 
Scripps Research Institute, La Jolla, CA, USA; ~.Division of 
Rheumatology, Scripps Clinic, La Jolla, CA, USA 
Lysosomal glycosidases represent an important class of the 
enzymes involved in glycosaminoglycan catabolism. However, the 
role of these enzymes in cartilage degradation is not well defined. 
Recently, we demonstrated that hexosaminidase, including its two 
isoenzymes A and B, represents one of the dominant glycosidases 
secreted by human cultured articular chondrocytes. Stimulation of 
chondrocytes with interleukin-l~ results in much higher release 
and accumulation of hexosaminidase into the extracellular 
compartment as compared to other glycosaminoglycan-degrading 
glycosidases, including ~-galactosidase, [3-glucuronidase, c~-N- 
acetylgluosaminidase, c~-L-iduronidase, aryl sulfatase and 
galactose-6-sulfate sulfatase. Moreover, hexosaminidase was 
found to be more active than the other glycosidases studied, even 
at neutral pH. In order to estimate the contribution of hexos- 
aminidase to the degradation of cartilage glycosaminoglycans, we 
analyzed the effect of the enzyme inhibition on accumulation of 
sulfated glycosaminoglycans and hyaluronic acid in cultured 
human articular chondrocytes and human chondrosarcoma cells. 
The iminosugar analog of N-acetyl-~-D-glucosamine was used as 
the hexosaminidase inhibitor. The inhibitor was capable of 
efficiently inhibiting both extracellular and intracellular hexos- 
aminidase activity and was nontoxic to the cells. Incubation of 
human articular chondrocytes and chondrosarcoma cells with the 
inhibitor resulted in a statistically significant accumulation of 
sulfated glycosaminoglycans in the cell-associated matrix and in 
the decrease of the sulfated glycosaminoglycan released into the 
supernatant. Similar results were observed with hyaluronic acid 
accumulation. Incubation of human cartilage tissue with the 
inhibitor resulted in a measurable accumulation of safranin-O- 
positive material in the pericellular space. Therefore, results of the 
experiments indicate that hexosaminidase acts as one of the key 
enzymes in the cartilage glycosaminoglycan degradation, and its 
inhibition may represent a potentially valuable therapeutic 
approach in chondroprotection. 
TH097 
EFFECTS OF SPECIFIC LIGANDS OF PEROXISOME 
PROLIFERATOR-ACTIVATED RECEPTOR-a AND -7 AND 
RETINOID Z RECEPTOR IN ILll]- AND LPS-STIMULATED 
RAT SYNOVIAL FIBROBLASTS 
M,-A. Simonin*, K. Bordji °, S. Boyault*, A. BianchiJ-, P, Netter" and 
B. Terlain" 
*Laboratoire de Pharmacologie, UMR CNRS 7561, Vando~uvre- 
les-Nancy, France; tLaboratoire de Biologie du Developpement, 
UPRES 2402, Vanoeuvre-les-Nancy, France 
Aim of the study: Peroxisome proliferator-activated receptors 
(PPAR~, PPARy, RZR(x) are members of the nuclear receptors 
family of transcription factors. Recently, they have been shown to 
modulate the effects and the production of pro-inflammatory 
cytokines in numerous cell types or animal models. In the present 
work, we evaluated their expression in normal and IL-I~- or 
LPS-stimulated rat synovial fibroblasts. The potentially anti- 
inflammatory effects of specific ligands have been further 
investigated at the level of COX-2 and iNOS mRNA expression on 
the one hand and at the level of IL-I~ expression on the other 
hand. 
Methods: Rat synovial fibroblasts were obtained from healthy 
rats and cells were used between the third and the sixth passages. 
Cultured cells were stimulated by LPS (10 IJg/ml) or recombinant 
human IL-I~} (rh-lL-l~, 50 U/ml) in the presence or absence of 
ligands [10 IJM troglitazone and 10 pM 15d-A 12';4 prostaglandin J2 
(15d-PGJ2) for PPARy, 250pM Wy-14,643 for PPARo~, 10pM 
CGP-52608 for RZRe~]. Total cellular RNA was extracted from rat 
cultured synovial cells and mRNA expression of PPARy, PPARc~, 
RZRc~, iNOS, COX-2 and IL-I~ was examined by quantitative 
RT-PCR. Immunoblotting and immunocytochemistry analysis of 
PPARo~, PPARy, RZRc~ were performed on synovial cells treated or 
not with LPS. 
Results: We demonstrated the presence of the three nuclear 
receptors in synovial fibroblasts at both nRNA and protein levels. 
PPARo~ and PPARy were mainly nuclear localized with a non- 
negligible presence in the cytoplasm. PPAR 7 mRNA expression 
was significantly decreased in LPS or rhlL-l~-stimulated synovial 
fibroblasts. The level of PPARc~ mRNA did not change in both 
(rhlL-113 or LPS)-stimulated synovial cells. By contrast, stimulation 
of synovial cells with LPS did not modify the expression of RZRc~ 
mRNA, whereas it was significantly increased when cells were 
stimulated with rhlL-l~. Changes in mRNA levels encoding the 
three nuclear receptors, upon treatment with LPS or rhlL-l[}, are 
related to the variations of the corresponding proteins. 15D- 
PGJ2 significantly decreased the LPS-or rhlL-l~}-induced 
iNOS and COX-2 expression whereas specific PPAR7 ligand 
(troglitazone), PPARo~ ligand (WY-14,643) and RZRc~ ligand (CGP 
52608) had no effect. 15D-PGJ2 also inhibited the expression of 
IL-1[3 in rhlL-l~-stimulated synovial fibroblasts. However, it failed 
to block the induction of IL-1 ~ expression in LPS-stimulated cells. 
Conclusion: The presence of PPAR 7, PPARe~ and RZRcc in rat 
synovial cells at both mRNA and protein levels was demonstrated 
for the first time. mRNA expression of the three nuclear receptors 
was differently modulated by rhlL-l~ or LPS stimulation. These 
results demonstrate that PPARc~ and RZRc~ ligands seem not to 
constitute potential targets to counteract he effects of rhlL-113 and 
LPS on synovial cells. Concerning PPAR 7 ligands, if 15d-PGJ2 
decreased the LPS- or rhlL-1 ~-induced iNOS and COX-2 expres- 
sion, no significant effect was observed with troglitazone. More 
interestingly, 15d-PGJ2 was able to block the IL-I[~ expression 
only in response to rhlL-1 J} stimulation but not after LPS treatment. 
These results offer new insights in regard to the anti-inflammatory 
potential of the 15d-PGJ2, and underline that its action should be 
differently implicated in both IL-1 and LPS-pathways. 
TH098 
CALCIUM PENTOSAN POLYSULFATE DOWNREGULATES 
ESTROGEN RECEPTOR PRESENTATION IN SYNOVIAL 
FIBROBLASTS IN AN OVINE MODEL OF OSTEOARTHRITIS 
M. M. Smith, L. J. A. Reichman, S. M. Smith, S.-Y. Hwa and 
P. Ghosh 
/nstitute of Bone and Joint Research, University of Sydney at The 
Roya/ North Shore Hospital, Sydney, Australia 
Objectives: Although it is well established that the incidence of 
osteoarthritis (OA) in post-menopausal females is higher than 
males of the same age, the molecular mechanisms responsible 
have not been defined. We consider that estrogen receptor (ER) 
levels of joint target cells could contribute to disease progression 
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by influencing gene expression. The aim of the present study was 
to test this hypothesis as well as determine if the structure- 
modifying anti-arthritic drug, calcium pentosan polysulfate 
(CaPPS) could influence this process. 
Methods: Eighteen 8-year-old Merino ewes were used for the 
study; 12 underwent bilateral ateral meniscectomy (Mx) to induce 
OA. Six Mx sheep received oral CaPPS (20 mg/kg twice weekly) 
for 24 weeks (OA+CaPPS group) and the remaining six Mx ewes 
were used as non-drug-treated controls (OA group). Six untreated 
non-Mx ewes served as non-operated controls (NOC group). All 
sheep were killed 6 months post surgery. The synovium was 
aseptically removed from both knee joints, enzymatically digested 
and the resulting synoviocytes established in monolayer culture. At 
the 3rd passage, cells were resuspended in buffer and ER levels 
assessed in the cytosolic and nuclear subcellular fractions by the 
established radiolabelled estrogen/dextran-coated charcoal 
method. Histological sections (4 pm) of undigested synovium were 
also prepared and stained overnight at 4°C with monoclonal 
mouse anti-human ER (Dako), detected with a Streptavidin-biotin 
kit and counterstained with Mayer's haematoxylin. 
Results: The total specific estrogen binding capacity of cultured 
synoviocytes from OA joints was significantly elevated 
(l.5+0.3fmol/mg protein, p<0.05) compared to NOC cells 
(0.56±0.34). CaPPS treatment returned estrogen binding to NOC 
levels (0.39±0.19, p<0.05). Immunolocalization f ER in synovium 
revealed the presence of both ER-positive and ER-negative cells. 
OA significantly increased both the percentage of ER+ cells 
(p<0.05) and the total number of cells along the synovial intima 
(p<0.0005). In contrast, in the OA+CaPPS synovium the total 
intimal cells (p<0.05) buttage of ER+ cells were reduced, suggest- 
ing a reduction in the expression of ER per cell in the drug treated 
OA group. 
Conclusions: This is the first report of upregulation of ER in 
synovial fibroblasts from OA joints. While the significance of this 
finding is still to be resolved, by analogy with other cellular 
systems, it would suggest that OA synovial cells would be more 
sensitive to circulating estrogen, possibly resulting in enhanced 
production of matrix metalloproteinases and proinflammatory 
cytokines. The ability of CaPPS to reduce ER in OA synovium to 
normal levels is therefore consistent with the known anti-OA 
activity of this agent and provides an additional pathway for its 
mode of action. 
TH099 
ESTROGEN REPLACEMENT THERAPY RESTORES 
PROTEOGLYCAN SYNTHESIS IN PATELLAR CARTILAGE OF 
OSTEOARTHRITIC SHEEP 
M. M. Smith, J. M. Engle, S.-Y. Hwa and- P. Ghosh 
Institute of Bone and Joint Research, UniversiO/ of Sydney at the 
Royal North Shore Hospital, St. Leonards NSW 2065 
Objectives: Although the prevalence of osteoarthritis (OA) in 
females is similar to males prior to menopause, it increases 
steadily in the post-menopausal years. Estrogen has therefore 
been considered to play an important role in the pathogenesis of 
OA, however previous studies have generated controversial data. 
The aim of the present study was to examine the effects of 
transdermal estrogen replacement therapy on the biosynthesis of 
proteoglycans (PGs) and the production of matrix metallo- 
proteinase (MMP) activity from ex vivo cultures of patellar cartilage 
explants in an ovine model of OA. 
Methods: Twenty-four Merino ewes of approximately 8 years 
were ovariectomized (Ovx). Eighteen of the Ovx sheep also 
underwent bilateral ateral meniscectomy to induce OA. Six of the 
Ovx+Oa sheep received low dose estrogen (human release 
rate =12.51Jg/day) and six more received high dose estrogen 
(50 IJg/day) using Femtran-50 (3M) patches applied to the skin of 
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the inner thigh. Six more sheep were used as non-operated 
non-estrogen treated controls. After 3 months of treatment, the 
sheep were sacrificed and the patellae removed. Three mm plugs 
were cultured from the patellar cartilage in Hams F12/10% FCS for 
24 hours. The media was then replaced and supplemented with 
Na235SO4 for 48 hours before harvesting. Following papain 
digestion, DNA and proteoglycan (PG) synthesis were measured 
using established procedures. MMPs in media were measured 
using a commercial fluorogenic substrate. 
Results: OVx significantly lowered PG synthesis compared to 
NOC (5770-640 DPM/pg DNA to 3710±440; p<0.005). Ovx 
combined with OA diminished PG synthesis even further (to 
2770±340; p<0.002). Cartilage explants from Ovx+OA animals 
who were treated with low or high dose estrogen replacement 
therapy significantly increased PG synthesis (3930±760 and 
3460±500 respectively) relative to non-estrogen treated controls 
p<0.05). However, estrogen treatment had no significant effect on 
MMP activity in culture media, although levels in OA explant media 
were elevated. 
Conclusions: Ovadectomy and OA both reduced the biosynthe- 
sis of PGs in cartilage explants. Since this response could be 
reversed by estrogen replacement therapy we conclude that this 
sex hormone plays an important role in the regulation of PG 
metabolism and its depletion in females following menopause 
may contribute to cartilage degeneration and the progression of 
their OA. 
TH 100 
PHARMACOLOGICAL EFFECTS ON THE BIOSYNTHESIS 
AND ACTIVITY OF INDUCIBLE NITRIC OXIDE SYNTHASE IN 
CHONDROCYTES 
T. Sadowski ° and J. Steinmeyer 
Department of Orthopaedic Surgery, University of GieBen, 
Germany 
"Department of Biology, University of Konstanz, Germany 
Objective: The identification of nitric oxide (NO) as a major 
catabolic factor in joint diseases has prompted several studies on 
the therapeutic usefulness of inhibition of inducible nitric oxide 
synthase (iNOS) activity. Clinical and animal studies suggest that 
tetracyclines might be effective in the treatment of patients with 
rheumatoid arthritis and osteoarthritis. The purpose of this study 
was to examine whether tetracyclines might act against the 
interleukin-1 (IL-1) induced NO production in articular chondro- 
cytes. As inhibition of iNOS has emerged as a new mode of action 
of nonsteroidal anti-inflammatory drugs (NSAIDs), we also 
evaluated the effects of diclofenac-Na and meloxican on iNOS 
expression and NO production. 
Methods: Chondrocytes were isolated from macroscopically 
healthy metacarpophalangeal joints of 18-24 months old steers 
and subsequently encapsulated in alginate beads. Chondrocytes 
were cultured for 8 days in supplemented Ham's F12 media with 
media changes every second day. During the final 48 h culture 
media contained 0.5 ng/hl IL-lo~ either alone or together with 
tetracyclines (1 pM to 100pM), NSAIDs (10pM) or the drug 
vehicle, respectively. Nitrite levels in media and solubilized alginate 
samples were measured by using the Griess reaction, iNOS 
protein synthesis was analyzed by metabolic labeling of chondro- 
cytes followed by immunoprecipitation, separation on SDS-PAGE 
and measuring of the single protein band with an automatic linear 
analyzer. Expression of mRNA for iNOS was analyzed by RT-PCR- 
ELISA. Experiments were repeated 4-12 times. 
Results: Minocycline dose-dependently reduced the IL-1 
stimulated NO production by inhibition of the mRNA expression 
(IC~o=69.9 pM) and protein synthesis (ICso=37.1 ~M) of iNOS. 
Diclofenac-Na at a concentration of 10 I.JM only weakly reduced 
nitrite accumulation and mRNA expression of iNOS. No effects 
were observed for tetracycline, doxycycline and meloxicam, 
respectively. 
Conclusions: Inhibition of the expression of iNOS in articular 
chondrocytes by minocycline at therapeutically achievable concen- 
trations suggest a new mechanism by which the efficacy of this 
drug in the treatment of joint diseases might be explained. 
TH I01  
ASSESSMENT OF THE GENE EXPRESSION PROFILE OF 
DIFFERENTIATED AND DE-DIFFERENTIATED HUMAN 
CHONDROCYTES BY MICROARRAY ANALYSIS 
D. G_Stokes, G. Liu, P. Zhang, and S. A. Jimenez 
Division of Rheumatology, Department of Medicine, Jefferson 
Medical School, Thomas Jefferson University, Philadelphia, USA 
It has long been known that chondrocytes undergo a process 
termed de-differentiation when they are grown as a monolayer in 
cell culture. De-differentiated chondrocytes in monolayer acquire a 
different morphology (fibroblast-like) and a different pattern of gene 
expression as compared to chondrocytes that have been main- 
tained in a differentiated state by culture in agarose, alginate, or in 
suspension. During de-differentiation, the gene expression pattern 
changes from one of expression of chondrocyte-specific genes 
such as types II, IX, and XI collagen and aggrecan to a more 
fibroblastic or pre-chondrogenic pattern (i.e., types I, III, and V 
collagen and versican). Recent evidence has shown that during 
the osteoarthritis (OA) disease process, some of the resident 
chondrocytes also acquire a chondroprogenitor-like phenotype. 
Therefore, we studied the changes in patterns of gene expression 
exhibited by human chondrocytes as they de-differentiate in 
culture in order to better understand the mechanisms that control 
this process and its relationship to the phenotypic hanges that 
occur in chondrocytes during the development of OA. To this end, 
we have performed a microarray gene expression analysis of 
differentiated and de-differentiated human fetal chondrocytes. 
Epiphyseal chondrocytes were isolated from the developing knee 
joint and split into two different culture conditions. Half of the 
chondrocytes were grown on poly-(2-hydroxethyl) methacrylate 
coated plates (differentiated) while the other half were grown in 
plastic tissue culture flasks as a monolayer (de-differentiated). 
After 11 days of culture, poly-A+ RNA was isolated from the two 
cell populations and subjected to a microarray analysis containing 
5000 known human genes and 3000 ESTs. We observed a 3 fold 
or higher difference in expression between 62 known genes and 6 
ESTs. Preliminary analysis of several of the genes showing 
differential expression by Northern analysis has confirmed the 
microarray results. 
TH 102 
REGULATION OF THE HUMAN COL2A1 PROMOTER BY 
TUMOR NECROSIS FACTOR-a AND INTERFERON-./ 
D. G. Stokes, G. Liu, P. Zhang and S. A. Jimenez 
Division of Rheumato/ogy, Department of Medicine, Jefferson 
Medica/ School Thomas Jefferson University, Philadelphia, USA 
The proinflammatory c tokines IL-113, TNF-o., and IFN-~, are known 
to play a role in the progression of degenerative joint diseases 
such a rheumatoid arthritis and osteoarthritis. These cytokines 
modulate the expression of many genes by both synoviocytes and 
chondrocytes, including genes for matrix degrading metallo- 
proteinases and extracellular matrix proteins. In general, these 
cytokines induce a catabolic response from chondrocytes in that 
they repress the synthesis of extracellular matrix proteins such as 
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type II collagen and aggrecan while inducing the expression of 
metalloproteinases such as stromelysin and coltagenase-3 
(MMP13). Previous work has shown that the repression of matrix 
gene expression in chondrocytes by treatment with these 
cytokines is controlled primarily at the level of transcription. How- 
ever, the identity of the cis- and trans-acting factors involved in the 
cytokine .induced down-regulation of cartilage-specific matrix 
genes remains largely unknown. We have begun to characterize 
the cis- and trans-acting factors that are responsible for the 
down-regulation of the human COL2A1 promoter in human 
chondrocytes by TNF-r~ and IFN-y. We show that treatment 
of chondrocytes transiently transfected with a COL2A1 
promoter-CAT construct with either TNF-~ and or IFN-y results in a 
50% decrease of promoter activity. We also find that treatment with 
either TNF-oc and/or IFN-y reduces the binding of an Spl-like 
binding activity present in chondrocyte nuclear extracts to 
sequences within the COL2A1 promoter region. We theorize that 
the reduction in the availability of Spl, a known positive regulator 
of the COL2A1 promoter, may be partly responsible for the 
negative effects that these cytokines have on COL2A1 gene 
expression in chondrocytes. 
TH 103 
DETERMINATION OF MMP ACTIVITY IN 
o2MACROGLOBULIN-MMP COMPLEXES IN SERUM OF 
RA/0A PATIENTS AS A POTENTIAL MARKER FOR JOINT 
DESTRUCTION 
I. Tchetverikov*l-, J. DeGroot*:l:, B. Beekman*, B. Van El*, 
W. H. Van der Laan*l, M C. Kraan§, F. C. Breedveld*, 
R. Hanemaaijer*, J. M. TeKoppele ° (JMTKoppele@pg.tno.nl) 
*TNO Prevention and Health, Leiden, The Netherlands; TLUMC, 
Leiden, The Netherlands; SUMC, Utrecht, The Netherlands; 
§AMC, Amsterdam, The Netherlands 
Aim of the study: Matrix Metallo Proteinases (MMPs) are 
believed to play a crucial role in joint destruction in OA and RA. It 
is generally believed that an excess of active MMP in synovial 
tissue is due to an imbalance between active MMPs and their 
tissue inhibitors (TIMPs). We hypothesize that such an excess of 
active MMPs results in spill over of the active enzyme into the 
circulation. The aim of the study was to provide evidence that such 
a spill over of active MMPs results in the formation of 
o~2Macroglobulin-MMP (~2M-MMP) complexes in the circulation. 
As such, the o~2M-MMP complexes are hypothesized to reflect the 
enzyme activity at tissue level and present a marker of joint 
destruction. 
Methods: To mimic the in vivo situation, active MMP-13 
(collagenase-3) was spiked to human plasma or to buffer in the 
absence or presence of cc2M. 100kDa filters were used to 
investigate in which fraction MMP-13 activity could be measured 
after ultrafiltration. Fractionation was also achieved by FPLC; 
MMP-13 activity was determined in all fractions using the small 
fluorogenic substrate TNO211-F. The same fluorogenic substrate 
was used to monitor the changes in MMP activity in serum of 4 
leflunomide-treated RA patients at baseline and after 16 weeks 
of treatment. 
Results: Ultrafiltration of plasma spiked with active MMP-13 
(48 kDa) resulted in measuring enzyme activity in a high molecular 
weight fraction (> 100 kD cut off ultrafiltration filter), consistent with 
formation of rx2M-MMP (>750 kDa) complex in buffer. FPLC 
analysis of active MMP-13 resulted in a major peak of enzyme 
activity at the tail of the albumin peak (Fig. 1 ). Free cz2M (725 kDa) 
eluted earlier than the albumin (69 kDa) peak. Enzyme activity was 
measured in o~2M-MMP-13 complexes, eluted at the identical 
position as ~M.  Similarly, enzyme activity of plasma spiked with 
MMP-13 (mimicking the pathological situation of spill over of active 
enzyme into the circulation), showed an MMP enzyme activity 
peak at the c~zM and ~M-MMP position (Fig. 1). Altogether, these 
different approaches confirm the existence of c~M-MMP 
complexes in plasma. The results of MMP activity measurements 
of leflunomide-treated RA patients show significant reduction in 
serum MMP activity after 16 weeks of treatment (Fig. 2). 
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Conclusion: 1. Upon entering the circulation, e.g. due to spill 
over of active MMPs from joint tissue, active MMPs become 
complexed with o~2M and can be measured with low molecular 
weight fluorogenic substrate. 
2. MMP activity in serum of leflunomide-treated RA patients was 
significantly reduced after 16 weeks of treatment. That indicates 
that plasma or serum MMP activity measurements merit 
exploration as a candidate for a marker of joint destruction. 
TH 104 
ANALGESIC PROPERTIES OF $19812, AN INHIBITOR OF 
CYCLOOXYGENASE AND LIPOXYGENASE PRODUCTS, IN 
MICE AND RATS 
C~Tordj_rnan, F. Sauveur*, M. Wierzbicki*, Y. Bresson, I. Bellot, 
N. Andre and J. Bonnet 
Rheumatology Dvision and *Medicinal Chemistry Division, Institut 
de Recherches Servier, Suresnes, France 
Aim of the study: Based on the experimental evidence that 
inhibition of the production of LTB4 counteracts the gastric damage 
due to cyclooxygenase inhibition, a series of balanced inhibitors of 
cyclooxygenase and lipoxygenase pathways of arachidonic acid 
led to the selection of S 19812 (4-(4.5-bis(4-methoxy phenyl) 
thiophen-2-yl) N-hydroxy N-methyl butanamide). The properties of 
S 19812 on PGE 2 and LTB4 production have been previously 
demonstrated in vitro (rat polymorphonuclear cells and human 
blood) as well as after ex vivo oral administration in mice, and the 
compound has been shown to be devoid of gastric toxicity in 
rodents and dogs. In this study the analgesic properties of $19812 
were investigated in screening acute models of hyperalgesia in 
rodents. 
Methods and results: Acute oral administration of $19812 one 
hour before paraphenylbenzoquinone injection dose-dependently 
prevented the nociceptive behaviour in mice (ED50=2.1 mg/kg). It 
was more potent than ibuprofen and naproxen and less potent 
than diclofenac and indomethacin. This effect was maximal after 
ten minutes and became negligible after three hours. Content in 
whole brain PGE2, measured by enzyme immuno-assay, 
decreased with treatment of S 19812. The compound, admin- 
istered orally simultaneously to carragenJn injection in paw, 
reduced the hyperalgesia induced by focal thermal stimulation, 
measured five hours later (ED50=9.1 mg/kg). It was devoid of 
activity on the response latency (licking of the forepaw) in the 
hot-plate test in mice. 
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Conclusion: These data indicate that $19812, a balanced 
inhibitor of cyclooxygenase and lipoxygenase, possesses 
analgesic properties in acute models in rodents. They may be due 
at least in part to its interaction with the arachidonic acid 
metabolism at the peripheric and central levels. The compound is 
devoid of opioid-like activity as shown in the hot-plate test. These 
results suggest that $19812, which has been shown to be 
non ulcerogenic, may represent an attractive candidate for the 
treatment of pain in rheumatoid diseases. 
TH 105 
AQUAPORIN WATER CHANNELS IN HUMAN ARTICULAR 
CARTILAGE; DIFFERENTIAL EXPRESSION IN 
PATHOLOGIES OF HUMAN CARTILAGE 
E. Trujillo, R. Marin, B~ Masrani, D. Marples, P. Martin-Vasallo, 
A. Mobasheri 
Unidad de linvestigacion y Servicio de Reumatologia, Hospital 
Universitario de Canarias. Departamento de Bioquimica y Biologia 
Molecular and Departamento de Fisiologia, Universidad de La 
Laguna, La Laguna 38206. Tenerife, Spain. School of Biomedical 
Sciences. University of Leeds, Leeds LS2 9NQ, UK. Department 
of Biomedical Sciences, University of Westminster. 115 New 
Cavendish Street, London W1M 8JS. UK 
Aim: Aquaporins are responsible for transporting water across 
the plasma membrane of absorptive and secretory epithelia. The 
interaction between water and cations in the extracellular matrix 
(ECM) substantially influences the load bearing performance of 
cartilage. However, despite the importance of water in cartilage 
function, thus far, there have been no reports of aquaporin expres- 
sion in cartilage cells. In this study we detected the expression of 
aquaporin 1 water channel (AQP1) in human articular cartilage 
articular. We compared the expression of AQP1 in isolated 
chondrocytes and several chondrocyte-like cells. We also com- 
pared the expression of AQP1 in normal human cartilage and 
cartilage obtained from subjects with osteoarthritis (OA) and rheu- 
matoid arthritis (RA). 
Methods: Immunohistochemical and immunofluorescence 
techniques were used to detect AQP1 in human articular cartilage 
using a polyclonal antibody exhibiting broad species specificity. 
Immunoblotting and immunocytochemistry was used to compare 
expression of AQP1 in freshly isolated chondrocytes and a variety 
of chondrocyte-like cells derived from human and rabbit cartilage. 
Immunofluorescence confocal laser scanning microscopy was 
used in conjunction with image acquisition and analysis to 
compare expression of AQP1 in normal human cartilage, OA and 
RA samples. 
Results: The results of immunohistochemical studies show that 
AQP1 is expressed throughout the various zones of human 
articular cartilage. However. AQP1 expression was reduced or lost 
following chondrocyte isolation. AQP1 was altogether absent in 
established chondrocyte-like cells. 
Discussion: This study shows, for the first time, that AQP1 is 
expressed by chondrocytes in situ within cartilage but is not 
present in chondrocyte cell lines. Comparison of normal, OA and 
RA cartilage showed no difference between AQP1 expression in 
normal and OA but indicated a significant upregulation in RA 
cartilage. The presence of AQP1 in chondrocytes supports a role 
for AQP1 in water transport in chondrocytes and the down- 
regulation of AQP1 following isolation suggests that isolated and 
cultured cells do not have a physiological requirement for 
AQP1 mediated water transport. Thus, AQP1 may be important for 
volume regulation in chondrocytes, allowing the cells to respond to 
changes that routinely occur in their ionic and osmotic environment 
in the ECM of load bearing joints. 
TH 106 
THE AMILORIDE-SENSITIVE EPITHELIAL SODIUM CHANNEL 
(ENaC) IS REGULATED BY THE EXTRACELLULAR [Na ÷] IN 
CHONDROCYTES 
E: Trujil!o',l, A. Mobasheri§, I. Ferrazt, S. Bustabadl, 
M F. ArteagaJ:, I. C6zar"4:, J. Avila~, T. Gonzalezl", 
P. Martin-Vasallo:l: 
*Unidad de Investigacion y tServicio de Reumatologia, Hospital 
Universitario de Canarias. J;Departmento de Bioquimica y Biologia 
Molecular, Universidad de La Laguna, Tenerife 38206, Spain. 
§Department of Biomedical Sciences, School of Biosciences, 
University of Westminster, London WlM 8JS, UK 
Aim: Three homologous subunits (oq 13 and 7) assemble to form 
ENaC, an amiloride-sensitive and highly Na ÷ selective channel. 
We have previously demonstrated by immunohistochemical 
analysis in human cartilage tissue sections that oq [:~ and 7 ENaC 
subunit proteins are expressed in healthy cartilage the expression 
of the three ENaC subunits in cartilage in cartilage derived from 
subjects with osteoarthritis (OA) is substantially reduced or 
undetectable. Changes in extracellular matrix [Na +] occur in OA. 
Our previous results suggested that chondrocytes are sensitive to 
these changes and respond with variations in the amount of ENaC 
copies in the plasma membrane. Here we studied the effect of 
extracellular [Na ÷] on the subcellutar localization and expression of 
ENaC in a human chondrocyte-like cell line, C20/A4. 
Materials and methods: Immunocytochemistry: Expression and 
subcellular localization of ENaC were investigated in the human 
chondrocyte cell line C20/A4 cultured in increasing [Na ÷] (154, 
175, 200, 225, 250, 275 and 300 mM). Specific antibodies against 
the cz, 13 and ), subunits of ENaC and secondary TRITC conjugated 
antibodies were used for fluorescence and confocal laser scanning 
microscopy. Immunoprecipitation and Western-blot analysis: 
C20/A4 cells cultured in increasing [Na +] were lysed, treated with 
glycanases, and ENaC cz, I~ and )' subunits were immune- 
precipitated with specific antibodies, loaded on polyacrylamide 
gels and processed for Western blotting using the corresponding 
anti ENaC antibodies, Quantification of Western-blots was 
performed and subsequent comparing of the intensity of the 
bands. 
Results: The fluorescence immunohistochemistry shows 
specific expression of cJ., J~ and ,( ENaC subunits in chondrocytes 
cultured in standard [Na ÷] (154 nm). The amount of the three 
ENaC subunits expression drastically decreased as the [Na*] in 
culture medium increased. In Western blots, the intensities of 
bands specific for o~, 13 and t' ENaC immunoprecipitated also 
progressively decreased as extracellular [Na ÷] was increased. 
Discussion: This study demonstrates that c~, 13 and 7 ENaC are 
expressed, in the same order of magnitude, in the human chondro- 
cyte cell line C20/A4. These results confirm earlier observations 
made in human articular cartilage. The expression of ENaC o., I~ 
and 7 subunits in this cell line are inhibited by increases of 
extracellutar [Na+]. These observations demonstrate the critical 
role of ENaC in the maintenance of Na+ balance in chondrocytes. 
Dysregulation of ENaC may play a role in the pathogenesis of OA. 
Supported by FIS grant 99/0695. (Spain). 
TH 107 
EFFECT OF EXTRACELLULAR [Na*] IN BIGLYCAN AND 
DECORIN SYNTHESIS BY CNONDROCYTES 
E. Trujillo*l, A. Mobasheri§, M. F. Arteaga:l:, I. Ferrazt, 
S. Bustabadt, I. C6zar:l:, J. Avila:l:, T. Gonzalezt, 
P. Martin-Vasallo:l: 
"Unidad de Investigacion y tServicio de Reumatologia, Hospital 
Universitario de Canarias. :~.Departmento deBioquimica y Biologia 
Molecular, Universidad de La Laguna, Tenerife 38206, Spain. 
§Department of Biomedical Sciences, School of Biosciences, 
University of Westminster, London W1M 8JS, UK 
Aim: An altered chondrocyte phenotypic expression of biglycan 
and decorin is an early event in osteoarthritis (OA). Changes in 
extracellular matrix [Na ÷] occur in OA. Previous results suggested 
that chondrocytes are sensitive to changes in their extracellular 
Na+ environment and respond with variations in the matrix 
synthesis. 
Here we studied the influence of extracellular [Na +] on the 
metabolism of small proteoglycans, biglycan and decorin, in a 
human chondrocyte-like cell line, C20/A4. 
Methods: Extracellular deposition of biglycan and decorin was 
analyzed immunohistochemically in the human chondrocyte cell 
line C20/A4 cultured in increasing [Na ÷] (154, 175, 200, 225, 250, 
275 and 300 mM). Specific antibodies against biglican and decorin 
and secondary TRITC conjugated antibodies were used for fluor- 
escence and confocal laser scanning microscopy. The biosynthe- 
sis of biglycan and decorin was examined by immunoprecipitation 
and sodium dodecyl sulfate-polyacrylamide g l electrophoresis of 
the synthesized small proteoglycans: C20/A4 cells cultured in 
increasing [Na*] were immunoprecipitated with specific antibodies, 
loaded on polyacrylamide gels and processed for Western blotting 
using the corresponding antibodies. Quantification of Western- 
blots was performed and subsequent comparing of the intensity of 
the bands. 
Results: Fluorescence immunohistochemistry shows specific 
extracellular expression of biglycan and decorin in chondrocytes 
cultured in standard [Na ÷] (154 nm). Immunostaining revealed 
significantly greater amounts of biglycan and decorin expression 
as the [Na ÷] in culture medium increased. In Western blots, the 
intensities of bands specific for biglycan and decorin immuno- 
precipitated also progressively increased as extracellular [Na ÷] 
was increased. 
Discussion: This study demonstrates that biglycan and decorin 
are expressed in the human chondrocyte cell line C20/A4. The 
chondrocytes exposed to high extracellular [Na*] synthesized 
significantly more biglycan and decorin. These observations 
demonstrate the critical role of extracellular [Na*] in chondrocytes 
proteoglycans ynthesis. 
Supported by FIS grant 99/0695. (Spain). 
TH 108 
PHENOTYPIC DIFFERENCES IN MURINE CHONDROCYTE 
CELL LINES DERIVED FROM MATURE ARTICULAR 
CARTILAGE 
H. M. van Beuningen, P. M. van der Kraan, W. B. van den Berg 
University Hospital, Nijmegen, Nijmegen. The Netherlands 
Objective: Investigation of chondrocyte responses to cytokines 
and other environmental signals in health and disease is greatly 
hindered by their phenotypic instability in culture. We have 
immortalized chondrocytes in an attempt o stabilize the pheno- 
type. We immortalized mature articular chondrocytes, instead of 
embryonal cells which were used in most studies. Moreover, to 
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preserve the differentiated phenotype, cells were cultured in a 
three-dimensional carrier, in alginate beads. 
Methods: Pieces of articular cartilage were cut from murine 
patellae or femoral heads. Chondrocytes were isolated by 
digestion with collagenase. The obtained cells were cultured in 
monolayer with DMEM/Ham's F12 + 10% fetal calf serum and 
immortalized by transfection of the SV40 large T antigen gene. 
Sixteen clones were obtained and their phenotypes were 
characterized after 2 weeks culture in alginate beads (8x106 
cells/ml). The following parameters were used to characterize their 
phenotypes. Effect of 1 ng/ml interleukin-1 (IL-1) on proteoglycan 
synthesis as measured by 3SS-sulfate incorporation, mRNA levels 
of collagen types I, II, and X determined using RT-PCR. Deposition 
of collagen types I, II, and X and of alkaline phosphatase 
in alginate beads as demonstrated by immunolocalization on 
cryosections. 
Results: Sixteen cell lines were obtained, ten (P1 to P10) 
derived from patellar cartilage, and six (H1 to H6) from femoral 
head cartilage. Effects of IL-1 on proteoglycan synthesis varied 
between 90% suppression and 47% stimulation. Suppression 
comparable to that in normal murine articular cartilage (50%) was 
found in cell lines P2, P5, P8, H1, H3, H4, H5, and H6. RT-PCR 
showed that mRNA levels of collagen types I and X did not differ 
from levels found in normal murine cartilage. However, mRNA 
levels of type II collagen ranged between the level of normal 
murine cartilage and 500 times lower levels. High levels were 
found in cell lines P2, P5, P6, P7, H1, H3, H4, and H5. Moreover, 
there were differences in the relative amounts of the embryonal 
proform IIA, and the mature, smaller collagen type liB. Normal 
murine cartilage contains mainly the liB type mRNA, but all cell 
lines produced both types, although in different proportions. Rela- 
tively high levels of collagen type liB were present in cell lines P2, 
P3, P5, P6, and H1-H6. If cells were cultured in monolayer, 
instead of alginate beads, a shift to the immature type IIA collagen 
mRNA was found. Immunolocalization demonstrated that collagen 
types I and X were produced in all cell lines (and in normal murine 
cartilage). Production of collagen type X did not necessarily mean 
that cells were hypertrophic, because only cell line P7 and to a 
lesser extent P2, P6, P8 and P10 produced alkaline phosphatase. 
Collagen type II protein expression was found in cell lines P2, P3, 
P5, P6, P7, H1, H3, H4, H5, and H6, with highest amounts present 
in H1 and H5. 
Conclusions: From adult murine cartilage we developed 16 
chondrocyte cell lines with different phenotypes ranging from 
dedifferentiated to hypertrophic hondrocytes. Response to IL-1, 
level of collagen type liB mRNA expression, and production 
of collagen type II appeared to be reliable indicators of cell 
differentiation. 
TH 109 
SYNOVIAL LINING MACROPHAGES ARE INVOLVED IN 
OSTEOPHYTE FORMATION AND SYNOVIAL FIBROSIS 
AFTER INTRA-ARTICULAR INJECTION OF TGF~ 
P. L. E. M: Van Lent, A. Blom, A. E. A. Holthuysen, R. L. Smeets, 
Nico van Rooijen* and W. B. van den Berg 
*Department of Cell Biology, Free University Amsterdam. 
Department of Rheumatology, University Hospital Nijmegen, The 
Netherlands 
Objective: New formation of cartilage and bone (osteophytes) 
and synovial fibrosis in joints are characteristic features of oste- 
oarthritis. Macrophages are known to produce growth factors. In 
this study we investigated whether synovial lining macrophages 
which cover the inside of diaarthrodial joints are involved 
in osteophyte formation and synovial fibrosis induced by 
intra-articular injection of TGFI3. 
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Methods: Synovial lining macrophages were selectively 
depleted using clodronate-containing lipsomes which induce 
apoptosis. Osteophyte formation and synovial fibrosis were 
induced by triple injections of various concentrations (20 and 
200 ng) TGFI3 into the knee joints of C57BL/6 mice on alternate 
days. Total knee joint sections were made seven days after the last 
injection and stained with haematoxylin/eosin and safranin-o. 
Osteophyte formation at the medial and lateral patella were scored 
using an arbitrary scale with a maximal of eight. I~ibrosis at the 
lateral and medial side of the patellar/femur egion was scored 
using an image analyzer. 
Results: Seven days after a single injection of clodronate- 
containing liposomes into the mouse knee joint, optimal depletion 
of macrophage-like synovial lining cells was observed. No side 
effects of this treatment were found on cartilage metabolism like 
PG synthesis or degradation as measured by 35S uptake studies. 
Furthermore fluorescent liposomes showed that only the surface 
layer of the synovium was targeted and the liposomes did not 
penetrate in the deeper layers of the synovium and did not reach 
the periost. Triple injections of a control protein BSA into normal 
knee joints did not induce osteophytes or fibrosis. In contrast, triple 
injection of TGF~ into control knee joints showed that 1 week after 
the last injection significant osteophyte formation was observed at 
the lateral and medial sides of patella and femur (20 ng and 200 ng 
TGF~ respectively 2.7+1.1 and 6.4+0.5). Strikingly, triple 
injections of TGFI~ into synovial macrophage depleted knee joints 
showed a significantly lower osteophyte formation (20 ng and 
200 ng TGF~ respectively 80% and 70% lower). Furthermore 
fibrosis induced by 200 ng TGFI3 was high both at the lateral and 
medial side (39584±6930 pm 2 and 30733_+1519 pm 2) in normal 
joints and again significantly lower in lining depleted joints 
(respectively 60% and 80% lower). Injection of knee joints with 
similar amounts of free clodronate had no inhibiting effect on 
osteephyte or fibrosis formation after injections with TGF~. 
Conclusion: This study suggests that synovial macrophages are 
crucial in osteophyte formation and synovial fibrosis induced by 
TGFI~ and may be a novel target in osteoarthritis. 
TH110 
COL11A1 AND COL9A1 IN HUMAN CARTILAGE 
A. Vaughan-Thomas, D. J. Mason, S. M. Bishop and V. C. Duance 
Connective Tissue Biology Laboratories, School of Biosciences, 
Cardiff University, Wales, UK 
The role of the minor collagen types IX and XI in maintaining 
cartilage structural and functional integrity remains unresolved. 
This study is focused on the expression, interactions and degra- 
dation of the N-terminal domains of these collagens in ageing 
human articular cartilage. 
Aim: To evaluate the topography of collagen fibrils in ageing 
cartilage and to identify interactions occurring at the fibril surface 
through the N-terminal domains of collagen types IX and XI. 
Methods: Macroscopically normal human cartilage was 
analyzed by RT-PCR, immunoblotting of cyanogen bromide 
derived peptides, immunolocalization and recombinant technology. 
Results: Using RT-PCR of RNA extracted from adult human 
cartilage, seven variants of the NC3 domain of COL11A1 were 
identified, which result from alternative splicing of exons 6A, 6B 
and 8. Two of the COL11A1 variants, containing both exons 6A and 
6B, with or without exon 8, have not been described previously. 
Also, the region of COL9A1 encoding the NC4 domain of the 
cf.1 (XI) chain was identified in adult cartilage. 
Both the NC4 domain of type IX collagen and the NC3 domain of 
type XI collagen are believed to be present on the surface of the 
heterotypic fibrils, suggesting that they are able to interact with a 
range of other extracellular matrix molecules. However, using a 
combination of immunoblotting and immunostaining methods, we 
have observed that there is a dramatic reduction in the amount of 
these N-terminal domains present in articular cartilage post 
adolescence. 
Conclusions: We have identified several COL11A1 mRNA 
variants in adult human cartilage, two of which have not been 
described previously, and have found that COL9A1 mRNA is also 
expressed. The proteins encoded by these genes are potentially 
highly interactive at the surface of the heterotypic fibril, due to 
distinct regions of charged amino acid residues. As a result, the 
sum of these interactions may be a major contributor to cartilage 
tissue integrity. The interacting domains however, appear to be 
dramatically reduced with age, as well as subject to alternative 
splicing, suggesting that the cohesive properties of cartilage may 
be modified. The consequences of their loss from the matrix are 
currently being investigated using genetic manipulation of 
chondrocytes and also by identification of specific interactions in 
which they participate. 
TH111 
EXPRESSION OF TENASCIN IN BIOMECHANICALLY 
DAMAGED HUMAN ARTICULAR CARTILAGE 
K. Veje', J. L. Hullested °, L. E. Bestwickl-, R. M. Aspdent, 
K. Ostergaard ° 
"Osteoarthritis Research Unit, Institute for Inflammation Research, 
National University Hospital, Copenhagen, Denmark. ~r Department 
of Orthopaedics, University of Aberdeen, Aberdeen, Scotland, UK 
Aim of the study: The extracellular matrix glycoprotein Tenascin 
(TN) is suggested to be involved in the repair processes of articular 
cartilage and to be subjected to biomechanical regulation. The 
expression of TN has been shown to correspond to the degree of 
structural damage in human cartilage from the femoral head. In 
addition, the expression of TN is reported to concentrate around 
superficial esions. The objective of this study was to detail the TN 
expression in human articular cartilage showing lesions limited to 
the superficial zone due to biomechanical impact loading and 
compare it with non-loaded articular cartilage. 
Methods: 10 normal human articular cartilage biopsies were 
sampled from the supero-lateral part of the femoral head of 10 
patients undergoing hip replacement surgery due to fractured 
femoral necks resulting in a total of 100. Only macroscopically 
intact femoral heads were included. The biopsies were stored in 
DMEM with 2% fetal calf serum; in an drop tower a 500 g weight 
from a height of 5cm was dropped on 5 biopsies from each 
femoral head, and 5 biopsies from each femoral head were kept as 
controls. All 100 biopsies were then incubated in" DMEM and 2% 
FCS at 37°C and collected for processing at the following 
timepoints: 0, 24, 48, 72 and 192 hours. Biopsies were then 
snap-frozen and stored. 5 pm thin cryosections were made and 
stained immunohistochemically with a monoclonal antibody (Clone 
TN2 M0636, DAKO) against tenascin and the sections were 
evaluated for the superficial zone. Cellular, pericellular and inter- 
cellular compartments were evaluated in each section and scoring 
was performed by two blinded observers as follows: intracellular 
0-4 (0=all cells negative, 1 =some positive cells, 2=equal number 
of cells positive and negative, 3=more than half the cells positive, 
"and 4=all cells positive), peri- and intercellular 0-2 (0=no staining, 
1=some staining, 2=strong staining). The scores were agreed 
upon. Impacted sections showing either no structural lesions or 
lesions extending deeper than the superficial zone were 
excluded--resulting in a total of 29 impacted sections being 
analyzed. Non-loaded sections showing structural damage were 











Intracell Pericell. Inlefcell 
2 0 0 
4 1 0 
3 0 0 
3 1 0 
1 0 0 
Scores were ranked. The median scores are shown. 
Impact loaded seclians 
Intracell, Pericell Inlercell 
2 1 0 
3 1 0 
3 1 1 
4 1 1 
3 1 0 
Regarding intracellular staining no significant difference between 
the loaded and control sections was present. Pericellular staining 
was present at all timepoints in the loaded sections, while being 
only occasionally present in the control group. In the intercellular 
compartment no staining is present in the control group whereas 
some staining is present in the loaded group. Interestingly, the 
intercellular staining seems to accumulate around lesions in some 
of the sections. 
Conclusions: This biomechanical model of cartilage damage 
does not seem to produce a significant increase in the expression 
of tenascin. In the extracellular compartments increased expres- 
sion of tenascin is present, and in addition some superficial esions 
show remarkable accumulation of tenascin, suggesting that the 
chondrocytes respond with secretion of preformed tenascin. More 
detailed evaluation of the expression of tenascin around the 
lesions is needed. 
TH l12  
NON-ENZYMATIC GLYCATION BY THREOSE RESULTS IN 
INCREASED STIFFNESS OF HUMAN ARTICULAR 
CARTILAGE 
N. Verzijl*l-, J. DeGroot*l, R. A. Bank', A. Maroudas:l:, 
S. R. Thorpe§, J. W. Baynes§, J. W. J. Bijlsmal, F. P. J. G. Lafebet 
and J. M. TeKoppele ° 
°Div. Vascular and Connective Tissue Research, TNO Prevention 
and Health, Leiden, The Netherlands. tDept. Rheumatology & 
Clinical Immunology, University Medical Center Utrecht, The 
Netherlands. J;Dept. Biomedical Engineering, Technion, Haifa, 
Israel. §Dept. Chemistry and Biochemistry, University of South 
Carolina, Columbia, SC, U.S.A. 
Aim of the study: Age is an important risk factor for degener- 
ation of articular cartilage (osteoarthritis). The collagen network 
plays a key role in cartilage function. During aging, this collagen 
network is extensively modified by advanced glycation end- 
products (AGEs). We hypothesize that AGE crosslinking results in 
increased stiffness of the collagen network, which impairs its 
resistance to mechanically-induced damage. In the present 
study, we investigated the effect of glycation by the ascorbate 
degradation product threose on the biomechanical properties of 
the collagen network of human articular cartilage. 
Methods: AGE levels in cartilage were increased by incubation 
with threose. The instantaneous deformation (ID) of the 
cartilage---a measure of the stiffness of the collagen network--was 
measured before and after the incubation. AGE levels in the 
collagen network were determined as: pentosidine (HPLC), 
N~-carboxy-(m)ethyllysine (GC/MS), amino acid modification 
(arginine, lysine and hydroxylysine; by HPLC) and fluorescence 
(370/440 nm). 
Results: Incubation of cartilage with threose resulted in amino 
acid modification and AGE crosslinking. In addition, threose 
incubation of cartilage resulted in a dose-dependent increase in 
stiffness (i.e. it decreased the ID; p<0.05). The increase in 
collagen network stiffness was strongly correlated with increased 
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AGE crosslink levels (r=0.93, p<0.005; Figure 1) and amino acid 
modification (r=0.97, p<0.01). The 40% increase in stiffness at 
200 mM threose could be prevented by co-incubation with arginine 
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Figure 1. Increased collagen AGE crosslink levels due to 
incubation of cartilage plugs with different threose concentrations 
result in increased stiffness of the collagen network (measured as 
a decrease in ID of the cartilage plugs after vs. before treatment). 
Conclusion: The increase in stiffness of the cartilage collagen 
network by AGE crosslinking can contribute to the age-related 
failure of the collagen network to resist fatigue (increased brittle- 
ness). Thus, accumulation of AGE crosslinks presents a putative 
molecular mechanism whereby age is a predisposing factor for the 
development of osteoarthritis. 
This work was supported by the Netherlands Organization for 
Scientific Research (NWO) and the 'Dutch League against 
Rheumatism' 
THl13  
EFFECTS OF TNF~-ANTAGONISTS ON NITRIC OXIDE 
PRODUCTION IN HUMAN ARTICULAR CARTILAGE 
K: Vuolteenaho, T, Moilanen, E. Moilanen 
The /mmunopharmaco/ogica/ Research Group, Medica/ School, 
University of Tampere; Departments of Surgery and Clinical 
Chemistry, Tampere University Hospital, Tampere, Finland 
Nitric oxide (NO) produced by cartilage and synovial membrane is 
implicated in the Pathogenesis of osteoarthritis (OA), The aim 
of the present study was to investigate the effects of 
TNFc~-antagonists infliximab and etanercept on NO production in 
human OA. 
Cartilage specimens were collected from OA patients undergoing 
knee replacement surgery and studied for NO production in organ 
culture to allow intact chondrocyte-matrix interactions. Nitrite, a 
stable product of NO in aqueous solutions, was measured using 
the Griess reaction. Inducible nitric oxide synthase (iNOS) enzyme 
was detected by western blotting. 
OA cartilage produced low concentrations of nitrite in the absence 
of exogenous cytokines. Nitrite accumulation was linear up to 72 h 
follow-up and it was inhibitable with a non-selective nitric oxide 
synthase (NOS) inhibitor L-NIO, indicating that it was due to NO 
production. TNFo~-antagonists infliximab and etanercept had no 
effect on unstimulated NO production. Proinflammatory 
cytokinesTNFo~ and IL-1-13 as well as bacterial lipoplysaccharide 
(LPS) induced iNOS expression and NO synthesis in OA cartilage 
in a dose- and time-dependent manner. TNFc~-induced NO prod- 
uction was inhibitable with infliximab and etanercept in a 
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concentration-dependent manner. In contrast IL-11~- and LPS- 
stimulated NO production was not altered by infliximab and etaner- 
cept, suggesting that TNFc~ is not an autacoid mediator in these 
processes. In addition, neutralizing antibodies against soluble 
TNFo~ receptors enhanced spontaneous NO production, suggest- 
ing that endogenous cartilage-derived 'TNFc~ antagonists' 
modulate NO production in OA cartilage. 
In conclusion, OA cartilage produced NO spontaneously and 
its production was enhanced by TNFct, IL-}I~ and LPS. 
TNFo~-antagonists infliximab and etanercept had an inhibitory 
effect on TNFc~-induced NO production but not on IL-I~- and 
LPS-stimulated NO production. 
TH l14  
FAT-SUPPRESSED THREE-DIMENSIONAL SPOILED 
GRADIENT-ECHO MR IMAGING OF AUTOLOGOUS 
CHONDROCYTE IMPLANTATION 
Yuichi Wada, Takahisa Sasho, Koichi Hakagawa, Kenji Takahashi, 
Kouji Fujita, Kan Takase, Rie Kou, Takeshi Yamashita, Hiroshi 
Kitahara, Hideshige Moriya 
Department of Orthopaedic Surgery, Chiba University, Chiba, 
Japan 
Introduction: Autologous chondrocyte implantation (ACI) is 
becoming a widely used technique for treating symptomatic 
defects of cartilage, while little is known of the structural organiz- 
ation and maturation of the repair tissue. We have therefore 
undertaken MR imaging analysis till one year after ACI. 
Methods: We assessed 4 consecutive patients of ACI of medial 
femoral condyle with MR imaging using both Tl-weighted spin- 
echo sequence and fat suppressed three-dimensional spoiled 
gradient echo (3D/SPGR) sequence. MR images were analyzed 
for the structural organization and maturation of the repair tissue at 
0, 3, 6, 9, and 12 months after ACI, In addition, we have under- 
taken routine histological analysis of biopsies of repair tissue to 
compare with the MR findings from same patients one year after 
ACI. 
Results: Patients' overall condition and symptoms were pro- 
gressively improved up to 12 months. In a 3D/SPGR imaging, 
repair tissue showed various signal intensities within substance of 
overlying articular cartilage under a thick, low signal superficial 
layer corresponding to implanted periosteum. This alteration of 
signal could be measured by contrast noise ratio (CNR). In 
Tl-weighted images, the repair tissue appears relatively faintly 
throughout one year after ACI. CNR of the deeper zone of the 
repair tissue was increasing with time after ACI. Histological 
analysis showed that the deeper zone of the repair tissue 
resembled hyalin-like cartilage, whereas the superficial layer 
remained fibrous tissue. 
Discussion and conclusion: MR imaging of 3D/SPGR was felt 
to be the best for assessment of repair tissue. 3D/SPGR MR 
findingdemonstrated a pattern of layers similar to that observed in 
histological analysis. 
TH l15  
EFFECTS OF HYALURONAN ON THE DISTRIBUTION AND 
MOVEMENT OF AGGRECAN AROUND CHONDROCYTES 
CULTURED IN ALGINATE BEADS 
H. Yamada °, T. Kikuchil", K. Fujikawal 
"Fujita Health University, Second Hospital, Nagoya, Japan 
"[National Defense Medical College, Tokorozawa, Japan 
Objective: Effects of hyaluronan (HA) on the matrix metabolism 
of chondrocytes have not been fully understood. We studied the 
effects of HA on the distribution and movement of newly- 
synthesized aggrecan around the cells in alginate beads. 
Methods: Rooster comb-derived HA (MW 8x 10 s Da, Seikagaku) 
was co-polymerized in alginate gel to study the direct effects of 
extrinsic HA on chondrocytes. Aggrecan metabolism of rabbit 
chondrocytes cultured in alginate beads was examined by 
measuring the incorporation of [3SS]sulfate into glycosaminoglycan 
in two distinct regions around chondrocytes, the cell-associated 
matrix (CM) and the further-removed matrix (FRM). Immunohisto- 
chemical analysis was performed using monoclonal antibodies 
against chondroitin sulfate and keratan sulfate. Autoradiography 
using degenerated cartilage tissue from the rabbit OA model was 
performed to know the effect of HA on the distribution of newly- 
synthesized aggrecan in the cartilage tissue. 
Results: The incorporation of [35S]sulfate into newly-synthesized 
aggrecan in the FRM increased dose-dependently with the 
addition of HA, while the incorporation in the CM decreased. These 
effects of HA on the distribution of newly-synthesized aggrecan 
were the same either in chondrocytes with CM or chondrocytes 
without CM. Immunohistochemical nalysis showed that staining 
of aggrecan in the CM was decreased and staining in the FRM was 
increased in the HA treated group compared to the control group. 
Autoradiography using degenerated cartilage tissue from the rabbit 
OA model indicated that [35S]-Iabeled macromolecules howed a 
more diffuse distribution in the HA treated group compared to the 
control group. 
Conclusions: These results indicate that extrinsic HA could 
affect the movement of newly-synthesized aggrecan from the CM 
to the Frankenstein in both alginate beads and cartilage tissue. 
TH l16  
CARTILAGINOUS GENE EXPRESSION IN THE 
PSEUDO-TENDON SHEATH FORMED BY A SILICON ROD 
Y. Yutani and Y. Yamano 
Dept. Orthop. Surg., Osaka City University Medical School, Osaka, 
Japan 
Aim of the study: Various tissues show differentiation and 
proliferation according to the environment around them. When a 
joint-like sliding surface is formed, undifferentiated mesenchymal 
cells have been reported to show expression of cartilage-specific 
genes and cartilage-specific matrix production. In flexor tendon 
injury with severely injured tendon sheath, tendon grafting is 
performed. When primary repair is impossible, a tendon sheath is 
constructed using a silicon rod, and tendon grafting with this 
pseudo-tendon sheath is performed. This area forms a sliding 
surface between the rod and the surrounding tissue, and 
cartilaginous differentiation is expected. We obtained the tissues in 
.this area and evaluated the expression of cartilaginous genes. 
Patients and methods: Patients were 22-year-old and 46-year- 
old males. For both patients, the two stage operations with artificial 
tendon to reconstruct he pseudo-tendon sheath were performed. 
At the time of grafting of the palmaris Iongus, the original tendon 
sheath was absent. Tissue was obtained from the inner and outer 
layer of the newly formed tendon sheath tissue. Total RNA was 
extracted directly from each tissue. Single-stranded cDNA was 
prepared from the extracted RNA. The target sequence in reverse- 
transcripted cDNA was amplified by PCR. The sequences 
are located within the published human cDNA sequences for 
aggrecan, type I collagen, type II collagen, TGF-13 and 
glyceraldehyde-3-phosphate d hydrogenase (GAPDH). 
Results: The expression of cartilage specific genes was investi- 
gated in the region forming the inner and the outer layer of the 
newly formed tendon sheath. Although aggrecan was absent at the 
outer layer, the ratio of the expression of this gene to the expres- 
sion of GAPDH was 0.15 at the inner layer of the newly formed 
tendon sheath. Gene expression of type II collagen, another 
cartilage specific gene, was seen at a ratio of 0.28 at the inner 
layer, although it was also absent at the outer layer. On examining 
the gene expression of type I collagen and TGF-~, the ratios of 
gene expression compared to GAPDH were 0.49 and 0.17, 
respectively. The expression ratio of type II collagen to type I 
collagen was 0.57. 
Discussion: The area forming a sliding surface, unlike the 
original tissue, shows differentiation and proliferation according to 
its tissue environment. In the tissue evaluated in this study, the 
original tendon sheath had been destroyed, and new tissue 
formation was observed around the site of artificial tendon 
insertion. In addition, the formation of a sliding surface between 
this tissue and the artificial tendon is expected to induce the 
formation of a tendon sheath structure. In the tissue of this area, 
mechanical stimulation may have played an important role in the 
differentiation of mesenchymal tissue. Therefore, we will further 
examine the changes detected in the tissues and evaluate 
mechanical stress for formation of the tendon sheath. 
TH l17  
RELATIONSHIP BE'f3NEEN THE MECHANICAL STRESS AND 
THE CARTILAGINOUS DIFFERENTIATION 
Y. Yutani, H. Ohashi and Y. Yamano 
Dept. Orthop. Surg., Osaka City University Medical School, Osaka, 
Japan 
Aim of the study: In recent years, interest in the effects of 
mechanical stress has been increasing, and it plays an important 
role in the processes of cell differentiation and proliferation. In 
congenital dislocation of the hip joint (CDH), the femoral head is 
not retained in the original acetabulum, but is posterolaterally 
dislocated, and the joint capsule, which keeps the femoral head in 
the dislocated position, primarily fulfills the joint function. In this 
study, weight-bearing and non-weight-bearing areas of the joint 
capsule were collected and the development of cartilaginous 
differentiation function was evaluated in terms of gene expression. 
Patients and methods: From 3 patients with CDH but without 
other underlying diseases, tissue in each area of the joint capsule 
was obtained during total hip replacement surgery. In all patients, 
the femoral head was dislocated and was retained in that position 
by the joint capsule. The inner layer of the joint capsule that forms 
a sliding surface with the femoral head was obtained as the 
weight-bearing part, and the medioinferior area that does not form 
a sliding surface served as the non-weight-bearing part, For 
analysis of gene expression, immediately after collection of tissue, 
total RNA was extracted directly from each piece. 
Results: The amount of cartilage-specific gene expression in 
tissue in each area was evaulated by comparing it to GAPDH gene 
expression. In the weight-bearing part the amount of aggrecan 
gene expression was 0.097, though this gene is originally not 
detected in connective tissue which does not have the joint 
function. Aggrecan gene expression was 0.003 in the non-weight- 
bearing part, but was not observed in the outer layer of the joint 
capsule. Similar findings were observed for type II collagen gene 
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expression; gene expression was 0.082 in the weight-bearing part, 
and not detected in the non-weight-bearing part. The weight- 
bearing tissue showed 0.030 for TGF-I3. 
Discussion: In this study, examination of gene expression in the 
weight-bearing part compared to the non-weight-bearing pads in 
the same joint showed increased expression of the aggrecan and 
type II collagen genes, as was expected. TGF-,6 gene expression 
was increased, which together with expression of the aggrecan 
and type II collagen genes, suggests that changes in the histo- 
logical environment induced the expression of cartilage-specific 
genes that are not originally detected. The tissue in this area did 
not include mature cartilaginous tissue, and evaluation of 
proteoglycan production and its molecular size also revealed a 
smaller molecular size than the size of mature cartilaginous 
molecules, as previously described. However, in the originally 
noncartilaginous tissue in the same joint environment, cartil- 
aginous gene expression in amounts consistent with mechanical 
stress in this area were observed. These findings may provide 
much data for further studies on cartilaginous differentiation of 
mesenchymal tissue, and its detailed evaluation may become 
possible using a similar experimental system. 
FR001 
ISOMETRIC HIP ABDUCTOR AND ADDUCTOR STRENGTH IN 
MEN WITH HIP OSTEOARTHRITIS AND IN HEALTHY AGE 
AND SEX-MATCHED CONTROLS 
M. H. Arokoski, M. Kankaanp.~, H. J. Helminen, J. P. A. Arokoski 
Departments of Physical and Rehabilitation Medicine, Kuopio 
University Hospital and Department of Anatomy Kuopio Universitj4 
Kuopio, Finland 
Aims of the study: Persons with radiographic knee osteo- 
arthrosis (OA) have weaker quadriceps muscles than those with- 
out knee OA. There is, however, little literature dealing with the 
muscle strength on patients with hip OA. The aim of this study was 
to examine hip abductor and adductor strength in men with hip OA 
and in age and sex-matched controls. 
Methods: Based on the American College of Rheumatology 
criteria for the classification of OA of hip, 27 men with unilateral or 
bilateral primary hip OA and 29 healthy age-matched (45-65 
years) randomly selected healthy subjects were studied. Hips were 
graded using Kellgren-Lawrence scale. Isometric strength of the 
hip was measured with a computerised dynamometer (Newtest, 
Oulu, Finland) using the belt-resisted method. When testing the 
abductors and adductors, the hip was kept in 0 ° of flexion and 0 ° of 
adduction/abduction with the knee joint in full extension while in 
supine position using a pelvic stabilizing belt. Three maximal 
isometric force (N) measurements of right (healthy subjects) and 
OA hip joint were made and the mean value of these measure- 
ments was calculated and divided by the subject's individual body 
weight (N/kg). Hip pain during strength testing was rated on a 
visual analogue scale (VAS) (range 0-100mm). Statistical 
comparison between groups was made by Mann-Whitney U-test. 
Results: Mean±SD body mass index (BMI) (kg/m 2) was 
26.5±2.9 and 26.8±3.2 in control (C) and OA groups, respectively 
(p--NS). From the hips with OA changes, 22.2% had grade 10A,  
48.1% grade 20A and 29.7% grade 30A.  Isometric hip abductor 
strength (N/kg) was significantly lower in OA subjects (OA: 
3.30±1.01; C: 3.95±0.82, p<0.01). Also isometric hip adductor 
strength (N/kg) was significantly lower in OA subjects (OA: 
3.49±1.13; C: 3.92±0.77, p<0.05). However, hip pain rated on a 
VAS was significantly higher in OA subjects (13.7±21.3mm) 
(p<0.001), whereas control subject had no pain during strength 
testing. 
Conclusions: Our results suggest that men with hip OA have 
lower isometric hip abductor and adductor muscle strength. 
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However, impaired hip strength in OA patients may be more 
strongly associated with pain than with muscle properties. This 
should be taken into account in interpretation of muscle strength 
results of OA patients. 
FR002 / 
COMPARISON OF HIP JOINT-SPACE WIDTHS IN 
RADIOGRAPHS TAKEN IN SUPINE AND STANDING 
POSITIONS IN HEALTHY MEN AND MEN WITH HIP 
OSTEOARTHRITIS 
J. P. A. Arokoski, M. H. Arokoski, T. Voivalin, L. Niemitukia 
Department of Physical and Rehabilitation Medicine, Clinical 
Radiology, Kuopio University Hospital and Kuopio University, 
Kuopio, Finland 
Aims of the study: There are studies which show that weight 
bearing affects joint-space width in hip, but the subject is still 
controversial. Our aim was to find out if there exists difference in 
hip joint-space width between standing (weight-bearing) and 
supine (non-weight-bearing) positions in conventional radiographs. 
Methods: Based on the American College of Rheumatology 
criteria for the classification of osteoarthritis (OA) of hip 22 men 
(45-65 years) with unilateral or bilateral primary hip OA and 25 
(45-65 years) randomly selected healthy men were studied. Hip 
radiographs were taken with the subjects supine and standing 
positions. Hips were graded using Kellgren-Lawrence scale of 0 
(no OA) to 4 (severe OA) based on the radiographic features 
present. The joint-space width of one hip of each man was 
measured by digital caliper (Absolute Digimatic, Mitutoyo, U.K.) in 
two anatomical locations: the lateral and the medial part of the 
superior 1/3 of the joint. Three measurements were performed of 
each point, and the average was calculated. Statistical comparison 
between radiographs was made by Willcoxon's matched-pairs 
signed-rank test. 
Results: In healthy men superolateral hip joint-space width 
(mean+SD) was 4.6+_0.8 mm and 4.9+_1.0 mm on standing and 
supine positions, respectively (p<0.05). In healthy men superome- 
dial hip joint-space width was 4.0±0.5 mm and 4.3±0.6 mm on 
standing and supine positions, respectively (p<0.01). From the 
hips with OA changes, 22.7% had grade 10A (n =5), 50.0% grade 
20A (n--11) and 27.3% grade 30A (n=6). In OA (grade 1-3) 
subjects superolateral hip joint space width was 3.2±1.5 mm and 
3.5±1.6mm in standing and supine positions, respectively 
(p<0.05). In all OA (grade 1-3) subjects superomedial hip joint- 
space width was 3.6±1.8 mm and 3.9±1.9 mm in standing and 
supine positions, respectively (p<0.01). However, when different 
OA grade groups were tested separately only the superomedial 
joint-space width was significantly decreased (p<0.05) on standing 
position in the subjects with grade 1 and 20A.  
Conclusions: In both healthy men and men with hip OA, both 
superolateral and the superomedial hip joint space decreased 
significantly (5.1-10.0%) in weight-bearing posture compared to 
non-weight-bearing posture. However, the severity of OA seems to 
affect the narrowing of the joint space in weight-bearing position. 
This study emphasizes the value of the positions for radiographs 
used for the quantification of joint-space width and in evaluation of 
radiological changes of hip joint. 
FR003 
BONE MINERAL DENSITY OF THE PROXIMAL FEMUR AND 
CALCANEUS IN MEN WITH HIP OSTEOARTHRITIS AND IN 
HEALTHY AGE AND SEX-MATCHED CONTROLS 
J. P. A. Arokoski, M. H. Arokoski, H. Kr6ger, H. J. Helminen, 
J. S. Jurvelin 
Departments of Physical and Rehabifitation Medicine, Surgery, 
Clinical Physiology Kuopio University Hospital and Department of 
Anatomy Kuopio University, Kuopio, Finland 
Aims of the study: Although several studies have suggested 
that osteoarthritis (OA) is associated with greater bone mineral 
density (BMD) and decreased risk of osteoporosis, the subject is 
still controversial. The aim of this study was to examine closer the 
pattern of bone mass and bone size in the proximal femur in men 
with hip OA and in age and sex-matched controls. Also the BMD of 
the calcaneus was determined. 
Methods: Based on the American College of Rheumatology 
criteria for the classification of OA of hip 27 men with unilateral or 
bilateral primary hip OA and 31 healthy age-matched (45-65 
years) randomly selected healthy subjects were studied. Hip 
radiographs were taken with the subjects' standing positions. Hips 
were graded using Kellgren-Lawrence scale of 0 (no OA) to 4 
(severe OA) based on the radiographic features present. BMD, 
bone mineral content (BMC) and bone width were measured with 
dual x-ray absorptiometry (DXA) (Lunar Expert, Madison, USA) at 
the proximal neck of the femur. BMD at the calcaneous was 
measured from the central area of the bone using the standard 
region of interest on the image. Statistical comparison between 
groups was made by Mann-Whitney U-test. 
Results: Mean+SD body mass index (BMI) (kg/m 2) was 
26.1 +3.2 and 26.8±3.2 in control (C) and OA groups, respectively 
(p=NS). From the hips with OA changes, 22.2% had grade 10A,  
48.1% grade 20A and 29.7% grade 30A.  There were no 
significant differences in femoral neck BMD (g/cm 2) between the 
groups (OA: 1.044±0.217; C: 0.995±0.134, p=NS). Femoral neck 
BMC (g) was significantly higher in OA subjects (6.43±1.36 vs. 
5.60±0.73, p<0.001). Similarly femoral neck bone width (cm) was 
greater (4.11±0.27 vs. 3.76±0.27, p<0.001). There were no 
significant differences in calcaneus BMD (g/cm 2) between the 
groups (OA: 0.816+_0.158; C: 0.766±0.115, p=NS). Correlation of 
the femoral neck bone and calcaneus BMD was 0.565 (p<0.01) 
and 0.619 (p<0.01) in control and OA groups, respectively. 
Conclusions: Our results suggest that men with hip OA have 
significantly higher femoral neck BMC and greater femoral neck 
size. Obesity may not be a denominator, since BMI was not 
increased in OA group. These findings do not support the concept 
that patients with hip OA have a higher femoral neck BMD than 
healthy people. It is supposed that BMD of the femoral neck is not 
significantly increased because hip OA subjects have significantly 
increased femoral neck size. 
FR004 
SUBCHONDRAL BONE LESIONS IN OSTEOARTHRITIS OF 
THE KNEE: ARTHROSCOPIC CORRELATIONS 
T. Boyer*, V. Daumen-Legret, D. Folinais:l: 
*Hopital Bichat, Paris; ~rCHU La Timone, Marseille; $Clinique 
Nollet, Paris, France 
Background: Changes in the subchondral bone are often seen 
on MRI in knees with osteoarthritis. They are thought to be painful, 
but their significance is still unknown. 
Objective: To examine the relationship between subchondral 
bone lesions (SBL) on MRI, and articular cartilage condition on 
arthroscopy, in femorotibial osteoarthritis. 
Methods: We recruited 30 knees with painful access of 
femorotibial osteoarthritis (diagnosed on PA knee X-rays) and 
concomitant subchondral bone lesions on MRI (T1 sagittal, T2 W, 
coronal spin echo T2 W, fat suppressed fast spin echo). SBL 
affecting the femoral condyle or the tibial plateau were the 
following: 
--bone marrow lesions (non specific bone edema) defined as 
areas of increased signal adjacent to subcortical bone, on T2 
weighted images. 
--Stress fractures 
--Subchondral bone defect 
--Osteonecrosis 
Arthroscopy, which is the gold standard for precise examination of 
articular cartilage, and which has a therapeutic effect on osteo- 
arthritic joints, was performed within one month after obtaining MRI 
in the 30 patients. The use of ICRS classification allowed a precise 
localization and evaluation of the depth and extent of the cartilage 
lesions (4 grades) (reaching the subchondral bone). We paid 
particular attention to the articular area adjacent to SBL seen on 
MRI, which was carefully examined and photographed. 
Results: 
--Edemas were sometimes found adjacent to meniscal tears 
(50%) or facing grade IV cartilage lesions (reaching the 
subchondral bone). 
--Stress fractures and osteonecrosis were facing grade III 
cartilage lesions in 75%, but amazingly were never located 
facing grade IV lesions. 
-- In osteonecrosis following non laser-assisted meniscectomy, the 
rim of the removed meniscus, which appeared thick and hard, 
was facing the bone necrosis MRI image. 
Conclusions: Arthroscopy is of great interest in the comprehen- 
sion of subchondral bone lesions seen on MRI, in patients with 
painful osteoarthritis of the knee. 
FRO05 
A STUDY ON THE PREVALENCE OF SYMPTOMATIC 
OSTEOARTHRITIS AND ITS CORRELATES IN THE ADULT 
SPANISH POPULATION 
L Carmona, C. Fernandez-Carballido, E. Trujillo, for the EPISER 
study group 
Spanish Society of Rheumato/ogy, Spain 
The study objectives were: (1) To estimate the prevalence of 
symptomatic hand and knee osteoarthritis (OA), as well as 
osteoarthritis causing low back pain, in the adult Spanish popula- 
tion. (2) To examine the relationship of symptomatic OA with 
sociodemographic and health care utilisation features. 
This study is part of a large population survey to assess the 
prevalence of rheumatic diseases in Spain (EPISER 2000 Study). 
The survey was conducted at 20 municipalities of Spain and was 
addressed to 2998 subjects, 20 years old or more, who were 
selected by stratified polystage cluster sampling from city 
censuses. Trained rheumatologists administered a structured 
interview with questions on sociodemographic issues, low back 
pain, clinical OA, and health care services, utilisation and 
medication use. Subjects with pain at the target joints were 
examined following a standardised protocol. Clinical hand and 
knee OA were defined by Altman (ACR) criteria plus included 
cases of OA with previous surgical joint replacement. Spinal OA 
was defined by self-report in subjects with low back pain in the last 
six months when a physician had given the diagnosis of spinal 
osteoarthritis. 
Recruitment rate was 70%, most failures being due to census 
errors. The prevalence of symptomatic OA in the adult Spanish 
population has been estimated: (a) hand OA: 6.2% [5.9-6.5]; (b) 
knee OA: 10.2 [8.5-11.9]; (c) lumbar OA: 10.2 [8.5-11.9]. All types 
of OA were significantly more common among women (21.8% 
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versus 10.7% in men). There is a prevalence peak at the 70-79 
age group (47%) with a descent in older people. Hand and spinal, 
but no knee OA, are related to the type of town and to the type of 
work performed. About 40% used analgesics, and 45% NSAIDs on 
a regular basis for OA pain. Sixty six per cent had visited a doctor 
in the past year for musculoskeletal pain. There is a significant 
correlation of clinical OA with the study level achieved and the 
type of work performed. Functional ability, and quality of life are 
significantly affected by OA pain. 
At any given point in time, a significant percentage of the Spanish 
adult population presents with pain related to osteoarthritis. There 
is a significant impact of OA pain on functionality, quality of life, 
and health care utilisation, especially among people with lower 
socioeconomic status. 
FRO06 
EFFECTS OF ORAL GLUCOSAMINE SULFATE AND 
NIMESULIDE ON THE PROGRESSION OF KNEE 
OSTEOARTHRITIS 
C. Chiriac, E. Rezus, D. Stratan, O. Poparda, M. Chiriac, 
O. Iordachi, I. Balacel 
Rehabilitation Hospital, lasi, Romania 
The aim of this study was to assess the clinical, radiological and 
biological efficacy and tolerability of oral glucosamine sulfate 
associated with a selective-COX2 inhibitor, nimesulide, in patients 
suffering from knee osteoarthritis (OA). This was a 6-month 
randomized, double-blind study, which included 35 patients of both 
sexes, aged between 45 and 72 years, with symptomatic knee OA, 
with Kellgren and Lawerence radiological scores I-II. Patients 
were treated orally with 1500 mg glucosamine sulfate and 100 mg 
nimesulide daily or with a placebo (PBO) associated with 100 mg 
nimesulide per day. The main outcome criteria were the degree of 
spontaneous joint pain and the overall mobility capacity; secondary 
outcome criteria included the joint space measurement and 
the levels of biochemical markers of bone and joint meta- 
bolism (osteocalcin, deoxypyridoline, nitric oxide, matrix- 
metalloproteinases). 
The results of this study confirm that the association glucosamine 
sulfate-nimesulide was well-tolerated and both reduced signifi- 
cantly pain and increased overall joint mobility; a stabilization of 
the femoro-tibial joint narrowing (measured with a digitized image 
analyzer) was noted in these patients, whereas joint narrowing 
space increased in placebo-treated patients. In addition, the 
metabolism of bone and joint assessed by different biochemical 
parameters also stabilized in patients receiving glucosamine 
sulfate and nimesulide combination, while-remaining unchanged in 
the PBO patients. 
These results demonstrate that the association oral glucosamine 
sulfate nimesulide is effective and safe; glucosamine sulfate is an 
effective symptomatic and structure modifying slow-acting drug for 
the treatment of knee OA, that may be able to stabilize the joint 
space width and to modulate bone and joint metabolism. 
FRO07 
CHONDROITINE SULFATE AS AN EFFECTIVE REMEDY FOR 
TREATING PATIENTS WITH OSTEOARTHRITIS OF THE HIP 
E. I. Chmidt, D. G. Soldatov, K. M. Kogan, I. V. Belozyorova 
The 1-st City Hospital, Moscow, Russia 
The search for new effective remedies for treating osteoarthritis is 
one of the most urgent problems in modern rheumatology. The aim 
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of this work was to study the efficiency and endurance of chondro- 
itine sulfate (structum, Pierre Fabre) in treating patients with 
osteoarthritis of the hip. We used chondroitin sulfate in 31 patients 
with the gravest form of osteoarthritis---osteoarthritis of the hip 
stage I-III (stage I in 6 patients, stage II in 14 patients, stage III in 
11 patients). Twenty-five females and 6 males, aged 37-70 were 
included into the research (the average age of the patients, 55 
years old). The duration of having osteoarthritis was from 6 months 
to 50 years (the average duration of the disease, 7.4 years). By the 
moment of starting of the research Leken's index I'lad comprised 
from 3 to 20 (the average indicator, 12.2). Twenty-five of 31 
patients had to use various nonsteroid anti-inflammatory drugs 
(NSAIDs) or analgesics due to manifested joint pain at the begin- 
ning of the research. The presence of patients, chiefly with 
osteoarthritis of the hip stage II and III in the group under research, 
the necessity of constantly taking NSAIDs and analgetics points to 
a serious hip-joint affection and a pronounced pain syndrome. 
Most patients had various coexisting diseases, most frequently 
--arterial hypertension, chronic gastritis, gastric and duodenum 
ulcer. Chondroitine sulfate was prescribed according to the next 
pattern: for 3 weeks--6 capsules, fu r ther~ capsules a day. The 
drug was taken during 6 months. The efficiency of treating with 
chondroitine sulfate was estimated according to the degree of 
anaesthetic effect manifestation and functional possibilities 
increase (Leken's index). The pain at rest at the beginning of the 
research was estimated according to VAS from 80 to 10 mm, at the 
end of the research--from 60 to 0 mm. The average indicator of 
the pain at rest was 32.3 mm before treatment and 17.1 after 
treatment. In 12 patients the pain at rest disappeared completely. 
The pain in motion was estimated from 10 to 100 mm before 
treatment and from 0 to 100 mm after treatment. The average 
indicator of the pain in motion before treatment was 57.1 mm and 
34.2--after treatment. The absence of analgesic effect was noted 
in 1 patient. The average of Leken's index reduced from 12.2 to 7 
at the end of the treatment. There with after treatment in 3 patients, 
Leken's index came to be equalled 0. Fifteen of 25 patients who 
used to take NSAIDs at the beginning of the treatment, at the end 
of the treatment didn't take any drugs but chondroitine sulfate in 
the context of the absence of the demand for extra analgesia. The 
endurance of the drug was estimated as good in 29 of 31 patients. 
In 2 cases the drug was cancelled in connection with appearance 
of undesirable reactions. In one patient the cause of cancelling 
chondroitine sulfate was epigastralgia which passed after cancel- 
ling the drug and resumed after the second treatment attempt. 
Gastroscopy didn't show any pathological gastric and duodenum 
changes. The second patient had chondroitine sulfate cancelled 4 
months later after treatment in spite of a clearly manifested positive 
effect, when appearing wide-spread nettle rash and fever 
(however, we failed to conclusively exclude the presence of food 
allergen). The research performed allows us to make a conclusion 
about a high efficiency and good endurance of chondroitine sulfate 
by patients with a grave course of osteoarthritis. 
FR008 
URINARY CONCENTRATION OF C-TELOPEPTIDE 
FRAGMENTS OF COLLAGEN TYPE II IN HEALTHY 
INDIVIDUALS AND PATIENTS WITH RHEUMATOID 
ARTHRITIS 
S. Christgau °, H.-J. Lehmannt, U. Mouritzent, C. Christiansent, 
T. Jensen:l:, D. B. Henriksen* 
"Osteometer BioTech A/S, Herlev, Denmark; tCenter for Clinical 
and Basic Research, Ballerup, Denmark; :t;Hvidovre County 
Hospital Hvidovre, Denmark 
Collagen type II is the major component of articular cartilage. Even 
though this tissue has a very low metabolic activity in normal 
adults, fragments of collagen type II can be measured in serum 
and urine. It has been reported that in situation with pathologically 
elevated cartilage degradation such as Rheumatoid Arthritis (RA) 
and Osteo-Arthritis (OA), elevated levels of collagen type II frag- 
ments can be detected. We have developed an ELISA (CartiLaps) 
specific for urinary fragments derived from collagen type II 
C-telopeptides. In order to assess the clinical potential of this 
assay we have measured normal ranges of urinary Collagen type 
II C-telopeptide fragments in healthy individuals, and in patients 
with RA. Furthermore, we have assessed the short and long term 
intra-individual biological variation of the marker. 
Second morning void urine samples were collected from 734 adult 
individuals in the age range from 21 to 89 years. The study cohort 
consisted of 486 women and 248 men. The total cohort showed an 
average creatinine corrected CartiLaps concentration of 0.36 pg/ 
mmol, with a range from 0.04 to 3.12. There was no significant 
difference between men and women, although the values in 
women were slightly higher than men (0.37 vs. 0.33 IJg/mmol). 
Furthermore there was a significant trend towards an increase in 
CartiLaps concentration with age. This was especially pronounced 
in women where there was a significant difference between the 
age group 45-55 and 55-65, 0.24 compared to 0.39 pg/mmot, 
p<0.0001. Long-term variation in the CartiLaps concentration was 
measured in 20 healthy individuals aged 52-65 years, who were 
sampled for second morning void urine samples at baseline and 
after 6 and 12 months. The median CV of the creatinine corrected 
CartiLaps concentration in this group was 11.2% over the twelve 
months observation period. In order to assess the ability of the 
assay to reflect elevated cartilage degradation, CartiLaps concen- 
tration was measured in 40 RA patients (aged 39-81) with active 
RA according to ACR criteria. This patient population showed an 
average CartiLaps concentration of 1.01 #g/mmol, which was 
significantly above the CartiLaps concentration seen in the healthy 
control group. The CartiLaps measurements correlated with 
number of swollen Joints in the RA patients (r=0.36, p=0.02), but 
no correlation was found to markers of inflammation (CRP) or 
bone resorption (urinary C-telopeptide fragments of collagen type 
1, CrossLaps ELISA). 
In conclusion, the urinary concentration of collagen type II 
C-telopeptide fragments as measured in the CartiLaps assay 
showed a low long-term intra-individual variation. CartiLaps 
concentration was significantly elevated in individuals with RA, 
suggesting that the marker can be used clinically to monitor 
patients with elevated cartilage degradation. 
FR009 
INTRA-ARTICULAR INJECTION OF HYLAN GF-20 
(SYNVISC e) IN PATIENTS WITH HIP OSTEOARTHRITIS: 
PRELIMINARY RESULTS OF EFFICACY AND SAFETY IN A 
MULTICENTRE PILOT STUDY 
T. Conrozier', P. Bertint, E Bailleul$, P. Mathieu*, R. Trevest, 
El Vignon*, X. Chevalier§ 
"CHU Lyon Sud, Lyon, France; ~rCHU Dupuytren, Limoges, 
France; ~.Biomatrix; §CHU Henri Mondor, Creteil, France 
Rationale: Viscosupplementation with hylan GF-20 has been 
proven effective and is widely used in the treatment of knee 
osteoarthritis (OA) but has not yet been assessed in hip OA. 
Aim: To obtain pilot data on efficacy, safety and duration of 
efficacy of intra-articular injection of hylan GF-20 in patients with 
hip OA. 
Patients and methods: open, pilot, multicentre (3 centres) 
clinical trial. 
Principal inclusion criteria are: (1) Primary hip OA diagnosed for 
more than one year (ACR criteria), (2) Kellgren-Lawrence (K-L) 
grade II or III, (3) age 40 or over, (4) Walking pain score of 50 to 
90 mm on a 100 mm visual analogue scale (VAS). Study design: 
D-7: screening visit (NSAIDs washout if necessary), DO: baseline; 
hylan GF-20 (2 ml) injected intra-articularly in the hip under fluor- 
oscopy, D7-30-60-90: efficacy and safety evaluation. A second and 
last injection can be performed at D30, 60 or 90 if walking pain 
returns to baseline level, and thereafter patients will be followed for 
an additional 3 months. Sa!ety evaluat!on: assessment of local and 
systemic tolerance at each visit. Efficacy evaluation: walking pain 
on VAS (primary criteria), WOMAC questionnaire, patient and 
physician global evaluation on VAS. 
Results: Population: 34 patients to date have received the first 
injection in this ongoing study; mean age 60.12 (range 47-79), 15 
patients with K-L Grade II, 19 K-L Ill, mean duration of OA 5.19 
years (1.3-17.4). A mean of 0.32 ml of contrast was used to 
visualise the injection space (0.2-1). No patients were lost for 
follow-up. 
Preliminary results on the primary efficacy criteria: 
Baseline Day 7 Day 30 Day 60 Day 90 
N of pls reaching 34 34 32 20 10 
Ihis visil to date 
Walking pare M-69.50 M=41 59 M=38 41 M=36.10 M=27 80 
(VAS, ram) SD= 12.32 SD-23.57 SD=26.89 SD-28.87 SD- 26.61 
N of pts having n.a. n.a 5 5 3 
received a second 
iniechon 
Forty-four per cent of the patients had a VAS score improvement 
>50% at D7, 59% at D30, 60% at D60 and 70% at D90. Safety: 
increased pain at the injection site was reported after 4 injections in 
3 patients; these local events occurred 24-48 hours after the 
injection and resolved within a few days. No systemic events 
associated with the device were reported. 
Conclusion: These preliminary results suggest that visco- 
supplementation with hylan GF-20 is a safe and effective treatment 
of hip OA. 
FR010 
MUSCULOSKELETAL CARE IN THE UNITED KINGDOM: 
ISSUES RAISED BY CHANGING SERVICE PROVISION 
D. J. Dickson*, G. Hosie*, J. English1, A. J. Dickson:l: 
*Primary Care Rheumatology Society, Northallerton, UK; 
t Wokingham, UK; $Freelance Health Economist, York, UK 
Musculoskeletal problems account for a large proportion of primary 
care physicians' (GPs') workload, yet the extent of the provision of 
such services in the NHS remains unclear. This poster presents 
data from an annual assessment of the changing 
provision of services in musculoskeletal care by GPs in the British 
National Health Service (NHS). 
Aim: To determine how the current NHS reforms are affecting 
GPs' ability to provide musculoskeletal care, and whether (in the 
eyes of GPs) the services they provide are an improvement on the 
old regime. 
Methods: In November 1998, the Primary Care Rheumatology 
(PCR) society mailed each of its members a questionnaire to 
assess the impact of the NHS reforms on musculoskeletal care. A 
follow-up questionnaire was mailed in November 1999. Using 
Microsoft Excel, the numerical data was quantified as means, 
medians or ranges, whilst free text answers were summarised 
using categories based on the responses. 
Results: Although the NHS's National Institute for Clinical 
Excellence (NICE) has identified musculoskeletal care as a prime 
area for concern, due to growing medical expenditure, the surveys 
show a lack of concern amongst NHS decision makers at 
the primary-care level. In the surveys, GPs expressed growing 
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frustration over increasing waiting times and a general 'dumbing 
down' of musculoskeletal service provision since the NHS reforms 
were introduced. 
Conclusions: The introduction of COX-II inhibitors, with their 
improved efficacy and greater tolerability than NSAIDs, might have 
been expected to occur in tandem with a new era of improved 
musculoskeletal care for patients. Unfortunately, these two surveys 
indicate that (at least in Britain) until basic patient needs in the 
provision of musculoskeletal services are met, the introduction of 
better, yet more expensive, drugs is unlikely to have much impact. 
Rather, educating NHS decision makers, especially those at the 
grassroots level, will be the key to success. 
FR011 
A RANDOMISED CONTROLLED TRIAL OF PHYSIOTHERAPY 
FOR PATELLOFEMORAL JOINT OSTEOARTHRITIS OF THE 
KNEE (PFJ OA) 
B. Quilty*, M. Tucker*, P. A. Dieppet 
*Rheumatology Unit and tMRC Health Services Research 
Collaboration. University of Bristol, Bristol, UK 
Background: PFJ OA is a common cause of knee pain and 
disability in the community. Physiotherapy is a widely available 
treatment. However, the literature supporting physiotherapy for 
knee OA is limited. We have performed a randomised controlled 
trial to examine effectiveness of a physiotherapy treatment 
programme for PFJ OA. 
Methods: Eighty-seven patients with knee pain and radiographic 
evidence of PFJ OA were recruited from a large community 
cohort--the SASH study. The trial compared the efficacy of a 
'package of care' involving patellar taping and quadriceps exer- 
cises with continuing standard care. The treatment arm received 
10 supervised physiotherapy sessions over 8 weeks, and were 
encouraged to continue the taught exercises at home. Outcome 
assessments, blind to allocation status, were made at 5 and 12 
months from baseline, including pain in both knees by 100 mm 
visual analogue score (VAS), disability by WOMAC function, 
isometric quadriceps muscle strength by maximum voluntary con- 
traction (MVC) and direct timed tests of walking and stair climbing. 
Data has been analysed on an intention-to-treat basis. 
Results: Thirty-eight out of 43 (88%) patients allocated to the 
treatment arm completed the treatment programme. Ninety-three 
per cent of all patients completed all questionnaires and 83% 
completed all strength and function tests. Between group compari- 
son of worst (index) knee VAS pain at 5 months showed a small 
and transient treatment effect that did not reach conventional 
statistical significance (adjusted difference in means=-6.5  mm, 
95% C1-16, 2.9, p=0.17). Quadriceps MVC on the index knee side 
showed a significant treatment effect at 5 months (adjusted differ- 
ence in means--12.9 Nm, 95% CI 4.6, 21.7, p=0.003) but this 
effect had been lost by 12 months. There were no significant 
changes between groups at any stage in WOMAC function or 
timed tests. 
Conclusion: Physiotherapy (quadriceps exercises and patellar 
taping) produced small improvements in pain and more marked 
improvements in muscle strength in the index knee, which were 
not paralleled by measurable changes in self-reported or 
measured function. The treatment effects were transient and had 
been lost by 12 months. Undoubtedly some patients respond well 
and adhere to treatment protocols, but many do not. Identifying 
those patients most likely to benefit could help target treatment and 
improve efficient care delivery. Further work is in progress in an 
attempt to identify this group. 
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FR012 
EXPLORING THE PRIORITIES OF PATIENTS WITH 
OSTEOARTHRITIS OF THE KNEE 
D. Tallon, J. A. Chard, P. A. Diepp__e 
MRC-Health Services Research Collaboration, Bristol UK 
Aims: To explore the perceived importance of symptoms, 
treatment preferences and research priorities of people with 
osteoarthritis of the knee (OAK). 
Methods: Results of a patient focus group (7 participants) were 
used to help populate a questionnaire, distributed to 112 people 
with OAK. The questionnaire contained 93 items and used a 
mixture of open and closed question formats to explored patients' 
symptoms, treatments and research priorities. 
Results: We received 93 (83%) completed questionnaires. 
Analysis of the data showed that pain, disability and insecurity of 
the joint were the most important symptoms and anxiety about 
OAK caused distress to many people. Oral drugs (90%), physical 
therapy (62%) and aids (56%) were the most commonly used 
treatments. Surgery, oral drugs and intra-articular injections were 
perceived as the most efficacious interventions. Patients' highest 
priorities for research were surgery and educational interventions, 
in spite of the fact that few had had surgery and education was not 
perceived as very effective. 
Conclusions: There is a mismatch between the perceptions and 
priorities of patients and those of health care professionals with 
regard to the treatment, research priorities and outcomes of OAK. 
FR013 
THE EPIDEMIOLOGY OF RESEARCH INTO INTERVENTIONS 
FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE 
JOINT 
J. A. Chard, D. Tallon, P. A. Dieppe 
MRC--Health Services Research Collaboration, Department of 
Social Medicine, Bristol. UK 
Aims: To assess the published research based for interventions 
for osteoarthritis of the knee (OAK), and to identify areas in need of 
further research. 
Methods: Literature searches were conducted on electronic 
databases (MEDLINE, EMBASE, BIDS/ISI, and Cochrane library), 
bibliographies of existing review articles were hand-searched, and 
a postal questionnaire was sent to members of the Osteoarthritis 
Research Society International (OARSI). All relevant articles were 
copied and searched for treatment type, study methodology, 
statistical results, conclusions, funding source, researcher 
affiliations and year of publications, using a pre-determined ata 
extraction form. 
Results: The review identified 930 eligible articles. Analysis 
showed that there have been marked changes in the literature over 
the period studied (1950-1998), with a recent rise in trials of 
physical therapy, educational interventions and complementary 
therapies. However, overall the majority of research was either 
drug (59.2%) or surgically (25.5%) related. Most of the studies 
reported positive results (94%). Research on oral drugs was 
significantly more likely to provide a positive result than research 
on any other intervention (p<0.001 by Z2 test). Commercially 
funded studies were significantly more likely to produce a positive 
result than non-commercially funded research (p=0.0027 by 
Z2 test). 
Conclusions: Analysis of time trends demonstrates the 
changing nature of research into osteoarthritis of the knee. How- 
ever, the research base does appear to be biased towards certain 
treatment areas. 
FR014 
RANDOMIZED DOUBLE BLIND COMPARISON OF ALEVE 
AND DI-ANTALVIC (DEXTROPROPOXYPHENE 30 MG AND 
PARACETAMOL 400 MG) FOR MINOR OR MODERATE PAIN 
ASSOCIATED WITH OSTEOARTHRITIS OF THE HIP OR 
KNEE 
R. L. Dreiser*, P. Bourgeoist, B. de La Giclais:l: 
*Paris, t Pitie-Salp&triere Paris, $ Gaillard, France 
The aim of the study was to compare the efficacy of Aleve 
(naproxen sodium 220 mg) vs Di-antalvic (dextropropoxyphene 
30 mg) with an unic study design to mimic real life situations where 
patients can titrate their own dose of analgesic as needed. 
Method: This trial was a multicenter, multidose, randomized, 
parallel, double-blind study of 7-day duration. The 218 enrolled 
patients were healthy males and females aged 40 and older, with 
a diagnosis of osteoarthritis of the hip or knee that had been 
verified by radiographic evidence (i.e. documentation from an X 
ray taken within the previous 2 years), who had been given a rating 
of at least moderate pain by a study investigator (ACR criteria and 
self VAS). Investigators were rheumatologists or GPs. 
Patients were randomized to receive either Aleve 220 mg 
(naproxen sodium capsules) or Di-antalvic (dextropropoxyphene 
30 mg and paracetamol 400 mg capsules). Only in the Ateve 
group, the three first capsules were containing naproxen whilst the 
last three remaining were containing paracetamol 500 mg. In both 
groups, patients were asked to take one capsule at 8.00 am then 
one capsule PRN and could not exceed more than six doses of 
medication a day. 
Efficacy assessments included 'number of capsule intake per day', 
efficacy measurement by the Investigators (Lequesne index) and 
patients assessment; Patients made daily assessments of their 
arthritis condition in the patient diary; investigators and patients 
made overall evaluations of the study drug at the end of the study. 
Safety of the compound was assessed by reporting of the adverse 
events. 
Results: 218 patients were enrolled into the study. 
Efficacy: after 7 days, patients adopted a similar posology for the 
two treatments (p=0.23): 2.84 capsules per day in the Di-antalvic 
group and 3.06 capsules per day in the Aleve group. There is a 
clear tendency in favour of Aleve (p=0.07) regarding the results of 
the Lequesne index. Furthermore, global efficacy assessed by the 
patient was statistically in favour of Aleve (p--0.04). 
Safety: 15% of patients experienced at least an adverse event 
without any difference between the two groups. The most frequent 
A.E. was a digestive disease (11 in the Aleve group and 8 in the 
Di-antalvic group). There were no differences between the two 
groups in term of severity or outcome. There were no serious 
adverse events. 
Discussion/conclusion: This trial showed that when prescrip- 
tion is well initiated, patients get responsible to manage them- 
selves their analgesic therapy. No difference was shown between 
the two groups in term of posology and efficacy between the two 
groups: an intake of three capsules in average a day was 
described in the two groups in moderate pain due to osteoarthritis. 
Furthermore, there was a trend for a decrease of capsule intake 
during the study. The results showed that, using the same 
posology, Aleve appears to be more efficient than Di-antalvic, 
whereas Di-antalvic, as a combination of two different analgesics, 
is expected to be stronger, from a pharmacologic point of view. The 
number of patients who experienced at least one adverse event is 
sinqilar in the two groups. 
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FR015 
ANALYSIS OF CHONDROITIN SULFATE (CS): 
PHARMACOLOGICAL RESPONSE IN PATIENTS WITH KNEE 
OSTEOARTHRITIS (KOA) 
P. du Souich 
Department of Pharmacology, Faculty of Medicine, University of 
Montreal, Quebec, Canada 
CS is a symptomatic slow-acting drug for the treatment of osteo- 
arthritis characterized by a slow onset of action, an effect that 
continues after cessation of therapy. The aim of this study was to 
define the characteristics of CS response during therapy and after 
its cessation. To this purpose, we have evaluated randomized 
double blind, placebo-controlled trials including patients with KOA, 
where the response to CS was recorded as a function of time and 
dose. As a reference, the effect of 150 mg of sodium diclofenac 
(SD) has been analyzed. It has been assumed that the patients of 
the different clinical trials are comparable. CS effect on the 
functional status (Lequesne's Index), spontaneous pain 
(Huskisson VAS), and pain on load score was evaluated with a 
computer-assisted non-linear curve fitting using the Emax model. 
This methodology allows to predict the maximal effect attainable 
(Emax), and the time required to elicit 50% of Emax (T50). With 
daily doses of 800 mg of CS for 90 days, predicted Emax indicates 
that baseline values of Lequesne's ndex, Huskisson's VAS and 
pain on load score could be reduced by 80 to 100%, with a T5O of 
around 35 days. The half-life of CS remnant effect varies with the 
outcome criteria, i.e~ 210 days for Lequesne's index, extremely 
long for the Huskisson's VAS, and 120 days for the pain on load 
score. Predicted Emax elicited by placebo on Lequesne's index 
and Huskisson's VAS indicates that baseline parameters may be 
decreased by around 25% with a T5O of around 7 days. Daily 
doses of 200 and 800 mg of CS for 90 days increase Emax 
dose-dependently, and 1200 rag/day of CS do not increase the 
effect further. Treatment with 800 mg/day of CS for 180 or 360 
days appear to decrease predicted Emax, and prolongs T50. With 
doses of 150 mg/day of SD for 30 days, predicted Emax indicates 
that baseline values of Lequesne's Index, Huskisson's VAS and 
pain on load could be reduced ~y around 75%, with a T50 of 
around 18 days. The half-life of SD remnant effect is approximately 
95 days. Treatment for 7 days with 150 rag/day of SD allows to 
predict a maximal decrease in Huskisson's VAS by 51%; these 
results are improved when treatment is prolonged for 30 days, 
when predicted Emax is 76%. However, longer treatments, i~e. 84 
days, do not improve the response. These results suggest that 
predicted maximal beneficial response in patients with KOA given 
800 mg/day of CS for 90 days is slightly greater than that predicted 
for SD, but it takes twice longer to achieve the maxima~ beneficial 
effect. Remnant effect of CS persists twice longer than that 
observed for SD. The rate of decline of the remnant effect appears 
specific to each outcome criteria. These computer simulations 
predict that treatment with CS over long periods of time do not 
increase further the response, suggesting that intermittent treat- 
ments may be more beneficial. 
University of Montreal and Bioib~rica Laboratorios 
FR016 
TGF-~I AS A PROGNOSTIC FACTOR IN THE PROCESS OF 
EARLY OSTEOARTHROSlS IN THE RABBIT KNEE 
A. Fahlgren, B. Andersson, K. Messner 
Sports Medicine, Department of Neuroscience and Locomotion, 
Faculty of Health Sciences, LinkSping University, LinkSping, 
Sweden 
Concentration of transforming rowth factor-~l (TGF-131) has been 
used as an inflammatory marker for early osteoarthrosis (OA) 
changes (1,2). Previously we have noted an association between 
osteochondral injury and spontaneous repair in the rabbit knee 
joint, and the concentrations of TGF-~I and proteoglycan (PG) 
fragments in joint fluid (3). The aim of the present study was to 
assess change s in knee joint fluid concentrations of TGF-~I and 
PG fragments during the early course Of posttraumatic osteo- 
arthrosis after meniscectomy in the rabbit knee, and to ascertain 
whether the concentrations of these substances shortly after 
operation, could be used as prognostic markers for the OA 
process. 
Methods: In 15 female adult rabbits with medial meniscectomy 
in one knee and a sham operation in the other knee, joint fluid 
samples were taken repeatedly, before operation, every third week 
postoperatively until 12 weeks, thereafter every 6th week, and at 
death. Five rabbits each were killed at 13, 25 and 40 weeks. Joint 
fluid samples from five n0n-0perated rabbits served as controls, At 
death, two histological scores were formed that charaCteriZed the 
highest (MAX) and the overall (ALL)degree of OA changes in each 
joint. 
Results: TGF-[31 and PG fragment concentrations in joint fluid 
correlated highly at all time points (r=0.81, p<0.001) (Fig. la). 
Both QA scores were higher in meniscectomized than controls 
(p<0.05). The joint fluid concentration of TGF-]31 at 3 weeks, but 
no Other time point, correlated to the histological scores as 
evaluated at time of death (ALL, r=&58; MAX, r=0.52; 
p<0.001)(Fig, lb). 
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Fig, 1. CorrelationS (a) concentrations of TGF-~I and PG 
fragments in joint fluid (all follow-up values combined) (b) TGF-~I 
3 weeks after Operation and CA Score (MAX). 
Conclusion: Higher concentrations of TCF-J31 early after 
surgery seemed indicative for the later development of more 
severe CA changes in contrast o lower concentration& The role of 
TGF-~I in the initiation of CA was underlined by the high correla- 
tions between this substance and PG fragment concentrations in 
joint fluid. Thus in the early process of posttraumatic CA after 
meniscectomy, TGF-~I seem t0 play a decisive role. 
References: 1. Van Beuningen et aL, Lab Invest, 1:994; 71:279; 
2. Dequeker et aL, Arthritis Rheumatism 1:993; 36: 1702; 3. Wei 
and Messner, Osteoarthritis Cartilage, t:998; 6: 10. 
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FR017 
TREATMENT WITH HYALURONIC ACID IN PATIENTS 
AFFECTED WITH GONARTHROSIS WITH AND WITHOUT 
CHONDROCALCINOSIS 
J. Mon[0rt, P. Benito 
Hospital del Mar, Universitat AutSnoma de Barcelona, Barcelona, 
Spain 
The scientific literature has informed of cases of rdonoarthritis of 
the knee in patients affected with gonarthrosis and chondro- 
calcinosis (CC), treated with hyaluronic acid (AH). For this reason 
it was thought ill-advisable to treat these patients with visco- 
supplementers. Monoarthritis, however, only appeared in isolated 
cases within the context of large series of patients. On the other 
hand there exists no studies assessing the effectiveness of AH by 
comparing patients affected with gonarthrosis with or without CC. 
To assess the effectiveness and safety of the treatment with AH in 
a series of patients with gonarthrosis and CC compared with a 
series of patients affected with gonoarthrosis without CC. 
Methods: A series of 50 patients with gonarthrosis with and 
without CC (17/33) were treated with 3 infiltrations of AH (47 p low 
molecular weightJ3 p (2 chondro/1 non chondro) high molecular 
weight). A prospective study was carried out assessing Lequesne's 
index (LE), WOMAC (W) and visual analog scale (EAV) in the 
initial moment, after one month and after 3 months of treatment. 
Side effects referred by the patients were also recorded. For the 
statistic study non parametric tests were used. (Wilcoxon's W for 
studying each group (CC/Non CC) apart and Mann-Whitney's U to 
compare both groups). 
Results: The radiologic degree was higher in CC group (degree 
I: 5.8%, degree I1: 47.05%, degree II1: 23.5%, degree IV: 23.5%) 
with respect to the non CC group (degree I: 21.21%, degree I1: 
39.39%, degree II1: 27.27%, degree IV: 12.12%). W average at the 
beginning was CC/non CC 45/41 after one month 26.88/23.80 and 
after 3 months 20.50/23.90. The difference between averages of W 
beginning/W 1 month and W beginning/W 3 months were statisti- 
cally significant; however, the comparison of W averages between 
CC and non CC groups did not reach a statistic significance. The 
average for LE index at the beginning was CC/non CC 12.25/ 
10.40; after one month 7.50/6.10 and after 3 months 6.38/6.80. 
The difference between average index of LE beginning/LE one 
month and LE beginning/LE 3 months were statistically significant. 
Comparing LE averages between CC and non CC groups did not 
reach statistic significance. EAV average at the beginning was 
CC/non CC 62.25/45.20; after one month 38.75/26 and after 3 
months 25.13/30.90. The difference of averages between EAV 
beginning/EAV 1 month was significant in both groups (CC and 
non CC) while EAV beginning/EAV 3 months was statistically 
significant for CC group but not for non CC group. Comparing EAV 
averages between CC and non CC groups did not reach a statistic 
significance. Only one patient of CC group has shown post 
infiltration knee monoarthritis which was heated with AINE and 
one-week rest. 
Conclusions: (1) AH is an effective and safe drug for the 
treatment of gonoarthrosis for patients with CC as well as for the 
group without CC. (2) No statistic significance was obtained when 
comparing both groups, however, the fact that the group of patients 
without CC did not achieve any statistic significance when com- 
paring EAV 3 months/initial EAV while the CC group did achieve it; 
together with a higher radiologic affectation of CC group allows to 
infer that the treatment is discreetly more effective in the groups of 
patients affected with CC. 
FR018 
PECULIARITIES OF THE OSTHEOARTHRITIS IN 
OCHRONOSIS 
Brandusa Florica, Oana Ahire, Codrina Chiriac, Maria Cardeiu 
Rehabilitation Hospital, University of Medicine and Pharmacy lasi, 
Romania 
Autosomal recessive metabolic disorder, the alkaptonuric 
ochronosis can result in the clinical expression of osteoarthritis. 
We studied clinically, biologically and radiologically, two patients 
with ochronosis, with an uncertain familial relationship. They com- 
plained of the osteoarthritis like symptoms in knee, hip and 
shoulder joints, and in the spinal column. Clinically objective, the 
patients have had the classical signs of ochronosis (violet color of 
the ear cartilage, pigmentation of the sclere, hyperchrome urines, 
after the exposure to light) and, also the presence of the homo- 
gentisic acid in the urine. The imaging investigations consisted of 
only the conventional radiography and emphasized the main 
characteristic manifestations of ochronotic arthritis: the vertebral 
disk calcifications, shoulder and hip severe arthrosis, sacroiliac 
and pubian arthrosis and the calcifications in the auricular 
cartilage. The characteristics of these findings are the severity of 
the injuries, the involvement of the joints unusually affected pri- 
mary anthrosis and the early age of the onset. The clinical and 
radiological aspects could result in the different diagnosis of 
seronegative spondilarthritis. Echocardiographic examinations of 
the patients revealed the calcification depositions on the 
aortic valves, along with coaptation deficiency and slight aortic 
regurgitation. 
Conclusion: Ochronosis is clinically and radiologically charac- 
terized by an early and severe involvement of the joints usually 
non-affected by primary ostheoarthritis (shoulder, pubis, 
sacroiliac). Any ostheoarthritis with these situations and clinical 
peculiarities has to be suspected for ochronosis. The diagnostic 
can be easy confirm by the homogentisic aciduria and the 
characteristic radiological manifestations. 
FR019 
ENDOSCOPIC EVALUATION COMPARING THE 
GASTRODUODENAL SAFETY OF MELOXICAM AND 
PROGLUMETACIN: A RANDOMISED DOUBLE-BLIND STUDY 
K. K~ F6rster*, M. Bonnl-, P. MQIlert, K. Schmid*, B. Simon:l: 
*Department of Clinical Research, OPFERMANN Arzneim. GmbH, 
Wiehl, Germany; tHospital 'Salem', Heidelberg, Germany; 
:~Department of Gastroenterology, District Hospital, Schwetzingen, 
Germany 
Introduction: The therapeutical use of classical non-steroidal 
anti-inflammatory drugs (NSAIDs) is often accompanied by 
gastrointestinal adverse effects (AEs) and even potentially serious 
complications may occur. This has led to different strategies to 
prevent, or at least reduce, such AEs. One strategy for example 
was the development of proglumetacin (Protaxon® forte), 
a molecular combination of the NSAID indomethacin with 
proglumide, a gastrin- and cholecystokinin-antagonist. A strategy 
of topical interest was the development of preferential or even 
selective COX-2-inhibitors. 
Aim of the study: The COX-2-preferential drug meloxicam was 
introduced in Germany as first substance out of this group. 
Therefore, the gastroduodenal safety of proglumetacin was 
comparatively evaluated with that of meloxicam 
Methods: Daily dosages of either 600 mg proglumetacin 
(300mg b.Ld.) or of 15rag meloxicam (7.5rag b.i.d.) were 
comparatively evaluated in healthy volunteers in a double-blind 
cross-over study. Application duration was 7! days each (wash-out 
period of 13 days between the two treatments). 
Results: Twenty healthy volunteers (2 women, 18 men; mean 
age of 28.5 years) were randomly assigned to treatment sequence 
either with 'proglumetacin and then meloxicam' or with 'meloxicam 
and then proglumetacin'. The damage of oesophageal, gastral and 
duodenal mucous membrane was endoscopically evaluated 
according to a modified LANZA score. Neither total damage score 
(P: 96 points; M: 97 points) nor mean values (P: 4.80; M: 4.85) 
showed a statistically significant difference. 
Conclusions: In summary, proglumetacin--300 mg b.i.d., given 
over a period of 7! days--is as safe as meloxicam--7.5 mg b.i.d., 
given over a period of 7! days--with regard to gastroduodenal 
tolerability. 
FR020 
OSTEOARTHRITIS OF THE LUMBAR SPINE AND ITS 
CONSERVATIVE TREATMENT WITH GLUCOSAMINE 
SULFATE: A PLACEBO-CONTROLLED, RANDOMISED, 
DOUBLE-BLIND STUDY 
K. K. F6rster*, K. Schmid °, L. C. Rovatit 
*Department of Clinical Research, OPFERMANN Arzneim. GmbH, 
WiehL Germany; tDepartment of Clinical Pharmacology, ROTTA 
Research Laboratory, Monza, Italy 
Aim of the study: Assessment of efficacy and safety of oral 
glucosamine sulfate (GS) in the control of lumbar spondylarthrosis 
symptoms, compared with placebo during a 6 week treatment and 
a 4 week follow-up period. 
Methods: The study was performed following a multicentre, 
placebo-controlled, randomised, double-blind, parallel-group 
design in patients with lumbar spondyloarthrosis, demonstrated by 
pain and movement limitation for at least 6 months and positive 
radiology. Clinic visits were performed at enrolment, after 3 weeks, 
at the end of the 6 weeks of treatment (1.500 mg GS or placebo, 
once daily) as well as 4 weeks after drug discontinuation. Main 
parameter of evaluation was the clinical investigator's global 
judgement at the end of treatment, secondary parameters were 
patient's global assessment, pain severity, measured by a visual 
analogue scale (VAS), functional limitation, measured by several 
function tests, morning stiffness, interference with daily activities, 
as well as, concerning safety, adverse events and laboratory 
parameters. 
Results: 160 patients with cervical and/or lumbar spondyl- 
arthrosis were enrolled and completed the study, 92 patients with 
osteoarthritis (OA) of the lumbar spine (76 women, 16 men; mean 
age: 65.2+9.9 years) are described here in more detail. Concern- 
ing the investigator's global judgement, 51.2% of the 43 GS group 
patients were either 'definitely improved' or 'improved', vs. 28.6% 
of the 49 placebo group patients (p=0.0334). Concerning patient's 
global judgement, figures were higher, but no longer statistically 
significant. GS induced a more pronounced (in part, statistically 
significant) decrease in severity of all pain parameters, and this 
was maintained after drug discontinuation. A similar pattern was 
found concerning movement limitation. Morning stiffness and inter- 
ference with daily activities was positively and in a greater extent 
influenced by GS, Tolerability was comparably good (16.3% vs. 
10.0% mild and transient adverse events; n.s.). 
Conclusions: As already well established in OA of the knee 
(M(Jller-FafJbender and Bach 1990; Noack et al. 1994; Reichelt 
et al. 1994), GS has a significantly better symptomatic efficacy 
than placebo in controlling pain and movement limitation in OA 
lumbar spondylarthrosis. This efficacy continues even after the end 
of treatment, whereby and all in all the safety of GS is good and 
comparable to that of placebo. 
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FRO21 
PREDICTORS OF RESPONSIVENESS TO PHYSIOTHERAPY 
TREATMENT FOR PATIENTS WITH OSTEOARTHRITIS OF 
THE KNEE 
M. Fransen, J. Crosbie, J. Edmunds 
St. George Hospital, Kogarah, Australia 
Aim: To assess if baseline age, BMI, symptom duration and/or 
medial joint space width (JSW) will predict responsiveness to 
physiotherapy treatment in patients with CA knee. 
Methods: 126 patients appearing on the physiotherapy out- 
patients waiting list of a large hospital were randomized into one of 
three 8-week allocations: individual treatments, small group format 
exercise program or waiting list control. Assessments included 
pain, physical function (WOMAC) and health-related quality of life 
(SF-36) as well as objective measures of physical performance 
(gait analysis and isometric muscle strength). All subjects were 
required to obtain a standing, semi-flexed radiograph of their most 
painful knee. One month test-retest digital measurement reliability 
on 18 randomly selected radiographs (114 radiographs obtained) 
was ICC (2,1)=0.98 (0.97--0.99). 
Results: Split-median stratification according to age, BMI or 
symptom duration did not reveal trends in differential treatment 
responsiveness. In contrast, split-median stratification according to 
medial JSW, despite comparable self-reported baseline symptom 
severity, did reveal a consistent trend in treatment responsiveness 
(Table). Patients with a medial JSW<I.9 mm improved markedly 
less than patients with a medial JSW >1.9 mm. The interaction 
reached significance for WOMAC physical function (p=0.04), 
SF-36 PCS (p<0.01), fast gait speed (p<0.01), fast stride length 
(0=0.02) and peak isometric extensor strength (0=0.05). The fact 
that the group with more severe loss of medial JSW (<1.9 mm) 
unexpectedly had greater baseline extensor strength and compar- 
able gait scores is attributed to the higher ratio of males in this 
group (39% vs 16%). 
Outcomes stratified by medial joint space width 
Basehne Baseline Change EHect 
charactenstics mean (sd} mean (95% Cl) size 
Media! JSW <1.9 mm {n=57} 
Mean (sd) medtal JSW (ram) 
Mean age, °o male 
Symptoms <1. 1-5. >5 years (%) 
WOMAC pain (100-O) 
WOMAC function (100--0) 
SF-36 PCS (mean = 50) 
SF-36 MCS (mean=50) 
Knee extensors (N) 
Fast velocity (cm.sec -1) 
Fast slride length (cm) 
Medial JSW >1.9 mm (n=57) 
Mean (sd) medial JSW (mm) 
Mean age. % male 
Symptoms <1. 1-5. >5 years (%) 
WOMAC pain (100-0) 
WOMAC |unclion (100--0) 
SF-36 PCS (mean=50) 
SF-36 MCS (mean=50) 
Knee extensors (N) 
Fast velocity (cm.sec - I )  
Fasl stride length (cm) 
0.9 (0.4) 
690. 39°o 
7. 46, 47 
3.2 (O.9) 
65.2, 16% 
21.42 .37  
62.4 (20.3) 56  (0.6, 10.6) 30  
599  (19.3) 2.6 ( -1.6.8.8)  .17 
33.6 (93) 1.4 (-0.5, 3.3) .20 
44.0 (7.6) 1.3 (-0.0, 2.6) .27 
1851 (76.2) 4.0 (-2.5, 10.5) 16  
1277 (25.2) 1.5 (-1 0. 4.0) 16  
129.3 (22.0) 1.1 (-0.9. 3.t) .14 
61,2 (20.3) 11.0 (6.3. 15.5) 63  
621 (22.6) 9.1 (5.7. 12.5) .72 
33.2 (9.8) 4.5 (2.5. 6,5) 59  
42.4 (9.8) 2.8 (1.4.4,3) .51 
153.0 (60.3) 11.7 (5.9. 17.5) .53 
130.1 (26.4) 8.9 (6.0. 11.3) .82 
128.1 (21.7) 5,2 (3.1. 7.3) ,67 
Conclusion: In contrast to age, BMI or symptom duration, 
medial JSW as measured on a standing semi-flexed magnification- 




PERCUTANEOUS VERTEBROPLASTY (PVP) IN 
OSTEOPOROTIC VERTEBRAL COLLAPSE AND VERTEBRAL 
HEMANGIOMA 
M. C. Garcia Gomez, C. Galisteo, M. Castellanos, N. Navarro, 
C. Alegre, J. Obach, M Rovira', J. Serra*, A. Mejiast, 
L.I. Mebarakl- 
*Hospital de Malalties Reumatiques, Barcelona,/Spain; "rCRC, 
Barcelona. Neurosurgery 
Introduction: The PVP is a procedure made since 1984, and 
it consists of the percutaneous injection of a biomaterial, poli- 
methylmethacrylate, inside of vertebral body. With this we get to 
consolidate the vertebral body and to relieve the pain. It is 
indicated in the treatment of the persistent pain of vertebral body 
injury, mainly the aggressive hemangioma, the tumoural processes 
(myeloma and metastasis) and also in the osteoporotic vertebral 
collapse. We present our experience in this technique. 
Material and methods: We show three clinical cases, with 
radiology pictures, about PVP guided by TAC, under local anaes- 
thesia and general sedation, which first indications were to relieve 
the pain. Woman 59 years old, with mechanical dorsal pain by a 
collapse of D l l ,  women 77 years old with lumbar pain irradiated 
down to inferior limbs by collapse of L2, and men 72 years old with 
a mechanical lumbar pain by an hemangioma located in L3. 
Results: In the three cases we got to relieve the pain before, the 
consolidation of the vertebral body, the reduction of the hospital- 
ization period and saving to have analgesic drugs. In none of them 
we had complications. 
Conclusions: The PVP has been an effective technique in the 
treatment of the persistent pain in the osteoporotic vertebral 
collapse and vertebral hemangioma in our patients. It could be an 
alternative good treatment, and besides it allows an earlier 
mobilization, as it prevents the apparition of deformities and 
possible secundaries complications about this. This is an expen- 
sive procedure with possible risk, and we should make controlled 
studies to specify which patients could be benefitted by this 
technique. 
FR024 
EFFECTIVENESS OF EVALUATION OF PHYSICAL THERAPY 
FOR PATIENTS WITH OSTEOARTHRITIS AFTER TOTAL HIP 
ARTHROPLASTY 
A. Gocentas, M. Tamutaitien@, A. Juocevi6ius 
Center for Gerontology and Rehabilitation of the Institute of 
Experimental and Clinical Medicine, Vllnius, Lithuania 
Aim: Treatment programs for patients with osteoarthritis (OA) 
after total hip arthroplasty (THA) have been observed to differ in 
functional activities, exercises, frequency and progression. The 
purpose of this investigation was to compare functional outcomes 
of patients with OA after THA in two groups: who were treated 5 
days/weekly physical therapy (PT) versus patients with OA after 
THA who were treated 7 days/weekly. 
Methods: Patients:. persons with OA 2 weeks after THA with 
uncertain functional prognosis who needed inpatient rehabilitation. 
Collected data: pain assessment by the patients (VAS 100 mm), 
range of active motion, manual muscle testing (0-5 points), time(s) 
for 10 m ambulation, Maryland disability score (Barthel index). 
Procedure: Inpatient 4 weeks physical therapy. Time of collection: 
2 weeks after THA, 6 weeks after THA, 6 months after THA. 
Analysis: in the statistical data analysis a t-Student test was used. 
A significance probability value of p<0.05 was considered. 
Results: 77 patients were recruited: 34 patients in 7 days/weekly 
PT group and 43 in 5 days/weekly group. There were no stat- 
istically significant differences between groups after 4 weeks 
inpatient PT and after 6 months follow-up in ROM, pain, and time 
for 10 m ambulation, Maryland disability score. After 4 weeks 
inpatient PT statistically significant differences between groups 
were only in muscle manual testing (p--0,048). 
Conclusion: Functional outcomes were similar after inpatient 
treatment in THA groups treated 5 or 7 days/weekly. These results 
show that PT program 5 days/weekly is sufficient for the treatment 
of patients with osteoarthritis after THA. 
FR025 
Cd44 AND TGF-~ EXPRESSION IN NORMAL AND 
OSTEOARTHRITIC CARTILAGE OF THE HUMAN KNEE 
BEFORE AND AFTER HYALURONAN TREATMENT 
D. Guerra, D. Guidelin*, E. Carnevali, S. Nerbano, E. Lini*, 
L. Frizzierot, I. Pasquali-Ronchetti 
Biomedical Sciences Department, University of Modena and 
Reggio-Emilia; l-Department of Internal Medicine, Rheumatology 
Unit, Maggiore Hospital, Bologna; *Fidia R&D, Abano Terme (PD), 
Italy 
Aim: The aim of the study was to investigate the expression of 
CD44 and of TGF-~ in the articular cartilage of osteoarthritic 
human knee before and after 6 months from treatment with sodium 
hyaluronate (HA) (2 ml of 20 mg/ml, one local injection/week for 5 
weeks) or methyl-prednisolone acetate (MP) (1 ml of 40 mg/ml, 
one local injection/week for 3 weeks). Data were compared with 
those obtained on articular cartilage samples from apparently 
normal human knees. 
Material and Methods: After informed consent, cartilage 
samples were taken during arthroscopy from patients with primary 
osteoarthritis (OA) before and 6 months after treatment with HA 
(10 patients, age 52+8 year) or with MP (10 patients, age 57±6 
years). Specimens were embedded for electron microscopy and 
immuno-reactiens were performed on semithin sections. Positivity, 
evaluated with scores from 0 to 5, was revealed with a Leica TCS 
4D confocal microscope for CD44 (fluoresceinated monoclonal, 
clone A3D8 Sigma) and by the immuno-peroxidase method for 
TGF-13 (potyclonal, R&D). 
Results: Normal articular cartilage chondrocytes were CD-44 
more positive in the deep than in the superficial zone. In OA, CD44 
expression on chondrocytes was similar or higher than in controls; 
it became more similar to controls after both treatments. HA was 
more effective than MP in reducing the chondrocytes expression of 
CD44. In normal subjects, both the nucleus and the cytoplasm of 
chondrocytes were positive for TGF-13; the positivity of the extra- 
cellular matrix was rather low and tended to increase with age. In 
OA, the chondrocyte expression of TGF-I~ was similar or lower 
than in controls and it was even lower after HA treatment. The 
extracellular matrix was more positive for TGF-I~ in OA compared 
to controls; both HA and MP were able to reduce matrix positivity 
for TGF-13 towards normal values. 
Conclusion: With individual differences, both HA and MP local 
treatments seem to modify the expression on chondrocytes of 
hyaluronan receptor CD44 and of TGF-~, and to reduce the 
presence of immunostainable TGF-I~ in the extracellular matrix of 
the osteoarthritic artilage of the human knee. 
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FR026 
SUBCHONDRAL BONE IN OSTEOARTHRITIS 
L. M. Miller*, D. Hamermanl-, M R. Chance:l: and C. S. Carlson§ 
*National Synchrotron Light Source, Brookhaven National Lab- 
oratory, Upton, NY: tResnick Gerontology Center and J;Depart- 
ment of Physiology and Biophysics, Albert Einstein College of 
Medicine, Bronx, NY; and §Department of Veterinary Diagnostic 
Medicine, College of Veterinary Medicine, University of Minnesota, 
St. Paul, MN, USA 
Subchondral bone sclerosis is observed by histologic and 
radiographic studies in osteoarthritis (OA). Mechanical impact on 
thickened subchondral bone has been thought to contribute to 
articular cartilage breakdown (Radin et al., Clin Orthop 213: 34, 
1986). However, the biological basis for thickened subchondral 
bone needs to be defined because bone changes may contribute 
to OA progression and influence treatment decisions (Dieppe, 
Osteoarth Cartil 7: 325, 1999). Low levels of CSF-1 with failure of 
osteoclastic resorption were considered as a basis for dense 
subchondral bone (Hamerman and Stanley, J Bone Miner Res 11: 
1205, 1996), but CSF-1 levels in OA synovial fluids did not differ 
from those in traumatic fluids (Hamerman et al., Anne Rheum Dis 
57: 260, 1998). Enhanced production of IGF-1, a bone growth 
factor, was demonstrated in osteoblasts from OA bone (Hilal et al., 
Arthritis Rheum 41: 981, 1998). We have studied a model of OA in 
aging cynomolgus monkeys where subchondral bone sclerosis 
has been shown histologically to precede cartilage breakdown 
(Carlson et al., J Bone Miner Res 11: 1209, 1996). In the present 
study, samples of subchondral bone were obtained from histo- 
logically normal monkey tibias and compared with osteoarthritic 
tibias by means of synchrotron infrared microspectroscopy. This 
technique permits analysis of intact bone sections at 3-5 IJm 
spatial resolution for protein, mineral content, crystallinity, and 
collagen structure. Results can be expressed quantitatively as a 
function of OA severity. Our findings showed increased mineral- 
ization in osteoarthritic bone with a higher phosphate/protein ratio, 
and a carbonate protein/ratio significantly higher in severe 
(p<0.05). We also found altered collagen structure in OA which 
may contribute to the increased mineralization. We postulate that 
these changes in subchondral bone may make it more brittle and 
lead to microfractures with increased remodelling, consistent with 
clinical studies that suggest high bone turnover (Dieppe et al., Ann 
Rheum Dis 52: 557, 1993; Sharif et al., Arthritis Rheum 38: 78, 
1995). 
FR027 
GENETIC INFLUENCES IN PRIMARY OSTEOARTHRITIS OF 
THE HIP IN TWINS 
William Page, Franklin Hoaglund & Lynne Steinbach 
Institute of Medicine National Academy of Sciences, Washington 
D.C. & The University of California, San Francisco 
Aim of Study: To measure genetic inheritance of primary 
osteoarthritis of the hip by comparing concordance of monozygotic 
and dizygotic twin pairs of the NAS-MFU Twins Registry who are 
all white males born between 1917 and 1927. 
Methods: In a telephone questionnaire to 6,419 twins done 
primarily to study degenerative neurological conditions 2,562 twin 
pairs responded to the question of having had a total hip replace- 
ment or having symptoms of hip pain. 
One or both of 92 twin pairs responded to having had a total hip 
replacement (THR). Subsequent written/telephone questionnaires, 
requested recovery of medical records, and pre-operative pelvic 
x-rays on operated twins. All un-operated co-twins were invited to 
have a current x-ray whether symptomatic or not. 113 X-rays were 
read independently by an orthopaedic surgeon and musculo- 
skeletal radiologist without knowledge of zygosity for co-twin. 
Results: Primary osteoarthritis was the etiology for total hip 
replacement in 69 of 92 twin pairs. 
Concordance: X-rays were available for both of 34 twin pairs 
where one had primary osteoarthritis of the hip. Four pairs were 
excluded because of unknown zygosity. Of the 16 monozygotic 
pairs, 10 were concordant (63%) for primary osteoarthritis, versus 
2 of the 14 dizygotic pairs (14%). ;(2=7.23, 1 df, p=0.007. Eleven 
additional twin pairs had available x-ray diagnosis for one twin, 
primary osteoarthritis or normal and a co-twins with a physician 
diagnosis of osteoarthritis or self reported hip replacement for 
osteoarthritis. For all 41 twin pairs with available radiographic/ 
physician diagnosis, 13 of the 23 monozygotic pairs are concord- 
ant (57%) versus 2 of dizygotic pairs, this difference is statistically 
significant Z2=8.98, 1 df, p=0.003. 
Conclusion: The statistically significant higher rates of con- 
cordance for osteoarthritis among monozygotic than dizygotic 
twins can be taken as evidence for a genetic influence on osteo- 
arthritis. 
FR028 
A TECHNIQUE FOR THE ANALYSIS AND VISUALIZATION OF 
LOCAL SIGNAL INTENSITY ALTERATIONS IN HUMAN 
ARTICULAR CARTILAGE 
J. Hohe*l -, S. Faber:l:, K. H. Englmeierl-, M. Reiser:l:, R Eckstein" 
*Musculoskeletal Research Group, Anatomische Anstalt 
Muenchen, Pettenkoferstr. 11, 80336 Muenchen: tMedis Institut, 
GSF Neuherberg; J;Radiologische Diagnostik Grosshadern, 
Germany 
Earliest signs of osteoarthritis have been shown to include 
ultrastructural alterations of the main constituents of articular 
cartilage, namely water, collagen and proteoglycans. The concen- 
tration of these major components varies within and between 
articular cartilage plates and it is believed that this balanced 
biochemical composition is altered in early osteoarthritis. Magnetic 
resonance imaging (MRI) has the potential to supply specific 3D 
data sets for studying the structural composition of the main 
constituents of cartilage by analyzing the signal intensities of the 
image data. This work supplies a method for the global and 
regional quantitative analysis of the signal intensity in MR images 
of articular cartilage and visualizes the results of the respective 
area on a 3D model of the cartilage. The technique was applied to 
15 (8 female, 7 male) in vivo proton density maps for the global 
analysis between patellar and tibial cartilage and another 6 (3 in 
vitro, 3 in vivo) MRI proton density and water excitation data sets 
for the regional signal intensity analysis within the patellar 
cartilage. For the regional analysis the segmented cartilage of 
each slice was automatically separated into 3 layers (superficial, 
middle and deep zone) and then into 8 sections (medial to lateral). 
The data sets were normalized to a phantom. In the 15 data sets 
we found higher average proton density values in the patellar than 
in the tibia (p<0.001) and remarkable interindividual differences 
(29%-36%). The regional analysis showed a trend for higher 
values in the specimens (proton density: 0.8-1.38, water ex- 
citation: 1.61-1.85) than in the volunteers (0.52-0.76, 1.39-1.65). 
The section analysis for the proton density showed highest signal 
intensity values in the peripheral sections whereas the highest 
values in the water excitation data sets tended to o{:cur in middle 
sections. The proton density layer analysis demonstrated high 
signal intensities in deep cartilage zones for the specimens but low 
values for the volunteers. Five water excitation data sets showed 
noticeable higher signal intensity values in the middle and super- 
ficial than in the deep zone. The technique presented here is 
capable of supplying information about the global and regional 
signal intensity distribution in articular cartilage and to compare 
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these findings to histological analyses of this tissue. Applied to 3D 
MRI sequences, which provide specific information about water, 
collagen or proteoglycan, this technique is of particular interest for 
the diagnosis and progression control of osteoarthritis in an early 
state when there are predominantly focal lesions and alterations in 
the biochemical composition of the cartilage. 
FRO29 
COLLAGEN PEPTIDES IN THE TREATMENT OF 
OSTEOARTHRITIS 
MAda m, H. Hulejova., P. ~pa~ek 
The Rheumatism/nstitute, Prague, Czechia 
Aim of study: To objectivise the beneficial effect of collagen 
peptides supplementation on osteoarthritic troubles. 
Methods: 80 patients with osteoarthritis of large bearing joints 
were supplemented perorally for three months with 10 g of col- 
lagen peptides (CP) from bovine skin (average molecular mass 
3000, DGF Stoess, Eberbach, Germany) every day. Patients 
troubles were monitored by scoring different troubles (moderate 
intensity-~one point, severe intensity--two points), total possible 
score was 28 points. Further were determined urinary pyriclinolines 
(UPD) by HPLC (Spectra-Physics, San Jose, CA, USA, using 
strong cationic exchanger Separon HEMA-BIO 1000 SB, Tessek, 
Prague, CR). Both serum bone alkaline phosphatase (BAP) as 
well as chondrex (YKL-40) were determined by ELISA (Metra, CA, 
USA) before and after the trial. For statistical evaluation patients 
were divided according to X-ray pictures into two subgroups: (a) 
synovial form (11. stage) of OA, (b) bone form (111. or IV. stage) 
or OA. 
Results: Basal score of the total group showed a moderate 
activity of the disease---10.64 points. After treatment with CP score 
was down regulated to 5.60. Score of patients with synovial form 
(31) of OA decreased after treatment from 9.66 to 5.25 and that of 
bone form (49) from 11.51 to 5.94. Collagen peptides treatment 
down regulated UPD values of the total group from 58.83 to 
43.03 nmol/mmol creat. The main decrease was observed in the 
synovial form (from 67.88 to 39.50) whereas in the bone form the 
decrease was from 53.03 to 45.55. Changes of chondrex owing to 
the treatment were only slight, in some patients they even 
increased. BAP is a marker of bone formation--CP treatment 
showed only a small increase of its values. 
Conclusions: Supplementation OA patients with CP is causing 
reduction of joint troubles in most patients, what is reflected in 
decrease of troubles score and UPD values. Because chondrex is 
synthesized not only by articular cells (chondrocytes, synovio- 
cytes) but also by neutrophils and macrophages, its serum levels 
are evidently affected by changes also in other tissues than in joint 
compartment only. 
FR030 
SERUM CHONDREX AS A MARKER OSTEOARTHRITIC 
PROCESS 
H. Hulej_ova, P. 8pa~ek, M. Adam 
The Rheumatology Institute, Prague, Czechia 
The aim of the study: To verity validity of serum chondrex 
(YKL-40) and urinary pyridinoline as markers of intensity of 
osteoarthrotic (OA) process. 
Methods: 70 patients with osteoarthritis of great bearing joints 
were recruited. Patients troubles were evaluated by points (one 
point--moderate intensity of troubles, two points severe intensity 
of troubles). Possibility of total score was 28 points. 
Patients were divided into two subgroups according to the clinical 
and X-ray pictures: (a) synovial form (11. stage), (b) bone form (111. 
or IV. stage). Further patients were divided according to their 
urinary pyridinolines (UPD) into antoher groups (a) <80 nmol/mmol 
creat. (b) >80nmol/mmol creat, and chondrex levels were 
evaluated according to this criterion. 
Chondrex was measured using ELISA (Metra Biosystems, CA, 
USA). For determination of urinary pyridinoline we used column 
type CGC, 150x3 mm filled with strong cation exchanger as the 
stationary phase (Separon HEMA-BIO 1000SB, Tessek, Praque, 
CR) in the equipment of Spectra Physics (San Jose, CA, USA, 
type SP). Statistical evaluation was performed with the Student's 
t-test. 
Results: Whereas chondrex values in 20 controls ranged from 
19.2 to 73.8 ng/mL with average 38.9+13.2, in the total OA groups 
average chondrex was up regulated to 96.01+61.0ng/mL 
However, correlation between score and chondrex was rather poor 
(r=0.344). More deep insight showed that chondrex was more 
increased in the bone form (105.32+63.13). Also in patients with 
high UPD values (>80 nmol/mmol creat.) in agreement with this 
observation higher chondrex values were present (128.37+63.71 ) 
and higher values reached values 240.0-260.0 ng/mL. Correlation 
of chondrex and UPD was very small (r=-0.012). 
Conclusions: From the above mentioned results it may be 
concluded that chondrex does not reflect changes in bone collagen 
metabolism. Because there was a rather negligible correlation 
between score of clinical symptoms and chondrex it is difficult to 
judge what processes chondrex reflects. It is synthesized not only 
by cells of joint compartment but also by macrophages and 
neutrophils. Therefore it may be anticipated that chondrocytes and 
synoviocytes are only a small source of serum chondrex. This 
conclusion is supported by the rather fast down regulation of 
serum chondrex in RA patients after beginning of corticosteroid 
therapy. 
FRO32 
HISTOLOGICAL ASSESSMENT OF BIOMECHANICALLY 
INDUCED DAMAGE TO HUMAN ARTICULAR 
CARTILAGE--SURFACE STRUCTURE AND CLONES 
J. L. Hyllested °, K. Veje*, L. E. Bestwickl-, R. M. Aspdent and 
K. Ostergaard ° 
*Osteoarthfitis Research Unit, Institute for Inflammation, National 
University Hospital, Copenhagen, Denmark; tDepartment of 
Orthopaedics, Polwarth Building, University of Aberdeen, 
Aberdeen, Scotland 
Objective: Studies have shown that the variables 'surface 
structure' and 'clones' may be reproducible if precise definitions of 
the variables are available. The objective of this study was to 
assess the correlation between these histological variables and an 
in vitro model of articular cartilage damage. 
Methods: 10 normal human articular cartilage biopsies were 
sampled from the superolateral part of the femoral head of 10 
patients undergoing hip replacement surgery due to fractured 
femoral neck, resulting in a total of 100 biopsies. Only macro- 
scopically intact femoral heads were included. The biopies were 
stored in DMEM with 2% FCS; 5 biopsies from each femoral head 
were single-impact loaded (500 g weight) in a drop tower and 
5 biopsies from each femoral head were kept as controls. All 
biopsies were then stored in DMEM with 2% FCS at 37°C and 
collected for processing at 0, 24, 48, 192 hours. Biopsies were 
then snap-frozen and stored. 5 IJ cryosections were cut and fixed 
for 24 hours in formalin. To evaluate the morphology of the 
sections, staining with Safranin O- Fast Green FCF-Weigert 
haematoxylin were made. All sections were evaluated by two 
blinded observers and the score agreed upon. 
Sections were evaluated regarding the two variables 'surface 
structure' and 'clones'. A 'gold standard' was reached in unison and 
photographs of surface variations and clones were taken and 
available during the evaluation sessions. If in doubt at any given 
point, the photographs were consulted for standards. 
The surface structure was regarded as either (1) normal, (2) 
uneven or (3) showing fissures extending into the superficial, (4) 
middle or (5) deep zone. 
The organisation of cells was regarded as showing either none, 
few (1-2) or many fissure related clones (a clone was defined as 
more than three chondrocytes). In addition, it was noted whether or 
not ubiquitous (non-fissure related) clones were present. 
Results: Impact-loaded cartilage showed clear signs of damage, 
75% of impact-loaded biopsies having fissures (a score of 3 or 
above)--79% superficial, 18% middle and 5% deep. There was no 
difference between short and long incubation times. In contrast, 
81% of non-loaded cartilage biopsies had normal (88%) or 
uneven (12%) surface. Again there appeared to be no difference 
accreditable to incubation time. 
With regards to the variable 'clones', impact-loaded cartilage 
showed clonal expansion of cells; 80% of sections with fissures 
showed fissure-related clones (50% few and 50% many). Non- 
loaded cartilage showed no fissure related clones. Approximately 
30% of all sections showed some diffuse sign of clonal expansion 
not Iocalised to any particular zone or defect. Again, no difference 
between short vs long incubation time was seen. 
Conclusion: This in-vitro biomechanical cartilage damage 
model shows morphological changes in human articular cartilage 
as measured by the two variables 'surface structure' and 'clones'. 
There appears to be some clone formation in damaged areas of 
impact-loaded cartilage, but the exact cause-effect relationship 
between the appearance of clones and fissures remains to be 
established. 
FR033 
THE BONE MINERAL DENSITY, CYTOKINES AND 
TREATMENT IN PREMENOPAUSAL AND 
POSTMENOPAUSAL WOMEN WITH RHEUMATOID 
ARTHRITIS 
Li Juan, Chen Xiaoguang and Qiu Yurong 
Nan Fang Hospital, The First Military Medical University, Guang 
Zhou 510515, China 
Aim: Rheumatoid arthritis (RA) is a disease which mainly cause 
arthritis and meanwhile affect the bone. Typical osteosporosis is 
often observed in the X-ray photo of the early RA patient. The bone 
mineral density (BMD) and cytokines (IL-10 and TNF-a) level in 
premenopausal and postmenopausal women with RA were 
measured in the present study. 
Method: BMD of the lumbar spine (L2-L4) and the proximal 
femur (femoral neck, Ward's triangle and trochanter major) were 
measured using dual X-ray absorptiometry (DEXA) and IL-10, 
TNF-a were assayed using ELISA kit. The patient group is 32 
premenopausal and postmenopausal women with RA, the control 
group is the same number of normal subjects matched for age, sex 
and menopausal status. 
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Result: There was a significant decrease (P<0.05) in BMD 
(g/cm 2) in the patient group at the lumbar spine and the proximal 
femur as compared with the normal subjects. There was a signifi- 
cant negative correlation between age-matched Z-score of BMD at 
the L2-L4 (r=-0.58, p=0.003, n=28) and the duration of gluco- 
corticoid therapy in patients with RA. The IL-10 level in premeno- 
pausal and postmenopausal women with RA were lower than the 
normal subjects, the difference was significant (P<0.05). The 
TNF-a level was higher than the normal but the difference was not 
significant (P>0.05). The patients were treated with anti-RA drug 
as well as anti-opteoporosis drug 'Gu-Ling-Wan', a Chinese 
herb which is supposed to strong the kidney. The dose for 
'Gu-Ling-Wan' was 6 g/kg, tid. After 6 months, the DEXA result 
showed that the BMD was much higher than before and the 
difference is significant (P<0.05). 
Conclusion: BMD is decrease in premenopausal and post- 
menopausal women with RA. IL-10 and TNF-a play some role in 
the process of osteoporosis. IL-10 might be up-regulating and 
TNF-a might be down-regulating. 'Gu-Ling-Wan' can abate 
effectively the bone loss of premenopausal and postmenopausal 
women with RA. 
FR034 
EFFECT OF ACUPUNCTURE IN KNEE OSTEOARTHRITIS 
E. Tukmachi, E. Dempsey, R. W. Jubb 
University Hospital Birmingham, Birmingham, UK 
Aim: To demonstrate, in an open pilot study, that acupuncture 
has a beneficial, measurable effect on the symptoms of osteo- 
arthritis of the knee. 
Methods: 30 patients with symptomatic osteoarthritis of the knee 
were randomised to one of three groups: 
1. Ten acupuncture sessions over five weeks instead of 
conventional drug therapy. 
2. Ten acupuncture sessions over five weeks as well as 
conventional drug therapy. 
3. Conventional drug therapy for five weeks followed by five 
weeks of additional acupuncture sessions. 
Symptoms were assessed three times, at entry to the study, 
immediately after the course of acupuncture, and at a follow-up 
visit 4-5 weeks later. Pain was measured both by a 10cm 
Visual Analogue Scale and the Western Ontario and McMaster 
Universities Osteoarthritis Index (WOMAC-LK 3.0) on each 
occasion. Results presented as a mean of the group. 
Results: 
Overall Knee Pain (VAS 10 cm) 
first visit afler five weeks follow-up visit 
1 acupunclure alone (n=9) 6.0 3.2 2.8 
2. acupuncture and drugs (n = 10) 5.9 1.7 2,2 
3. drugs then acupuncture (n = 10) 7.0 6.9 1.5 
WOMAC Pain 
firsl visit after five weeks follow-up visil 
1. acupuncture alone 10,2 6.0 5.1 
2. acupuncture and drugs 12.3 4.5 5.6 
3. drugs then acupunclure 12.6 12,7 4.7 
WOMAC Stiffness 
firsl visit after live weeks follow-up visit 
1. acupuncture alone 4.8 3.2 3.2 
2. acupuncfure and drugs 5.7 2.3 3.4 
3. drugs then acupunclure 5.5 5.8 2.6 
Statistical analysis (Paired Student "t" test) gave highly significant 
results between first visit and after acupuncture but not control 
treatment. 
Conclusions: Acupuncture, in an open study, has profound, 
lasting effects on the pain and stiffness of osteoarthritis of the 
knee. This effect is additional to the action of conventional 
analgesic and anti-inflammatory drugs. These encouraging results 
now allow us to continue a research programme that dissects out 




HIP DYSFUNCTION AND OSTEOARTHRITIS OUTCOME 
SCORE (HOOS) AN EXTENSION OF THE WESTERN 
ONTARIO AND MACMASTER UNIVERSITIES 
OSTEOARTHRITIS INDEX (WOMAC) 
M. Kl&ssbo*l', E. Larsson:l:, E. Mannevik§, E. Roos¶ 
"Department of Phys Ther, S~ffle Hospital, S~ffle, Sweden; 
tDepartment of Phys Ther, Karofinska Institute, Stockholm, 
Sweden; $Fr61unda Specialist Hospital, GSteborg, Sweden; 
§Prim~arvardsrehab Hisingen. G(Jteborg, Sweden; ¶Department 
of Orthopedics, Lund University, Lund, Sweden 
The aim of the present study was to produce a sensitive hip 
outcome instrument, especially for younger and/or physically more 
active persons with hip dysfunction with or without radiological 
evidence of hip osteoarthritis (OA). 
Methods: 52 persons (35 women/17 men, median age 64 years, 
hip problems _>5 years), 13 without hip OA, 16 with unilateral and 
23 with bilateral hip OA, completed the WOMAC with additional 
items twice, at an interval of one week. The additional items were 
from the Knee injury and Osteoarthritis Outcome Score (KOOS) 
with the word knee changed to hip (18 items), and 9 specific hip 
items. The importance score for each item was also requested. 
Content validity (floor and ceiling effects, mean score of symptoms 
and importance) and test-retest reliability (percentage agreement) 
were assessed. 
Results: After analysis of floor and ceiling effects, mean score of 
symptoms and importance and percentage agreement between 
test occasions, 24/24 WOMAC items, 10/18 KOOS items and 9/9 
specific hip items were included in the instrument, HOOS. 5 items 
were added to the original WOMAC Pain sub-scale, 2 items to the 
Stiffness sub-scale renamed General Symptoms, 7 items were 
added to the Function sub-scale and a new sub-scale, Hip-related 
Quality of Life with 5 items, was composed. The sum score on 
each sub-scale was transformed into a 0 to 100, best to worst 
scale. 
Comparison between the HOOS and the WOMAC showed fewer 
items with floor effects for the HOOS (35% compared to 58%) and 
fewer items with mean scores indicating no or mild symptoms 
(19% compared to 33%). Both these facts resulted in higher 
sub-scale means for the HOOS. Importance score and percentage 
agreement were equivalent. 
Conclusions: The HOOS fulfils basic criteria of outcome 
measures and has a high potential to measure change in important 
self-rated hip problems in persons with hip dysfunction, with or 
without radiological evidence of hip OA. 
FR036 
OUTCOME OF THE 'HIP SCHOOL'--EDUCATION PROGRAM 
FOR PATIENTS WITH HIP DYSFUNCTION 
M. Kl&ssbo'l', G. Larsson:l:, K. Harm-Ringdahll- 
"Department of Phys Ther, S~ffle Hospital, Sweden; t Department 
of Phys Ther, Karolinska Institute, Stockholm, Sweden; ~.National 
Defence College, Department of Leadership, Karlstad, Sweden 
A 'Hip School' was started in S&ffle, Sweden, in 1984. It consists of 
an individual start-up session, three group meetings, and an 
individual follow-up session two months later, all led by a physical 
therapist. The aim of the 'Hip School' was to reduce fear, promote 
physical activity to the extent of 'lagom' (untranslatable Swedish 
word meaning 'a reasonable degree'), and prevent/reduce hip 
dysfunction. The aim of the present study was to analyze the 
outcome of the 'Hip School' in patients with hip dysfunction with or 
without radiological evidence of hip osteoarthritis (CA). 
Methods: Physicians in primary health care and orthopaedic 
settings consecutively recruited patients with hip dysfunction who 
fulfilled inclusion criteria, including x-ray, for the study. According to 
residential are the patients were assigned to a treatment (n=77) or 
a control group (n=68). In the treatment and control group respect- 
ively the mean age was 61.5/62.2 years, 37 males/40 females/22 
males/46 females and 53/46 with radiological evidence of hip OA. 
The treatment group was tested before and 6 months after the Hip 
School, with the same time intervals for the control group. Western 
Ontario and McMaster Universities Osteoarthritis index (self-rated 
hip problems) and Nottingham Health Profile (health-related quality 
of life disturbances) were used. 
Results: The treatment group showed significantly less pain, 
function difficulty, and total hip problems. They also showed 
improved health-related quality of life in the sub-scales of sleeping 
disturbances, pain, physical mobility and total health-related 
quality of life. 
Initially, there were no significant differences between the patients 
with or without hip OA, in respect of self-rated hip problems or 
health-related quality of life, with the exception of higher values for 
the no OA group on the sub-scale of sleep disturbances. 
Conclusions: The results indicate that the Hip School can 
alleviate hip problems and improve health-related quality of life. 
FR037 
SYNOVlAL BLOOD FLOW DEMONSTRATED BY 
POWER-DOPPLER SONOGRAPHY IN KNEE 
OSTEOARTHRITIS 
H. Kristoffersen, L. Terslev, E. Qvistgaard, S. Torp-Pedersen, 
B. Danneskiold-Samsoe, H. Bliddal 
The Parker Institute, Department of Rheumatology, Frederiksberg 
Hospital, Copenhagen, Denmark 
Aim: The degree of inflammation in knee osteoarthritis is still 
under debate. The power-Doppler sonography is established as a 
non-invasive tool for the evaluation of synovitis in e.g. rheumatoid 
arthritis. This study was performed to investigate the ultrasono- 
graphical evidence of vascularisation in patients with moderate to 
severe knee osteoarthritis. 
Methods: Consecutive patients (16 women and 2 men, age 
median 70 years, range 42-85 years) with knee osteoarthritis were 
investigated. Patients were included if they fulfilled the ACR criteria 
for knee osteoarthritis in addition to: Lequesne score above 10 and 
radiological proof of osteoarthritis, but an Ahlbb.ck grade less than 
4. Ultrasonography was performed with an Acuson Sequoia'-'~', 
using a near focused transducer with a center frequency of 8 to 
13 MHz. Blood flow in the synovial membrane was visualised with 
color Doppler. With spectral Doppler the flow profile was evaluated 
for diastolic flow as a sign of inflammatory activity. 
Results: Most patients had grey scale ultrasonographic hanges 
over the joint margins, typically a swelling of the synovial mem- 
brane, and in 14 patients synovial fluid was found in the supra- 
patellar bursa. A measurable vascularisation on power-Doppler 
was observed in 12 of 18 patients. In all 12 patients with Doppler 
activity the vascularisation was present over the medial joint 
margin, while only 8 had activity over the lateral joint margin. In 
none of the patients Doppler activity was observed in the bursa 
per se. Doppler activity was only present in one of four patients 
without fluid in the bursa, In all 12 patients the flow profile on 
spectral Doppler showed a diastolic component as evidence of 
inflammation. 
Conclusion: Changes in the synovial membrane were demon- 
strated by grey scale sonography, i.e. swelling of the synovial 
membrane and accumulation of fluid in the bursa. Color Doppler 
and spectral Doppler showed abnormal vascularisation with an 
inflammatory flow profile. The present ultrasonographic evidence 
indicates that inflammation is present in the majority of patients 
with moderate to severe osteoarthritis of the knee. This may be of 
consequence for the choice of therapy in osteoarthritis. 
FR038 
IS THE WOMAC A USEFUL TOOL AS KNEE OA OUTCOME 
MEASURE IN CLINICAL PRACTICE: A SURVEY 
S. Kroesen and R. Theiler 
Rheumato/ogy Unit, Cantonal Hospital Aarau, 5000 Aarau, 
Switzerland; Department of Internal Medicine, Federal Hospital 
Hochzirl, 4692 Zirl, Austria 
Introduction: Chondroitinsulfate is a drug treatment option for 
patients suffering from painful osteoarthritis. Clinical trials docu- 
mented a dose and time dependent effect on pain and function 
assessed by different outcome questionnaires. The therapy with 
chondroitinsulfate is usually well tolerated by all patients. The drug 
is currently classified as "slow acting symptom modifying drug in 
OA". 
Method: A prospective, uncontrolled survey in patients suffering 
from painful knee osteoarthritis was performed to investigate the 
effect of chondroitinsulfate administration (Structure®). 60 out- 
patients visiting general practitioners were treated for 3 months 
with chondroitinsulfate (500 mg bid). The outcome was measured 
by the WOMAC osteoarthritis index (version 3.0), a subjective, 
disease specific outcome measurement instrument. The numeric 
rating scale was used with 0 for best health and 10 for worst health. 
After three months treatment a follow up was performed. The 
calculation of the standardized response of the mean (SRM) was 
performed to measure the effect on pain and function. 
Result: At baseline the patients had a mean WOMAC pain, 
stiffness and function score of 3.95 (±2.6), 3.91 (+2.5) and 3.94 
(±2.6), respectively and after 3 months of treatment with 
chondroitinsulfate they had a score of 2.27 (±1.9), 2.41 (±2.5) and 
2.66 (+1.9), respectively. The differences were highly significant 
for all three dimensions (p<0.0001). The effects of treatment were 
calculated by standardized response of the mean (SRM). After 3 
months treatment WOMAC pain, stiffness and function scales 
indicated an SRM of 0.97, 0.65 and 1.18 respectively. 
Discussion: After three months of treatment with chondroit- 
insulfate an effect over standard deviation was measured in the 
function dimension of WOMAC. For pain the calculated value was 
below the range of standard deviation. In this survey the pain and 
stiffness sections indicated an effect in the range of the standard 
deviation. The drug was well tolerated by all patients and no 
severe side effects have been documented. For full interpretation 
of these data the amount of pain rescue medication would have 
been very helpful. 
Conclusion: After three months treatment with chondroit- 
insulfate the WOMAC function dimension indicates an effect of 
about a standard deviation. The key symptom in the WOMAC to 
measure pain and function in knee OA was clearly associated with 
the question "going up and downstairs". A shorter instrument could 
be useful in daily clinical practice. 
Supported by an educational grant of Robapharm/Pierre Fabre. 
$77 
FR039 
PROLONGED DIMINISHED SUBCHRONDRAL SCLEROSIS 
MIGHT BE INVOLVED IN THE BENEFICIAL EFFECT OF 
JOINT DISTRACTION IN TREATMENT OF OSTEOARTHRITIS 
A. C. A. Marijnissen, P. M. Van Roermund, K. L. Vincken, 
J. W. J. Bijlsma, F. P. J. G. Lafeber 
Rheumatology & Clin. ImmunoL, University Medical Center 
Utrecht, Utrecht, The Netherlands (F. Lafeber@DIGD.AZU.NL) 
Aim of the study: Joint distraction is a new approach in treat- 
ment of osteoarthritis (OA) based on a temporary (3 month) 
distraction, using an external distraction frame, resulting in a 
prolonged (>5 years) statistically significant clinical benefit. A 
beneficial change in chondrocyte activity as a result of distraction 
could be demonstrated in a canine experimental OA model. In the 
present study, we evaluated if the temporary periarticular osteo- 
penia, as a result of joint distraction, was involved in the clinical 
benefit of the treatment. 
Methods: Standard radiographs were taken before, and yearly 
after joint distraction of patients with severe ankle OA. Sub- 
chondral sclerosis of the tibial-talar joint, and the tibial shaft bone 
density as a reference, were determined using ankle images digital 
analysis (AIDA). This newly developed interactive computer 
technique for evaluation of digitised X-rays, was validated and 
allowed objective measurement of subchondral sclerosis. 
Subchondral sclerosis before and after joint distraction was 
correlated with clinical parameters of OA. 
Results: On average, subchondral sclerosis in tibia and talus of 
the OA ankles was evident, as compared to the contra-lateral 
control ankle (p_<0.004). After joint distraction diminished bone 
density, peri-articular and in tibial shaft, was observed. One year 
after distraction bone density was normalised in the tibial shaft, 
whereas subchondral sclerosis remained diminished for up to 4 
years (p_<0.04; not different from contralateral control ankles any 
more). Moreover, there was a significant correlation between 
subchondral sclerosis and clinical parameters (e.g., functional and 
physical impairment, p<_0.001 and p<_0.008, respectively). 
Conclusion: The prolonged clinical benefit of joint distraction in 
the treatment of osteoarthritis might depend at least in part on the 
sustained diminished subchondral sclerosis as a result of the 
distraction. 
This study was supported by the 'Dutch League against 
Rheumatism'. 
FR040 
PROGRESSION OF OSTEOARTHRITIS: PREDISPOSING 
FACTORS IDENTIFIED IN A LONGITUDINAL MRI STUDY 
P. Lang, S. Biswal, M. F. Dillingham, G. Bergman, T. Hastie 
Departments of Radiology, Statistics, and Mechanical Engineering, 
Stanford University 
Purpose: To evaluate the natural evolution of osteoarthritis of 
the knee joint using MRI and to determine potential risk factors for 
more rapid cartilage loss. 
Methods: We evaluated baseline and follow-up MRIs of the knee 
in 43 patients (GE 1.5T; knee coil; FSE, 3500/15 (TR/TE in msec), 
ETL 8, fat-saturated FSE 4000/108, ETL 8) (minimum time interval 
of 1 year, mean 1.8 years, range 52-285 weeks). Cartilage loss 
was graded in the anterior, central, posterior regions of the medial 
and lateral knee compartments [normal=grade 0, signal hetero- 
geneity=grade 1, superficial fraying=grade 2, fissuring=grade 3, 
thinning less than 50%=grade 4, thinning greater than 50%=grade 
5, and full thickness cartilage loss=grade 6]. Knee joints were also 
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evaluated for other pathology. The data were analyzed using 
ANOVA models. 
Results: No specific grade of lesion identified at baseline hada 
predilection for more rapid cartilage loss (p<_0.93). Meniscal tears 
(p_<0.0009) had a significant impact while ACL tears (p_<0.06) had 
a borderline significant influence on the progression of cartilage 
pathology. Interestingly, lesions located in the central region of the 
medial compartment were significantly (p_<0.003) more likely to 
progress to more advanced cartilage pathology than' lesions in the 
anterior (p_<0.564) and posterior (p_<0.957) regions or lesions 
located in the lateral compartment. Lesions located in the anterior 
region of the lateral compartment were significantly more 'immune' 
to further cartilage degradation (p_<0.001). 
Conclusion: Unlike conventional radiography, MRI can detect 
progressive cartilage loss in patients with osteoarthritis within a 
short observation period of only 1 to 2 years which makes it ideally 
suited for assessing the effect of chondroregenerative drugs and 
interventions. Meniscal and ACL tears predispose knee articular 
cartilage to more rapid cartilage loss. Cartilage lesions located in 
the central region of the medial compartment are prone to more 
rapid cartilage loss than cartilage lesions in the anterior and 
posterior portions of the medial compartment, probably a reflection 
of the high biomechanical loads seen in this region. 
FR041 
FUNCTIONAL JOINT IMAGING: A NEW TECHNIQUE 
INTEGRATING MRI AND BIOMOTION STUDIES 
E Lang M.D.*, G. Alexander Ph.D.1, T. R Andriacchi Ph.D.t 
Departments of Radiology* and Mechanical Engineeringt, 
Stanford University 
Introduction: Recent studies have demonstrated a relationship 
between the dynamic loads at the knee during gait and progres- 
sion of knee osleoarthritis (OA). The combination of imaging 
methods with functional kinematic information obtained during 
walking could greatly enhance our ability to study OA. The primary 
purpose of this work is to integrate cartilage imaging techniques 
with newly developed methods to study the functional kinematics 
of the knee joint. 
Methods: Data acquired in the biomotion gait laboratory can be 
used to define the motion of subject specific 3D anatomic elements 
identified on an MR scan. Fidelity of these animations requires 
calculation and application of a sequence of rigid body trans- 
formation, some of which are directly calculable and some of which 
are the result of optimizations. In summary, the process is: 
a) Acquire static MR images (supine, knee in neutral position) of 
the articular cartilage, the femur and the tibia. 
b) Acquire the data from biomotion gait protocols using the point 
cluster technique (1). 
c) Directly calculate a set of transformations from the data. 
d) Calculate a set of transformations from optimizations. 
e) Generate a 3D reconstruction of the articular cartilage and 
femoral and tibial bone from the MR data. 
f) Apply the transformation sequence to the geometric 
representation. 
AFgu!re _the data f rom MR and PCT gait protoc_ols: With the 
Point Cluster Technique (PCT) movement analysis protocol (1), a 
subject has a number of retro-reflective markers attached to each 
limb segment under observation. Multiple video cameras acquire 
data with the patient standing still and during activities of interest. 
The markers are filled with gadolinium and covered with a retro- 
reflective material, rendering them visible to both imaging modes, 
MRI and gait analysis. A fat-saturated 3D SPGR sequence is used 
for imaging and subsequent segmentation of the articular cartilage 
(GE Signa 1.5"1", TR=60 msec, TE=5msec, a=40 °, 256x192, 
1 NEX, FOV 14 cm). 
Calculate a set of transformations from optimizations: The 
three transformations required to integrate MRI and biomotion 
analysis are: Optimization 1: Calculate the linear least square error 
rigid body transformation from the MR common local coordinate 
system to the biomotion video common local coordinate system. 
Optimization 2: For each limb segment, calculate the linear least 
square rigid body transformation from the MR limb segment 
anatomic coordinate system to the video limb segment anatomic 
coordinate system, using the subset of common markers appropri- 
ate for each segment. Optimization 3: Calculate a correction for the 
deviation of the limb segment from rigidity during each time step of 
the activity, using the PCT with interval deformation algorithms. 
Results: These transformations result in a 4D color animation: 
biomotion is superimposed onto a three-dimensional reconstruc- 
tion of the femur and tibia and the femoral and tibial cartilage. The 
location of cartilage defects relative to the tibiofemoral contact area 
can be visualized for normal gait and various other physical 
activities such as stair climbing. 
Discussion: Medical images are generally static. This method- 
ology describes a technique that combines MR images of articular 
cartilage and bone with dynamic measurement of human move- 
ment. Thus, for the first time the relative in vivo movement of 
cartilage in the weight bearing portion of the knee can be 
examined. Local defects can be identified and studied relative to 
the areas loaded during such activities as walking. Prior studies 
have shown that the position of a cartilage defect along the medial 
or lateral femoral condyle influences the rate of progression of 
osteoarthritis (2). This technique holds the potential to determine 
the prognosis of cartilage defects more accurately by integrating 
MRI and biomotion measurements. 
References: 1. Andriacchi, T. P., Alexander, E. J., et al. 
J Biomechan Eng, 120(12) 743-749, 1998; 2. Biswal, S., Hastie, 
T., Bergman, A. G., Beaulieu, C. F., Lang, P. Radiology, 213(P): 
203, 1999. 
Acknowledgements: This work was supported in part by grants 
from the National Institutes of Health, AR20702-17, AR39421-8, 
and AR54327-01. 
FR042 
SELECTING X-RAY INCLUSION/EXCLUSION CRITERIA FOR 
MULTICENTER STUDIES OF OSTEOARTHRITIS 
Dmitri Lissin, Manish Kothari, Martine Sieffert, Yves Miaux, 
Gabriele yon Ingersleben, Jiao Li, Randall M. Stevens*, Charles 
Peterfy 
Synam, Inc., San Francisco, USA; *Hoffman La Roche, Inc., 
Nutley, New Jersey 
Imaging is used in clinical trials of osteoarthritis (.OA) to monitor 
disease progression and treatment response, but also to select 
patients for study. Joint space narrowing and osteophyte formation 
are the most commonly used radiographic endpoints for these 
purposes. In addition to diagnosing QA and grading its severity, 
patient selection criteria must consider the dynamic range of the 
imaging endpeints that will be used to monitor change in order to 
avoid floor or ceiling effects. For example, 2 mm is usually selected 
as the lower limit for minimum joint-space width (min-JSW) in order 
to allow sufficient room to detect further narrowing on follow-up. 
However, selection of upper and lower limits for min-JSW and 
osteophyte score lOST) impact on patient recruitment rates and 
therefore on the cost and total duration of a study, and must be 
considered carefully. In this report, we present the distribution of 
rnin-JSW and OST in a large cohort of patients with chronic knee 
pain, and examine the impact of selection criteria on screening 
failure and recruitment rate. 
Methods: 2102 patients (1373 women: 62 year+8 year; 729 
men: 63 year+8 year) with chronic knee pain including moderate 
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pain (WOMAC) for at least 15 days prior to screening were 
examined at 65 different sites in the US. At each site, both knees 
were radiographed on separate films using posteroanterior, weight 
bearing, fixed-flexion on-fluoroscopic radiography with 10" beam 
angulationL Reproducible positioning was facilitated with a 
specially designed frame. Radiographs were centrally analysed by 
three trained and experienced readers (DL, Gvl, JL). Minimum 
JSW in the medial femorotibial joint was measured manually with a 
hand-held graduated lens, and maximum medial or lateral 
femorotibial osteophyte scores (OST) were determined using the 
OARSI atlas 2. 
Results: Fig. 1 shows the distribution of minJSW and OST 
scores in the right knees of the 2102 patients. Min-JSW showed a 
bimodal distribution, with maxima of 1 mm and 3.1-4.0 mm The 
most dynamic range (1 mm-3 mm) was found in only 18% of 
knees. Grade 1 was the most common (49%) OST score. Only 
19% of OST1 patients but 62% and 74% of OST2 and OST3 
patients had min-JSW less than 3,1 mm. The same pattern was 
seen in the left knee. Fig. 2 shows the screening impact of varying 
mJSW criteria on a per-patient basis. Fig. 3 shows the effect of 
three different combinations of eligibility criteria on recruitment 
rate. 
Fig. 1 Fig 2 
~l~rolmenl 
NUl l  
Fig 3 
Discussion: These results illustrate the impact of varying 
radiographic eligibility criteria on patient recruitment rates for 
clinical trials in OA. Knowledge of the expected radiographic 
characteristics of the population to be screened facilitates rational 
selection of eligibility criteria, which must balance practical 
considerations, such as recruitment rate and cost, with scientific 
objectives and potential floor and ceiling effects of the endpoints 
used. 
References: 1. Peterfy C. G. et al. Arthritis Rheum. 1998: 41(9): 
$361; 2. AItman R. D. et al. Osteoarthritis and Cartilage 1995(3) 
Suppl. A 3-70. 
FR043 
HAND OSTEOARTHRITIS PATIENTS CHARACTERISTICS 
ACCORDING TO THE EXISTENCE OF A HORMONE 
REPLACEMENT THERAPY 
E. Maheu" and R. L. Dreiserl- 
"Cochin Hospital. tBichat Hospital. 
emaheu @ clubin ternet, fr
Paris. France. E-marl: 
Background: Hand osteoarthritis (OA) mostly occurs in women 
around the time of menopause, but its relationship with sexual 
hormones remains a controversial issue. The eventual influence 
of hormone replacement therapy (HRT) on the incidence and 
progression of HOA is still debated. 
Aim of the study: To assess whether HRT influences the 
occurrence and disease activity of hand OA. 
Methods/patients: Epidemiological, prospective, cross-sectional 
study. Patients: Menopausal women, aged 50-75. consulting for 
painful hand OA, for another rheumatic condition with hand OA or 
controls (no disease of the upper limbs), Eligibility criteria: Hand 
OA (American College Rheumatology (ACR) criteria) with X-ray 
evidence. Patients with 'painful' hand OA defined by a Dreiser's 
functional index score >6 and pain on VAS >35 mm. Study 
parameters: Demographics, personal histories and gynecological 
data for patients and controls including the administration of HRT 
(+) or (-). For patients, description and symptom activity of hand 
OA. Statistics: Descriptive analysis in the studied population and in 
subsets taking into account treatment and disease activity factors. 
Results: 711 women were studied: 238 with 'painful' hand OA, 
240 with 'quiescent' and 233 controls. Baseline characteristics 
were similar for patients and controls except for age (patients were 
older). HRT+ patients were younger ( -5 years) (P<0,0001), 
slightly taller (P<0.0045) and more often cigarette smokers 
(P<0.012) than HRT- patients. They did not differ in gynecological 
characteristics with the exception that the women in the HRT+ 
group had been menopausal for a shorter period of time, probably 
because of their younger age. There were no differences between 
HRT+ and HRT- patients, whatever the symptom activity, on the 
characteristics of hand OA: Dreiser's index scores were respect- 
ively 11.3±3.8 vs 12.3-*4.5 in 'painful' patients, 3.6-*2.5 vs 3.7+2.7 
in 'quiescent' patients. Pain on VAS showed no difference between 
HRT+ and HRT- patients. 
Conclusion: Few differences were found between hand OA 
patients receiving HRT and those who were not. HRT did not seem 
to influence the severity or the symptom activity of hand OA. 
Further prospective longitudinal studies are required in order to 
evaluate the exact effect of HRT on hand OA. 
This study was funded by PHARMASCIENCE Laboratories 
(France). 
FR044 
QUADRICEPS ISOKYNETIC PEAK TORQUE IN WOMEN 
WITH KNEE OSTEOARTHRITIS 
M. Mateus, M. Pacheco, A. A. Matos, J. C. Branco 
Unidade Reumatologia. Hospital Egas Moniz, Lisbon, Portugal 
Aim of the study: This study was performed to evaluate 
quadriceps isokynetic peak torque in women with knee osteo- 
arthritis (OA), the method's reproducibility and its correlation with 
patient and disease features. 
Methods: Thirteen female patients with gonarthrosis performed 
measurement of the isokynetic knee extension torque using a 
dynamometer, at weeks 0 and 1, at a motion angle of 60 °, between 
0 ° and 60 ° (0 ° corresponding to full extension), in 3 series of 10, 5 
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and 3 repetitions for the angular velocities of 300, 180 and 60 
degrees per second (°/s), respectively. The parameter evaluated 
was peak torque/body weight (PT). All patients performed the 
WOMAC for functional assessment. Psychopathologic evaluation 
was done with the SCL-90-R. All patients had an AP and profile 
knee X-ray under load with a 30 ° flexion and a tangential patella 
X-ray. The radiological quantification was made using the Altman 
method. In the statistical data analysis a Student's t-test with a 
two-tailed distribution was used. The correlation analysis between 
the several variables considered was made throul:jh the deter- 
mination of the various linear regression coefficients. A significance 
probability value of P<0.05 was considered. 
Results: The probabilities obtained for the different PT velocities 
validate the reproducibility of this method. There is good corre- 
lation between age and PT for the 60°Is and 180°/s velocities, but 
not for the 300°Is. Globally, PT decreases with ageing. Although no 
correlation between X-ray and PT was found, there is a decrease 
in PT with the increase in the radiological index. PT decreases with 
the increase of disease duration, but the significance levels are 
low. The correlations of.the 5 WOMAC dimensions with PT were 
also not significant. Nevertheless, the global linear regression 
trend shows a decrease in PT with the increase of pain level and 
functional disability. The 9 dimensions and the 3 indexes of 
SCL-90-R do not correlate with PT. 
Conclusions: The results obtained in the preliminary phase of 
this research have shown a good reproducibility of the adopted 
method, and a negative but significant correlation between age 
and muscle strength. No other correlation with significance was 
achieved for the remaining parameters, possibly due to the small 
size of the sample. Because the 300°/s angular velocity didn't 
produce conclusive results, the test angular velocities were 
changed to 60°/s, 120°/s and 180°/s for the continuation of the 
research, in accordance with those encountered in previous 
studies. The scope of the study was also extended to include 
age-matched controls. 
FRO45 
DEVELOPMENT OF A LOGICALLY DEVISED LINE DRAWING 
ATLAS FOR GRADING OF KNEE OSTEOARTHRITIS 
Y. Nagaosa, M Mateus, B. Hassan, P. Lanyon, M. Doherty 
Academic Rheumatology, University of Nottingham, Clinical 
Sciences Building, City Hospital Nottingham. Nottingham, UK 
Objectives: To: (1) develop an atlas of line drawings for the 
assessment and grading of narrowing and osteophyte (i.e. 
changes of osteoarthritis) on knee radiographs, and; (2) compare 
the performance of this atlas with that of the standard Osteo- 
arthritis Research Society (OARS) photographic atlas of 
radiographs. 
Methods: Normal joint space widths (Grade 0) for the medial 
and lateral tibio-femoral and medial and lateral patello-femoral 
compartments were obtained from a previous community study. 
Grades 1-3 narrowing in each compartment were calculated 
separately for men and women, grade 3 being bone on bone, 
grades 1 and 2 being two thirds and one third the value of Grade 
0. Maximum osteophyte size (Grade 3) for each of 8 sites was 
determined from 715 bilateral knee X-rays obtained in a knee OA 
hospital clinic; grades 1-2 were calculated as two thirds and one 
third reductions in area of Grade 3. Drawings for narrowing and 
osteophyte were presented separately. 50 sets of bilateral knee 
X-rays (standing, extended antero-posterior; flexed skyline) 
showing a spectrum of OA grades were scored by 3 observers, 
twice using the OARS atlas and twice using the drawn atlas. 
Results: Intra- and and inter-observer reproducibility was similar 
and generally good with both atlases, though varied according to 
site. All 3 observers preferred the line drawing atlas for ease and 
convenience of use. Higher scores for patello-femoral narrowing 
and lower scores for osteophyte, especially medial femoral 
osteophyte, were seen using the line drawing atlas, demonstrating 
that the two atlases are not equivalent instruments. 
Conclusion: We have produced a logically derived line drawing 
atlas for grading of narrowing and osteophyte at the knee. The 
atlas showed comparable reproducibility to the OARS atlas, but 
was discordant in several aspects of grading. Such a system has 
several theoretical and practical advantages and should be 
considered for use in knee OA studies. 
FR046 
DESCRIPTIVE AND COMPARATIVE STUDY OF THE 
RHEUMATOLOGIC DISEASES PREVALENCE FROM 1980 TO 
1999 
N Navarro, M. Castellanos, M.C. Garcia, C. Galisteo, C. Alegre 
Hospital de Malalfies Reumatiques, Barcelona, Spain 
Objective: To compare, in our town, the prevalence of the 
rheumatology diseases for 20 years. 
Methods: We studied 80 patients from 1980 and 80 patients 
from 1999. We analysed the prevalence of osteoporosis, fibro- 
myalgia, osteoarthritis, infectious arthopathy, gout, pseudogout, 
reumatoid arthritis, lupus erytematosus, polymyositis, demato- 
myositis, scleroderma, spondyloarthritis and vasculitis. 
Results: The group of 1980 shows a middle age of 51 years with 
a standard deviation (SD)±12, 27% were men and 73% were 
women. Osteoporosis 26%, fibromyalgia 6%, osteoarthritis 75%, 
infectious arthropathy 3%, gout 5%, pseudogout 1%, reumatoid 
arthritis 8% and lupus erythematous 6%. The group of 1999 shows 
a middle age of 53 years with a SD+17, 13% were men and 87% 
were women. Osteoporosis 15%, fibromyalgia 20%, osteo- 
arthritis 61%, infectious arthropathy 2.5%, gout 4%, pseudogout 
1%, AR 4% and LE 4%. 
Conclusion: In the group studied we didn't find significant 
differences in the prevalence of rheumatologic diseases during 
these 20 years (Fisher's test), except the fibromyalgia (P=0.01). 
This difference could be explained by the fact that fibromyalgia has 
been described since 1990. 
Discussion: As far as we know, we should wait that primary 
attention brings us more inflammatory diseases than osteoarthritis 
and this study didn't show it. On the other hand, we should see 
an increase of the osteoporosis. It will be more important the 
prevention and the earlier diagnostic in the primary attention. 
FR047 
EFFICACY AND SAFETY OF INTRA-ARTICULAR 
HYALURONATE IN OSTEOARTHRITIS OF THE KNEE 
David H. Neustadt 
University of Louisville School of Medicine, Louisville, KY, USA 
This report describes retrospective data on the use of intra- 
articular hyaluronate injections in 116 knees in 108 patients with 
symptomatic osteoarthritis of the knee. Patients not under 
adequate control with conventional therapy for OA of the knee(s), 
including NSAIDs and intra-articular corticosteroids, were selected 
for a course of intra-articular hyaluronate. 
Methods: Five intra-articular injections (20 mg sodium hyal- 
uronate) were administered at weekly intervals. Response was 
determined by physical examination, assessment of pain including 
visual analog scale of 1 to 10, monitoring at each visit of any 
reactions or adverse effects, and repeat standing AP radiographs 
of the knees after 1 year of completing the course of hyaluronate 
injections. 
Results: 72% of patients achieved greater than 50% improve- 
ment for one year or longer. Measures of beneficial response 
included reduction in pain and tenderness, increased range of 
motion, and improved functional capacity and walking ability. 
Adverse effects were minor and infrequent, including brief 'after 
pain', slight pain or bruising at the site of injection and rare 
headache and nausea. No patient withdrew from the series of 
injections because of any side effect. Twelve of 15 patients who 
were considering TKR no longer considered the procedure neces- 
sary. Some information on seven patients who were given 'booster' 
(supplementary) injections approximately 6 weeks after completing 
the 5 injections, will be included. A patient with ochronotic OA did 
not show improvement. Duration of significant response in some 
patients exceeded 2 years. 
Conclusion: Intra-articular hyaluronate is an effective and safe 
treatment in OA of the knee. No additional oss of joint space was 
noted after 1 year from the course of injections. Improvement 
correlated to some degree with the stage of severity as related to 
joint space narrowing. 
FR048 
RADIOGRAPHS AND GENDER AS PREDICTORS FOR 
OUTCOME AFTER TOTAL HIP ARTHROPLASTY 
A. Nilsdotter*:l:, Y. Aurellt, A.-K. Si6steent, S. Lohmander:l:, 
H. Roos§ 
*Department of Orthopaedics, Halmstad County Hospitak 
t Department of Radiography, Halmstad County Hospital; 
SDepartment of Orthopaedics, Lund University Hospital, 
§Department of Orthopaedics, Helsingborg Hospital, Sweden 
Aim of the study: To investigate whether patients with a severe 
radiographic osteoarthritis (OA) have a different outcome after total 
hip replacement han patients with a moderate radiographic OA. To 
investigate gender-related ifferences in preoperative radiographic 
status or in pre- or postoperative outcome. 
Methods: 184 patients (96 women) with a mean age at surgery 
of 71.4 years (50-92), with primary OA of the hip were investigated 
preoperatively and 6 and 12 months postoperatively with two 
self-administered questionnaires, SF-36 and WOMAC. The radio- 
graphs were evaluated by two independent radiologists by the use 
of an atlas. Minimal joint space narrowing, cysts, sclerosis and 
deformity were taken into consideration. A summary grade 0-3 
was made, where 3 is severe osteoarthritis. The reference 
population for SF-36 consisted of 2901 age and gender-matched 
subjects from the general Swedish population. 
Results: 162 patients fulfilled the study criteria. 113 had grade 3, 
47 grade 2 and two grade 1 radiographic OA. There was no 
difference in preoperative or postoperative pain and physical 
impairment between patients with moderate and severe radio- 
graphic osteoarthritis. There were no gender-related ifferences in 
the preoperative radiographic status nor in the postoperative 
outcome. Neither did we find any differences in preoperative 
radiographic status of OA in patients with previous total hip 
replacement on the contralateral hip compared to those who were 
not operated on before. All patients, regardless of preoperative 
radiographic QA stage, showed significant postoperative improve- 
ment and achieved a similar health-related quality of life as the 
reference group. 
Conclusion: The severity of radiographic hanges indicating OA 
often weigh heavily in the surgeon's decision to perform a total hip 
replacement. Yet the findings of this study emphasize that the 
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preoperative radiographic stage of OA has no correlation to the 
postoperative outcome. Further, this study failed to detect any 
gender-related ifferences in preoperative radiographic status or in 
pre- or postoperative outcome. 
FR049 
RESPONSIVENESS OF MEASURES OF PAIN AND 
FUNCTION AFTER TOTAL HIP REPLACEMENT 
A comparison of clinical examination, functional tests, 
observer-administered questions and self-administered 
questionnaires 
Anna Nilsdotter*, Ewa Roost, Jonas Westerlund*, Harald Roost, 
Stefan Lohmandert 
*Departments of Orthopedics at Halmstad County Hospital, 
tLund University Hospital, fcHelsingborg Hospital, Sweden 
Introduction: Assessment of patients with osteoarthritis (OA) of 
the lower extremities usually includes both measurements of 
impairment and health-related quality of life. Various clinical rating 
systems may be used for the outcome measurement of OA. The 
measures must be valid, reliable and responsive to a clinically 
meaningful change, in clinical studies, a more responsive measure 
allows for fewer subjects at the same statistical power. For clinical 
use, the measures must also be time- and cost-efficient. 
Aim of the study: The objective of the study was to compare the 
responsiveness over time of three outcome measures validated for 
total hip replacement: one measure based on clinical examination, 
performance tests, and observer-administered questions, and two 
self-administered questionnaires. 
Methods: 20 patients (13 women), with a mean age at surgery of 
72.6 years (50-78), with primary OA of the hip were assessed 
preoperatively and 3, 6 and 12 months postoperatively. The 
measures used were: FAS (Functional Assessment System, a 
functional test for dysfunction in the lower extremities which takes 
about 45 minutes to complete), WOMAC (a disease-specific out- 
come measure for OA in lower extremities) and SF-36 (a generic 
outcome measure). The responsiveness was calculated as SRM 
(Standardized Response Mean) which was defined as mean score 
change divided by the standard deviation of that score change. 
Results: The pain and function scores for WOMAC and SF-36 
already showed greater responsiveness than FAS at 3 months 
after hip replacement, and these results remained after 12 months. 
The variables based on clinical examination of the FAS showed 
less responsiveness at 12 months than the FAS variables based 
on performance tests. The pain scores for SF-36 and WOMAC 
showed equal responsiveness while the function score for 
WOMAC showed greater responsiveness than SF-36 function 
score after 12 months. 
Conclusions: We found no advantages from using a 
complicated and time consuming functional test, compared 
to easily administered patient relevant questionnaires when 
evaluating the outcome of total hip replacement. 
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FR050 
QUANTITATIVE ASSESSMENT OF OVINE STIFLE 
OSTEOARTHRITIS USING CHONDROSCOPY 
S. P. Oak/ey, I. Portek, Z. Szomor, M. N. Lassere 
SL George Hospital Sydney, Australia 
Aim: To determine the repeatability of simple quantitative 
estimates of cartilage damage using chondroscopy in ovine stifle 
osteoarthritis. 
Methods: Three sheep underwent bilateral medial meniscec- 
tomy. All three had chondroscopy before meniscectomy and then 
at monthly intervals for 3 months. 4 and 6 month data from 2 other 
sheep was also studied. Video recordings of 25 chondroscopies 
were blindly assessed by two observers. 13 of these recordings 
were assessed twice. Observers gave separate quantitative global 
scores of cartilage damage for the femur and tibia (no damage=0, 
complete cartilage Ioss=100). On a second viewing estimates of 
percentage of cartilage surface occupied by 5 grades of chon- 
dropathy were made using the method described by Ayral et al (1). 
Grade 0 (normal), grade 1 (softened), grade 2 (superficially fibril- 
lated), grade 3 (deeply fibrillated), and grade 4 (exposed bone). 
Repeatability was described in terms of intra-class correlation 
coefficients. 
Results: Chondroscopic global damage scores increased with 
the duration of osteoarthritis such that statistically significant 
differences could be found over 2 month intervals. The smallest 
change detected was a 16 point increase in global damage score 
from baseline to 3 months by observer 1 (P<0.006). Intra-observer 
repeatability of chondroscopic area estimates was good (observer 
1 ICC 0.75, observer 2 ICC 0.65) and comparable with chondro- 
scopic global scores (observer 1 ICC 0.77, observer 2 ICC 0.71). 
Inter-observer epeatability was poor for physician global assess- 
ments (ICC 0.33) but moderate for area estimates (ICC 0.60). The 
repeatability of area estimates ranged from -0.05 (observer 1 
grade 2 lesions) and ICC 0.62 (observer 1 grade 4 lesions). The 
reliability of global damage score was better on the femoral surface 
than on the tibial surface (observer 1 ICC 0.79 vs 0.25, observer 2 
ICC 0.78 vs 0.66, inter-observer ICC 0.49 vs 0.20). 
Conclusions: Simple chondroscopic global damage scores can 
be used to detect changes in damage status of cartilage in ovine 
osteoarthritis over short periods of time in small studies. 
Intra-observer epeatability of simple chondroscopic quantitative 
assessments of cartilage damage in ovine osteoarthritis is good. 
Inter-observer repeatability may be affected by the method used to 
assess cartilage. Reliability of global scores is influenced by the 
location of the surface being assessed and the reliability of area 
estimates of lesions is influenced by the grade of lesion. 
References: 1. Chondroscopy: A new method for scoring 
chondropathy. Ayral, X. et al. Seminars in Arthritis and 
Rheumatism: 22: 289-297. 
FR051 
CLINICAL FOLLOW-UP OF PATIENTS WITH 
OSTEOARTHRITIS OF THE KNEE TREATED WITH 
INTRAARTICULAR PENTOXlFYLLINE APPLICATION 
P. T. Paradowski', K. 2.oly~ski', M. T. Paradowskit 
"Department of Trauma Surgery and Orthopaedics; ~rDepartment 
of Laboratory Diagnostics, Clinical Hospital Military University 
Medical School Lodz, Poland 
Introduction: We have previously shown that methylxanthine 
derivative, pentoxifylline (PTX) produces complex effects on the 
cell activity and cytokine network within the osteoarthritic joint. It 
may also affecl the clinical course of OA. 
Objective: The aim of this study was to evaluate patient-relevant 
outcomes in patients with osteoarthritis of the knee undergoing 
intraarticular PTX therapy and to correlate these results with levels 
of leukocytes, proteins and C-reactive protein (CRP) in synovial 
joint fluid. 
Materials and methods: A series of 57 patients (average 64 
years, range 43 to 80 years) with knee OA according to the ACR 
criteria were enrolled in the study. One cycle of five intraarticular 
injections (once a week) of PTX was given. 
The clinical analysis evaluated the impact of PTX on pain, joint 
stiffness and physical function as measured by the Western 
Ontario and McMaster University Questionnaire (WOMAC), VA3.0 
version. The study consisted of a screening visit, a baseline visit 
before the therapy and a final visit after a five-week therapy. 
Joint fluid was aspirated from knee joints of patients with knee 
synovitis in the course of OA while performing PTX application at 
entry and one week after the last injection. Laboratory analysis 
consisted of synovial fluid cell determination, fluid protein and 
C-reactive protein (CRP) levels assessment. 
Results: Patients were seen weekly for five weeks of the 
therapy. There were no systemic side effects of PTX. Of 32 knees 
with fluid aspirated at entry only 18 had symptoms of joint swelling 
after the therapy. The questionnaire subscales indicated significant 
benefit after PTX injections. In most of cases post-therapy poly- 
morphonuclear (PMN) cell count and CRP levels decrease from 
the baseline levels. We observed significant positive correlation 
between fluid CRP levels and WOMAC global assessment before 
(r=0.44, P<0.001) and after (r=0.38, P<0.05) PTX injections and 
between fluid PMN cell count before (r=52, P<0.01) and after 
(r=0.34, P<0.01) the therapy. 
Conclusion: The results of our study provide evidence for 
intraarticular intervention with PTX. Due to its pharmacological 
properties without undesired systemic effects PTX appears to be a 
new suitable approach of the treatment of OA. 
FR052 
KNEE OSTEOARTHRITIS PROGRESSION EVALUATED BY 
MAGNETIC RESONANCE IMAGING AND A NOVEL 
QUANTIFICATION SOFTWARE TOOL 
J. P. Raynauld, (3. Kauffmann, B. Godbout, G. Beaudoin, 
M. J. Berthiaume, J. DeGuise, R. Gagnon, D. Bloch, A. Airman, 
J. MarteI-Pelletier, G. Cline*, J. Meyer*, J. P. Pelletier 
Osteoarthritis Research Unit, Centre Hospitalier de I'Universite de 
Montreal, H6pital Notre-Dame, Montreal, Quebec, Canada and 
*Procter & Gamble Pharmaceuticals, Mason, Ohio, USA 
Existing X-ray methods used to evaluate knee osteparthritis (QA) 
progression require a long evaluation period (at least two years) for 
assessment. Visualization of articular cartilage is now possible with 
magnetic resonance imaging (MRI) but quantification of the 
images is pivotal in following the progression of the disease. The 
aim of this study is to evaluate the role of a novel software tool in 
assessing cartilage toss in QA patients using data obtained with 
sucessive knee MRI. 
Forty (40) patients with symptomatic knee OA were recruited from 
outpatient clinics. Patients mean age was 64.7 years (range 
49-79), 57% were female, with an average body mass index (BMI) 
of.30.3. Grade IV radiographs were an exclusion criteria. An MRI 
acquisition of the knee was done at baseline and at 6 months with 
another scheduled at 12 months. From these images, volumes of 
the internal and external compartments of the knee were analysed 
separately. Data were also pooled resulting in a total cartilage 
volume of the femoral condyle and tibial plateau. The disease 
progression will also be compared at each time point (baseline, 6 
and 12 months) with classic disease evaluation variables including 
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the WOMAC, Visual Analog Scales of pain experienced by the 
patient, global evaluation (patient and physician) of the disease, 
co-medication consumption and physical examination of the knee. 
The progression will also be compared to standardized semi-flexed 
knee radiographs done at baseline and at 12 months. 
The data on knee OA progression (cartilage volume losses) as 
computed by two readers and averaged on 11 patients at 6 months 
of follow-up were striking and statistically significant. 
Mean Total Cartilage Medial Condyle Medial Condyle 
Volume (condyle &.plateau) cm-  (cenlral 4area )
(SO) cm-- cm-  
Baseltne 17.550 (3,808) 3,122 (8,79) 1,129 (0.317) 
6 Months 17.201 (3,783) 3.011 (8.97) 1,071 (0.307) 
% Difference - 1 99% -3.54% -5.20°;, 
p Value 0,009 0.05 0,05 
Paired I-lest; null hypothesis=no difference belween 6 months versus baseline. Inlfa-observer 
reliabilily as measured by intra-class correlalion equals 0.99 
Data on the 40 patients followed at 12 months and compared to the 
clinical and radiological data will be presented. These data support 
the strong advantage of quantitative MRI over existing X-ray 
techniques in that they are able to detect significant changes in 
knee OA cartilage volume as early as over a period of 6 months. 
Supported by a grant from Procter & Gamble Pharmaceuticals, 
Mason, Ohio, USA. 
FR053 
SHORT TERM RESULTS AFTER COMPUTER ASSISTED 
TOTAL KNEE ARTHROPLASTY 
L. Plesak, F. Zimmermann, T. Leonhard 
Orthopaedic Clinic Goldenbdhl, City Hospital Villingen- 
Schwenningen, Germany 
Aim of the study: This study was conducted to compare the 
early clinical and radiological results of standard total knee 
arthroplasty to computer assisted total knee arthroplasty. 
Methods: Since May 1999 the 'Orthopilot' Navigation System of 
Aesculap has been used in total knee arthroplasty at our institute. 
This system controls the three-dimensional orientation of total 
knee implants and is supposed to lead to an optimized and 
reproducible implantation which implements a gain in knee 
function and long time performance. 
In this prospective study, 60 patients with osteoarthritis of the knee 
were randomly split into two groups and total knee arthroplasty 
was performed either with or without he compute assistance of the 
navigation system. The same standard knee implant was used in 
both groups. The clinical results are presented using the score of 
the American Knee Society. Radiological results are presented 
after comparison of standard X-rays 6 to 12 months postoperative. 
Results: The clinical results revealed no significant differences 
after the short time period, especially concerning mobility and 
patient satisfaction. The postoperative complications didn't reveal 
any major differences either. Distinct differences were found when 
postoperative radiographs were compared. Most obvious was the 
improved patella tracking due to an optimized orientation of the 
femoral component and the exact realization of preoperative 
planning. Standard knee arthroplasty revealed distinct differences 
when preoperative planning was compared with postoperative 
radiographs. 
Conclusions: The use of the computer assisted navigation 
system in total knee arthroplasty lead to an improved orientation 
of the implant, which is specifically important when severe 
deformities due to an earlier osteotomy was present. If these 
improvements will lead to significant differences in long term 
results will be the aim of future investigations. 
FRO54 
ORAL CHONDROITIN SULFATE THERAPY IN OA: A REVIEW 
OF EFFICACY AND SAFETY DATA 
D. Uebelhart 
Department of Rheumatology & Institute of Physical Medicine, 
University Hospital, Zdrich, Switzerland and Department of 
Biochemist~ Rush Presbyterian-St. Luke's Medical Center, 
Chicago, II, USA 
Symptomatic Slow-Acting Drugs for the treatment of Osteoarthritis 
(SYSADOA) are compounds which are mostly prescribed as drugs 
in European countries, whereas they are sold as nutraceuticals in 
the USA. The rationale behind this therapeutic lass is to reduce 
the use of NSAIDs in the overall drug management of OA and 
consequently to limit the risks of upper GI tract erosions, ulcers 
with bleeding and/or deleterious renal effects in elderly patients. 
Two recent meta-analyses regarding both glucosamine and/or 
chondroitin sulfate (CS) as treatment modalities for OA (Leeb, B. F. 
et al., 2000; McAlindon T. E. et al., 2000) did provide some new 
evidence suggesting that these compounds could be of some help 
in the management strategy of painful OA. The proposed review 
focuses on both the clinical efficacy and tolerability of OA therapy 
based on oral chondroitin sulfate intake. Many studies, testing 
different durations of treatment and doses, addressing the different 
OA locations and using chondroitin sulfate of various origins have 
been conducted so far. Most of the earliest open, non-randomized 
studies have not been published, whereas the most recent double- 
blinded, placebo-controlled studies have been or are about to be 
published. These ones do both take into account ICH-GCP 
guidelines and the international guidelines on OA clinical trial 
assessment as formulated by the EMEA. Therefore their design, 
methodology and statistical analysis approach were optimally 
designed to fit the international standards and regulations, which is 
a true originality as compared to previously published studies. As a 
consequence the author believes that definitively enough clinical 
data are available supporting oral chondroitin sulfate as a valuable 
symptomatic treatment for OA. The symptomatic and functional 
benefits of the treatment appear to be of delayed onset, but CS 
does have a significant carry-over effect which in clinical practice 
allows 3-month therapy cycles. In addition, no serious adverse 
event has ever been linked to oral CS treatment which appears to 
be a safe and well tolerated compound. Recent data suggest that 
CS might also have some structure-modifying properties for OA. 
References: 1. Leeb B. F. et al. J. Rheumatol. 2000; 27: 
205-211; 2. McAiindon T. E. et al. JAMA 2000; 283: 1469-1475. 
FR055 
THE URINARY CONCENTRATION OF COLLAGEN TYPE II 
C-TELOPEPTIDE FRAGMENTS IS ELEVATED IN PATIENTS 
WITH OSTEOARTHRITIS 
M Jung*, S. Christgaut, C. Kibler*, D. Henriksent, W. Richter* 
*Clinic for Orthopaedic Surgery, University Heidelberg, 69118 
Heidelberg, Germany; tOsteometer Biotech A/S. 2730 Herlev, 
Denmark 
Aim: The objective of this study was to assess whether osteo- 
arthritis patients have an elevated urinary concentration of collage 
type II fragments compared to healthy control persons. 
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Methods: Urine samples were obtained from 91 patients (43 
male and 50 female) with manifest OA of either the hips or the 
knees. The diagnosis of OA was confirmed by X-ray and clinical 
investigation. The age range was from 31 to 88 years with an 
average age of 64.0 years. 
As a control we used urine samples from healthy post-menopausal 
women with an age range from 50 to 63 years and an average age 
of 55.3 years. 
Degradation products of collagen type II in urine were measured in 
a newly developed ELISA based on a monoclonal antibody specific 
for C-telopeptide fragments of collagen type II. All values were 
normalized for creatinine and the differentiation was evaluation by 
using a two-tailed T-test. 
Results: There was a wide variance in the concentration of 
collagen type II degradation products in the urine from OA patients, 
ranging from 0.03 to 3.67 pg/mmol. The concentration in the 
control group varied less in a range from 0.01 to 0.35 pg/mmol. 
The mean value from'the OA group (0.584) showed a highly 
significant increase (P<0.0001)in comparison with the control 
group (0.156) as shown in the figure. 
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Conclusions: Our results clearly demonstrated that the newly 
developed ELISA could be used to routinely evaluate collagen type 
II degradation in OA. The assay could be a helpful clinical tool to 
monitor the disease and its progression. Further studies are 
needed to evaluate the correlation between elevated levels of 
collagen type I1 measured by this assay and other clinical 
parameters of OA disease. 
FR056 
CHONDROITIN 4&6 SULPHATE IN EROSIVE 
OSTEOARTHRITIS OF THE HANDS 
G. Rovetta, A. Brignone, L. Molfetta*, P. Monteforte 
DISEM, Cattedra di Reumatologia, Universita degli Studi di 
Genova; *DISM, Clinica Ortopedica, Universita degfi Studi di 
Genova, Switzerland 
In the management of hand osteoarthritis (OA) the main aims are 
to improve the patient's pain and functional state. For the erosive 
subset (or phase) of hand OA, the number of joints presenting 
articular erosions is a well detectable marker of progression of 
the disease. There are different papers reporting usefulness of 
Chondroitin 4&6 Sulphate in OA of the hands. 
The aim of our prospective study was to evaluate the number of 
joint with erosions in patients with OA of the hands treated with 
800 mg/die of Chondroitinsulphate administered orally. 
Only the patients with almost one joint presenting the radiographic 
characteristics of erosive osleoarthritis (EOA) as described by 
Crain were considered. Two independent observers evaluated DIP 
and PIP joints for erosions. Due to the employment of a structure- 
modifying drug, we established as an outcome measure a precise 
structural change, namely the number of joints with erosions. 
Other erosive inflammatory and dysmetabolic conditions were 
accurately ruled out for all the patients. 
A total of 24 consecutive patients (22 females and 2 males, mean 
age 53.0±6) suffering with symptomatic OA and showing central 
erosions of DIP and/or PIP were randomly assigned to two groups 
of 12 patients. The first group was treated with Choindroitin 4&6 
Sulphate 800 mg orally and with analgesics or NSAIDs if required; 
the second group took analgesics or NSAIDs only. Radiological 
examinations were performed during the study at the baseline, 
after 12 and 24 months. 
At the baseline the number of erosions in the two groups didn't 
differ significantly. The overall patient assessment demonstrated 
an increase of the number of joints with erosions in the following 2 
years. This increase was significant in both the groups, in the first 
one with p<0.02 and group 2 with p<0.001. However, after I year 
the radiological joint count didn't show any significant difference 
between the two groups. A significant difference between the two 
groups (p<0.01) was present at the end of the study, after 
twenty-four months of therapy. 
In this study, taking 800 mg of Chondroitin 4&6 Sulphate plus 
NSAIDs was associated in patients with erosive osteoarthritis of 
the hands with a lesser progression of erosions at twenty-four 
months versus patients taking NSAIDs only. However, the number 
of affected joints was signilicantly increased in all the patients 
respect to baseline. 
FR057 
POSSIBLE ROLE OF MRI AS AN INDICATOR OF DISEASE 
PROGRESSION AND SEVERITY OF OSTEOARTHRITIS OF 
THE KNEE 
T. Sasho, Y. Wada, K. Fujita, K. Takahashi, S. Sano, R. Koh and 
H. Moriya 
Department of Orthopaedic Surgery, Chiba University School of 
Medicine, Chiba, Japan 
Introduction: X-ray grading system for the osteoarthritis of the 
knee is a standard and widely used method for the evaluation of 
the disease progression. It has been said that the clinical severity 
of osteoarthritis correlates well to x-ray grading, but on the other 
hand, we often experience the discrepancy between disability or 
complaints of patients and x-ray findings. In that sense, x-ray 
gradings might be the indicator of the disease progression, but we 
cannot relay much upon it when we estimate the patients. In the 
present paper we report the strong correlation between the MRI 
findings and clinical severity of osteoarthritis of the knee. 
Methods :  Forty-six medial-type osteoarthritic knees were 
examined either with x-ray and MRI. Their clinical status were 
evaluated on a 0-100 knee score system composed of walking 
ability, stairway walking, range of motion, and hydrops. First, 
patients were divided into four groups according to the Kellgren 
and Lawrence x-ray grading (K/L grading) and evaluated with knee 
score. Second, MRI findings of each patients group were exam- 
ined to find what kind of MRI findings were frequently observed in 
each group. Computer image analysis was used for examining the 
thickness of the contour of femoral condyle. Third, we again 
divided the patients into four groups according to the MRI findings 
and their knee scores were examined. 
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Results: Low intensity lesion (LI) was frequently observed 
in proton-weighed sagittal MRI as the x-ray grading went up. 
Multi-granular lesion adjacent to the subchondral bone (MG) was 
observed in 50% of the grade III patients in K/G grading and 65% 
of grade IV. Thinner and irregular contour of femoral condyle (TC) 
was observed in 83% of the patients in grade III and 55% in grade 
IV. We consider these three findings could be the indicator of 
severity of osteoarthritis, and we divided the patients into four 
groups according to the MRI findings. Group 1 had no findings out 
of these three findings, group 2 had only LI lesion, group 3 had LI 
lesion either with MG or TC, and group 4 had all three findings. 
Knee score of these four groups were examined and found to 
be much more clearly different in each group with statistical 
significance than that of based upon K/L grading. 
Discussion and conclusion: We showed that MRI is more 
highly reliable in evaluating the status of osteoarthritis of the knee 
than x-ray examinations. We presumed that not cartilage but 
pathological status of bone marrow and subchondral bone 
determined the severity of the disease. LI, MG and TC lesion found 
in MRI were considered to be the results of severely pathological 
status of bone marrow and subchondral bone. 
level. Comparisons were also made with respect to the principal 
component scores. No clear differences emerged. A comparison 
was made between those with lone medial pain (n=7) and those 
with combined medial pain (n= 11). Again, no apparent differences 
emerged. 
Conclusions: This study demonstrated variability in the location 
of knee pain associated with OA. The locations recorded are 
concordant with those of the study by Creamer et al., par- 
ticularly the presence of pain in an inferomedial location. No clear 
differences in pain type emerged (other than severity of WOMAC 
scores) but this is not unexpected given the sample size. It is 
possible that these patients had conditions that would not develop 
into radiographically evident knee OA, accounting for some of the 
variability in location. A clear definition of OA in primary care is 
therefore desirable. 
References: A/tman R. D. The classification of osteoarthritis. 
J Rheumatol 1995; 22(1): 42-43; Creamer P, et al. Where does it 
hurt? Pain localization in OA of the knee. Osteoarthritis Cart 1998; 
6:318-323. 
FR058 
PATTERNS OF OSTEOARTHRITIC KNEE PAIN IN PRIMARY 
CARE--A PILOT STUDY 
L. Shepstone, M. Koutantji, C. Hand 
Musculo-skeletal Research Group, School of Health Policy and 
Practice, University of East Anglia, UK 
Aim: A pilot study to provide preliminary information on locations 
of pain associated with osteoarthritis (OA) of the knee in patients 
presenting to their general practitioner. 
Introduction: The primary symptom of OA, and the usua~ reason 
for a sufferer to seek care, is the presence of pain. However, the 
pain associated with osteoarthritis remains an enigma. The cause 
of the pain (in particular the originating tissues) is unknown and, 
given the heterogeneous nature of the condition, is likely to vary 
greatly between individuals. The need for classification of pain 
types has been highlighted (Airman, 1996). There have been 
several studies investigating the location of pain (e.g. Creamer 
et aL, 1998) using patients in secondary care. Since it is desirable 
to target interventions at an early stage knowledge of pain types in 
patients in primary care is desirable. It is also likely that pain types 
will be most distinct at this stage and may differ from those in 
secondary care, 
Methods: Six general practices in Norfolk and Suffolk, UK, took 
part. Knee OA was defined using criteria similar to the ACR 
non-radiologic riteria. Patients included had to have: pain present 
for most days of last month; age greater than 45; no hip or back 
pain; no history of RA; no recent trauma; no definite diagnosis 
other than OA. Pain location was recorded using diagrams similar 
to those used by Creamer et aL McGill Pain and WOMAC 
questionnaires were completed. Multidimensional scaling (MDS) 
was used to seek patterns of pain quality from the McGill 
responses. A principal components analysis (PCA) was carried out 
on the pain and function dimensions of the WOMAC. Statistical 
analyses were exploratory aimed at identifying potential patterns 
and location differences to be investigated in a future study. 
Results: 28 patients were included. The following pain locations 
were recorded: lone medial, 7; medial and lateral, 7; medial and 
inferior to patella, 4; anterior, 5; superior to patella, 2; lone inferior, 
1 ; non-specific, 2. No pattern of pain quality emerged from the MDs 
with regard to McGill response. The WOMAC scores were com- 
pared between those with medial pain (n=18) and the remainder 
(n= 10). The medial group had greater pain scores (mean diff: 9.8, 
95% C.I.: -0.8 to 20.2) and worse function scores (mean diff.: 10.5, 
95% C.I.: 1.8 to 19.2), the latter difference significant at the 5% 
FR059 
RADIOGRAPHIC QUALITY ASSURANCE: RESULTS IN A 
MULTICENTER STUDY 
M. Sieffert, M. Kothat" i, G. yon Ingersteben, [3. Lissin, 
J. Li, Y. Miaux, R. M. Stevens*, C. Peterfy 
Synarc, Inc., San Francisco, USA; *Hoffman La Roche, Inc., 
Nutley, New Jersey, USA 
Quality assurance of radiographs is required in multicenter studies 
of osteoarthritis in order to ensure that the images are of sufficient 
quality for accurate and precise quantification and grading. The 
criteria for acceptance/rejection of an image depends on the 
quantitative and grading techniques being used. A priori informa- 
tion regarding radiograph rejection rates for different techniques 
can be useful in the design of studies. The aim of this abstract is to 
describe the quality assurance rates for a large, multicenter study 
of osteoarthritis. 
Methods: Knee images of 2032 osteoarthritic patients (1321 
women: 62 yr.±9 yr.; 711 men: 63 yr.±9 yr.) were acquired at 
baseline. A subset of 457 patients with similar age distribution were 
also imaged at 6 months; a subset of 167 out of the 457 were 
further imaged around 1 year from the baseline. The imaging was 
performed at 58 different centers in the US. At each center, both 
knees were imaged on separate films using posteroanterior, weight 
bearing, fixed-flexion on-fluoroscopic radiography with 10 ° beam 
angulation. Hand radiographs were also obt&ined of both hands at 
the same timepoints. The knee radiographs were graded for joint 
space narrowing and osteophytes, and were also used for 
computer-assisted measurements of joint space width. The hand 
radiographs were graded for proximal interphalangeal and 
trapeziometacarpal joint space narrowing, as well as distal inter- 
phalangeal joint malalignment. Quality assurance criteria focused 
on image exposure and resolution, delineation of the articular 
cortices, anatomical projection, and stability of these projectional 
relationships on serially acquired images. 
Results: Figure 1 shows the distribution of overall rejection rates 
by site for knee radiographs. A similar, right-skewed distribution 
was seen for the hand radiographs--from 0% to 33.3%. The 
average rejection rate over the duration of the study was 9.5% for 
the knees and 4.4% for the hands. The rate of rejection for knees 
decreased from 9.7% to 9.9% to 6.6% over the three visits. Taking 
a sample of the worst 10% of the sites, the rejection rate for knees 
decreased from 22.5% to 21.8% to 6.7%. 
Conclusions: The data reveals that there was a wide disparity 
between different sites with regards to the quality of data. The 
primary reason for rejection of both hand and knee radiographs 
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was improper positioning. The rate of rejection decreased during 
the course of the study with the greatest improvement being 
amongst the worst performing sites. These results support the 
value of quality assurance and site management in multicenter 
clinical trials. 
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Figure 1. Histogram of.rejection rate vs. number of sites. 
FRO60 
EVIDENCE OF A BIOLOGICAL EFFECT OF CHONDROITIN 
SULFATE 4 & 6 [ACS 4-6] (STRUCTUM TM) IN KNEE 
OSTEOARTHRITIS (OA), ANALYSIS OF OA MARKERS IN 
SYNOVIAL FLUID 
Pierre Mathieu*, Thierry Conrozier*, Muriel Grynfelttl, 
Michel Richard', Henri Cousse:l:, Eric Vignon* 
*Claude Bernard University (Lyon, France) and ~rlnstitut de 
Recherche Pierre Fabre (Labege, France) 
Rationale: ACS 4-6 has been proven to be an effective treat- 
ment of knee OA. Its mechanism of action remains to be 
determined. 
Aim: To investigate whether ACS 4-6 induces biological 
variations in synovial fluid (SF) of OA knees, when administered 
orally over a three month period. 
Material and methods: 18 patients with knee OA (ACR criteria 
and KL II or Ill) and joint effusion were included in a 3 month 
double-blind controlled study comparing ACS 4-6 (1 g daily) and 
placebo. SF was collected at DO, D28 and D91 and stored at 
-80°C. All samples were assayed at the end of the study for 
markers of inflammation (PGE2, PLA2, protein concentration, 
hyalurenic acid [HA], YKL-40), collagen turn-over (PlCP, 
MMP 1-protein, cross-laps, hydroxyprolin), metalloproteases (colla- 
genase, stromelysin, gelatinase), osidases (glucuronidase, 
N-acetyl-galactosaminidase, N-acetyl-glucosaminidase), GAG, 
chondroitinase, hyaluronidase, TIMP-1 and COMP. 
Results.: Chondroitinase activity was found to be significantly 
decreased at D91 in the ACS 4-6 group (p=0.05} while P1CP and 
MMP1 protein increased in the treated patients (p=0.01 and 0.03), 
No difference between ACS 4--6 and placebo was shown for the 
other markers. Significant correlations were found between PLA2 
and PGE2 (r=0.53), MMP1 and TIMP-1 (r=0.49), PlCP and 
MMP-lprotein (r=0.74), YKL-40 and protein concentration 
(r=0.65), chondroitinase and N-acetyl-galactosaminidase 
(r=0.80), HA and protein concentration (r=0.61). 
Conclusion: This study suggest that ACS 4-6, administered 
orally over 3 months, is able to modify joint metabolism. Its 
mechanism of action may be related to chondroitinase inhibition 
and collagen turn-over stimulation. 
FR061 
MEASUREMENT OF THE OSTEOARTHRITIC HIP JOINT 
SPACE (JS) WIDTH. AN EVALUATION OF VARIOUS 
METHODS 
T. Conrozier, M. Lequesne, H. Favret, A. Taccoen, E. Vignon 
Claude Bernard University, Lyon, France 
Objective: To compare measurement of minimum interbone 
width (MI), mean width of the whole JS (MWl) and mean width of 
a region of interest of the JS, delimited in a 10 ° angle (MW2). 
MW1, MW2 were measured using an image analysis system. MI 
was measured both with the computer (MIc) and with a 0.1 mm 
graduated eyepiece (MIg). 
A totat of 70 hips, 55 hip osteoarthritis (OA) and 15 normal hips, 
originating from 36 patients of the ECHODIAH study was used. 
Repetitive measurement were obtained in 64 hips which have 
been radiographed yearly over a 3 year follow up. 
Mean value+_SD of Mic, MIg, MW2 and MW1 was 2.4±0.9, 
2.6_+1.2, 2.6_+1.2, 2.6_+0.9 and 3.3+0.9 mm, respectively. MIg and 
MIc were highly correlated (R2=0.81). MIg was significantly larger 
than MIc (0.18+0.63 mm, p<0.001), but difference between MIg 
and MIc varied according to topography of JSN. The intraobserver 
intraclass coefficient of correlation of MIc and MW2 was 0.98 and 
0.94. The mean difference first film- last film was 0.43_+0.53, 
0.45±0.65, 0.46±0.63 mm and 0.49-+0.73 for MIc, MIg, MW2 and 
MWl, respectively (p<0.05 for each). Standardized response 
mean for MWl, MIg, MW2 and MIc was 0.66, 0.70, 0.72 and 0.80, 
respectively. Superiority of MIc, in term of sensitivity to change, 
was mainly attributable to hips showing a supero-medial or 
superior JSN topography. 
Conclusion: Minimum interbone distance measured with a 
computer assisted method is suggested as a suitable method for 
the evaluation of hip OA progression. 
FR062 
THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE 
WITH HYLAN G-F20 IN ORTHOPAEDIC PRACTICE 
C. Weiss, W. Tillero 
Mount Sinai Medical Center, Miami Beach, USA 
Aim: To determine the efficacy and safety of intra-articular hylan 
G-F20 in patients with osteoarthritis of the knee in an orthopaedic 
practice. 
Methods: All patients treated with hylan G-F20 for osteoarthritis 
of the knee from 31/3/97 through 28/1/98 who were followed 
prospectively for 24 months. Patients were evaluated at 3, 6, 9, 12, 
18 and 24 months. Global pain scores were rated by patients on a 
ten-point scale at base line and at each evaluation. Efficacy and 
patient satisfaction was rated on a five-point sca~e by patients from 
much worse (1) to much better (5). Safety was evaluated by clinical 
evaluation of systemic and local symptoms. 93 patients (123 
knees) were studied (45 men and 48 women). The mean age was 
74_+10.6 years with an average duration of osteoarthritis of 8.6 
years. 71% of knees had Kellgren-Lawrence radiographic Grade 
IV arthritis in at least one compartment, 19% Grade III, 5% Grade 
II, 1% Grade I. 49% of knees had a history of effusion at baseline. 
All patients had failed counselling, exercise and analgesics. 85% 
had failed NSAID therapy, NSAIDS were contraindicated in 15%. 
66% of patients had failed steroid injections and 33% had failed 
arthroscopic debridement. 
Results: 10 patients were lost to follow-up, 21 underwent total 
knee arthroplasty, 33 required repeat treatment and 3 patients 
died, 56 were managed with a single course of treatment. With 
respect to overall patient satisfaction, 74% were better or much 
better at 3 months, 58% at 6 months, 46% at 12 months and 33% 
at 24 months. Early effectiveness was predictive of long term 
success with 61% and 40% of those who were better at 3 months 
being better at 12 and 24 months, 64% of those better at 12 
months remained better at 24 months. Of the knees with a history 
of effusion at baseline, 60% had decreased effusion volume, 23% 
had no change in the volume of effusion and 17% had an increase 
in effusion volume during the course of these twelve months. Of 
the knees with no history of effusion at baseline, 22% had an 
effusion at some time during the year and 5% of these had 
developed effusions >10 ml. 57% of these patients were rated 
better or much better at the end of the full year. 21 of a historically 
anticipated 45 knees underwent total knee arthroplasty. The 
highest incidence (30%) occurred in those patients with a history of 
effusion equal to or >20 ml at baseline. Of the remaining knees, 
only 14% required arthroplasty. 33 knees had a repeat course, 
average time to retreat was 11 months with a median time of 15 
months and 84% of these knees were better at 6 months and 78% 
at 12 months. There were no systemic adverse reactions or 
hospitalizations attributable to treatment with hylan G-F20.5 knees 
experienced local adverse events (increased pain, swelling and/or 
effusion). Four of these knees were treated with aspiration and 
intra articular corticosteroids, 3 of 33 knees had similar local 
adverse events on second course treatment. All knees recovered 
uneventfully with no permanent sequelae. 
Conclusions: Treatment with intra-articular hylan G-F20 was 
effective and safe in patients with advanced disease. There were 
fewer total knee arthroplasties in this population than would be 
anticipated based on historical controls during the 24 months of 
this study. 
FR063 
EFFICIENCY AND SAFETY OF SELECTIVE 
CYCLOOXYGENASE-2 (COX-2) INHIBITION (MELOXlCAM) 
THERAPY IN COMPARISON WITH DICLOFENAC IN 
OSTEOARTI-IRITIS 
M. Wisfowska 
Rheumatology Department, Central Clinical Hospital, 137 Wotoska 
St., Warsaw, Poland 
Selective COX-2 inhibition with Meloxicam (7.5mg) was as 
efficacious as Diclofenac (100 mg) but without serious gastro- 
intestinal adverse event compared with Diclofenac. 
Objective: The aim of this study was to compare the efficiency 
and safety of Meloxicam versus Diclofenac in patients with 
osteoarthritis. 
Methods: The data were based on a six-week clinical trial. A total 
of 60 patients with osteooarthritis of the knee were divided in two 
groups (1) treated with Diclofenac (100 mg daily) and (2) treated 
with Meloxicam (7.5mg daily). The WOMAC index, which 
measures 24 items related to pain, stiffness and functioning was 
administered at Baseline and Weeks 6. 
Results: Meloxicam therapy resulted in better results in compari- 
son with Diclofenac if we used the WOMAC index. For patients 
taking Meloxicam 2% we detected a minor gastrointestinal effect in 
contrast to 6% in the Diclofenac group. 
Conclusion: Inhibition of the COX-1 izoform of COX by NSAID, 
frequently gastrointestinal adverse event may occur, particularly, in 
the elderly ranging from mild abdominal pain to more serious 
ulcers, bleeding or perforation. The inhibition of COX-2 might be 
the cause of the antiinflammatory, analgetic and antypyretic effects 
on NSAID but without serious gastrointestinal adverse event. 
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FR064 
HYALURONIC ACID SERUM LEVELS IN PATIENTS WITH 
OSTEOARTHRITIS OF THE KNEE RECEIVING DIACEREIN 
THERAPY 
I. Yaron, I. Wigler, E. Shabtai, M. Yaron 
Ichilov Hospital, TeI-Aviv, Israel 
Objective: Correlate changes of hyaluronic acid (HA) serum 
levels and clinical response to diacerein therapy in patients with 
gonarthrosis. 
Methods: 21 patients (6 males and 15 females, age range 
50-80 years) with OA of the knee (ACR criteria) were started on 
diacerein 50-100 per day after a one week washout period from 
NSAIDs. At 0, 3, 6 and 12 weeks visits the following parameters 
were evaluated by a 10cm visual analog scale (VAS): pain, 
handicap, patient and investigator global assessment of response 
(not on visit 0). HA serum levels were evaluated by a radiometric 
assay. Statistical evaluation was by analysis of variance with 
repeated measures and Pearson correlation coefficient. 
Results: Pain and handicap decreased significantly along visits 
(p<0.003 and p<0.0001 respectively). However the improvement 
trend observed by patient and physician global assessment did not 
reach statistical significance. 
A correlation was found between a decrease in HA serum levels 
(visits 3--4) and VAS of pain (visits 2-3) and also with VAS 
handicap (visits 2-3), (R=0.384, p<0.086; R=0.447, p<0.0042, 
respectively). 
A correlation was also found between a decrease in HA serum 
levels (visits 3-4) and the improvement observed by patient and 
physician global assessment (visit 2-3) (R=0.651, p<0.01; 
R=0.549, p<0.08, respectively). HA serum levels started to 
decrease only after six weeks of therapy (at 12 week visit). 
Conclusions: HA serum levels in patients with OA of knee 
receiving diacerein decrease only after 6 weeks of therapy and this 
delayed effect correlates with observed clinical improvement. 
Longer studies are needed to establish the value of serum HA 
determination in OA patients receiving diacerein. 
FR065 
COMPLEMENTARY MEDICINES--ARE OUR OA PATIENTS 
SPENDING THEIR MONEY WISELY? 
J. Zochling*, L. March', H. Lapsleyl, K. Tribet, M. Cross1, 
R Brooks:l: 
*Institute of Bone and Joint Disease, University of Sydney, 
Australia; tUniversity of New South Wales, Sydney, Australia; 
~.University of Queensland, Australia 
Aims: The purchase of non-prescription medications was 
evaluated among osteoarthritis (OA) patients. 
Methods: Between 1994 and 1999 two cohorts of OA subjects 
were recruited. A random sample from the community with self- 
reported OA (non-surgical; n=118) and one who were undergoing 
total hip or knee joint replacement surgery for OA (surgical; 
n=399). All completed 3 month retrospective cost diaries about 
out-of-pocket expenses related to their OA as well as the WOMAC 
measure of health status. 
Results: Overall 70% of the study population (73% non-surgical 
and 69% surgical) were taking non-prescription preparations for 
their arthritis. Females (62%) were more likely than males (44%) to 
take such medications, with no significant differences in types of 
medications between groups, The group of subjects who were 
taking 'complementary' preparations were younger (mean age 65 
years vs 69 years, p<0.001). This difference in age was not seen 
$88 
for simple analgesics such as paracetamol, NSAIDs or aspirin- 
based medications. Topical therapies, including tea tree or goanna 
oil, sports rubs and bath salts were used by 53%. Forty-ooe 
percent were taking vitamin or mineral supplements or herbal 
preparations including ginseng, evening primrose oil, celery 
extract, garlic and horseradish. Fish oils were used by 14%. 
Pain and functional state were significantly better in those patients 
taking simple analgesics compared with those not taking analge- 
sics (9.19 vs 10.06, p=0.045, and 31.74 vs 36.32, p=0.003 
respectively), but did not differ with respect to 'complementary' 
preparations. 
The mean estimated out-of-pocket annual expense for the non- 
surgical group was A$157.48, and for the surgical group was 
A$181.32. The estimated average cost of non-prescription simple 
analgesics was A$63.00, whereas 'complementary' medications 
cost $192.68 per head per year. 
Conclusions: The vast majority of OA subjects spend money on 
non-prescription medications. Those paying for analgesics had 
better WOMAC scor~s, while those buying 'complementary' 
medications had no apparent gain despite a trebling of out-of- 
pocket expense. 
